Background  ||| S:24 E:43 ||| NNP
Rab  ||| S:43 E:47 ||| NNP
proteins  ||| S:47 E:56 ||| NNS
comprise  ||| S:56 E:65 ||| VBP
a  ||| S:65 E:67 ||| DT
large  ||| S:67 E:73 ||| JJ
family  ||| S:73 E:80 ||| NN
of  ||| S:80 E:83 ||| IN
Ras-related  ||| S:83 E:103 ||| JJ
GTPases  ||| S:103 E:111 ||| NN
that  ||| S:111 E:116 ||| IN
function  ||| S:116 E:125 ||| NN
in  ||| S:125 E:128 ||| IN
the  ||| S:128 E:132 ||| DT
anterograde  ||| S:132 E:144 ||| NN
and  ||| S:144 E:148 ||| CC
retrograde  ||| S:148 E:167 ||| JJ
trafficking  ||| S:167 E:179 ||| NN
of  ||| S:179 E:182 ||| IN
proteins  ||| S:182 E:191 ||| NNS
in  ||| S:191 E:194 ||| IN
mammalian  ||| S:194 E:204 ||| JJ
cells  ||| S:204 E:210 ||| NNS
[  ||| S:210 E:212 ||| -LRB-
1  ||| S:212 E:214 ||| CD
2  ||| S:214 E:216 ||| CD
3  ||| S:216 E:218 ||| CD
]  ||| S:218 E:220 ||| -RRB-
.  ||| S:220 E:230 ||| .
Different  ||| S:230 E:240 ||| JJ
Rab  ||| S:240 E:244 ||| NNP
proteins  ||| S:244 E:253 ||| VBZ
reside  ||| S:253 E:260 ||| VBN
in  ||| S:260 E:263 ||| IN
specific  ||| S:263 E:272 ||| JJ
subcellular  ||| S:272 E:292 ||| JJ
membranes  ||| S:292 E:302 ||| NN
or  ||| S:302 E:305 ||| CC
organelles ||| S:305 E:315 ||| NN
,  ||| S:315 E:317 ||| ,
where  ||| S:317 E:323 ||| WRB
they  ||| S:323 E:328 ||| PRP
mediate  ||| S:328 E:336 ||| VBP
vesicular  ||| S:336 E:354 ||| JJ
transport  ||| S:354 E:364 ||| NN
between  ||| S:364 E:372 ||| IN
discrete  ||| S:372 E:381 ||| JJ
donor  ||| S:381 E:387 ||| NN
and  ||| S:387 E:391 ||| CC
acceptor  ||| S:391 E:400 ||| JJ
compartments  ||| S:400 E:421 ||| NN
in  ||| S:421 E:424 ||| IN
the  ||| S:424 E:428 ||| DT
endocytic  ||| S:428 E:438 ||| NN
or  ||| S:438 E:441 ||| CC
exocytic  ||| S:441 E:450 ||| JJ
pathways  ||| S:450 E:459 ||| NNS
[  ||| S:459 E:461 ||| -LRB-
4  ||| S:461 E:463 ||| CD
5  ||| S:463 E:465 ||| CD
]  ||| S:465 E:467 ||| -RRB-
.  ||| S:467 E:469 ||| .
Detailed  ||| S:469 E:486 ||| JJ
studies  ||| S:486 E:494 ||| NNS
of  ||| S:494 E:497 ||| IN
a  ||| S:497 E:499 ||| DT
few  ||| S:499 E:503 ||| JJ
Rab  ||| S:503 E:507 ||| JJ
proteins  ||| S:507 E:516 ||| NNS
(  ||| S:516 E:527 ||| -LRB-
e.g  ||| S:527 E:531 ||| NNP
. ||| S:531 E:532 ||| .
;  ||| S:532 E:534 ||| :
Rab1 ||| S:534 E:538 ||| CD
,  ||| S:538 E:540 ||| ,
Rab5  ||| S:540 E:545 ||| NNP
and  ||| S:545 E:549 ||| CC
Rab9 ||| S:549 E:553 ||| CD
)  ||| S:553 E:555 ||| -RRB-
have  ||| S:555 E:560 ||| VBP
led  ||| S:560 E:572 ||| VBN
to  ||| S:572 E:575 ||| TO
a  ||| S:575 E:577 ||| DT
general  ||| S:577 E:585 ||| JJ
model  ||| S:585 E:591 ||| NN
wherein  ||| S:591 E:599 ||| VBZ
Rab  ||| S:599 E:603 ||| JJ
proteins  ||| S:603 E:612 ||| NNS
are  ||| S:612 E:616 ||| VBP
presumed  ||| S:616 E:625 ||| VBN
to  ||| S:625 E:636 ||| TO
cycle  ||| S:636 E:642 ||| NN
on  ||| S:642 E:645 ||| IN
and  ||| S:645 E:649 ||| CC
off  ||| S:649 E:653 ||| JJ
donor  ||| S:653 E:659 ||| NN
and  ||| S:659 E:663 ||| CC
acceptor  ||| S:663 E:672 ||| JJ
membranes  ||| S:672 E:682 ||| NN
in  ||| S:682 E:685 ||| IN
connection  ||| S:685 E:704 ||| NN
with  ||| S:704 E:709 ||| IN
changes  ||| S:709 E:717 ||| NNS
in  ||| S:717 E:720 ||| IN
their  ||| S:720 E:726 ||| PRP$
guanine  ||| S:726 E:734 ||| JJ
nucleotide  ||| S:734 E:745 ||| JJ
state  ||| S:745 E:751 ||| NN
[  ||| S:751 E:753 ||| -LRB-
6  ||| S:753 E:755 ||| CD
7  ||| S:755 E:757 ||| CD
8  ||| S:757 E:759 ||| CD
]  ||| S:759 E:761 ||| -RRB-
.  ||| S:761 E:771 ||| .
In  ||| S:771 E:774 ||| IN
the  ||| S:774 E:778 ||| DT
active  ||| S:778 E:785 ||| JJ
GTP-bound  ||| S:785 E:795 ||| JJ
state ||| S:795 E:800 ||| NN
,  ||| S:800 E:802 ||| ,
Rab  ||| S:802 E:806 ||| NNP
proteins  ||| S:806 E:815 ||| NNS
associate  ||| S:815 E:825 ||| VBP
with  ||| S:825 E:838 ||| IN
budding  ||| S:838 E:846 ||| VBG
transport  ||| S:846 E:856 ||| NN
vesicles  ||| S:856 E:865 ||| NNS
[  ||| S:865 E:867 ||| -LRB-
9  ||| S:867 E:869 ||| CD
10  ||| S:869 E:872 ||| CD
11  ||| S:872 E:875 ||| CD
]  ||| S:875 E:877 ||| -RRB-
and  ||| S:877 E:881 ||| CC
appear  ||| S:881 E:888 ||| VB
to  ||| S:888 E:899 ||| TO
participate  ||| S:899 E:911 ||| VB
in  ||| S:911 E:914 ||| IN
the  ||| S:914 E:918 ||| DT
assembly  ||| S:918 E:927 ||| NN
of  ||| S:927 E:930 ||| IN
membrane  ||| S:930 E:939 ||| JJ
docking  ||| S:939 E:947 ||| JJ
complexes  ||| S:947 E:957 ||| NNS
[  ||| S:957 E:967 ||| -LRB-
12  ||| S:967 E:970 ||| CD
13  ||| S:970 E:973 ||| CD
14  ||| S:973 E:976 ||| CD
]  ||| S:976 E:978 ||| -RRB-
.  ||| S:978 E:980 ||| .
Following  ||| S:980 E:990 ||| VBG
vesicle  ||| S:990 E:998 ||| JJ
fusion  ||| S:998 E:1005 ||| NN
with  ||| S:1005 E:1010 ||| IN
the  ||| S:1010 E:1014 ||| DT
acceptor  ||| S:1014 E:1031 ||| JJ
compartment  ||| S:1031 E:1043 ||| NN
and  ||| S:1043 E:1047 ||| CC
GTP  ||| S:1047 E:1051 ||| NNP
hydrolysis ||| S:1051 E:1061 ||| NN
,  ||| S:1061 E:1063 ||| ,
the  ||| S:1063 E:1067 ||| DT
inactive  ||| S:1067 E:1076 ||| JJ
GDP-bound  ||| S:1076 E:1086 ||| JJ
Rab  ||| S:1086 E:1098 ||| NNP
is  ||| S:1098 E:1101 ||| VBZ
extracted  ||| S:1101 E:1111 ||| VBN
from  ||| S:1111 E:1116 ||| IN
the  ||| S:1116 E:1120 ||| DT
membrane  ||| S:1120 E:1129 ||| NN
by  ||| S:1129 E:1132 ||| IN
a  ||| S:1132 E:1134 ||| DT
carrier  ||| S:1134 E:1142 ||| NN
protein  ||| S:1142 E:1150 ||| FW
termed  ||| S:1150 E:1165 ||| FW
guanine  ||| S:1165 E:1173 ||| FW
nucleotide  ||| S:1173 E:1184 ||| FW
dissociation  ||| S:1184 E:1197 ||| FW
inhibitor  ||| S:1197 E:1207 ||| FW
( ||| S:1207 E:1208 ||| -LRB-
GDI ||| S:1208 E:1211 ||| NNP
)  ||| S:1211 E:1213 ||| -RRB-
[  ||| S:1213 E:1215 ||| -LRB-
15  ||| S:1215 E:1218 ||| CD
16  ||| S:1218 E:1221 ||| CD
17  ||| S:1221 E:1232 ||| CD
]  ||| S:1232 E:1234 ||| -RRB-
.  ||| S:1234 E:1236 ||| .
The  ||| S:1236 E:1240 ||| DT
GTPase  ||| S:1240 E:1247 ||| NN
can  ||| S:1247 E:1251 ||| MD
then  ||| S:1251 E:1256 ||| RB
re-enter  ||| S:1256 E:1265 ||| VB
the  ||| S:1265 E:1269 ||| DT
transport  ||| S:1269 E:1279 ||| NN
cycle  ||| S:1279 E:1293 ||| NN
through  ||| S:1293 E:1301 ||| IN
nucleotide  ||| S:1301 E:1312 ||| JJ
exchange  ||| S:1312 E:1321 ||| NN
promoted  ||| S:1321 E:1330 ||| VBN
by  ||| S:1330 E:1333 ||| IN
a  ||| S:1333 E:1335 ||| DT
specific  ||| S:1335 E:1344 ||| JJ
exchange  ||| S:1344 E:1361 ||| NN
factor  ||| S:1361 E:1368 ||| NN
at  ||| S:1368 E:1371 ||| IN
the  ||| S:1371 E:1375 ||| DT
donor  ||| S:1375 E:1381 ||| FW
vesicle  ||| S:1381 E:1389 ||| FW
membrane  ||| S:1389 E:1398 ||| FW
[  ||| S:1398 E:1400 ||| -LRB-
18  ||| S:1400 E:1403 ||| CD
19  ||| S:1403 E:1406 ||| CD
20  ||| S:1406 E:1409 ||| CD
]  ||| S:1409 E:1411 ||| -RRB-
.  ||| S:1411 E:1413 ||| .
In  ||| S:1413 E:1424 ||| IN
addition  ||| S:1424 E:1433 ||| NN
to  ||| S:1433 E:1436 ||| TO
changes  ||| S:1436 E:1444 ||| NNS
in  ||| S:1444 E:1447 ||| IN
guanine  ||| S:1447 E:1455 ||| JJ
nucleotide  ||| S:1455 E:1466 ||| JJ
state ||| S:1466 E:1471 ||| NN
,  ||| S:1471 E:1473 ||| ,
the  ||| S:1473 E:1485 ||| DT
posttranslational  ||| S:1485 E:1503 ||| JJ
prenylation  ||| S:1503 E:1515 ||| NN
of  ||| S:1515 E:1518 ||| IN
Rab  ||| S:1518 E:1522 ||| NNP
proteins  ||| S:1522 E:1531 ||| NNS
plays  ||| S:1531 E:1537 ||| VBZ
an  ||| S:1537 E:1548 ||| DT
important  ||| S:1548 E:1558 ||| JJ
role  ||| S:1558 E:1563 ||| NN
in  ||| S:1563 E:1566 ||| IN
the  ||| S:1566 E:1570 ||| DT
cycling  ||| S:1570 E:1578 ||| NN
mechanism ||| S:1578 E:1587 ||| NN
.  ||| S:1587 E:1589 ||| .
Non-modified  ||| S:1589 E:1602 ||| NNP
Rabs  ||| S:1602 E:1615 ||| NNPS
have  ||| S:1615 E:1620 ||| VBP
a  ||| S:1620 E:1622 ||| DT
low  ||| S:1622 E:1626 ||| JJ
affinity  ||| S:1626 E:1635 ||| NN
for  ||| S:1635 E:1639 ||| IN
GDI  ||| S:1639 E:1643 ||| NNP
[  ||| S:1643 E:1645 ||| -LRB-
21  ||| S:1645 E:1648 ||| CD
17  ||| S:1648 E:1651 ||| CD
]  ||| S:1651 E:1653 ||| -RRB-
and  ||| S:1653 E:1657 ||| CC
do  ||| S:1657 E:1660 ||| VBP
not  ||| S:1660 E:1664 ||| RB
associate  ||| S:1664 E:1682 ||| VBP
effectively  ||| S:1682 E:1694 ||| RB
with  ||| S:1694 E:1699 ||| IN
membranes  ||| S:1699 E:1709 ||| NNS
[  ||| S:1709 E:1711 ||| -LRB-
22  ||| S:1711 E:1714 ||| CD
23  ||| S:1714 E:1717 ||| CD
]  ||| S:1717 E:1719 ||| -RRB-
.  ||| S:1719 E:1729 ||| .
Rab24 ||| S:1729 E:1734 ||| NNP
,  ||| S:1734 E:1736 ||| ,
originally  ||| S:1736 E:1747 ||| RB
identified  ||| S:1747 E:1758 ||| VBN
by  ||| S:1758 E:1761 ||| IN
Olkkonen  ||| S:1761 E:1779 ||| NNP
et  ||| S:1779 E:1782 ||| FW
al  ||| S:1782 E:1785 ||| FW
.  ||| S:1785 E:1787 ||| .
[  ||| S:1787 E:1789 ||| -LRB-
24  ||| S:1789 E:1792 ||| CD
]  ||| S:1792 E:1794 ||| -RRB-
,  ||| S:1794 E:1796 ||| ,
remains  ||| S:1796 E:1804 ||| VBZ
one  ||| S:1804 E:1808 ||| CD
of  ||| S:1808 E:1819 ||| IN
several  ||| S:1819 E:1827 ||| JJ
members  ||| S:1827 E:1835 ||| NNS
of  ||| S:1835 E:1838 ||| IN
the  ||| S:1838 E:1842 ||| DT
Rab  ||| S:1842 E:1846 ||| JJ
family  ||| S:1846 E:1853 ||| NN
without  ||| S:1853 E:1861 ||| IN
a  ||| S:1861 E:1863 ||| DT
confirmed  ||| S:1863 E:1881 ||| VBN
biological  ||| S:1881 E:1892 ||| JJ
function ||| S:1892 E:1900 ||| NN
.  ||| S:1900 E:1902 ||| .
We  ||| S:1902 E:1905 ||| PRP
have  ||| S:1905 E:1910 ||| VBP
described  ||| S:1910 E:1920 ||| VBN
several  ||| S:1920 E:1928 ||| JJ
unusual  ||| S:1928 E:1944 ||| JJ
features  ||| S:1944 E:1953 ||| NNS
of  ||| S:1953 E:1956 ||| IN
Rab24  ||| S:1956 E:1962 ||| CD
that  ||| S:1962 E:1967 ||| IN
distinguish  ||| S:1967 E:1979 ||| VBG
it  ||| S:1979 E:1982 ||| PRP
from  ||| S:1982 E:1987 ||| IN
all  ||| S:1987 E:1991 ||| DT
other  ||| S:1991 E:2005 ||| JJ
members  ||| S:2005 E:2013 ||| NNS
of  ||| S:2013 E:2016 ||| IN
the  ||| S:2016 E:2020 ||| DT
Rab  ||| S:2020 E:2024 ||| JJ
family  ||| S:2024 E:2031 ||| NN
studied  ||| S:2031 E:2039 ||| VBN
to  ||| S:2039 E:2042 ||| TO
date  ||| S:2042 E:2047 ||| VB
[  ||| S:2047 E:2049 ||| -LRB-
25  ||| S:2049 E:2052 ||| CD
]  ||| S:2052 E:2054 ||| -RRB-
.  ||| S:2054 E:2056 ||| .
Rab24  ||| S:2056 E:2070 ||| NNP
has  ||| S:2070 E:2074 ||| VBZ
a  ||| S:2074 E:2076 ||| DT
markedly  ||| S:2076 E:2085 ||| RB
reduced  ||| S:2085 E:2093 ||| VBN
GTPase  ||| S:2093 E:2100 ||| JJ
activity ||| S:2100 E:2108 ||| NN
,  ||| S:2108 E:2110 ||| ,
due  ||| S:2110 E:2114 ||| RB
primarily  ||| S:2114 E:2124 ||| RB
to  ||| S:2124 E:2135 ||| TO
the  ||| S:2135 E:2139 ||| DT
presence  ||| S:2139 E:2148 ||| NN
of  ||| S:2148 E:2151 ||| IN
a  ||| S:2151 E:2153 ||| DT
serine  ||| S:2153 E:2160 ||| JJ
residue  ||| S:2160 E:2168 ||| NN
instead  ||| S:2168 E:2176 ||| RB
of  ||| S:2176 E:2179 ||| IN
the  ||| S:2179 E:2183 ||| DT
usual  ||| S:2183 E:2197 ||| JJ
glutamine  ||| S:2197 E:2207 ||| NN
at  ||| S:2207 E:2210 ||| IN
the  ||| S:2210 E:2214 ||| DT
position  ||| S:2214 E:2223 ||| NN
equivalent  ||| S:2223 E:2234 ||| NN
to  ||| S:2234 E:2237 ||| TO
Q61  ||| S:2237 E:2241 ||| CD
in  ||| S:2241 E:2244 ||| IN
H-Ras ||| S:2244 E:2249 ||| JJ
.  ||| S:2249 E:2259 ||| .
Furthermore ||| S:2259 E:2270 ||| RB
,  ||| S:2270 E:2272 ||| ,
Rab24  ||| S:2272 E:2278 ||| NNP
is  ||| S:2278 E:2281 ||| VBZ
not  ||| S:2281 E:2285 ||| RB
efficiently  ||| S:2285 E:2297 ||| RB
geranylgeranylated  ||| S:2297 E:2324 ||| JJ
and  ||| S:2324 E:2328 ||| CC
does  ||| S:2328 E:2333 ||| VBZ
not  ||| S:2333 E:2337 ||| RB
form  ||| S:2337 E:2342 ||| VB
a  ||| S:2342 E:2344 ||| DT
detectable  ||| S:2344 E:2355 ||| JJ
complex  ||| S:2355 E:2363 ||| NN
with  ||| S:2363 E:2368 ||| IN
GDI ||| S:2368 E:2371 ||| NNP
.  ||| S:2371 E:2373 ||| .
These  ||| S:2373 E:2387 ||| DT
unique  ||| S:2387 E:2394 ||| JJ
properties  ||| S:2394 E:2405 ||| NNS
of  ||| S:2405 E:2408 ||| IN
Rab24  ||| S:2408 E:2414 ||| NNP
suggest  ||| S:2414 E:2422 ||| VBP
that  ||| S:2422 E:2427 ||| IN
it  ||| S:2427 E:2430 ||| PRP
may  ||| S:2430 E:2434 ||| MD
not  ||| S:2434 E:2438 ||| RB
function  ||| S:2438 E:2455 ||| VBP
according  ||| S:2455 E:2465 ||| VBG
to  ||| S:2465 E:2468 ||| TO
the  ||| S:2468 E:2472 ||| DT
accepted  ||| S:2472 E:2481 ||| JJ
cyclical  ||| S:2481 E:2490 ||| JJ
model ||| S:2490 E:2495 ||| NN
.  ||| S:2495 E:2505 ||| .
In  ||| S:2505 E:2508 ||| IN
the  ||| S:2508 E:2512 ||| DT
present  ||| S:2512 E:2520 ||| JJ
study  ||| S:2520 E:2526 ||| NN
we  ||| S:2526 E:2529 ||| PRP
set  ||| S:2529 E:2533 ||| VBD
out  ||| S:2533 E:2537 ||| RP
to  ||| S:2537 E:2540 ||| TO
learn  ||| S:2540 E:2546 ||| VB
about  ||| S:2546 E:2552 ||| IN
the  ||| S:2552 E:2564 ||| DT
biological  ||| S:2564 E:2575 ||| JJ
function  ||| S:2575 E:2584 ||| NN
of  ||| S:2584 E:2587 ||| IN
Rab24  ||| S:2587 E:2593 ||| CD
by  ||| S:2593 E:2596 ||| IN
using  ||| S:2596 E:2602 ||| VBG
a  ||| S:2602 E:2604 ||| DT
well-established  ||| S:2604 E:2629 ||| JJ
paradigm  ||| S:2629 E:2638 ||| NN
in  ||| S:2638 E:2641 ||| IN
which  ||| S:2641 E:2647 ||| WDT
a  ||| S:2647 E:2649 ||| DT
dominant-negative  ||| S:2649 E:2667 ||| JJ
Rab  ||| S:2667 E:2671 ||| JJ
construct  ||| S:2671 E:2681 ||| NN
is  ||| S:2681 E:2692 ||| VBZ
expressed  ||| S:2692 E:2702 ||| VBN
in  ||| S:2702 E:2705 ||| IN
cultured  ||| S:2705 E:2714 ||| JJ
cells ||| S:2714 E:2719 ||| NNS
,  ||| S:2719 E:2721 ||| ,
anticipating  ||| S:2721 E:2734 ||| VBG
that  ||| S:2734 E:2739 ||| IN
it  ||| S:2739 E:2742 ||| PRP
will  ||| S:2742 E:2755 ||| MD
suppress  ||| S:2755 E:2764 ||| VB
the  ||| S:2764 E:2768 ||| DT
trafficking  ||| S:2768 E:2780 ||| NN
step ||| S:2780 E:2784 ||| NN
( ||| S:2784 E:2785 ||| -LRB-
s ||| S:2785 E:2786 ||| LS
)  ||| S:2786 E:2788 ||| -RRB-
mediated  ||| S:2788 E:2797 ||| NN
by  ||| S:2797 E:2800 ||| IN
its  ||| S:2800 E:2804 ||| PRP$
endogenous  ||| S:2804 E:2823 ||| JJ
counterpart ||| S:2823 E:2834 ||| NN
.  ||| S:2834 E:2836 ||| .
Amino  ||| S:2836 E:2842 ||| JJ
acid  ||| S:2842 E:2847 ||| NN
substitutions  ||| S:2847 E:2861 ||| NN
at  ||| S:2861 E:2864 ||| IN
the  ||| S:2864 E:2868 ||| DT
position  ||| S:2868 E:2885 ||| NN
cognate  ||| S:2885 E:2893 ||| NN
to  ||| S:2893 E:2896 ||| TO
N116  ||| S:2896 E:2901 ||| CD
in  ||| S:2901 E:2904 ||| IN
H-Ras  ||| S:2904 E:2910 ||| JJ
typically  ||| S:2910 E:2920 ||| RB
yield  ||| S:2920 E:2926 ||| VB
soluble  ||| S:2926 E:2934 ||| JJ
Rab  ||| S:2934 E:2946 ||| JJ
proteins  ||| S:2946 E:2955 ||| NNS
that  ||| S:2955 E:2960 ||| WDT
have  ||| S:2960 E:2965 ||| VBP
a  ||| S:2965 E:2967 ||| DT
reduced  ||| S:2967 E:2975 ||| JJ
affinity  ||| S:2975 E:2984 ||| NN
for  ||| S:2984 E:2988 ||| IN
guanine  ||| S:2988 E:3004 ||| JJ
nucleotides ||| S:3004 E:3015 ||| NN
.  ||| S:3015 E:3017 ||| .
Such  ||| S:3017 E:3022 ||| JJ
constructs  ||| S:3022 E:3033 ||| NNS
have  ||| S:3033 E:3038 ||| VBP
been  ||| S:3038 E:3043 ||| VBN
used  ||| S:3043 E:3048 ||| VBN
successfully  ||| S:3048 E:3061 ||| RB
to  ||| S:3061 E:3072 ||| TO
define  ||| S:3072 E:3079 ||| VB
the  ||| S:3079 E:3083 ||| DT
functions  ||| S:3083 E:3093 ||| NNS
of  ||| S:3093 E:3096 ||| IN
Rab1A  ||| S:3096 E:3102 ||| NNP
and  ||| S:3102 E:3106 ||| CC
Rab1B  ||| S:3106 E:3112 ||| NNP
[  ||| S:3112 E:3114 ||| -LRB-
26  ||| S:3114 E:3117 ||| CD
27  ||| S:3117 E:3120 ||| CD
28  ||| S:3120 E:3123 ||| CD
]  ||| S:3123 E:3125 ||| -RRB-
,  ||| S:3125 E:3127 ||| ,
Rab4  ||| S:3127 E:3140 ||| NNP
[  ||| S:3140 E:3142 ||| -LRB-
29  ||| S:3142 E:3145 ||| CD
]  ||| S:3145 E:3147 ||| -RRB-
,  ||| S:3147 E:3149 ||| ,
Rab5  ||| S:3149 E:3154 ||| NNP
[  ||| S:3154 E:3156 ||| -LRB-
30  ||| S:3156 E:3159 ||| CD
31  ||| S:3159 E:3162 ||| CD
]  ||| S:3162 E:3164 ||| -RRB-
and  ||| S:3164 E:3168 ||| CC
Rab6  ||| S:3168 E:3173 ||| NNP
[  ||| S:3173 E:3175 ||| -LRB-
32  ||| S:3175 E:3178 ||| CD
]  ||| S:3178 E:3180 ||| -RRB-
.  ||| S:3180 E:3182 ||| .
Unexpectedly ||| S:3182 E:3194 ||| RB
,  ||| S:3194 E:3196 ||| ,
we  ||| S:3196 E:3207 ||| PRP
found  ||| S:3207 E:3213 ||| VBD
that  ||| S:3213 E:3218 ||| DT
expression  ||| S:3218 E:3229 ||| NN
of  ||| S:3229 E:3232 ||| IN
the  ||| S:3232 E:3236 ||| DT
mutant  ||| S:3236 E:3243 ||| JJ
forms  ||| S:3243 E:3249 ||| NNS
of  ||| S:3249 E:3252 ||| IN
Rab24  ||| S:3252 E:3258 ||| CD
in  ||| S:3258 E:3269 ||| IN
cultured  ||| S:3269 E:3278 ||| JJ
cells  ||| S:3278 E:3284 ||| NNS
resulted  ||| S:3284 E:3293 ||| VBD
in  ||| S:3293 E:3296 ||| IN
their  ||| S:3296 E:3302 ||| PRP$
accumulation  ||| S:3302 E:3315 ||| NN
in  ||| S:3315 E:3318 ||| IN
a  ||| S:3318 E:3320 ||| DT
striking  ||| S:3320 E:3337 ||| JJ
array  ||| S:3337 E:3343 ||| NN
of  ||| S:3343 E:3346 ||| IN
insoluble  ||| S:3346 E:3356 ||| JJ
intranuclear  ||| S:3356 E:3369 ||| JJ
inclusions  ||| S:3369 E:3380 ||| NN
which  ||| S:3380 E:3386 ||| WDT
disrupt  ||| S:3386 E:3402 ||| VBZ
the  ||| S:3402 E:3406 ||| DT
integrity  ||| S:3406 E:3416 ||| NN
of  ||| S:3416 E:3419 ||| IN
the  ||| S:3419 E:3423 ||| DT
nuclear  ||| S:3423 E:3431 ||| JJ
envelope ||| S:3431 E:3439 ||| NN
.  ||| S:3439 E:3463 ||| .
Results  ||| S:3463 E:3490 ||| NNS
Mutant  ||| S:3490 E:3497 ||| JJ
forms  ||| S:3497 E:3503 ||| NNS
of  ||| S:3503 E:3506 ||| IN
Rab24  ||| S:3506 E:3512 ||| CD
accumulate  ||| S:3512 E:3523 ||| NN
in  ||| S:3523 E:3526 ||| IN
nuclear  ||| S:3526 E:3544 ||| JJ
inclusions  ||| S:3544 E:3565 ||| NN
In  ||| S:3565 E:3568 ||| IN
all  ||| S:3568 E:3572 ||| DT
of  ||| S:3572 E:3575 ||| IN
the  ||| S:3575 E:3579 ||| DT
known  ||| S:3579 E:3585 ||| VBN
Ras-related  ||| S:3585 E:3597 ||| JJ
GTPases  ||| S:3597 E:3605 ||| JJ
the  ||| S:3605 E:3609 ||| DT
guanine  ||| S:3609 E:3627 ||| JJ
nucleotide  ||| S:3627 E:3638 ||| JJ
binding  ||| S:3638 E:3646 ||| JJ
site  ||| S:3646 E:3651 ||| NN
is  ||| S:3651 E:3654 ||| VBZ
surrounded  ||| S:3654 E:3665 ||| VBN
by  ||| S:3665 E:3668 ||| IN
a  ||| S:3668 E:3670 ||| DT
set  ||| S:3670 E:3674 ||| NN
of  ||| S:3674 E:3677 ||| IN
highly  ||| S:3677 E:3694 ||| RB
conserved  ||| S:3694 E:3704 ||| JJ
sequence  ||| S:3704 E:3713 ||| NN
elements  ||| S:3713 E:3722 ||| NNS
[  ||| S:3722 E:3724 ||| -LRB-
33  ||| S:3724 E:3727 ||| CD
34  ||| S:3727 E:3730 ||| CD
]  ||| S:3730 E:3732 ||| -RRB-
.  ||| S:3732 E:3734 ||| .
One  ||| S:3734 E:3738 ||| CD
of  ||| S:3738 E:3741 ||| IN
these  ||| S:3741 E:3757 ||| DT
elements ||| S:3757 E:3765 ||| NNS
,  ||| S:3765 E:3767 ||| ,
termed  ||| S:3767 E:3774 ||| VBD
the  ||| S:3774 E:3778 ||| DT
G2  ||| S:3778 E:3781 ||| JJ
motif ||| S:3781 E:3786 ||| NN
,  ||| S:3786 E:3788 ||| ,
consists  ||| S:3788 E:3797 ||| VBZ
of  ||| S:3797 E:3800 ||| IN
NKxD  ||| S:3800 E:3805 ||| NNP
( ||| S:3805 E:3806 ||| -LRB-
with  ||| S:3806 E:3811 ||| IN
the  ||| S:3811 E:3825 ||| DT
asparagine  ||| S:3825 E:3836 ||| NN
located  ||| S:3836 E:3844 ||| VBN
at  ||| S:3844 E:3847 ||| IN
position  ||| S:3847 E:3856 ||| NN
116  ||| S:3856 E:3860 ||| CD
in  ||| S:3860 E:3863 ||| IN
H-Ras ||| S:3863 E:3868 ||| NNP
) ||| S:3868 E:3869 ||| -RRB-
.  ||| S:3869 E:3871 ||| .
In  ||| S:3871 E:3874 ||| IN
Rab24 ||| S:3874 E:3879 ||| NNP
,  ||| S:3879 E:3891 ||| ,
and  ||| S:3891 E:3895 ||| CC
in  ||| S:3895 E:3898 ||| IN
some  ||| S:3898 E:3903 ||| DT
members  ||| S:3903 E:3911 ||| NNS
of  ||| S:3911 E:3914 ||| IN
the  ||| S:3914 E:3918 ||| DT
Rho  ||| S:3918 E:3922 ||| JJ
family ||| S:3922 E:3928 ||| NN
,  ||| S:3928 E:3930 ||| ,
threonine  ||| S:3930 E:3940 ||| NN
occurs  ||| S:3940 E:3957 ||| VBZ
instead  ||| S:3957 E:3965 ||| RB
of  ||| S:3965 E:3968 ||| IN
the  ||| S:3968 E:3972 ||| DT
asparagine ||| S:3972 E:3982 ||| NN
.  ||| S:3982 E:3984 ||| .
Amino  ||| S:3984 E:3990 ||| JJ
acid  ||| S:3990 E:3995 ||| NN
substitutions  ||| S:3995 E:4009 ||| NN
in  ||| S:4009 E:4022 ||| IN
the  ||| S:4022 E:4026 ||| DT
N ||| S:4026 E:4027 ||| NNP
( ||| S:4027 E:4028 ||| -LRB-
T ||| S:4028 E:4029 ||| NN
) ||| S:4029 E:4030 ||| -RRB-
KxD  ||| S:4030 E:4034 ||| JJ
motif  ||| S:4034 E:4040 ||| NNS
cause  ||| S:4040 E:4046 ||| VBP
a  ||| S:4046 E:4048 ||| DT
drastic  ||| S:4048 E:4056 ||| JJ
reduction  ||| S:4056 E:4066 ||| NN
in  ||| S:4066 E:4069 ||| IN
the  ||| S:4069 E:4083 ||| DT
affinity  ||| S:4083 E:4092 ||| NN
of  ||| S:4092 E:4095 ||| IN
Ras-related  ||| S:4095 E:4107 ||| JJ
GTPases  ||| S:4107 E:4115 ||| NN
for  ||| S:4115 E:4119 ||| IN
guanine  ||| S:4119 E:4127 ||| JJ
nucleotides  ||| S:4127 E:4139 ||| NNS
[  ||| S:4139 E:4151 ||| -LRB-
35  ||| S:4151 E:4154 ||| CD
36  ||| S:4154 E:4157 ||| CD
]  ||| S:4157 E:4159 ||| -RRB-
.  ||| S:4159 E:4161 ||| .
When  ||| S:4161 E:4166 ||| WRB
overexpressed  ||| S:4166 E:4180 ||| NNS
in  ||| S:4180 E:4183 ||| IN
cultured  ||| S:4183 E:4192 ||| JJ
cells ||| S:4192 E:4197 ||| NNS
,  ||| S:4197 E:4199 ||| ,
these  ||| S:4199 E:4215 ||| DT
mutant  ||| S:4215 E:4222 ||| JJ
GTPases  ||| S:4222 E:4230 ||| JJ
function  ||| S:4230 E:4239 ||| NN
as  ||| S:4239 E:4242 ||| IN
dominant-suppressors  ||| S:4242 E:4263 ||| JJ
of  ||| S:4263 E:4266 ||| IN
their  ||| S:4266 E:4282 ||| PRP$
endogenous  ||| S:4282 E:4293 ||| JJ
counterparts  ||| S:4293 E:4306 ||| NNS
[  ||| S:4306 E:4308 ||| -LRB-
26  ||| S:4308 E:4311 ||| CD
27  ||| S:4311 E:4314 ||| CD
31  ||| S:4314 E:4317 ||| CD
]  ||| S:4317 E:4319 ||| -RRB-
,  ||| S:4319 E:4321 ||| ,
presumably  ||| S:4321 E:4332 ||| RB
because  ||| S:4332 E:4350 ||| IN
they  ||| S:4350 E:4355 ||| PRP
can  ||| S:4355 E:4359 ||| MD
compete  ||| S:4359 E:4367 ||| VB
for  ||| S:4367 E:4371 ||| IN
interaction  ||| S:4371 E:4383 ||| NN
with  ||| S:4383 E:4388 ||| IN
effectors ||| S:4388 E:4397 ||| NN
,  ||| S:4397 E:4399 ||| ,
exchange  ||| S:4399 E:4418 ||| NN
factors  ||| S:4418 E:4426 ||| NNS
or  ||| S:4426 E:4429 ||| CC
docking  ||| S:4429 E:4437 ||| JJ
proteins ||| S:4437 E:4445 ||| NNS
,  ||| S:4445 E:4447 ||| ,
but  ||| S:4447 E:4451 ||| CC
cannot  ||| S:4451 E:4458 ||| JJ
cycle  ||| S:4458 E:4464 ||| NN
on  ||| S:4464 E:4467 ||| IN
and  ||| S:4467 E:4471 ||| CC
off  ||| S:4471 E:4485 ||| RB
membranes  ||| S:4485 E:4495 ||| VBN
in  ||| S:4495 E:4498 ||| IN
a  ||| S:4498 E:4500 ||| DT
nucleotide-dependent  ||| S:4500 E:4521 ||| JJ
manner ||| S:4521 E:4527 ||| NN
.  ||| S:4527 E:4529 ||| .
We  ||| S:4529 E:4532 ||| PRP
set  ||| S:4532 E:4536 ||| VBD
out  ||| S:4536 E:4540 ||| RP
to  ||| S:4540 E:4553 ||| TO
assess  ||| S:4553 E:4560 ||| VB
the  ||| S:4560 E:4564 ||| DT
function  ||| S:4564 E:4573 ||| NN
of  ||| S:4573 E:4576 ||| IN
Rab24  ||| S:4576 E:4582 ||| CD
by  ||| S:4582 E:4585 ||| IN
making  ||| S:4585 E:4592 ||| VBG
substitutions  ||| S:4592 E:4606 ||| NN
in  ||| S:4606 E:4619 ||| IN
its  ||| S:4619 E:4623 ||| PRP$
TKxD  ||| S:4623 E:4628 ||| JJ
motif ||| S:4628 E:4633 ||| NN
,  ||| S:4633 E:4635 ||| ,
starting  ||| S:4635 E:4644 ||| VBG
with  ||| S:4644 E:4649 ||| IN
D123--- ||| S:4649 E:4656 ||| CD
> ||| S:4656 E:4657 ||| CD
I ||| S:4657 E:4658 ||| NN
.  ||| S:4658 E:4660 ||| .
To  ||| S:4660 E:4663 ||| TO
facilitate  ||| S:4663 E:4684 ||| VB
localization  ||| S:4684 E:4697 ||| VBN
of  ||| S:4697 E:4700 ||| IN
the  ||| S:4700 E:4704 ||| DT
proteins ||| S:4704 E:4712 ||| NNS
,  ||| S:4712 E:4714 ||| ,
the  ||| S:4714 E:4718 ||| DT
wild-type  ||| S:4718 E:4728 ||| JJ
and  ||| S:4728 E:4732 ||| CC
mutant  ||| S:4732 E:4749 ||| JJ
constructs  ||| S:4749 E:4760 ||| NN
were  ||| S:4760 E:4765 ||| VBD
made  ||| S:4765 E:4770 ||| VBN
with  ||| S:4770 E:4775 ||| IN
a  ||| S:4775 E:4777 ||| DT
myc-epitope  ||| S:4777 E:4789 ||| JJ
tag  ||| S:4789 E:4793 ||| NN
at  ||| S:4793 E:4796 ||| IN
the  ||| S:4796 E:4800 ||| DT
amino  ||| S:4800 E:4816 ||| JJ
terminus ||| S:4816 E:4824 ||| NN
.  ||| S:4824 E:4826 ||| .
The  ||| S:4826 E:4830 ||| DT
addition  ||| S:4830 E:4839 ||| NN
of  ||| S:4839 E:4842 ||| IN
such  ||| S:4842 E:4847 ||| JJ
tag  ||| S:4847 E:4851 ||| NN
sequences  ||| S:4851 E:4861 ||| NN
to  ||| S:4861 E:4874 ||| TO
Ras-related  ||| S:4874 E:4886 ||| JJ
proteins ||| S:4886 E:4894 ||| NNS
,  ||| S:4894 E:4896 ||| ,
including  ||| S:4896 E:4906 ||| VBG
several  ||| S:4906 E:4914 ||| JJ
members  ||| S:4914 E:4922 ||| NNS
of  ||| S:4922 E:4925 ||| IN
the  ||| S:4925 E:4939 ||| DT
Rab  ||| S:4939 E:4943 ||| JJ
family ||| S:4943 E:4949 ||| NN
,  ||| S:4949 E:4951 ||| ,
does  ||| S:4951 E:4956 ||| VBZ
not  ||| S:4956 E:4960 ||| RB
appear  ||| S:4960 E:4967 ||| VB
to  ||| S:4967 E:4970 ||| TO
alter  ||| S:4970 E:4976 ||| VB
their  ||| S:4976 E:4982 ||| PRP$
function  ||| S:4982 E:4991 ||| NN
or  ||| S:4991 E:5004 ||| CC
subcellular  ||| S:5004 E:5016 ||| JJ
localization  ||| S:5016 E:5029 ||| NNS
[  ||| S:5029 E:5031 ||| -LRB-
36  ||| S:5031 E:5034 ||| CD
37  ||| S:5034 E:5037 ||| CD
38  ||| S:5037 E:5040 ||| CD
]  ||| S:5040 E:5042 ||| -RRB-
.  ||| S:5042 E:5054 ||| .
When  ||| S:5054 E:5059 ||| WRB
mycRab24 ||| S:5059 E:5067 ||| NNP
( ||| S:5067 E:5068 ||| -LRB-
wt ||| S:5068 E:5070 ||| LS
)  ||| S:5070 E:5072 ||| -RRB-
was  ||| S:5072 E:5076 ||| VBD
transiently  ||| S:5076 E:5088 ||| VBN
expressed  ||| S:5088 E:5098 ||| VBN
in  ||| S:5098 E:5101 ||| IN
293  ||| S:5101 E:5115 ||| CD
cells ||| S:5115 E:5120 ||| NNS
,  ||| S:5120 E:5122 ||| ,
immunofluorescence  ||| S:5122 E:5141 ||| JJ
microscopy  ||| S:5141 E:5152 ||| NN
revealed  ||| S:5152 E:5161 ||| VBD
a  ||| S:5161 E:5163 ||| DT
diffuse  ||| S:5163 E:5181 ||| JJ
reticular  ||| S:5181 E:5191 ||| JJ
distribution  ||| S:5191 E:5204 ||| NN
throughout  ||| S:5204 E:5215 ||| IN
the  ||| S:5215 E:5219 ||| DT
cytoplasm ||| S:5219 E:5228 ||| NN
,  ||| S:5228 E:5230 ||| ,
with  ||| S:5230 E:5235 ||| IN
a  ||| S:5235 E:5247 ||| DT
concentration  ||| S:5247 E:5261 ||| NN
in  ||| S:5261 E:5264 ||| IN
the  ||| S:5264 E:5268 ||| DT
perinuclear  ||| S:5268 E:5280 ||| JJ
region  ||| S:5280 E:5287 ||| NN
( ||| S:5287 E:5288 ||| -LRB-
Fig.  ||| S:5288 E:5293 ||| NNP
1A ||| S:5293 E:5295 ||| NNP
) ||| S:5295 E:5296 ||| -RRB-
.  ||| S:5296 E:5298 ||| .
In  ||| S:5298 E:5311 ||| IN
contrast ||| S:5311 E:5319 ||| NN
,  ||| S:5319 E:5321 ||| ,
when  ||| S:5321 E:5326 ||| WRB
the  ||| S:5326 E:5330 ||| DT
same  ||| S:5330 E:5335 ||| JJ
studies  ||| S:5335 E:5343 ||| NNS
were  ||| S:5343 E:5348 ||| VBD
performed  ||| S:5348 E:5358 ||| VBN
with  ||| S:5358 E:5363 ||| IN
cells  ||| S:5363 E:5379 ||| NNS
expressing  ||| S:5379 E:5390 ||| VBG
mycRab24 ||| S:5390 E:5398 ||| NNP
( ||| S:5398 E:5399 ||| -LRB-
D123I ||| S:5399 E:5404 ||| NNP
) ||| S:5404 E:5405 ||| -RRB-
,  ||| S:5405 E:5407 ||| ,
we  ||| S:5407 E:5410 ||| PRP
observed  ||| S:5410 E:5419 ||| VBD
a  ||| S:5419 E:5421 ||| DT
striking  ||| S:5421 E:5440 ||| JJ
accumulation  ||| S:5440 E:5453 ||| NN
of  ||| S:5453 E:5456 ||| IN
the  ||| S:5456 E:5460 ||| DT
mutant  ||| S:5460 E:5467 ||| JJ
protein  ||| S:5467 E:5475 ||| NN
in  ||| S:5475 E:5478 ||| IN
punctate  ||| S:5478 E:5487 ||| JJ
structures  ||| S:5487 E:5508 ||| NNS
localized  ||| S:5508 E:5518 ||| VBN
in  ||| S:5518 E:5521 ||| IN
both  ||| S:5521 E:5526 ||| DT
cytoplasmic  ||| S:5526 E:5538 ||| NN
and  ||| S:5538 E:5542 ||| CC
nuclear  ||| S:5542 E:5550 ||| JJ
compartments ||| S:5550 E:5562 ||| NN
.  ||| S:5562 E:5574 ||| .
In  ||| S:5574 E:5577 ||| IN
most  ||| S:5577 E:5582 ||| JJS
cells  ||| S:5582 E:5588 ||| NNS
the  ||| S:5588 E:5592 ||| DT
inclusions  ||| S:5592 E:5603 ||| NN
appeared  ||| S:5603 E:5612 ||| VBD
to  ||| S:5612 E:5615 ||| TO
be  ||| S:5615 E:5618 ||| VB
concentrated  ||| S:5618 E:5641 ||| VBN
predominantly  ||| S:5641 E:5655 ||| RB
within  ||| S:5655 E:5662 ||| IN
the  ||| S:5662 E:5666 ||| DT
nucleus  ||| S:5666 E:5674 ||| NN
( ||| S:5674 E:5675 ||| -LRB-
Fig.  ||| S:5675 E:5680 ||| NNP
1A ||| S:5680 E:5682 ||| NNP
) ||| S:5682 E:5683 ||| -RRB-
.  ||| S:5683 E:5685 ||| .
Identical  ||| S:5685 E:5705 ||| JJ
structures  ||| S:5705 E:5716 ||| NNS
were  ||| S:5716 E:5721 ||| VBD
seen  ||| S:5721 E:5726 ||| VBN
when  ||| S:5726 E:5731 ||| WRB
immunofluorescence  ||| S:5731 E:5750 ||| JJ
microscopy  ||| S:5750 E:5771 ||| NN
was  ||| S:5771 E:5775 ||| VBD
performed  ||| S:5775 E:5785 ||| VBN
with  ||| S:5785 E:5790 ||| IN
antibodies  ||| S:5790 E:5801 ||| NNS
against  ||| S:5801 E:5809 ||| IN
the  ||| S:5809 E:5813 ||| DT
N-terminal  ||| S:5813 E:5824 ||| JJ
myc  ||| S:5824 E:5838 ||| JJ
epitope  ||| S:5838 E:5846 ||| NN
or  ||| S:5846 E:5849 ||| CC
the  ||| S:5849 E:5853 ||| DT
C-terminal  ||| S:5853 E:5864 ||| JJ
hypervariable  ||| S:5864 E:5878 ||| JJ
domain  ||| S:5878 E:5885 ||| NN
of  ||| S:5885 E:5888 ||| IN
Rab24 ||| S:5888 E:5893 ||| NNP
,  ||| S:5893 E:5905 ||| ,
indicating  ||| S:5905 E:5916 ||| VBG
that  ||| S:5916 E:5921 ||| IN
the  ||| S:5921 E:5925 ||| DT
immunofluorescence  ||| S:5925 E:5944 ||| JJ
pattern  ||| S:5944 E:5952 ||| NN
reflected  ||| S:5952 E:5972 ||| VBD
the  ||| S:5972 E:5976 ||| DT
localization  ||| S:5976 E:5989 ||| NN
of  ||| S:5989 E:5992 ||| IN
full-length  ||| S:5992 E:6004 ||| JJ
mycRab24 ||| S:6004 E:6012 ||| NNP
( ||| S:6012 E:6013 ||| -LRB-
D123I ||| S:6013 E:6018 ||| NNP
) ||| S:6018 E:6019 ||| -RRB-
.  ||| S:6019 E:6021 ||| .
Finally ||| S:6021 E:6028 ||| RB
,  ||| S:6028 E:6040 ||| ,
the  ||| S:6040 E:6044 ||| DT
localization  ||| S:6044 E:6057 ||| JJ
pattern  ||| S:6057 E:6065 ||| NN
of  ||| S:6065 E:6068 ||| IN
Rab24 ||| S:6068 E:6073 ||| NNP
( ||| S:6073 E:6074 ||| -LRB-
D123I ||| S:6074 E:6079 ||| NNP
)  ||| S:6079 E:6081 ||| -RRB-
remained  ||| S:6081 E:6090 ||| VBD
the  ||| S:6090 E:6104 ||| DT
same  ||| S:6104 E:6109 ||| JJ
when  ||| S:6109 E:6114 ||| WRB
the  ||| S:6114 E:6118 ||| DT
protein  ||| S:6118 E:6126 ||| NN
was  ||| S:6126 E:6130 ||| VBD
expressed  ||| S:6130 E:6140 ||| VBN
without  ||| S:6140 E:6148 ||| IN
the  ||| S:6148 E:6152 ||| DT
myc  ||| S:6152 E:6156 ||| JJ
tag  ||| S:6156 E:6170 ||| NN
( ||| S:6170 E:6171 ||| -LRB-
Fig.  ||| S:6171 E:6176 ||| NNP
1B ||| S:6176 E:6178 ||| NNP
) ||| S:6178 E:6179 ||| -RRB-
.  ||| S:6179 E:6191 ||| .
Western  ||| S:6191 E:6199 ||| JJ
blot  ||| S:6199 E:6204 ||| JJ
analyses  ||| S:6204 E:6213 ||| NNS
of  ||| S:6213 E:6216 ||| IN
cytosol  ||| S:6216 E:6224 ||| NN
and  ||| S:6224 E:6228 ||| CC
particulate  ||| S:6228 E:6250 ||| JJ
fractions  ||| S:6250 E:6260 ||| NNS
obtained  ||| S:6260 E:6269 ||| VBN
from  ||| S:6269 E:6274 ||| IN
the  ||| S:6274 E:6278 ||| DT
transfected  ||| S:6278 E:6290 ||| JJ
293  ||| S:6290 E:6294 ||| CD
cells  ||| S:6294 E:6310 ||| NNS
indicated  ||| S:6310 E:6320 ||| VBD
that  ||| S:6320 E:6325 ||| IN
mycRab24 ||| S:6325 E:6333 ||| NNP
( ||| S:6333 E:6334 ||| -LRB-
wt ||| S:6334 E:6336 ||| LS
)  ||| S:6336 E:6338 ||| -RRB-
was  ||| S:6338 E:6342 ||| VBD
present  ||| S:6342 E:6350 ||| JJ
in  ||| S:6350 E:6353 ||| IN
both  ||| S:6353 E:6368 ||| DT
fractions ||| S:6368 E:6377 ||| NN
,  ||| S:6377 E:6379 ||| ,
consistent  ||| S:6379 E:6390 ||| JJ
with  ||| S:6390 E:6395 ||| IN
previous  ||| S:6395 E:6404 ||| JJ
results  ||| S:6404 E:6412 ||| NNS
with  ||| S:6412 E:6417 ||| IN
Rab24  ||| S:6417 E:6433 ||| NNP
and  ||| S:6433 E:6437 ||| CC
other  ||| S:6437 E:6443 ||| JJ
wild-type  ||| S:6443 E:6453 ||| JJ
Rab  ||| S:6453 E:6457 ||| NNP
GTPases  ||| S:6457 E:6465 ||| NNP
[  ||| S:6465 E:6467 ||| -LRB-
25  ||| S:6467 E:6470 ||| CD
39  ||| S:6470 E:6473 ||| CD
]  ||| S:6473 E:6475 ||| -RRB-
.  ||| S:6475 E:6477 ||| .
In  ||| S:6477 E:6480 ||| IN
contrast ||| S:6480 E:6488 ||| NN
,  ||| S:6488 E:6500 ||| ,
mycRab24 ||| S:6500 E:6508 ||| NNP
( ||| S:6508 E:6509 ||| -LRB-
D123I ||| S:6509 E:6514 ||| NNP
)  ||| S:6514 E:6516 ||| -RRB-
was  ||| S:6516 E:6520 ||| VBD
found  ||| S:6520 E:6526 ||| VBN
exclusively  ||| S:6526 E:6538 ||| RB
in  ||| S:6538 E:6541 ||| IN
the  ||| S:6541 E:6545 ||| DT
particulate  ||| S:6545 E:6567 ||| JJ
fraction  ||| S:6567 E:6576 ||| NN
( ||| S:6576 E:6577 ||| -LRB-
Fig.  ||| S:6577 E:6582 ||| NNP
1C ||| S:6582 E:6584 ||| NNP
) ||| S:6584 E:6585 ||| -RRB-
.  ||| S:6585 E:6587 ||| .
When  ||| S:6587 E:6592 ||| WRB
transfected  ||| S:6592 E:6604 ||| JJ
cells  ||| S:6604 E:6610 ||| NNS
were  ||| S:6610 E:6615 ||| VBD
disrupted  ||| S:6615 E:6635 ||| VBN
in  ||| S:6635 E:6638 ||| IN
a  ||| S:6638 E:6640 ||| DT
buffer  ||| S:6640 E:6647 ||| NN
containing  ||| S:6647 E:6658 ||| VBG
0.5 ||| S:6658 E:6661 ||| CD
%  ||| S:6661 E:6663 ||| NN
NP-40 ||| S:6663 E:6668 ||| NN
,  ||| S:6668 E:6670 ||| ,
0.5 ||| S:6670 E:6673 ||| CD
%  ||| S:6673 E:6675 ||| NN
deoxycholate  ||| S:6675 E:6688 ||| NNS
and  ||| S:6688 E:6702 ||| CC
0.1 ||| S:6702 E:6705 ||| CD
%  ||| S:6705 E:6707 ||| NN
SDS ||| S:6707 E:6710 ||| NNP
,  ||| S:6710 E:6712 ||| ,
most  ||| S:6712 E:6717 ||| JJS
of  ||| S:6717 E:6720 ||| IN
the  ||| S:6720 E:6724 ||| DT
Rab24 ||| S:6724 E:6729 ||| NNP
( ||| S:6729 E:6730 ||| -LRB-
D123I ||| S:6730 E:6735 ||| NNP
)  ||| S:6735 E:6737 ||| -RRB-
was  ||| S:6737 E:6741 ||| VBD
recovered  ||| S:6741 E:6751 ||| VBN
in  ||| S:6751 E:6754 ||| IN
the  ||| S:6754 E:6768 ||| DT
detergent-insoluble  ||| S:6768 E:6788 ||| JJ
fraction  ||| S:6788 E:6797 ||| NN
( ||| S:6797 E:6798 ||| -LRB-
Fig.  ||| S:6798 E:6803 ||| NNP
1D ||| S:6803 E:6805 ||| NNP
) ||| S:6805 E:6806 ||| -RRB-
.  ||| S:6806 E:6808 ||| .
This  ||| S:6808 E:6813 ||| DT
suggested  ||| S:6813 E:6833 ||| VBN
that  ||| S:6833 E:6838 ||| IN
the  ||| S:6838 E:6842 ||| DT
mutant  ||| S:6842 E:6849 ||| JJ
protein  ||| S:6849 E:6857 ||| NN
was  ||| S:6857 E:6861 ||| VBD
concentrated  ||| S:6861 E:6874 ||| VBN
in  ||| S:6874 E:6877 ||| IN
inclusion  ||| S:6877 E:6897 ||| NN
bodies  ||| S:6897 E:6904 ||| NNS
rather  ||| S:6904 E:6911 ||| RB
than  ||| S:6911 E:6916 ||| IN
membrane  ||| S:6916 E:6925 ||| JJ
components ||| S:6925 E:6935 ||| NNS
.  ||| S:6935 E:6947 ||| .
The  ||| S:6947 E:6951 ||| DT
nuclear  ||| S:6951 E:6959 ||| JJ
inclusions  ||| S:6959 E:6970 ||| NNS
containing  ||| S:6970 E:6981 ||| VBG
Rab24 ||| S:6981 E:6986 ||| NNP
( ||| S:6986 E:6987 ||| -LRB-
D123I ||| S:6987 E:6992 ||| NNP
)  ||| S:6992 E:6994 ||| -RRB-
were  ||| S:6994 E:7009 ||| VBD
not  ||| S:7009 E:7013 ||| RB
cell-type  ||| S:7013 E:7023 ||| JJ
specific ||| S:7023 E:7031 ||| JJ
.  ||| S:7031 E:7033 ||| .
Fig.  ||| S:7033 E:7038 ||| NNP
2Ashows  ||| S:7038 E:7046 ||| NNP
that  ||| S:7046 E:7051 ||| IN
similar  ||| S:7051 E:7069 ||| JJ
punctate  ||| S:7069 E:7078 ||| JJ
structures  ||| S:7078 E:7089 ||| NNS
were  ||| S:7089 E:7094 ||| VBD
formed  ||| S:7094 E:7101 ||| VBN
when  ||| S:7101 E:7106 ||| WRB
the  ||| S:7106 E:7110 ||| DT
D123I  ||| S:7110 E:7116 ||| CD
mutant  ||| S:7116 E:7123 ||| NNS
was  ||| S:7123 E:7137 ||| VBD
expressed  ||| S:7137 E:7147 ||| VBN
in  ||| S:7147 E:7150 ||| IN
NIH  ||| S:7150 E:7154 ||| NNP
3T3  ||| S:7154 E:7158 ||| NNP
fibroblasts ||| S:7158 E:7169 ||| NN
.  ||| S:7169 E:7171 ||| .
We  ||| S:7171 E:7174 ||| PRP
also  ||| S:7174 E:7179 ||| RB
verified  ||| S:7179 E:7188 ||| VBN
that  ||| S:7188 E:7203 ||| IN
the  ||| S:7203 E:7207 ||| DT
unique  ||| S:7207 E:7214 ||| JJ
behavior  ||| S:7214 E:7223 ||| NN
of  ||| S:7223 E:7226 ||| IN
the  ||| S:7226 E:7230 ||| DT
Rab24  ||| S:7230 E:7236 ||| CD
mutant  ||| S:7236 E:7243 ||| NNS
was  ||| S:7243 E:7247 ||| VBD
not  ||| S:7247 E:7251 ||| RB
related  ||| S:7251 E:7269 ||| VBN
specifically  ||| S:7269 E:7282 ||| RB
to  ||| S:7282 E:7285 ||| TO
the  ||| S:7285 E:7289 ||| DT
substitution  ||| S:7289 E:7302 ||| NN
at  ||| S:7302 E:7305 ||| IN
the  ||| S:7305 E:7309 ||| DT
aspartate  ||| S:7309 E:7329 ||| JJ
position  ||| S:7329 E:7338 ||| NN
in  ||| S:7338 E:7341 ||| IN
the  ||| S:7341 E:7345 ||| DT
N ||| S:7345 E:7346 ||| NNP
( ||| S:7346 E:7347 ||| -LRB-
T ||| S:7347 E:7348 ||| NN
) ||| S:7348 E:7349 ||| -RRB-
KxD  ||| S:7349 E:7353 ||| JJ
motif ||| S:7353 E:7358 ||| NN
.  ||| S:7358 E:7360 ||| .
Thus ||| S:7360 E:7364 ||| RB
,  ||| S:7364 E:7366 ||| ,
similar  ||| S:7366 E:7374 ||| JJ
inclusions  ||| S:7374 E:7395 ||| NN
were  ||| S:7395 E:7400 ||| VBD
observed  ||| S:7400 E:7409 ||| VBN
when  ||| S:7409 E:7414 ||| WRB
Rab24  ||| S:7414 E:7420 ||| NNP
was  ||| S:7420 E:7424 ||| VBD
expressed  ||| S:7424 E:7434 ||| VBN
with  ||| S:7434 E:7439 ||| IN
substitutions  ||| S:7439 E:7463 ||| NN
at  ||| S:7463 E:7466 ||| IN
the  ||| S:7466 E:7470 ||| DT
N ||| S:7470 E:7471 ||| NNP
/ ||| S:7471 E:7472 ||| NNP
T  ||| S:7472 E:7474 ||| NN
position ||| S:7474 E:7482 ||| NN
;  ||| S:7482 E:7495 ||| :
i.e.  ||| S:7495 E:7500 ||| FW
,  ||| S:7500 E:7502 ||| ,
T120A  ||| S:7502 E:7508 ||| NNP
( ||| S:7508 E:7509 ||| -LRB-
Fig.  ||| S:7509 E:7514 ||| NNP
2A ||| S:7514 E:7516 ||| NNP
)  ||| S:7516 E:7518 ||| -RRB-
or  ||| S:7518 E:7521 ||| CC
T120I  ||| S:7521 E:7537 ||| NNP
( ||| S:7537 E:7538 ||| -LRB-
not  ||| S:7538 E:7542 ||| RB
shown ||| S:7542 E:7547 ||| VBN
) ||| S:7547 E:7548 ||| -RRB-
.  ||| S:7548 E:7550 ||| .
To  ||| S:7550 E:7553 ||| TO
test  ||| S:7553 E:7558 ||| VB
the  ||| S:7558 E:7562 ||| DT
possibility  ||| S:7562 E:7574 ||| NN
that  ||| S:7574 E:7579 ||| IN
protein  ||| S:7579 E:7597 ||| NN
aggregates  ||| S:7597 E:7608 ||| NNS
might  ||| S:7608 E:7614 ||| MD
be  ||| S:7614 E:7617 ||| VB
formed  ||| S:7617 E:7624 ||| VBN
when  ||| S:7624 E:7640 ||| WRB
any  ||| S:7640 E:7644 ||| DT
Rab  ||| S:7644 E:7648 ||| NNP
GTPase  ||| S:7648 E:7655 ||| NNP
is  ||| S:7655 E:7658 ||| VBZ
overexpressed  ||| S:7658 E:7682 ||| VBN
with  ||| S:7682 E:7687 ||| IN
a  ||| S:7687 E:7689 ||| DT
mutation  ||| S:7689 E:7698 ||| NN
that  ||| S:7698 E:7703 ||| IN
impairs  ||| S:7703 E:7711 ||| JJ
nucleotide  ||| S:7711 E:7722 ||| JJ
binding ||| S:7722 E:7729 ||| NN
,  ||| S:7729 E:7731 ||| ,
we  ||| S:7731 E:7744 ||| PRP
examined  ||| S:7744 E:7753 ||| VBD
the  ||| S:7753 E:7757 ||| DT
localization  ||| S:7757 E:7770 ||| NN
of  ||| S:7770 E:7773 ||| IN
four  ||| S:7773 E:7778 ||| CD
additional  ||| S:7778 E:7789 ||| JJ
members  ||| S:7789 E:7797 ||| NNS
of  ||| S:7797 E:7810 ||| IN
the  ||| S:7810 E:7814 ||| DT
Rab  ||| S:7814 E:7818 ||| JJ
family  ||| S:7818 E:7825 ||| NN
containing  ||| S:7825 E:7836 ||| VBG
amino  ||| S:7836 E:7842 ||| JJ
acid  ||| S:7842 E:7847 ||| NN
substitutions  ||| S:7847 E:7861 ||| NN
in  ||| S:7861 E:7864 ||| IN
the  ||| S:7864 E:7878 ||| DT
N ||| S:7878 E:7879 ||| NNP
( ||| S:7879 E:7880 ||| -LRB-
T ||| S:7880 E:7881 ||| NN
) ||| S:7881 E:7882 ||| -RRB-
KxD  ||| S:7882 E:7886 ||| JJ
motif ||| S:7886 E:7891 ||| NN
.  ||| S:7891 E:7893 ||| .
In  ||| S:7893 E:7896 ||| IN
all  ||| S:7896 E:7900 ||| DT
cases ||| S:7900 E:7905 ||| NNS
,  ||| S:7905 E:7907 ||| ,
these  ||| S:7907 E:7913 ||| DT
proteins  ||| S:7913 E:7922 ||| NNS
exhibited  ||| S:7922 E:7932 ||| VBP
a  ||| S:7932 E:7944 ||| DT
general  ||| S:7944 E:7952 ||| JJ
cytoplasmic  ||| S:7952 E:7964 ||| JJ
localization  ||| S:7964 E:7977 ||| NN
with  ||| S:7977 E:7982 ||| IN
no  ||| S:7982 E:7985 ||| DT
evidence  ||| S:7985 E:7994 ||| NN
of  ||| S:7994 E:8007 ||| IN
nuclear  ||| S:8007 E:8015 ||| JJ
inclusions  ||| S:8015 E:8026 ||| NNS
( ||| S:8026 E:8027 ||| -LRB-
Fig.  ||| S:8027 E:8032 ||| NNP
2A ||| S:8032 E:8034 ||| NNP
) ||| S:8034 E:8035 ||| -RRB-
.  ||| S:8035 E:8047 ||| .
Rab24  ||| S:8047 E:8053 ||| NNP
is  ||| S:8053 E:8056 ||| VBZ
known  ||| S:8056 E:8062 ||| VBN
to  ||| S:8062 E:8065 ||| TO
be  ||| S:8065 E:8068 ||| VB
expressed  ||| S:8068 E:8078 ||| VBN
endogenously  ||| S:8078 E:8091 ||| VBN
in  ||| S:8091 E:8094 ||| IN
many  ||| S:8094 E:8109 ||| JJ
cell  ||| S:8109 E:8114 ||| NN
types ||| S:8114 E:8119 ||| NNS
,  ||| S:8119 E:8121 ||| ,
including  ||| S:8121 E:8131 ||| VBG
the  ||| S:8131 E:8135 ||| DT
cell  ||| S:8135 E:8140 ||| NN
lines  ||| S:8140 E:8146 ||| NNS
used  ||| S:8146 E:8151 ||| VBN
in  ||| S:8151 E:8154 ||| IN
these  ||| S:8154 E:8170 ||| DT
studies  ||| S:8170 E:8178 ||| NNS
[  ||| S:8178 E:8180 ||| -LRB-
24  ||| S:8180 E:8183 ||| CD
25  ||| S:8183 E:8186 ||| CD
]  ||| S:8186 E:8188 ||| -RRB-
,  ||| S:8188 E:8190 ||| ,
and  ||| S:8190 E:8194 ||| CC
we  ||| S:8194 E:8197 ||| PRP
have  ||| S:8197 E:8202 ||| VBP
estimated  ||| S:8202 E:8212 ||| VBN
that  ||| S:8212 E:8217 ||| IN
both  ||| S:8217 E:8232 ||| DT
mycRab24wt  ||| S:8232 E:8243 ||| NNP
and  ||| S:8243 E:8247 ||| CC
D123I  ||| S:8247 E:8253 ||| NNP
are  ||| S:8253 E:8257 ||| VBP
transiently  ||| S:8257 E:8269 ||| VBN
expressed  ||| S:8269 E:8279 ||| VBN
5-10  ||| S:8279 E:8284 ||| JJ
fold  ||| S:8284 E:8299 ||| NN
over  ||| S:8299 E:8304 ||| IN
the  ||| S:8304 E:8308 ||| DT
level  ||| S:8308 E:8314 ||| NN
of  ||| S:8314 E:8317 ||| IN
endogenous  ||| S:8317 E:8328 ||| CD
Rab24  ||| S:8328 E:8334 ||| CD
( ||| S:8334 E:8335 ||| -LRB-
data  ||| S:8335 E:8340 ||| NNS
not  ||| S:8340 E:8344 ||| RB
shown ||| S:8344 E:8349 ||| VBN
) ||| S:8349 E:8350 ||| -RRB-
.  ||| S:8350 E:8362 ||| .
Therefore ||| S:8362 E:8371 ||| RB
,  ||| S:8371 E:8373 ||| ,
a  ||| S:8373 E:8375 ||| DT
question  ||| S:8375 E:8384 ||| NN
raised  ||| S:8384 E:8391 ||| VBD
by  ||| S:8391 E:8394 ||| IN
these  ||| S:8394 E:8400 ||| DT
studies  ||| S:8400 E:8408 ||| NNS
is  ||| S:8408 E:8411 ||| VBZ
whether  ||| S:8411 E:8429 ||| IN
the  ||| S:8429 E:8433 ||| DT
genesis  ||| S:8433 E:8441 ||| NN
of  ||| S:8441 E:8444 ||| IN
nuclear  ||| S:8444 E:8452 ||| JJ
inclusions  ||| S:8452 E:8463 ||| NN
occurs  ||| S:8463 E:8470 ||| VBZ
indirectly ||| S:8470 E:8480 ||| RB
,  ||| S:8480 E:8492 ||| ,
through  ||| S:8492 E:8500 ||| IN
dominant  ||| S:8500 E:8509 ||| JJ
suppression  ||| S:8509 E:8521 ||| NN
of  ||| S:8521 E:8524 ||| IN
endogenous  ||| S:8524 E:8535 ||| CD
Rab24  ||| S:8535 E:8541 ||| CD
function  ||| S:8541 E:8560 ||| NN
by  ||| S:8560 E:8563 ||| IN
the  ||| S:8563 E:8567 ||| DT
D123I  ||| S:8567 E:8573 ||| NNP
and  ||| S:8573 E:8577 ||| CC
T120A  ||| S:8577 E:8583 ||| CD
mutants ||| S:8583 E:8590 ||| NN
,  ||| S:8590 E:8592 ||| ,
or  ||| S:8592 E:8595 ||| CC
directly ||| S:8595 E:8603 ||| RB
,  ||| S:8603 E:8605 ||| ,
through  ||| S:8605 E:8623 ||| IN
association  ||| S:8623 E:8635 ||| NN
of  ||| S:8635 E:8638 ||| IN
cellular  ||| S:8638 E:8647 ||| JJ
proteins  ||| S:8647 E:8656 ||| NNS
with  ||| S:8656 E:8661 ||| IN
the  ||| S:8661 E:8665 ||| DT
accumulating  ||| S:8665 E:8688 ||| JJ
mutant  ||| S:8688 E:8695 ||| JJ
protein ||| S:8695 E:8702 ||| NN
.  ||| S:8702 E:8704 ||| .
We  ||| S:8704 E:8707 ||| PRP
attempted  ||| S:8707 E:8717 ||| VBD
to  ||| S:8717 E:8720 ||| TO
distinguish  ||| S:8720 E:8732 ||| VB
between  ||| S:8732 E:8740 ||| IN
these  ||| S:8740 E:8756 ||| DT
possibilities  ||| S:8756 E:8770 ||| NNS
by  ||| S:8770 E:8773 ||| IN
using  ||| S:8773 E:8779 ||| VBG
an  ||| S:8779 E:8782 ||| DT
alternative  ||| S:8782 E:8794 ||| JJ
strategy  ||| S:8794 E:8803 ||| NN
to  ||| S:8803 E:8806 ||| TO
make  ||| S:8806 E:8811 ||| VB
a  ||| S:8811 E:8823 ||| DT
dominant-negative  ||| S:8823 E:8841 ||| JJ
form  ||| S:8841 E:8846 ||| NN
of  ||| S:8846 E:8849 ||| IN
Rab24 ||| S:8849 E:8854 ||| CD
.  ||| S:8854 E:8856 ||| .
Several  ||| S:8856 E:8864 ||| JJ
laboratories  ||| S:8864 E:8887 ||| NNS
have  ||| S:8887 E:8892 ||| VBP
shown  ||| S:8892 E:8898 ||| VBN
that  ||| S:8898 E:8903 ||| IN
in  ||| S:8903 E:8906 ||| IN
addition  ||| S:8906 E:8915 ||| NN
to  ||| S:8915 E:8918 ||| TO
mutations  ||| S:8918 E:8928 ||| VB
in  ||| S:8928 E:8931 ||| IN
the  ||| S:8931 E:8935 ||| DT
N ||| S:8935 E:8936 ||| NNP
( ||| S:8936 E:8937 ||| -LRB-
T ||| S:8937 E:8938 ||| NN
) ||| S:8938 E:8939 ||| -RRB-
KxD  ||| S:8939 E:8953 ||| JJ
motif ||| S:8953 E:8958 ||| NN
,  ||| S:8958 E:8960 ||| ,
which  ||| S:8960 E:8966 ||| WDT
reduce  ||| S:8966 E:8973 ||| VBP
overall  ||| S:8973 E:8981 ||| JJ
nucleotide  ||| S:8981 E:8992 ||| JJ
binding ||| S:8992 E:8999 ||| NN
,  ||| S:8999 E:9011 ||| ,
dominant-negative  ||| S:9011 E:9029 ||| NNP
Rab  ||| S:9029 E:9033 ||| NNP
constructs  ||| S:9033 E:9044 ||| NN
can  ||| S:9044 E:9048 ||| MD
be  ||| S:9048 E:9051 ||| VB
generated  ||| S:9051 E:9061 ||| VBN
by  ||| S:9061 E:9074 ||| IN
introducing  ||| S:9074 E:9086 ||| VBG
amino  ||| S:9086 E:9092 ||| JJ
acid  ||| S:9092 E:9097 ||| NN
substitutions  ||| S:9097 E:9111 ||| NNS
(  ||| S:9111 E:9124 ||| -LRB-
e.g.  ||| S:9124 E:9129 ||| NNP
,  ||| S:9129 E:9131 ||| ,
asparagine ||| S:9131 E:9141 ||| CD
)  ||| S:9141 E:9143 ||| -RRB-
at  ||| S:9143 E:9146 ||| IN
the  ||| S:9146 E:9150 ||| DT
position  ||| S:9150 E:9169 ||| NN
cognate  ||| S:9169 E:9177 ||| NN
to  ||| S:9177 E:9180 ||| TO
Ras  ||| S:9180 E:9184 ||| NNP
S17  ||| S:9184 E:9188 ||| NNP
(  ||| S:9188 E:9201 ||| -LRB-
i.e.  ||| S:9201 E:9206 ||| FW
,  ||| S:9206 E:9208 ||| ,
S22  ||| S:9208 E:9212 ||| NNP
in  ||| S:9212 E:9215 ||| IN
Rab24 ||| S:9215 E:9220 ||| CD
)  ||| S:9220 E:9222 ||| -RRB-
[  ||| S:9222 E:9224 ||| -LRB-
31  ||| S:9224 E:9227 ||| CD
40  ||| S:9227 E:9230 ||| CD
41  ||| S:9230 E:9233 ||| CD
42  ||| S:9233 E:9246 ||| CD
]  ||| S:9246 E:9248 ||| -RRB-
.  ||| S:9248 E:9250 ||| .
Such  ||| S:9250 E:9255 ||| JJ
proteins  ||| S:9255 E:9264 ||| NNS
are  ||| S:9264 E:9268 ||| VBP
thought  ||| S:9268 E:9276 ||| VBN
to  ||| S:9276 E:9279 ||| TO
be  ||| S:9279 E:9282 ||| VB
locked  ||| S:9282 E:9289 ||| VBN
in  ||| S:9289 E:9292 ||| IN
an  ||| S:9292 E:9295 ||| DT
inactive  ||| S:9295 E:9314 ||| JJ
GDP-bound  ||| S:9314 E:9324 ||| JJ
state  ||| S:9324 E:9330 ||| NN
because  ||| S:9330 E:9338 ||| IN
the  ||| S:9338 E:9342 ||| DT
mutation  ||| S:9342 E:9351 ||| NN
markedly  ||| S:9351 E:9360 ||| RB
reduces  ||| S:9360 E:9378 ||| VBZ
their  ||| S:9378 E:9384 ||| PRP$
affinity  ||| S:9384 E:9393 ||| NN
for  ||| S:9393 E:9397 ||| IN
GTP ||| S:9397 E:9400 ||| NNP
,  ||| S:9400 E:9402 ||| ,
compared  ||| S:9402 E:9411 ||| VBN
to  ||| S:9411 E:9414 ||| TO
GDP  ||| S:9414 E:9418 ||| NNP
[  ||| S:9418 E:9420 ||| -LRB-
42  ||| S:9420 E:9423 ||| CD
]  ||| S:9423 E:9425 ||| -RRB-
.  ||| S:9425 E:9427 ||| .
As  ||| S:9427 E:9430 ||| RB
shown  ||| S:9430 E:9446 ||| VBN
in  ||| S:9446 E:9449 ||| IN
Fig.  ||| S:9449 E:9454 ||| CD
2B ||| S:9454 E:9456 ||| CD
,  ||| S:9456 E:9458 ||| ,
when  ||| S:9458 E:9463 ||| WRB
mycRab24 ||| S:9463 E:9471 ||| NNP
( ||| S:9471 E:9472 ||| -LRB-
S22N ||| S:9472 E:9476 ||| NNP
)  ||| S:9476 E:9478 ||| -RRB-
was  ||| S:9478 E:9482 ||| VBD
expressed  ||| S:9482 E:9492 ||| VBN
in  ||| S:9492 E:9495 ||| IN
3T3  ||| S:9495 E:9509 ||| CD
cells ||| S:9509 E:9514 ||| NNS
,  ||| S:9514 E:9516 ||| ,
there  ||| S:9516 E:9522 ||| EX
was  ||| S:9522 E:9526 ||| VBD
no  ||| S:9526 E:9529 ||| DT
evidence  ||| S:9529 E:9538 ||| NN
of  ||| S:9538 E:9541 ||| IN
nuclear  ||| S:9541 E:9549 ||| JJ
inclusions ||| S:9549 E:9559 ||| NN
.  ||| S:9559 E:9571 ||| .
However ||| S:9571 E:9578 ||| RB
,  ||| S:9578 E:9580 ||| ,
when  ||| S:9580 E:9585 ||| WRB
the  ||| S:9585 E:9589 ||| DT
bound  ||| S:9589 E:9595 ||| JJ
32P-labeled  ||| S:9595 E:9607 ||| NN
nucleotides  ||| S:9607 E:9629 ||| VBZ
associated  ||| S:9629 E:9640 ||| VBN
with  ||| S:9640 E:9645 ||| IN
the  ||| S:9645 E:9649 ||| DT
expressed  ||| S:9649 E:9659 ||| JJ
protein  ||| S:9659 E:9667 ||| NN
were  ||| S:9667 E:9672 ||| VBD
analyzed  ||| S:9672 E:9681 ||| VBN
by  ||| S:9681 E:9694 ||| IN
thin-layer  ||| S:9694 E:9705 ||| JJ
chromatography  ||| S:9705 E:9720 ||| NNS
( ||| S:9720 E:9721 ||| -LRB-
Fig.  ||| S:9721 E:9726 ||| NNP
2C ||| S:9726 E:9728 ||| NNP
) ||| S:9728 E:9729 ||| -RRB-
,  ||| S:9729 E:9731 ||| ,
we  ||| S:9731 E:9734 ||| PRP
were  ||| S:9734 E:9739 ||| VBD
surprised  ||| S:9739 E:9749 ||| VBN
to  ||| S:9749 E:9762 ||| TO
find  ||| S:9762 E:9767 ||| VB
that  ||| S:9767 E:9772 ||| IN
the  ||| S:9772 E:9776 ||| DT
S22N  ||| S:9776 E:9781 ||| CD
mutant  ||| S:9781 E:9788 ||| NNS
was  ||| S:9788 E:9792 ||| VBD
predominantly  ||| S:9792 E:9806 ||| RB
in  ||| S:9806 E:9809 ||| IN
the  ||| S:9809 E:9823 ||| DT
GTP-bound  ||| S:9823 E:9833 ||| JJ
state ||| S:9833 E:9838 ||| NN
.  ||| S:9838 E:9840 ||| .
The  ||| S:9840 E:9844 ||| DT
inability  ||| S:9844 E:9854 ||| NN
of  ||| S:9854 E:9857 ||| IN
the  ||| S:9857 E:9861 ||| DT
S22N  ||| S:9861 E:9866 ||| JJ
substitution  ||| S:9866 E:9889 ||| NN
to  ||| S:9889 E:9892 ||| TO
substantially  ||| S:9892 E:9906 ||| RB
reduce  ||| S:9906 E:9913 ||| VB
the  ||| S:9913 E:9917 ||| DT
affinity  ||| S:9917 E:9926 ||| NN
of  ||| S:9926 E:9929 ||| IN
Rab24  ||| S:9929 E:9935 ||| CD
for  ||| S:9935 E:9939 ||| IN
GTP  ||| S:9939 E:9953 ||| NNP
adds  ||| S:9953 E:9958 ||| VBZ
to  ||| S:9958 E:9961 ||| TO
the  ||| S:9961 E:9965 ||| DT
growing  ||| S:9965 E:9973 ||| VBG
list  ||| S:9973 E:9978 ||| NN
of  ||| S:9978 E:9981 ||| IN
fundamental  ||| S:9981 E:9993 ||| JJ
differences  ||| S:9993 E:10015 ||| NNS
between  ||| S:10015 E:10023 ||| IN
Rab24  ||| S:10023 E:10029 ||| NNP
and  ||| S:10029 E:10033 ||| CC
other  ||| S:10033 E:10039 ||| JJ
members  ||| S:10039 E:10047 ||| NNS
of  ||| S:10047 E:10050 ||| IN
the  ||| S:10050 E:10054 ||| DT
Rab  ||| S:10054 E:10058 ||| JJ
family ||| S:10058 E:10064 ||| NN
.  ||| S:10064 E:10066 ||| .
In  ||| S:10066 E:10069 ||| IN
a  ||| S:10069 E:10081 ||| DT
previous  ||| S:10081 E:10090 ||| JJ
study  ||| S:10090 E:10096 ||| NN
we  ||| S:10096 E:10099 ||| PRP
observed  ||| S:10099 E:10108 ||| VBD
that  ||| S:10108 E:10113 ||| IN
replacing  ||| S:10113 E:10123 ||| VBG
S67  ||| S:10123 E:10127 ||| NN
with  ||| S:10127 E:10132 ||| IN
Q  ||| S:10132 E:10144 ||| NNP
( ||| S:10144 E:10145 ||| -LRB-
which  ||| S:10145 E:10151 ||| WDT
occupies  ||| S:10151 E:10160 ||| VBZ
this  ||| S:10160 E:10165 ||| DT
position  ||| S:10165 E:10174 ||| NN
all  ||| S:10174 E:10178 ||| DT
other  ||| S:10178 E:10184 ||| JJ
Rab  ||| S:10184 E:10188 ||| JJ
proteins ||| S:10188 E:10196 ||| NNS
)  ||| S:10196 E:10208 ||| -RRB-
increases  ||| S:10208 E:10218 ||| VBZ
the  ||| S:10218 E:10222 ||| DT
GTPase  ||| S:10222 E:10229 ||| JJ
activity  ||| S:10229 E:10238 ||| NN
of  ||| S:10238 E:10241 ||| IN
Rab24  ||| S:10241 E:10247 ||| NNP
[  ||| S:10247 E:10249 ||| -LRB-
25  ||| S:10249 E:10252 ||| CD
]  ||| S:10252 E:10254 ||| -RRB-
,  ||| S:10254 E:10256 ||| ,
resulting  ||| S:10256 E:10276 ||| VBG
in  ||| S:10276 E:10279 ||| IN
a  ||| S:10279 E:10281 ||| DT
modest  ||| S:10281 E:10288 ||| JJ
increase  ||| S:10288 E:10297 ||| NN
in  ||| S:10297 E:10300 ||| IN
the  ||| S:10300 E:10304 ||| DT
ratio  ||| S:10304 E:10310 ||| NN
of  ||| S:10310 E:10313 ||| IN
protein  ||| S:10313 E:10321 ||| NN
in  ||| S:10321 E:10324 ||| IN
the  ||| S:10324 E:10328 ||| DT
GDP  ||| S:10328 E:10342 ||| NNP
versus  ||| S:10342 E:10349 ||| CC
GTP  ||| S:10349 E:10353 ||| NNP
state  ||| S:10353 E:10359 ||| NN
( ||| S:10359 E:10360 ||| -LRB-
see  ||| S:10360 E:10364 ||| VB
Fig.  ||| S:10364 E:10369 ||| CD
2C ||| S:10369 E:10371 ||| CD
) ||| S:10371 E:10372 ||| -RRB-
.  ||| S:10372 E:10374 ||| .
When  ||| S:10374 E:10379 ||| WRB
this  ||| S:10379 E:10384 ||| DT
mutant  ||| S:10384 E:10391 ||| NN
was  ||| S:10391 E:10405 ||| VBD
expressed  ||| S:10405 E:10415 ||| VBN
in  ||| S:10415 E:10418 ||| IN
3T3  ||| S:10418 E:10422 ||| CD
cells  ||| S:10422 E:10428 ||| NNS
we  ||| S:10428 E:10431 ||| PRP
again  ||| S:10431 E:10437 ||| RB
failed  ||| S:10437 E:10444 ||| VBN
to  ||| S:10444 E:10447 ||| TO
observe  ||| S:10447 E:10465 ||| VB
inclusion  ||| S:10465 E:10475 ||| JJ
bodies  ||| S:10475 E:10482 ||| NNS
( ||| S:10482 E:10483 ||| -LRB-
Fig.  ||| S:10483 E:10488 ||| NNP
2B ||| S:10488 E:10490 ||| NNP
) ||| S:10490 E:10491 ||| -RRB-
.  ||| S:10491 E:10493 ||| .
Since  ||| S:10493 E:10499 ||| IN
neither  ||| S:10499 E:10507 ||| DT
Rab24 ||| S:10507 E:10512 ||| NNP
( ||| S:10512 E:10513 ||| -LRB-
S22N ||| S:10513 E:10517 ||| NNP
)  ||| S:10517 E:10519 ||| -RRB-
nor  ||| S:10519 E:10533 ||| CC
Rab24 ||| S:10533 E:10538 ||| NNP
( ||| S:10538 E:10539 ||| -LRB-
S67Q ||| S:10539 E:10543 ||| NNP
)  ||| S:10543 E:10545 ||| -RRB-
showed  ||| S:10545 E:10552 ||| VBD
evidence  ||| S:10552 E:10561 ||| NN
of  ||| S:10561 E:10564 ||| IN
being  ||| S:10564 E:10570 ||| VBG
locked  ||| S:10570 E:10577 ||| VBN
in  ||| S:10577 E:10580 ||| IN
a  ||| S:10580 E:10592 ||| DT
GDP-bound  ||| S:10592 E:10602 ||| JJ
state ||| S:10602 E:10607 ||| NN
,  ||| S:10607 E:10609 ||| ,
it  ||| S:10609 E:10612 ||| PRP
is  ||| S:10612 E:10615 ||| VBZ
unlikely  ||| S:10615 E:10624 ||| JJ
that  ||| S:10624 E:10629 ||| IN
either  ||| S:10629 E:10636 ||| DT
would  ||| S:10636 E:10652 ||| MD
function  ||| S:10652 E:10661 ||| VB
as  ||| S:10661 E:10664 ||| IN
a  ||| S:10664 E:10666 ||| DT
dominant-negative ||| S:10666 E:10683 ||| JJ
.  ||| S:10683 E:10685 ||| .
Thus ||| S:10685 E:10689 ||| RB
,  ||| S:10689 E:10691 ||| ,
the  ||| S:10691 E:10695 ||| DT
question  ||| S:10695 E:10704 ||| NN
of  ||| S:10704 E:10717 ||| IN
whether  ||| S:10717 E:10725 ||| IN
the  ||| S:10725 E:10729 ||| DT
nuclear  ||| S:10729 E:10737 ||| JJ
inclusions  ||| S:10737 E:10748 ||| NNS
containing  ||| S:10748 E:10759 ||| VBG
the  ||| S:10759 E:10763 ||| DT
D123I  ||| S:10763 E:10769 ||| NNP
and  ||| S:10769 E:10783 ||| CC
T120A  ||| S:10783 E:10789 ||| CD
mutants  ||| S:10789 E:10797 ||| NNS
are  ||| S:10797 E:10801 ||| VBP
caused  ||| S:10801 E:10808 ||| VBN
by  ||| S:10808 E:10811 ||| IN
dominant-negative  ||| S:10811 E:10829 ||| JJ
suppression  ||| S:10829 E:10851 ||| NN
of  ||| S:10851 E:10854 ||| IN
endogenous  ||| S:10854 E:10865 ||| CD
Rab24  ||| S:10865 E:10871 ||| CD
function  ||| S:10871 E:10880 ||| NN
remains  ||| S:10880 E:10888 ||| VBZ
to  ||| S:10888 E:10891 ||| TO
be  ||| S:10891 E:10894 ||| VB
resolved ||| S:10894 E:10902 ||| VBN
.  ||| S:10902 E:10932 ||| .
Morphological  ||| S:10932 E:10946 ||| JJ
characteristics  ||| S:10946 E:10962 ||| NNS
of  ||| S:10962 E:10965 ||| IN
the  ||| S:10965 E:10969 ||| DT
nuclear  ||| S:10969 E:10987 ||| JJ
inclusions  ||| S:10987 E:11008 ||| JJ
Several  ||| S:11008 E:11016 ||| JJ
follow-up  ||| S:11016 E:11026 ||| JJ
studies  ||| S:11026 E:11034 ||| NNS
supported  ||| S:11034 E:11044 ||| VBD
the  ||| S:11044 E:11048 ||| DT
notion  ||| S:11048 E:11055 ||| NN
that  ||| S:11055 E:11070 ||| IN
the  ||| S:11070 E:11074 ||| DT
punctate  ||| S:11074 E:11083 ||| JJ
structures  ||| S:11083 E:11094 ||| NNS
containing  ||| S:11094 E:11105 ||| VBG
the  ||| S:11105 E:11109 ||| DT
Rab24  ||| S:11109 E:11115 ||| CD
mutants  ||| S:11115 E:11123 ||| NNS
were  ||| S:11123 E:11138 ||| VBD
inclusion  ||| S:11138 E:11148 ||| JJ
bodies  ||| S:11148 E:11155 ||| NNS
rather  ||| S:11155 E:11162 ||| RB
than  ||| S:11162 E:11167 ||| IN
membrane-bound  ||| S:11167 E:11182 ||| JJ
organelles ||| S:11182 E:11192 ||| NN
.  ||| S:11192 E:11204 ||| .
For  ||| S:11204 E:11208 ||| IN
example ||| S:11208 E:11215 ||| NN
,  ||| S:11215 E:11217 ||| ,
immunofluorescence  ||| S:11217 E:11236 ||| JJ
microscopy  ||| S:11236 E:11247 ||| NN
revealed  ||| S:11247 E:11266 ||| VBD
little  ||| S:11266 E:11273 ||| JJ
or  ||| S:11273 E:11276 ||| CC
no  ||| S:11276 E:11279 ||| DT
overlap  ||| S:11279 E:11287 ||| NN
between  ||| S:11287 E:11295 ||| IN
these  ||| S:11295 E:11301 ||| DT
structures  ||| S:11301 E:11312 ||| NNS
and  ||| S:11312 E:11316 ||| CC
markers  ||| S:11316 E:11334 ||| NN
for  ||| S:11334 E:11338 ||| IN
Golgi  ||| S:11338 E:11344 ||| NNP
( ||| S:11344 E:11345 ||| -LRB-
Rab6 ||| S:11345 E:11349 ||| NNP
,  ||| S:11349 E:11362 ||| ,
Lens  ||| S:11362 E:11367 ||| NNP
culinaris  ||| S:11367 E:11377 ||| FW
lectin ||| S:11377 E:11383 ||| FW
) ||| S:11383 E:11384 ||| -RRB-
,  ||| S:11384 E:11386 ||| ,
endosome  ||| S:11386 E:11405 ||| NNS
( ||| S:11405 E:11406 ||| -LRB-
EEA1 ||| S:11406 E:11410 ||| NNP
)  ||| S:11410 E:11412 ||| -RRB-
or  ||| S:11412 E:11415 ||| CC
lysosome  ||| S:11415 E:11424 ||| NNS
( ||| S:11424 E:11425 ||| -LRB-
LAMP-1 ||| S:11425 E:11431 ||| NNP
)  ||| S:11431 E:11433 ||| -RRB-
membranes  ||| S:11433 E:11443 ||| NNS
( ||| S:11443 E:11444 ||| -LRB-
data  ||| S:11444 E:11449 ||| NNS
not  ||| S:11449 E:11453 ||| RB
shown ||| S:11453 E:11458 ||| VBN
) ||| S:11458 E:11459 ||| -RRB-
.  ||| S:11459 E:11471 ||| .
Although  ||| S:11471 E:11480 ||| IN
Rab24  ||| S:11480 E:11486 ||| NNP
has  ||| S:11486 E:11490 ||| VBZ
been  ||| S:11490 E:11495 ||| VBN
proposed  ||| S:11495 E:11504 ||| VBN
as  ||| S:11504 E:11507 ||| IN
a  ||| S:11507 E:11509 ||| DT
possible  ||| S:11509 E:11518 ||| JJ
regulator  ||| S:11518 E:11538 ||| NN
of  ||| S:11538 E:11541 ||| IN
autophagic  ||| S:11541 E:11552 ||| JJ
processes  ||| S:11552 E:11562 ||| NNS
[  ||| S:11562 E:11564 ||| -LRB-
24  ||| S:11564 E:11567 ||| CD
43  ||| S:11567 E:11570 ||| CD
]  ||| S:11570 E:11572 ||| -RRB-
,  ||| S:11572 E:11574 ||| ,
the  ||| S:11574 E:11578 ||| DT
accumulation  ||| S:11578 E:11591 ||| NN
of  ||| S:11591 E:11604 ||| IN
punctate  ||| S:11604 E:11613 ||| JJ
bodies  ||| S:11613 E:11620 ||| NNS
in  ||| S:11620 E:11623 ||| IN
cells  ||| S:11623 E:11629 ||| NNS
expressing  ||| S:11629 E:11640 ||| VBG
Rab24 ||| S:11640 E:11645 ||| NNP
( ||| S:11645 E:11646 ||| -LRB-
D123I ||| S:11646 E:11651 ||| NNP
)  ||| S:11651 E:11653 ||| -RRB-
was  ||| S:11653 E:11657 ||| VBD
not  ||| S:11657 E:11671 ||| RB
prevented  ||| S:11671 E:11681 ||| VBN
by  ||| S:11681 E:11684 ||| IN
3-methyadenine ||| S:11684 E:11698 ||| NNP
,  ||| S:11698 E:11700 ||| ,
a  ||| S:11700 E:11702 ||| DT
known  ||| S:11702 E:11708 ||| JJ
inhibitor  ||| S:11708 E:11718 ||| NN
of  ||| S:11718 E:11731 ||| IN
autophagosome  ||| S:11731 E:11745 ||| JJ
formation  ||| S:11745 E:11755 ||| NN
[  ||| S:11755 E:11757 ||| -LRB-
44  ||| S:11757 E:11760 ||| CD
]  ||| S:11760 E:11762 ||| -RRB-
.  ||| S:11762 E:11764 ||| .
Most  ||| S:11764 E:11769 ||| RBS
importantly ||| S:11769 E:11780 ||| RB
,  ||| S:11780 E:11792 ||| ,
electron  ||| S:11792 E:11801 ||| JJ
microscopy  ||| S:11801 E:11812 ||| NN
with  ||| S:11812 E:11817 ||| IN
immunogold  ||| S:11817 E:11828 ||| JJ
labeling  ||| S:11828 E:11837 ||| NN
of  ||| S:11837 E:11850 ||| IN
mycRab24 ||| S:11850 E:11858 ||| NNP
( ||| S:11858 E:11859 ||| -LRB-
D123I ||| S:11859 E:11864 ||| NNP
)  ||| S:11864 E:11866 ||| -RRB-
in  ||| S:11866 E:11869 ||| IN
ultra-thin  ||| S:11869 E:11880 ||| JJ
sections  ||| S:11880 E:11889 ||| NNS
confirmed  ||| S:11889 E:11899 ||| VBD
the  ||| S:11899 E:11913 ||| DT
initial  ||| S:11913 E:11921 ||| JJ
impression  ||| S:11921 E:11932 ||| NN
that  ||| S:11932 E:11937 ||| IN
the  ||| S:11937 E:11941 ||| DT
inclusions  ||| S:11941 E:11952 ||| NNS
are  ||| S:11952 E:11956 ||| VBP
in  ||| S:11956 E:11959 ||| IN
fact  ||| S:11959 E:11974 ||| NN
localized  ||| S:11974 E:11984 ||| NN
within  ||| S:11984 E:11991 ||| IN
the  ||| S:11991 E:11995 ||| DT
nucleus ||| S:11995 E:12002 ||| NN
.  ||| S:12002 E:12004 ||| .
The  ||| S:12004 E:12008 ||| DT
expressed  ||| S:12008 E:12018 ||| JJ
protein  ||| S:12018 E:12026 ||| NN
was  ||| S:12026 E:12040 ||| VBD
concentrated  ||| S:12040 E:12053 ||| VBN
in  ||| S:12053 E:12056 ||| IN
clusters  ||| S:12056 E:12065 ||| NNS
of  ||| S:12065 E:12068 ||| IN
dense  ||| S:12068 E:12074 ||| JJ
granules  ||| S:12074 E:12083 ||| NN
of  ||| S:12083 E:12086 ||| IN
fairly  ||| S:12086 E:12103 ||| RB
uniform  ||| S:12103 E:12111 ||| JJ
diameter  ||| S:12111 E:12120 ||| NNS
( ||| S:12120 E:12121 ||| -LRB-
80-150  ||| S:12121 E:12128 ||| FW
nm ||| S:12128 E:12130 ||| FW
)  ||| S:12130 E:12132 ||| -RRB-
with  ||| S:12132 E:12137 ||| IN
no  ||| S:12137 E:12140 ||| DT
evidence  ||| S:12140 E:12149 ||| NN
of  ||| S:12149 E:12152 ||| IN
a  ||| S:12152 E:12164 ||| DT
surrounding  ||| S:12164 E:12176 ||| VBG
membrane  ||| S:12176 E:12185 ||| NNS
( ||| S:12185 E:12186 ||| -LRB-
Fig.  ||| S:12186 E:12191 ||| NNP
3A ||| S:12191 E:12193 ||| NNP
, ||| S:12193 E:12194 ||| ,
3B ||| S:12194 E:12196 ||| CD
) ||| S:12196 E:12197 ||| -RRB-
.  ||| S:12197 E:12199 ||| .
The  ||| S:12199 E:12203 ||| DT
cytoplasmic  ||| S:12203 E:12225 ||| FW
inclusions  ||| S:12225 E:12236 ||| FW
containing  ||| S:12236 E:12247 ||| FW
mycRab24 ||| S:12247 E:12255 ||| FW
( ||| S:12255 E:12256 ||| -LRB-
D123I ||| S:12256 E:12261 ||| NNP
)  ||| S:12261 E:12263 ||| -RRB-
were  ||| S:12263 E:12268 ||| VBD
similar  ||| S:12268 E:12276 ||| JJ
to  ||| S:12276 E:12289 ||| TO
those  ||| S:12289 E:12295 ||| DT
observed  ||| S:12295 E:12304 ||| NN
inside  ||| S:12304 E:12311 ||| IN
the  ||| S:12311 E:12315 ||| DT
nucleus ||| S:12315 E:12322 ||| NN
,  ||| S:12322 E:12324 ||| ,
except  ||| S:12324 E:12331 ||| IN
that  ||| S:12331 E:12336 ||| WDT
they  ||| S:12336 E:12341 ||| PRP
were  ||| S:12341 E:12356 ||| VBD
larger ||| S:12356 E:12362 ||| JJR
,  ||| S:12362 E:12364 ||| ,
with  ||| S:12364 E:12369 ||| IN
a  ||| S:12369 E:12371 ||| DT
diameter  ||| S:12371 E:12380 ||| JJ
2-3  ||| S:12380 E:12384 ||| CD
times  ||| S:12384 E:12390 ||| NNS
that  ||| S:12390 E:12395 ||| IN
of  ||| S:12395 E:12398 ||| IN
the  ||| S:12398 E:12402 ||| DT
nuclear  ||| S:12402 E:12420 ||| JJ
particles  ||| S:12420 E:12430 ||| NNS
( ||| S:12430 E:12431 ||| -LRB-
Fig.  ||| S:12431 E:12436 ||| NNP
3D ||| S:12436 E:12438 ||| NNP
) ||| S:12438 E:12439 ||| -RRB-
.  ||| S:12439 E:12441 ||| .
Such  ||| S:12441 E:12446 ||| JJ
structures  ||| S:12446 E:12457 ||| NNS
were  ||| S:12457 E:12462 ||| VBD
never  ||| S:12462 E:12468 ||| RB
observed  ||| S:12468 E:12487 ||| VBN
in  ||| S:12487 E:12490 ||| IN
cells  ||| S:12490 E:12496 ||| NNS
expressing  ||| S:12496 E:12507 ||| VBG
mycRab24wt  ||| S:12507 E:12518 ||| NNP
or  ||| S:12518 E:12521 ||| CC
any  ||| S:12521 E:12525 ||| DT
other  ||| S:12525 E:12541 ||| JJ
over-expressed  ||| S:12541 E:12556 ||| JJ
Rab  ||| S:12556 E:12560 ||| NNP
GTPase ||| S:12560 E:12566 ||| NNP
.  ||| S:12566 E:12596 ||| .
Disruption  ||| S:12596 E:12607 ||| NN
of  ||| S:12607 E:12610 ||| IN
nuclear  ||| S:12610 E:12618 ||| JJ
architecture  ||| S:12618 E:12631 ||| NN
by  ||| S:12631 E:12634 ||| IN
inclusions  ||| S:12634 E:12655 ||| FW
containing  ||| S:12655 E:12666 ||| FW
Rab24 ||| S:12666 E:12671 ||| FW
( ||| S:12671 E:12672 ||| -LRB-
D123I ||| S:12672 E:12677 ||| NNP
)  ||| S:12677 E:12689 ||| -RRB-
The  ||| S:12689 E:12693 ||| DT
accumulation  ||| S:12693 E:12706 ||| NN
of  ||| S:12706 E:12709 ||| IN
nuclear  ||| S:12709 E:12717 ||| JJ
inclusions  ||| S:12717 E:12728 ||| NN
in  ||| S:12728 E:12731 ||| IN
cells  ||| S:12731 E:12747 ||| NNS
expressing  ||| S:12747 E:12758 ||| VBG
Rab24 ||| S:12758 E:12763 ||| NNP
( ||| S:12763 E:12764 ||| -LRB-
D123I ||| S:12764 E:12769 ||| NNP
)  ||| S:12769 E:12771 ||| -RRB-
led  ||| S:12771 E:12775 ||| VBD
to  ||| S:12775 E:12778 ||| TO
progressive  ||| S:12778 E:12790 ||| JJ
degeneration  ||| S:12790 E:12813 ||| NN
of  ||| S:12813 E:12816 ||| IN
nuclear  ||| S:12816 E:12824 ||| JJ
structure ||| S:12824 E:12833 ||| NN
.  ||| S:12833 E:12835 ||| .
Figure  ||| S:12835 E:12842 ||| NN
4shows  ||| S:12842 E:12849 ||| VBZ
a  ||| S:12849 E:12851 ||| DT
series  ||| S:12851 E:12858 ||| NN
of  ||| S:12858 E:12871 ||| IN
representative  ||| S:12871 E:12886 ||| JJ
photographs  ||| S:12886 E:12898 ||| NNS
of  ||| S:12898 E:12901 ||| IN
transfected  ||| S:12901 E:12913 ||| CD
3T3  ||| S:12913 E:12917 ||| CD
cells  ||| S:12917 E:12923 ||| NNS
that  ||| S:12923 E:12938 ||| WDT
were  ||| S:12938 E:12943 ||| VBD
co-stained  ||| S:12943 E:12954 ||| JJ
with  ||| S:12954 E:12959 ||| IN
antibody  ||| S:12959 E:12968 ||| NN
against  ||| S:12968 E:12976 ||| IN
the  ||| S:12976 E:12980 ||| DT
Rab24  ||| S:12980 E:12986 ||| FW
myc  ||| S:12986 E:13000 ||| FW
epitope ||| S:13000 E:13007 ||| FW
,  ||| S:13007 E:13009 ||| ,
combined  ||| S:13009 E:13018 ||| VBN
with  ||| S:13018 E:13023 ||| IN
DAPI  ||| S:13023 E:13028 ||| NNP
to  ||| S:13028 E:13031 ||| TO
visualize  ||| S:13031 E:13041 ||| VB
the  ||| S:13041 E:13045 ||| DT
chromatin  ||| S:13045 E:13065 ||| NN
( ||| S:13065 E:13066 ||| -LRB-
Fig.  ||| S:13066 E:13071 ||| NNP
4A ||| S:13071 E:13073 ||| NNP
) ||| S:13073 E:13074 ||| -RRB-
,  ||| S:13074 E:13076 ||| ,
or  ||| S:13076 E:13079 ||| CC
an  ||| S:13079 E:13082 ||| DT
antibody  ||| S:13082 E:13091 ||| NN
against  ||| S:13091 E:13099 ||| IN
lamins  ||| S:13099 E:13106 ||| JJ
A  ||| S:13106 E:13108 ||| NN
and  ||| S:13108 E:13112 ||| CC
B  ||| S:13112 E:13114 ||| NNP
to  ||| S:13114 E:13127 ||| TO
visualize  ||| S:13127 E:13137 ||| VB
the  ||| S:13137 E:13141 ||| DT
nuclear  ||| S:13141 E:13149 ||| JJ
envelope  ||| S:13149 E:13158 ||| NN
( ||| S:13158 E:13159 ||| -LRB-
Fig.  ||| S:13159 E:13164 ||| NNP
4B ||| S:13164 E:13166 ||| NNP
) ||| S:13166 E:13167 ||| -RRB-
.  ||| S:13167 E:13169 ||| .
At  ||| S:13169 E:13172 ||| IN
24  ||| S:13172 E:13175 ||| CD
h  ||| S:13175 E:13177 ||| NN
after  ||| S:13177 E:13193 ||| IN
transfection ||| S:13193 E:13205 ||| NN
,  ||| S:13205 E:13207 ||| ,
we  ||| S:13207 E:13210 ||| PRP
observed  ||| S:13210 E:13219 ||| VBD
many  ||| S:13219 E:13224 ||| JJ
cells  ||| S:13224 E:13230 ||| NNS
with  ||| S:13230 E:13245 ||| IN
mycRab24-positive  ||| S:13245 E:13263 ||| CD
inclusions  ||| S:13263 E:13274 ||| NNS
that  ||| S:13274 E:13279 ||| WDT
showed  ||| S:13279 E:13286 ||| VBD
fairly  ||| S:13286 E:13293 ||| RB
uniform  ||| S:13293 E:13311 ||| JJ
staining  ||| S:13311 E:13320 ||| NN
of  ||| S:13320 E:13323 ||| IN
the  ||| S:13323 E:13327 ||| DT
nuclear  ||| S:13327 E:13335 ||| JJ
envelope  ||| S:13335 E:13344 ||| NN
with  ||| S:13344 E:13349 ||| IN
no  ||| S:13349 E:13352 ||| DT
loss  ||| S:13352 E:13357 ||| NN
of  ||| S:13357 E:13370 ||| IN
chromatin  ||| S:13370 E:13380 ||| NN
or  ||| S:13380 E:13383 ||| CC
deformation  ||| S:13383 E:13395 ||| NN
of  ||| S:13395 E:13398 ||| IN
nuclear  ||| S:13398 E:13406 ||| JJ
shape ||| S:13406 E:13411 ||| NN
.  ||| S:13411 E:13413 ||| .
However ||| S:13413 E:13420 ||| RB
,  ||| S:13420 E:13422 ||| ,
in  ||| S:13422 E:13435 ||| IN
some  ||| S:13435 E:13440 ||| DT
cells  ||| S:13440 E:13446 ||| NNS
with  ||| S:13446 E:13451 ||| IN
larger  ||| S:13451 E:13458 ||| JJR
and  ||| S:13458 E:13462 ||| CC
more  ||| S:13462 E:13467 ||| RBR
numerous  ||| S:13467 E:13476 ||| JJ
inclusions  ||| S:13476 E:13487 ||| NN
we  ||| S:13487 E:13500 ||| PRP
observed  ||| S:13500 E:13509 ||| VBD
discontinuities  ||| S:13509 E:13525 ||| VBN
in  ||| S:13525 E:13528 ||| IN
the  ||| S:13528 E:13532 ||| DT
anti-lamin  ||| S:13532 E:13543 ||| JJ
staining  ||| S:13543 E:13552 ||| NN
of  ||| S:13552 E:13565 ||| IN
the  ||| S:13565 E:13569 ||| DT
nuclear  ||| S:13569 E:13577 ||| JJ
envelope  ||| S:13577 E:13586 ||| NN
and  ||| S:13586 E:13590 ||| CC
some  ||| S:13590 E:13595 ||| DT
co-localization  ||| S:13595 E:13611 ||| JJ
of  ||| S:13611 E:13614 ||| IN
lamin  ||| S:13614 E:13630 ||| NN
with  ||| S:13630 E:13635 ||| IN
mycRab24 ||| S:13635 E:13643 ||| NNP
( ||| S:13643 E:13644 ||| -LRB-
D123I ||| S:13644 E:13649 ||| NNP
)  ||| S:13649 E:13651 ||| -RRB-
in  ||| S:13651 E:13654 ||| IN
the  ||| S:13654 E:13658 ||| DT
intranuclear  ||| S:13658 E:13671 ||| JJ
aggregates ||| S:13671 E:13681 ||| NNS
.  ||| S:13681 E:13683 ||| .
The  ||| S:13683 E:13697 ||| DT
gaps  ||| S:13697 E:13702 ||| NN
in  ||| S:13702 E:13705 ||| IN
the  ||| S:13705 E:13709 ||| DT
nuclear  ||| S:13709 E:13717 ||| JJ
membrane  ||| S:13717 E:13726 ||| NN
were  ||| S:13726 E:13731 ||| VBD
clearly  ||| S:13731 E:13739 ||| RB
visible  ||| S:13739 E:13747 ||| JJ
in  ||| S:13747 E:13760 ||| IN
electron  ||| S:13760 E:13769 ||| JJ
micrographs  ||| S:13769 E:13781 ||| NN
of  ||| S:13781 E:13784 ||| IN
cells  ||| S:13784 E:13790 ||| NNS
with  ||| S:13790 E:13795 ||| IN
large  ||| S:13795 E:13801 ||| JJ
numbers  ||| S:13801 E:13809 ||| NNS
of  ||| S:13809 E:13822 ||| IN
intranuclear  ||| S:13822 E:13835 ||| JJ
aggregates  ||| S:13835 E:13846 ||| NNS
( ||| S:13846 E:13847 ||| -LRB-
Fig.  ||| S:13847 E:13852 ||| NNP
3C ||| S:13852 E:13854 ||| NNP
) ||| S:13854 E:13855 ||| -RRB-
.  ||| S:13855 E:13857 ||| .
In  ||| S:13857 E:13860 ||| IN
the  ||| S:13860 E:13864 ||| DT
most  ||| S:13864 E:13869 ||| RBS
extreme  ||| S:13869 E:13887 ||| JJ
cases ||| S:13887 E:13892 ||| NNS
,  ||| S:13892 E:13894 ||| ,
the  ||| S:13894 E:13898 ||| DT
nuclear  ||| S:13898 E:13906 ||| JJ
envelope  ||| S:13906 E:13915 ||| NN
was  ||| S:13915 E:13919 ||| VBD
significantly  ||| S:13919 E:13933 ||| RB
distorted  ||| S:13933 E:13953 ||| VBN
and  ||| S:13953 E:13957 ||| CC
fragmented  ||| S:13957 E:13968 ||| JJ
and  ||| S:13968 E:13972 ||| CC
there  ||| S:13972 E:13978 ||| EX
was  ||| S:13978 E:13982 ||| VBD
leakage  ||| S:13982 E:13990 ||| VBN
of  ||| S:13990 E:13993 ||| IN
chromatin  ||| S:13993 E:14003 ||| NN
into  ||| S:14003 E:14018 ||| IN
the  ||| S:14018 E:14022 ||| DT
cytoplasm  ||| S:14022 E:14032 ||| NN
( ||| S:14032 E:14033 ||| -LRB-
Fig.  ||| S:14033 E:14038 ||| NNP
4A ||| S:14038 E:14040 ||| NNP
&  ||| S:14040 E:14042 ||| CC
4B ||| S:14042 E:14044 ||| NNP
,  ||| S:14044 E:14046 ||| ,
lower  ||| S:14046 E:14052 ||| JJR
panels ||| S:14052 E:14058 ||| NNS
) ||| S:14058 E:14059 ||| -RRB-
.  ||| S:14059 E:14061 ||| .
The  ||| S:14061 E:14065 ||| DT
number  ||| S:14065 E:14082 ||| NN
of  ||| S:14082 E:14085 ||| IN
cells  ||| S:14085 E:14091 ||| NNS
with  ||| S:14091 E:14096 ||| IN
obvious  ||| S:14096 E:14104 ||| JJ
nuclear  ||| S:14104 E:14112 ||| JJ
disruption  ||| S:14112 E:14123 ||| NN
increased  ||| S:14123 E:14133 ||| VBN
with  ||| S:14133 E:14148 ||| IN
time ||| S:14148 E:14152 ||| NN
,  ||| S:14152 E:14154 ||| ,
so  ||| S:14154 E:14157 ||| RB
that  ||| S:14157 E:14162 ||| IN
by  ||| S:14162 E:14165 ||| IN
48-h  ||| S:14165 E:14170 ||| CD
this  ||| S:14170 E:14175 ||| DT
was  ||| S:14175 E:14179 ||| VBD
seen  ||| S:14179 E:14184 ||| VBN
in  ||| S:14184 E:14187 ||| IN
the  ||| S:14187 E:14191 ||| DT
majority  ||| S:14191 E:14200 ||| NN
of  ||| S:14200 E:14213 ||| IN
the  ||| S:14213 E:14217 ||| DT
transfected  ||| S:14217 E:14229 ||| JJ
cells  ||| S:14229 E:14235 ||| NNS
( ||| S:14235 E:14236 ||| -LRB-
not  ||| S:14236 E:14240 ||| RB
shown ||| S:14240 E:14245 ||| VBN
) ||| S:14245 E:14246 ||| -RRB-
.  ||| S:14246 E:14258 ||| .
The  ||| S:14258 E:14262 ||| DT
morphological  ||| S:14262 E:14276 ||| JJ
changes  ||| S:14276 E:14284 ||| NNS
occurring  ||| S:14284 E:14294 ||| VBG
in  ||| S:14294 E:14297 ||| IN
cells  ||| S:14297 E:14303 ||| NNS
with  ||| S:14303 E:14318 ||| IN
accumulated  ||| S:14318 E:14330 ||| CD
Rab24 ||| S:14330 E:14335 ||| CD
( ||| S:14335 E:14336 ||| -LRB-
D123I ||| S:14336 E:14341 ||| NNP
)  ||| S:14341 E:14343 ||| -RRB-
inclusions  ||| S:14343 E:14354 ||| NN
did  ||| S:14354 E:14358 ||| VBD
not  ||| S:14358 E:14362 ||| RB
match  ||| S:14362 E:14368 ||| VB
the  ||| S:14368 E:14382 ||| DT
hallmark  ||| S:14382 E:14391 ||| JJ
features  ||| S:14391 E:14400 ||| NNS
of  ||| S:14400 E:14403 ||| IN
apoptosis  ||| S:14403 E:14413 ||| NNS
(  ||| S:14413 E:14426 ||| -LRB-
e.g.  ||| S:14426 E:14431 ||| NNP
,  ||| S:14431 E:14433 ||| ,
membrane  ||| S:14433 E:14442 ||| JJ
blebbing ||| S:14442 E:14450 ||| NN
,  ||| S:14450 E:14462 ||| ,
condensation  ||| S:14462 E:14475 ||| VBG
of  ||| S:14475 E:14478 ||| IN
chromatin  ||| S:14478 E:14488 ||| NN
at  ||| S:14488 E:14491 ||| IN
the  ||| S:14491 E:14495 ||| DT
nuclear  ||| S:14495 E:14503 ||| JJ
periphery ||| S:14503 E:14512 ||| NN
) ||| S:14512 E:14513 ||| -RRB-
.  ||| S:14513 E:14515 ||| .
This  ||| S:14515 E:14530 ||| DT
was  ||| S:14530 E:14534 ||| VBD
confirmed  ||| S:14534 E:14544 ||| VBN
by  ||| S:14544 E:14547 ||| IN
TUNEL  ||| S:14547 E:14553 ||| NNP
assays  ||| S:14553 E:14560 ||| NN
where  ||| S:14560 E:14566 ||| WRB
cells  ||| S:14566 E:14572 ||| NNS
at  ||| S:14572 E:14575 ||| IN
various  ||| S:14575 E:14593 ||| JJ
stages  ||| S:14593 E:14600 ||| NNS
of  ||| S:14600 E:14603 ||| IN
nuclear  ||| S:14603 E:14611 ||| JJ
inclusion  ||| S:14611 E:14621 ||| NN
body  ||| S:14621 E:14626 ||| NN
accumulation  ||| S:14626 E:14639 ||| NN
showed  ||| S:14639 E:14646 ||| VBD
no  ||| S:14646 E:14659 ||| DT
evidence  ||| S:14659 E:14668 ||| NN
of  ||| S:14668 E:14671 ||| IN
DNA  ||| S:14671 E:14675 ||| NNP
fragmentation ||| S:14675 E:14688 ||| NN
,  ||| S:14688 E:14690 ||| ,
either  ||| S:14690 E:14697 ||| CC
before  ||| S:14697 E:14704 ||| RB
or  ||| S:14704 E:14707 ||| CC
after  ||| S:14707 E:14723 ||| IN
disruption  ||| S:14723 E:14734 ||| NN
of  ||| S:14734 E:14737 ||| IN
the  ||| S:14737 E:14741 ||| DT
nuclear  ||| S:14741 E:14749 ||| JJ
envelope  ||| S:14749 E:14758 ||| NN
( ||| S:14758 E:14759 ||| -LRB-
Fig.  ||| S:14759 E:14764 ||| NNP
5A ||| S:14764 E:14766 ||| NNP
) ||| S:14766 E:14767 ||| -RRB-
.  ||| S:14767 E:14769 ||| .
In  ||| S:14769 E:14782 ||| IN
contrast ||| S:14782 E:14790 ||| NN
,  ||| S:14790 E:14792 ||| ,
TUNEL-positive  ||| S:14792 E:14807 ||| JJ
cells  ||| S:14807 E:14813 ||| NNS
were  ||| S:14813 E:14818 ||| VBD
readily  ||| S:14818 E:14826 ||| RB
detected  ||| S:14826 E:14835 ||| VBN
in  ||| S:14835 E:14848 ||| IN
parallel  ||| S:14848 E:14857 ||| JJ
cultures  ||| S:14857 E:14866 ||| NNS
where  ||| S:14866 E:14872 ||| WRB
apoptosis  ||| S:14872 E:14882 ||| NNS
was  ||| S:14882 E:14886 ||| VBD
induced  ||| S:14886 E:14894 ||| VBN
by  ||| S:14894 E:14907 ||| IN
treatment  ||| S:14907 E:14917 ||| NN
with  ||| S:14917 E:14922 ||| IN
staurosporine  ||| S:14922 E:14936 ||| NNS
( ||| S:14936 E:14937 ||| -LRB-
Fig.  ||| S:14937 E:14942 ||| NNP
5B ||| S:14942 E:14944 ||| NNP
) ||| S:14944 E:14945 ||| -RRB-
.  ||| S:14945 E:14975 ||| .
Rab24 ||| S:14975 E:14980 ||| NNP
( ||| S:14980 E:14981 ||| -LRB-
D123I ||| S:14981 E:14986 ||| NNP
)  ||| S:14986 E:14988 ||| -RRB-
disrupts  ||| S:14988 E:14997 ||| JJ
nuclear  ||| S:14997 E:15005 ||| JJ
import  ||| S:15005 E:15012 ||| NN
of  ||| S:15012 E:15025 ||| IN
glucocorticoid  ||| S:15025 E:15040 ||| JJ
receptor  ||| S:15040 E:15059 ||| NN
Rab24  ||| S:15059 E:15065 ||| NN
contains  ||| S:15065 E:15074 ||| VBZ
a  ||| S:15074 E:15076 ||| DT
unique  ||| S:15076 E:15083 ||| JJ
arginine-rich  ||| S:15083 E:15097 ||| JJ
insert ||| S:15097 E:15103 ||| NN
,  ||| S:15103 E:15115 ||| ,
126EEDRRRRR  ||| S:15115 E:15127 ||| CD
133  ||| S:15127 E:15131 ||| CD
[  ||| S:15131 E:15133 ||| -LRB-
25  ||| S:15133 E:15136 ||| CD
]  ||| S:15136 E:15138 ||| -RRB-
in  ||| S:15138 E:15141 ||| IN
the  ||| S:15141 E:15145 ||| DT
domain  ||| S:15145 E:15152 ||| NN
cognate  ||| S:15152 E:15160 ||| NN
to  ||| S:15160 E:15163 ||| TO
loop-8  ||| S:15163 E:15170 ||| CD
in  ||| S:15170 E:15183 ||| IN
H-Ras  ||| S:15183 E:15189 ||| NNP
[  ||| S:15189 E:15191 ||| -LRB-
34  ||| S:15191 E:15194 ||| CD
]  ||| S:15194 E:15196 ||| -RRB-
.  ||| S:15196 E:15198 ||| .
The  ||| S:15198 E:15202 ||| DT
latter  ||| S:15202 E:15209 ||| JJ
sequence  ||| S:15209 E:15218 ||| NN
is  ||| S:15218 E:15221 ||| VBZ
reminiscent  ||| S:15221 E:15233 ||| VBN
of  ||| S:15233 E:15246 ||| IN
unusual  ||| S:15246 E:15254 ||| JJ
arginine-rich  ||| S:15254 E:15268 ||| JJ
nuclear  ||| S:15268 E:15276 ||| JJ
localization  ||| S:15276 E:15289 ||| JJ
signals  ||| S:15289 E:15297 ||| NNS
that  ||| S:15297 E:15312 ||| WDT
allow  ||| S:15312 E:15318 ||| VBP
proteins  ||| S:15318 E:15327 ||| NNS
like  ||| S:15327 E:15332 ||| IN
HIV  ||| S:15332 E:15347 ||| NNP
tet  ||| S:15347 E:15351 ||| NN
and  ||| S:15351 E:15366 ||| CC
rev  ||| S:15366 E:15370 ||| JJ
to  ||| S:15370 E:15373 ||| TO
undergo  ||| S:15373 E:15381 ||| VB
nuclear  ||| S:15381 E:15399 ||| JJ
translocation  ||| S:15399 E:15413 ||| NN
by  ||| S:15413 E:15416 ||| IN
association  ||| S:15416 E:15428 ||| NN
with  ||| S:15428 E:15433 ||| IN
importin-β ||| S:15433 E:15443 ||| NNP
,  ||| S:15443 E:15445 ||| ,
in  ||| S:15445 E:15448 ||| IN
the  ||| S:15448 E:15462 ||| DT
absence  ||| S:15462 E:15470 ||| NN
of  ||| S:15470 E:15473 ||| IN
importin-α  ||| S:15473 E:15484 ||| NNP
[  ||| S:15484 E:15486 ||| -LRB-
45  ||| S:15486 E:15489 ||| CD
46  ||| S:15489 E:15492 ||| CD
]  ||| S:15492 E:15494 ||| -RRB-
.  ||| S:15494 E:15496 ||| .
Since  ||| S:15496 E:15502 ||| IN
the  ||| S:15502 E:15506 ||| DT
loop-8  ||| S:15506 E:15513 ||| JJ
insert  ||| S:15513 E:15530 ||| NN
in  ||| S:15530 E:15533 ||| IN
Rab24  ||| S:15533 E:15539 ||| NNP
lies  ||| S:15539 E:15544 ||| VBZ
adjacent  ||| S:15544 E:15553 ||| JJ
to  ||| S:15553 E:15556 ||| TO
the  ||| S:15556 E:15560 ||| DT
conserved  ||| S:15560 E:15570 ||| JJ
N ||| S:15570 E:15571 ||| NNP
( ||| S:15571 E:15572 ||| -LRB-
T ||| S:15572 E:15573 ||| NN
) ||| S:15573 E:15574 ||| -RRB-
KxD  ||| S:15574 E:15588 ||| JJ
nucleotide  ||| S:15588 E:15599 ||| JJ
binding  ||| S:15599 E:15607 ||| JJ
cassette ||| S:15607 E:15615 ||| NN
,  ||| S:15615 E:15617 ||| ,
we  ||| S:15617 E:15620 ||| PRP
hypothesized  ||| S:15620 E:15633 ||| VBD
that  ||| S:15633 E:15648 ||| DT
conformational  ||| S:15648 E:15663 ||| JJ
changes  ||| S:15663 E:15671 ||| NNS
caused  ||| S:15671 E:15678 ||| VBN
by  ||| S:15678 E:15681 ||| IN
the  ||| S:15681 E:15685 ||| DT
D123I  ||| S:15685 E:15691 ||| JJ
substitution  ||| S:15691 E:15714 ||| NN
might  ||| S:15714 E:15720 ||| MD
render  ||| S:15720 E:15727 ||| VB
the  ||| S:15727 E:15731 ||| DT
Rab24  ||| S:15731 E:15737 ||| JJ
mutant  ||| S:15737 E:15744 ||| JJ
capable  ||| S:15744 E:15752 ||| JJ
of  ||| S:15752 E:15755 ||| IN
disrupting  ||| S:15755 E:15766 ||| VBG
the  ||| S:15766 E:15780 ||| DT
nuclear  ||| S:15780 E:15788 ||| JJ
import  ||| S:15788 E:15795 ||| NN
machinery  ||| S:15795 E:15805 ||| NN
[  ||| S:15805 E:15807 ||| -LRB-
47  ||| S:15807 E:15810 ||| CD
]  ||| S:15810 E:15812 ||| -RRB-
.  ||| S:15812 E:15814 ||| .
To  ||| S:15814 E:15817 ||| TO
test  ||| S:15817 E:15822 ||| VB
this  ||| S:15822 E:15837 ||| DT
possibility ||| S:15837 E:15848 ||| NN
,  ||| S:15848 E:15850 ||| ,
we  ||| S:15850 E:15853 ||| PRP
co-expressed  ||| S:15853 E:15866 ||| JJ
mycRab24wt  ||| S:15866 E:15877 ||| NN
or  ||| S:15877 E:15890 ||| CC
mycRab24 ||| S:15890 E:15898 ||| NNP
( ||| S:15898 E:15899 ||| -LRB-
D123I ||| S:15899 E:15904 ||| NNP
)  ||| S:15904 E:15906 ||| -RRB-
with  ||| S:15906 E:15911 ||| IN
GR-GFP ||| S:15911 E:15917 ||| NNP
,  ||| S:15917 E:15919 ||| ,
a  ||| S:15919 E:15921 ||| DT
fusion  ||| S:15921 E:15928 ||| NN
between  ||| S:15928 E:15936 ||| IN
the  ||| S:15936 E:15950 ||| DT
glucocorticoid  ||| S:15950 E:15965 ||| JJ
receptor  ||| S:15965 E:15974 ||| NN
and  ||| S:15974 E:15978 ||| CC
green  ||| S:15978 E:15984 ||| JJ
fluorescent  ||| S:15984 E:15996 ||| JJ
protein ||| S:15996 E:16003 ||| NN
.  ||| S:16003 E:16015 ||| .
This  ||| S:16015 E:16020 ||| DT
protein  ||| S:16020 E:16028 ||| NN
contains  ||| S:16028 E:16037 ||| VBZ
a  ||| S:16037 E:16039 ||| DT
prototypical  ||| S:16039 E:16052 ||| JJ
nuclear  ||| S:16052 E:16060 ||| JJ
localization  ||| S:16060 E:16083 ||| JJ
signal  ||| S:16083 E:16090 ||| NN
but  ||| S:16090 E:16094 ||| CC
remains  ||| S:16094 E:16102 ||| VBZ
in  ||| S:16102 E:16105 ||| IN
the  ||| S:16105 E:16109 ||| DT
cytoplasm  ||| S:16109 E:16119 ||| NN
when  ||| S:16119 E:16124 ||| WRB
expressed  ||| S:16124 E:16134 ||| VBN
in  ||| S:16134 E:16147 ||| IN
cultured  ||| S:16147 E:16156 ||| JJ
cells  ||| S:16156 E:16162 ||| NNS
in  ||| S:16162 E:16165 ||| IN
the  ||| S:16165 E:16169 ||| DT
absence  ||| S:16169 E:16177 ||| NN
of  ||| S:16177 E:16180 ||| IN
steroids ||| S:16180 E:16188 ||| NNS
.  ||| S:16188 E:16190 ||| .
Upon  ||| S:16190 E:16195 ||| IN
addition  ||| S:16195 E:16214 ||| NN
of  ||| S:16214 E:16217 ||| IN
1  ||| S:16217 E:16219 ||| CD
μM  ||| S:16219 E:16222 ||| JJ
dexamethasone  ||| S:16222 E:16236 ||| NNS
( ||| S:16236 E:16237 ||| -LRB-
Dex ||| S:16237 E:16240 ||| NNP
)  ||| S:16240 E:16242 ||| -RRB-
the  ||| S:16242 E:16246 ||| DT
receptor  ||| S:16246 E:16255 ||| NN
is  ||| S:16255 E:16258 ||| VBZ
translocated  ||| S:16258 E:16281 ||| VBN
into  ||| S:16281 E:16286 ||| IN
the  ||| S:16286 E:16290 ||| DT
nucleus  ||| S:16290 E:16298 ||| NN
within  ||| S:16298 E:16305 ||| IN
10  ||| S:16305 E:16308 ||| CD
min  ||| S:16308 E:16312 ||| NNS
[  ||| S:16312 E:16314 ||| -LRB-
48  ||| S:16314 E:16317 ||| CD
]  ||| S:16317 E:16319 ||| -RRB-
.  ||| S:16319 E:16321 ||| .
When  ||| S:16321 E:16326 ||| WRB
GR-GFP  ||| S:16326 E:16333 ||| NNP
was  ||| S:16333 E:16347 ||| VBD
co-expressed  ||| S:16347 E:16360 ||| JJ
with  ||| S:16360 E:16365 ||| IN
the  ||| S:16365 E:16369 ||| DT
wild-type  ||| S:16369 E:16379 ||| JJ
Rab24  ||| S:16379 E:16385 ||| NN
in  ||| S:16385 E:16388 ||| IN
NIH3T3  ||| S:16388 E:16395 ||| CD
cells ||| S:16395 E:16400 ||| NNS
,  ||| S:16400 E:16402 ||| ,
we  ||| S:16402 E:16415 ||| PRP
observed  ||| S:16415 E:16424 ||| VBD
normal  ||| S:16424 E:16431 ||| JJ
ligand-dependent  ||| S:16431 E:16448 ||| JJ
translocation  ||| S:16448 E:16462 ||| NN
of  ||| S:16462 E:16465 ||| IN
GR-GFP  ||| S:16465 E:16482 ||| JJ
into  ||| S:16482 E:16487 ||| IN
the  ||| S:16487 E:16491 ||| DT
nucleus  ||| S:16491 E:16499 ||| NN
when  ||| S:16499 E:16504 ||| WRB
Dex  ||| S:16504 E:16508 ||| NNP
was  ||| S:16508 E:16512 ||| VBD
applied  ||| S:16512 E:16520 ||| VBN
( ||| S:16520 E:16521 ||| -LRB-
Fig.  ||| S:16521 E:16526 ||| NNP
6A ||| S:16526 E:16528 ||| NNP
) ||| S:16528 E:16529 ||| -RRB-
.  ||| S:16529 E:16531 ||| .
However ||| S:16531 E:16538 ||| RB
,  ||| S:16538 E:16550 ||| ,
when  ||| S:16550 E:16555 ||| WRB
GR-GFP  ||| S:16555 E:16562 ||| NNP
was  ||| S:16562 E:16566 ||| VBD
coexpressed  ||| S:16566 E:16578 ||| VBN
with  ||| S:16578 E:16583 ||| IN
mycRab24 ||| S:16583 E:16591 ||| NNP
( ||| S:16591 E:16592 ||| -LRB-
D123I ||| S:16592 E:16597 ||| NNP
)  ||| S:16597 E:16599 ||| -RRB-
there  ||| S:16599 E:16615 ||| EX
was  ||| S:16615 E:16619 ||| VBD
a  ||| S:16619 E:16621 ||| DT
striking  ||| S:16621 E:16630 ||| JJ
perturbation  ||| S:16630 E:16643 ||| NN
of  ||| S:16643 E:16646 ||| IN
receptor  ||| S:16646 E:16655 ||| JJ
localization ||| S:16655 E:16667 ||| NN
.  ||| S:16667 E:16679 ||| .
Instead  ||| S:16679 E:16687 ||| RB
of  ||| S:16687 E:16690 ||| IN
remaining  ||| S:16690 E:16700 ||| VBG
in  ||| S:16700 E:16703 ||| IN
the  ||| S:16703 E:16707 ||| DT
cytoplasm  ||| S:16707 E:16717 ||| NN
in  ||| S:16717 E:16720 ||| IN
the  ||| S:16720 E:16724 ||| DT
absence  ||| S:16724 E:16732 ||| NN
of  ||| S:16732 E:16745 ||| IN
steroid ||| S:16745 E:16752 ||| NN
,  ||| S:16752 E:16754 ||| ,
nearly  ||| S:16754 E:16761 ||| RB
all  ||| S:16761 E:16765 ||| RB
of  ||| S:16765 E:16768 ||| IN
the  ||| S:16768 E:16772 ||| DT
GR-GFP  ||| S:16772 E:16779 ||| NN
was  ||| S:16779 E:16783 ||| VBD
found  ||| S:16783 E:16789 ||| VBN
in  ||| S:16789 E:16792 ||| IN
the  ||| S:16792 E:16806 ||| DT
cytoplasmic  ||| S:16806 E:16818 ||| NN
and  ||| S:16818 E:16822 ||| CC
nuclear  ||| S:16822 E:16830 ||| JJ
inclusion  ||| S:16830 E:16840 ||| NN
bodies  ||| S:16840 E:16847 ||| NNS
containing  ||| S:16847 E:16858 ||| VBG
the  ||| S:16858 E:16872 ||| DT
Rab24  ||| S:16872 E:16878 ||| CD
mutant  ||| S:16878 E:16885 ||| NNS
( ||| S:16885 E:16886 ||| -LRB-
Fig.  ||| S:16886 E:16891 ||| NNP
6A ||| S:16891 E:16893 ||| NNP
) ||| S:16893 E:16894 ||| -RRB-
.  ||| S:16894 E:16896 ||| .
The  ||| S:16896 E:16900 ||| DT
latter  ||| S:16900 E:16907 ||| JJ
point  ||| S:16907 E:16913 ||| NN
is  ||| S:16913 E:16916 ||| VBZ
clearly  ||| S:16916 E:16934 ||| RB
illustrated  ||| S:16934 E:16946 ||| VBN
by  ||| S:16946 E:16949 ||| IN
the  ||| S:16949 E:16953 ||| DT
overlap  ||| S:16953 E:16961 ||| NN
of  ||| S:16961 E:16964 ||| IN
GR-GFP  ||| S:16964 E:16971 ||| NNP
( ||| S:16971 E:16972 ||| -LRB-
green ||| S:16972 E:16977 ||| JJ
)  ||| S:16977 E:16979 ||| -RRB-
fluorescence  ||| S:16979 E:17002 ||| NN
with  ||| S:17002 E:17007 ||| IN
rhodamine-IgG  ||| S:17007 E:17021 ||| JJ
staining  ||| S:17021 E:17030 ||| NN
for  ||| S:17030 E:17034 ||| IN
mycRab24 ||| S:17034 E:17042 ||| NNP
( ||| S:17042 E:17043 ||| -LRB-
D123I ||| S:17043 E:17048 ||| NNP
)  ||| S:17048 E:17050 ||| -RRB-
( ||| S:17050 E:17051 ||| -LRB-
red ||| S:17051 E:17054 ||| JJ
)  ||| S:17054 E:17056 ||| -RRB-
in  ||| S:17056 E:17069 ||| IN
Fig.  ||| S:17069 E:17074 ||| CD
6B ||| S:17074 E:17076 ||| CD
.  ||| S:17076 E:17078 ||| .
The  ||| S:17078 E:17082 ||| DT
possibility  ||| S:17082 E:17094 ||| NN
that  ||| S:17094 E:17099 ||| IN
the  ||| S:17099 E:17103 ||| DT
inclusions  ||| S:17103 E:17114 ||| JJ
induced  ||| S:17114 E:17122 ||| NN
by  ||| S:17122 E:17135 ||| IN
mycRab24 ||| S:17135 E:17143 ||| NNP
( ||| S:17143 E:17144 ||| -LRB-
D123I ||| S:17144 E:17149 ||| NNP
)  ||| S:17149 E:17151 ||| -RRB-
contain  ||| S:17151 E:17159 ||| VBP
aggregated  ||| S:17159 E:17170 ||| JJ
nuclear  ||| S:17170 E:17178 ||| JJ
import  ||| S:17178 E:17195 ||| NN
complexes  ||| S:17195 E:17205 ||| NNS
was  ||| S:17205 E:17209 ||| VBD
further  ||| S:17209 E:17217 ||| RB
supported  ||| S:17217 E:17227 ||| VBN
by  ||| S:17227 E:17230 ||| IN
immuno-staining  ||| S:17230 E:17246 ||| JJ
with  ||| S:17246 E:17261 ||| IN
an  ||| S:17261 E:17264 ||| DT
antibody  ||| S:17264 E:17273 ||| NN
against  ||| S:17273 E:17281 ||| IN
importin-β  ||| S:17281 E:17292 ||| NNP
( ||| S:17292 E:17293 ||| -LRB-
karyopherin-β ||| S:17293 E:17306 ||| NNP
) ||| S:17306 E:17307 ||| -RRB-
,  ||| S:17307 E:17309 ||| ,
which  ||| S:17309 E:17325 ||| WDT
revealed  ||| S:17325 E:17334 ||| VBD
focal  ||| S:17334 E:17340 ||| JJ
concentrations  ||| S:17340 E:17355 ||| NNS
of  ||| S:17355 E:17358 ||| IN
importin-β  ||| S:17358 E:17369 ||| JJ
in  ||| S:17369 E:17372 ||| IN
these  ||| S:17372 E:17388 ||| DT
structures  ||| S:17388 E:17399 ||| NNS
( ||| S:17399 E:17400 ||| -LRB-
Fig.  ||| S:17400 E:17405 ||| NNP
7A ||| S:17405 E:17407 ||| NNP
) ||| S:17407 E:17408 ||| -RRB-
.  ||| S:17408 E:17410 ||| .
However ||| S:17410 E:17417 ||| RB
,  ||| S:17417 E:17419 ||| ,
other  ||| S:17419 E:17425 ||| JJ
proteins  ||| S:17425 E:17434 ||| NNS
such  ||| S:17434 E:17439 ||| JJ
as  ||| S:17439 E:17442 ||| IN
Ran  ||| S:17442 E:17456 ||| NNP
binding  ||| S:17456 E:17464 ||| JJ
protein  ||| S:17464 E:17472 ||| NN
( ||| S:17472 E:17473 ||| -LRB-
Fig.  ||| S:17473 E:17478 ||| NNP
7B ||| S:17478 E:17480 ||| NNP
)  ||| S:17480 E:17482 ||| -RRB-
and  ||| S:17482 E:17486 ||| CC
Ran  ||| S:17486 E:17490 ||| NNP
GAP  ||| S:17490 E:17494 ||| NNP
( ||| S:17494 E:17495 ||| -LRB-
not  ||| S:17495 E:17499 ||| RB
shown ||| S:17499 E:17504 ||| VBN
) ||| S:17504 E:17505 ||| -RRB-
,  ||| S:17505 E:17507 ||| ,
which  ||| S:17507 E:17523 ||| WDT
are  ||| S:17523 E:17527 ||| VBP
recruited  ||| S:17527 E:17537 ||| VBN
to  ||| S:17537 E:17540 ||| TO
the  ||| S:17540 E:17544 ||| DT
nuclear  ||| S:17544 E:17552 ||| JJ
import  ||| S:17552 E:17559 ||| NN
complex  ||| S:17559 E:17567 ||| NN
through  ||| S:17567 E:17585 ||| IN
interactions  ||| S:17585 E:17598 ||| NNS
with  ||| S:17598 E:17603 ||| IN
the  ||| S:17603 E:17607 ||| DT
Ran  ||| S:17607 E:17611 ||| NNP
GTPase ||| S:17611 E:17617 ||| NNP
,  ||| S:17617 E:17619 ||| ,
did  ||| S:17619 E:17623 ||| VBD
not  ||| S:17623 E:17627 ||| RB
appear  ||| S:17627 E:17634 ||| VB
to  ||| S:17634 E:17637 ||| TO
be  ||| S:17637 E:17650 ||| VB
present  ||| S:17650 E:17658 ||| JJ
in  ||| S:17658 E:17661 ||| IN
the  ||| S:17661 E:17665 ||| DT
inclusion  ||| S:17665 E:17675 ||| NN
bodies ||| S:17675 E:17681 ||| NNS
.  ||| S:17681 E:17711 ||| .
The  ||| S:17711 E:17715 ||| DT
C-terminal  ||| S:17715 E:17726 ||| JJ
hypervariable  ||| S:17726 E:17740 ||| JJ
domain  ||| S:17740 E:17747 ||| NN
of  ||| S:17747 E:17750 ||| IN
Rab24  ||| S:17750 E:17756 ||| NNP
is  ||| S:17756 E:17769 ||| VBZ
required  ||| S:17769 E:17778 ||| VBN
for  ||| S:17778 E:17782 ||| IN
the  ||| S:17782 E:17786 ||| DT
formation  ||| S:17786 E:17796 ||| NN
of  ||| S:17796 E:17799 ||| IN
inclusions  ||| S:17799 E:17820 ||| VBG
To  ||| S:17820 E:17823 ||| TO
learn  ||| S:17823 E:17829 ||| VB
more  ||| S:17829 E:17834 ||| JJR
about  ||| S:17834 E:17840 ||| IN
the  ||| S:17840 E:17844 ||| DT
structural  ||| S:17844 E:17855 ||| JJ
features  ||| S:17855 E:17864 ||| NNS
of  ||| S:17864 E:17877 ||| IN
Rab24 ||| S:17877 E:17882 ||| NNP
( ||| S:17882 E:17883 ||| -LRB-
D123I ||| S:17883 E:17888 ||| NNP
)  ||| S:17888 E:17890 ||| -RRB-
that  ||| S:17890 E:17895 ||| WDT
are  ||| S:17895 E:17899 ||| VBP
responsible  ||| S:17899 E:17911 ||| JJ
for  ||| S:17911 E:17915 ||| IN
triggering  ||| S:17915 E:17926 ||| VBG
the  ||| S:17926 E:17940 ||| DT
formation  ||| S:17940 E:17950 ||| NN
of  ||| S:17950 E:17953 ||| IN
nuclear  ||| S:17953 E:17961 ||| JJ
inclusions ||| S:17961 E:17971 ||| NN
,  ||| S:17971 E:17973 ||| ,
we  ||| S:17973 E:17976 ||| PRP
focused  ||| S:17976 E:17984 ||| VBD
on  ||| S:17984 E:17987 ||| IN
regions  ||| S:17987 E:17995 ||| NNS
of  ||| S:17995 E:18008 ||| IN
the  ||| S:18008 E:18012 ||| DT
protein  ||| S:18012 E:18020 ||| NN
that  ||| S:18020 E:18025 ||| IN
distinguish  ||| S:18025 E:18037 ||| JJ
Rab24  ||| S:18037 E:18043 ||| NN
from  ||| S:18043 E:18048 ||| IN
other  ||| S:18048 E:18054 ||| JJ
members  ||| S:18054 E:18062 ||| NNS
of  ||| S:18062 E:18075 ||| IN
the  ||| S:18075 E:18079 ||| DT
Rab  ||| S:18079 E:18083 ||| JJ
family ||| S:18083 E:18089 ||| NN
.  ||| S:18089 E:18091 ||| .
We  ||| S:18091 E:18094 ||| PRP
began  ||| S:18094 E:18100 ||| VBD
by  ||| S:18100 E:18103 ||| IN
deleting  ||| S:18103 E:18112 ||| VBG
a  ||| S:18112 E:18114 ||| DT
portion  ||| S:18114 E:18122 ||| NN
of  ||| S:18122 E:18125 ||| IN
the  ||| S:18125 E:18139 ||| DT
loop-8  ||| S:18139 E:18146 ||| JJ
insert ||| S:18146 E:18152 ||| NN
,  ||| S:18152 E:18154 ||| ,
described  ||| S:18154 E:18164 ||| VBN
in  ||| S:18164 E:18167 ||| IN
the  ||| S:18167 E:18171 ||| DT
preceding  ||| S:18171 E:18181 ||| JJ
section ||| S:18181 E:18188 ||| NN
.  ||| S:18188 E:18190 ||| .
Four  ||| S:18190 E:18205 ||| CD
amino  ||| S:18205 E:18211 ||| CD
acids  ||| S:18211 E:18217 ||| NNS
( ||| S:18217 E:18218 ||| -LRB-
ΔEDRR ||| S:18218 E:18223 ||| NNP
)  ||| S:18223 E:18225 ||| -RRB-
were  ||| S:18225 E:18230 ||| VBD
removed  ||| S:18230 E:18238 ||| VBN
from  ||| S:18238 E:18243 ||| IN
both  ||| S:18243 E:18248 ||| DT
Rab24 ||| S:18248 E:18253 ||| NNP
( ||| S:18253 E:18254 ||| -LRB-
wt ||| S:18254 E:18256 ||| LS
)  ||| S:18256 E:18258 ||| -RRB-
and  ||| S:18258 E:18272 ||| CC
Rab24 ||| S:18272 E:18277 ||| NNP
( ||| S:18277 E:18278 ||| -LRB-
D123I ||| S:18278 E:18283 ||| NNP
) ||| S:18283 E:18284 ||| -RRB-
.  ||| S:18284 E:18286 ||| .
Immunofluorescent  ||| S:18286 E:18304 ||| JJ
localization  ||| S:18304 E:18317 ||| JJ
studies  ||| S:18317 E:18335 ||| NNS
showed  ||| S:18335 E:18342 ||| VBD
that  ||| S:18342 E:18347 ||| IN
this  ||| S:18347 E:18352 ||| DT
modification  ||| S:18352 E:18365 ||| NN
had  ||| S:18365 E:18369 ||| VBD
no  ||| S:18369 E:18372 ||| DT
effect  ||| S:18372 E:18379 ||| NN
on  ||| S:18379 E:18392 ||| IN
distribution  ||| S:18392 E:18405 ||| NN
of  ||| S:18405 E:18408 ||| IN
the  ||| S:18408 E:18412 ||| DT
wild-type  ||| S:18412 E:18422 ||| JJ
protein  ||| S:18422 E:18430 ||| NN
in  ||| S:18430 E:18433 ||| IN
the  ||| S:18433 E:18437 ||| DT
cytoplasm  ||| S:18437 E:18457 ||| NN
( ||| S:18457 E:18458 ||| -LRB-
Fig.  ||| S:18458 E:18463 ||| NNP
8A ||| S:18463 E:18465 ||| NNP
)  ||| S:18465 E:18467 ||| -RRB-
and ||| S:18467 E:18470 ||| CC
,  ||| S:18470 E:18472 ||| ,
contrary  ||| S:18472 E:18481 ||| JJ
to  ||| S:18481 E:18484 ||| TO
expectations ||| S:18484 E:18496 ||| NNS
,  ||| S:18496 E:18498 ||| ,
did  ||| S:18498 E:18502 ||| VBD
not  ||| S:18502 E:18516 ||| RB
interfere  ||| S:18516 E:18526 ||| VB
with  ||| S:18526 E:18531 ||| IN
the  ||| S:18531 E:18535 ||| DT
accumulation  ||| S:18535 E:18548 ||| NN
of  ||| S:18548 E:18551 ||| IN
the  ||| S:18551 E:18555 ||| DT
D123I  ||| S:18555 E:18561 ||| JJ
mutant  ||| S:18561 E:18568 ||| NN
in  ||| S:18568 E:18581 ||| IN
nuclear  ||| S:18581 E:18589 ||| JJ
inclusions  ||| S:18589 E:18600 ||| NNS
( ||| S:18600 E:18601 ||| -LRB-
Fig.  ||| S:18601 E:18606 ||| NNP
8B ||| S:18606 E:18608 ||| NNP
) ||| S:18608 E:18609 ||| -RRB-
.  ||| S:18609 E:18621 ||| .
The  ||| S:18621 E:18625 ||| DT
second  ||| S:18625 E:18632 ||| JJ
region  ||| S:18632 E:18639 ||| NN
where  ||| S:18639 E:18645 ||| WRB
the  ||| S:18645 E:18649 ||| DT
sequence  ||| S:18649 E:18658 ||| NN
of  ||| S:18658 E:18661 ||| IN
Rab24  ||| S:18661 E:18667 ||| NNP
differs  ||| S:18667 E:18685 ||| VBZ
substantially  ||| S:18685 E:18699 ||| RB
from  ||| S:18699 E:18704 ||| IN
other  ||| S:18704 E:18710 ||| JJ
Rab  ||| S:18710 E:18714 ||| NNP
GTPases  ||| S:18714 E:18722 ||| NNP
is  ||| S:18722 E:18725 ||| VBZ
the  ||| S:18725 E:18729 ||| DT
last  ||| S:18729 E:18734 ||| JJ
38  ||| S:18734 E:18737 ||| CD
amino  ||| S:18737 E:18753 ||| CD
acids  ||| S:18753 E:18759 ||| NNS
of  ||| S:18759 E:18762 ||| IN
the  ||| S:18762 E:18766 ||| DT
C-terminal  ||| S:18766 E:18777 ||| JJ
tail ||| S:18777 E:18781 ||| NN
.  ||| S:18781 E:18783 ||| .
This  ||| S:18783 E:18788 ||| DT
region ||| S:18788 E:18794 ||| NN
,  ||| S:18794 E:18796 ||| ,
commonly  ||| S:18796 E:18815 ||| RB
referred  ||| S:18815 E:18824 ||| VBN
to  ||| S:18824 E:18827 ||| TO
as  ||| S:18827 E:18830 ||| IN
the  ||| S:18830 E:18834 ||| DT
hypervariable  ||| S:18834 E:18848 ||| JJ
domain ||| S:18848 E:18854 ||| NN
,  ||| S:18854 E:18856 ||| ,
plays  ||| S:18856 E:18862 ||| VBZ
a  ||| S:18862 E:18864 ||| DT
major  ||| S:18864 E:18880 ||| JJ
role  ||| S:18880 E:18885 ||| NN
in  ||| S:18885 E:18888 ||| IN
the  ||| S:18888 E:18892 ||| DT
subcellular  ||| S:18892 E:18904 ||| JJ
targeting  ||| S:18904 E:18914 ||| NN
and  ||| S:18914 E:18918 ||| CC
functional  ||| S:18918 E:18939 ||| JJ
specificity  ||| S:18939 E:18951 ||| NN
of  ||| S:18951 E:18954 ||| IN
each  ||| S:18954 E:18959 ||| DT
Rab  ||| S:18959 E:18963 ||| JJ
protein  ||| S:18963 E:18971 ||| NN
[  ||| S:18971 E:18973 ||| -LRB-
49  ||| S:18973 E:18976 ||| CD
]  ||| S:18976 E:18978 ||| -RRB-
.  ||| S:18978 E:18980 ||| .
In  ||| S:18980 E:18983 ||| IN
accord  ||| S:18983 E:18990 ||| NN
with  ||| S:18990 E:19005 ||| IN
this  ||| S:19005 E:19010 ||| DT
view ||| S:19010 E:19014 ||| NN
,  ||| S:19014 E:19016 ||| ,
replacement  ||| S:19016 E:19028 ||| NN
of  ||| S:19028 E:19031 ||| IN
the  ||| S:19031 E:19035 ||| DT
hypervariable  ||| S:19035 E:19049 ||| JJ
domain  ||| S:19049 E:19056 ||| NN
of  ||| S:19056 E:19069 ||| IN
Rab24 ||| S:19069 E:19074 ||| NNP
( ||| S:19074 E:19075 ||| -LRB-
wt ||| S:19075 E:19077 ||| LS
)  ||| S:19077 E:19079 ||| -RRB-
with  ||| S:19079 E:19084 ||| IN
the  ||| S:19084 E:19088 ||| DT
corresponding  ||| S:19088 E:19102 ||| JJ
domain  ||| S:19102 E:19109 ||| NN
from  ||| S:19109 E:19114 ||| IN
Rab1B ||| S:19114 E:19119 ||| NNP
,  ||| S:19119 E:19131 ||| ,
caused  ||| S:19131 E:19138 ||| VBD
the  ||| S:19138 E:19142 ||| DT
resulting  ||| S:19142 E:19152 ||| JJ
chimera  ||| S:19152 E:19160 ||| NN
to  ||| S:19160 E:19163 ||| TO
exhibit  ||| S:19163 E:19171 ||| VB
a  ||| S:19171 E:19173 ||| DT
discrete  ||| S:19173 E:19192 ||| JJ
juxtanuclear  ||| S:19192 E:19205 ||| JJ
Golgi-like  ||| S:19205 E:19216 ||| JJ
fluorescence  ||| S:19216 E:19229 ||| JJ
pattern  ||| S:19229 E:19237 ||| NN
typical  ||| S:19237 E:19245 ||| JJ
of  ||| S:19245 E:19258 ||| IN
Rab1B  ||| S:19258 E:19264 ||| CD
in  ||| S:19264 E:19267 ||| IN
293  ||| S:19267 E:19271 ||| CD
cells  ||| S:19271 E:19277 ||| NNS
[  ||| S:19277 E:19279 ||| -LRB-
50  ||| S:19279 E:19282 ||| CD
51  ||| S:19282 E:19285 ||| CD
]  ||| S:19285 E:19287 ||| -RRB-
.  ||| S:19287 E:19289 ||| .
( ||| S:19289 E:19290 ||| -LRB-
Fig.  ||| S:19290 E:19295 ||| NNP
8C ||| S:19295 E:19297 ||| NNP
) ||| S:19297 E:19298 ||| -RRB-
.  ||| S:19298 E:19300 ||| .
When  ||| S:19300 E:19305 ||| WRB
the  ||| S:19305 E:19309 ||| DT
D123I  ||| S:19309 E:19325 ||| JJ
substitution  ||| S:19325 E:19338 ||| NN
was  ||| S:19338 E:19342 ||| VBD
introduced  ||| S:19342 E:19353 ||| VBN
into  ||| S:19353 E:19358 ||| IN
the  ||| S:19358 E:19362 ||| DT
Rab24  ||| S:19362 E:19368 ||| JJ
portion  ||| S:19368 E:19376 ||| NN
of  ||| S:19376 E:19379 ||| IN
the  ||| S:19379 E:19393 ||| DT
Rab24 ||| S:19393 E:19398 ||| CD
/ ||| S:19398 E:19399 ||| CD
Rab1B  ||| S:19399 E:19405 ||| CD
chimera ||| S:19405 E:19412 ||| NN
,  ||| S:19412 E:19414 ||| ,
the  ||| S:19414 E:19418 ||| DT
protein  ||| S:19418 E:19426 ||| NN
was  ||| S:19426 E:19430 ||| VBD
no  ||| S:19430 E:19433 ||| RB
longer  ||| S:19433 E:19440 ||| RB
targeted  ||| S:19440 E:19459 ||| VBN
to  ||| S:19459 E:19462 ||| TO
inclusion  ||| S:19462 E:19472 ||| VB
bodies  ||| S:19472 E:19479 ||| NNS
( ||| S:19479 E:19480 ||| -LRB-
Fig.  ||| S:19480 E:19485 ||| NNP
8D ||| S:19485 E:19487 ||| NNP
) ||| S:19487 E:19488 ||| -RRB-
,  ||| S:19488 E:19490 ||| ,
but  ||| S:19490 E:19494 ||| CC
instead  ||| S:19494 E:19502 ||| RB
exhibited  ||| S:19502 E:19512 ||| VBN
a  ||| S:19512 E:19524 ||| DT
diffuse  ||| S:19524 E:19532 ||| JJ
distribution  ||| S:19532 E:19545 ||| NN
similar  ||| S:19545 E:19553 ||| JJ
to  ||| S:19553 E:19556 ||| TO
Rab1B ||| S:19556 E:19561 ||| CD
( ||| S:19561 E:19562 ||| -LRB-
N121I ||| S:19562 E:19567 ||| NNP
)  ||| S:19567 E:19569 ||| -RRB-
and  ||| S:19569 E:19573 ||| CC
other  ||| S:19573 E:19589 ||| JJ
Rabs  ||| S:19589 E:19594 ||| NNS
with  ||| S:19594 E:19599 ||| IN
mutations  ||| S:19599 E:19609 ||| NNS
in  ||| S:19609 E:19612 ||| IN
the  ||| S:19612 E:19616 ||| DT
N ||| S:19616 E:19617 ||| NNP
( ||| S:19617 E:19618 ||| -LRB-
T ||| S:19618 E:19619 ||| NN
) ||| S:19619 E:19620 ||| -RRB-
KxD  ||| S:19620 E:19624 ||| JJ
motif  ||| S:19624 E:19630 ||| NNS
( ||| S:19630 E:19631 ||| -LRB-
see  ||| S:19631 E:19635 ||| VB
Fig.  ||| S:19635 E:19640 ||| CD
2 ||| S:19640 E:19641 ||| CD
) ||| S:19641 E:19642 ||| -RRB-
.  ||| S:19642 E:19644 ||| .
To  ||| S:19644 E:19657 ||| TO
confirm  ||| S:19657 E:19665 ||| VB
the  ||| S:19665 E:19669 ||| DT
importance  ||| S:19669 E:19680 ||| NN
of  ||| S:19680 E:19683 ||| IN
the  ||| S:19683 E:19687 ||| DT
Rab24  ||| S:19687 E:19693 ||| JJ
hypervariable  ||| S:19693 E:19707 ||| JJ
domain  ||| S:19707 E:19724 ||| NN
for  ||| S:19724 E:19728 ||| IN
targeting  ||| S:19728 E:19738 ||| VBG
to  ||| S:19738 E:19741 ||| TO
inclusion  ||| S:19741 E:19751 ||| VB
bodies ||| S:19751 E:19757 ||| NNS
,  ||| S:19757 E:19759 ||| ,
we  ||| S:19759 E:19762 ||| PRP
performed  ||| S:19762 E:19772 ||| VBD
the  ||| S:19772 E:19786 ||| DT
reciprocal  ||| S:19786 E:19797 ||| JJ
experiment ||| S:19797 E:19807 ||| NN
,  ||| S:19807 E:19809 ||| ,
replacing  ||| S:19809 E:19819 ||| VBG
the  ||| S:19819 E:19823 ||| DT
C-terminal  ||| S:19823 E:19834 ||| JJ
domain  ||| S:19834 E:19841 ||| NN
of  ||| S:19841 E:19854 ||| IN
Rab1B ||| S:19854 E:19859 ||| NNP
( ||| S:19859 E:19860 ||| -LRB-
wt ||| S:19860 E:19862 ||| LS
)  ||| S:19862 E:19864 ||| -RRB-
or  ||| S:19864 E:19867 ||| CC
Rab1B ||| S:19867 E:19872 ||| NNP
( ||| S:19872 E:19873 ||| -LRB-
N121I ||| S:19873 E:19878 ||| NNP
)  ||| S:19878 E:19880 ||| -RRB-
with  ||| S:19880 E:19885 ||| IN
the  ||| S:19885 E:19889 ||| DT
hypervariable  ||| S:19889 E:19903 ||| JJ
domain  ||| S:19903 E:19920 ||| NN
from  ||| S:19920 E:19925 ||| IN
Rab24 ||| S:19925 E:19930 ||| CD
.  ||| S:19930 E:19932 ||| .
Instead  ||| S:19932 E:19940 ||| RB
of  ||| S:19940 E:19943 ||| IN
the  ||| S:19943 E:19947 ||| DT
usual  ||| S:19947 E:19953 ||| JJ
Rab1B  ||| S:19953 E:19959 ||| FW
juxtanuclear  ||| S:19959 E:19972 ||| FW
Golgi  ||| S:19972 E:19988 ||| FW
localization ||| S:19988 E:20000 ||| FW
,  ||| S:20000 E:20002 ||| ,
the  ||| S:20002 E:20006 ||| DT
Rab1B ||| S:20006 E:20011 ||| NNP
( ||| S:20011 E:20012 ||| -LRB-
wt ||| S:20012 E:20014 ||| LS
) ||| S:20014 E:20015 ||| -RRB-
/ ||| S:20015 E:20016 ||| CD
Rab24  ||| S:20016 E:20022 ||| CD
chimera  ||| S:20022 E:20030 ||| NNS
showed  ||| S:20030 E:20037 ||| VBD
a  ||| S:20037 E:20049 ||| DT
broader  ||| S:20049 E:20057 ||| JJR
cytoplasmic  ||| S:20057 E:20069 ||| JJ
distribution  ||| S:20069 E:20082 ||| NN
similar  ||| S:20082 E:20090 ||| JJ
to  ||| S:20090 E:20093 ||| TO
that  ||| S:20093 E:20098 ||| DT
of  ||| S:20098 E:20111 ||| IN
Rab24 ||| S:20111 E:20116 ||| NNP
( ||| S:20116 E:20117 ||| -LRB-
wt ||| S:20117 E:20119 ||| LS
)  ||| S:20119 E:20121 ||| -RRB-
( ||| S:20121 E:20122 ||| -LRB-
Fig.  ||| S:20122 E:20127 ||| NNP
8E ||| S:20127 E:20129 ||| NNP
) ||| S:20129 E:20130 ||| -RRB-
.  ||| S:20130 E:20132 ||| .
Most  ||| S:20132 E:20137 ||| RBS
notably ||| S:20137 E:20144 ||| RB
,  ||| S:20144 E:20146 ||| ,
replacement  ||| S:20146 E:20158 ||| NN
of  ||| S:20158 E:20171 ||| IN
hypervariable  ||| S:20171 E:20185 ||| JJ
domain  ||| S:20185 E:20192 ||| NN
of  ||| S:20192 E:20195 ||| IN
Rab1B ||| S:20195 E:20200 ||| NNP
( ||| S:20200 E:20201 ||| -LRB-
N121I ||| S:20201 E:20206 ||| NNP
)  ||| S:20206 E:20208 ||| -RRB-
with  ||| S:20208 E:20213 ||| IN
the  ||| S:20213 E:20227 ||| DT
corresponding  ||| S:20227 E:20241 ||| JJ
C-terminal  ||| S:20241 E:20252 ||| JJ
region  ||| S:20252 E:20259 ||| NN
from  ||| S:20259 E:20264 ||| IN
Rab24  ||| S:20264 E:20270 ||| NNP
caused  ||| S:20270 E:20277 ||| VBD
a  ||| S:20277 E:20279 ||| DT
major  ||| S:20279 E:20295 ||| JJ
change  ||| S:20295 E:20302 ||| NN
in  ||| S:20302 E:20305 ||| IN
the  ||| S:20305 E:20309 ||| DT
localization  ||| S:20309 E:20322 ||| NN
of  ||| S:20322 E:20325 ||| IN
the  ||| S:20325 E:20329 ||| DT
chimera  ||| S:20329 E:20337 ||| NN
from  ||| S:20337 E:20342 ||| IN
a  ||| S:20342 E:20354 ||| DT
predominant  ||| S:20354 E:20366 ||| JJ
cytoplasmic  ||| S:20366 E:20378 ||| JJ
distribution  ||| S:20378 E:20391 ||| NN
typical  ||| S:20391 E:20399 ||| JJ
of  ||| S:20399 E:20412 ||| IN
Rab1B ||| S:20412 E:20417 ||| NNP
( ||| S:20417 E:20418 ||| -LRB-
N121I ||| S:20418 E:20423 ||| NNP
)  ||| S:20423 E:20425 ||| -RRB-
( ||| S:20425 E:20426 ||| -LRB-
Fig.  ||| S:20426 E:20431 ||| CD
2 ||| S:20431 E:20432 ||| CD
)  ||| S:20432 E:20434 ||| -RRB-
to  ||| S:20434 E:20437 ||| TO
a  ||| S:20437 E:20439 ||| DT
pattern  ||| S:20439 E:20447 ||| NN
of  ||| S:20447 E:20450 ||| IN
large  ||| S:20450 E:20456 ||| JJ
intranuclear  ||| S:20456 E:20479 ||| NN
and  ||| S:20479 E:20483 ||| CC
cytoplasmic  ||| S:20483 E:20495 ||| JJ
inclusion  ||| S:20495 E:20505 ||| NN
bodies  ||| S:20505 E:20512 ||| NNS
( ||| S:20512 E:20513 ||| -LRB-
Fig.  ||| S:20513 E:20518 ||| NNP
8F ||| S:20518 E:20520 ||| NNP
) ||| S:20520 E:20521 ||| -RRB-
.  ||| S:20521 E:20533 ||| .
To  ||| S:20533 E:20536 ||| TO
determine  ||| S:20536 E:20546 ||| VB
whether  ||| S:20546 E:20554 ||| IN
the  ||| S:20554 E:20558 ||| DT
hypervariable  ||| S:20558 E:20572 ||| JJ
domain  ||| S:20572 E:20579 ||| NN
of  ||| S:20579 E:20582 ||| IN
Rab24  ||| S:20582 E:20598 ||| NNP
was  ||| S:20598 E:20602 ||| VBD
sufficient  ||| S:20602 E:20613 ||| JJ
to  ||| S:20613 E:20616 ||| TO
promote  ||| S:20616 E:20624 ||| VB
the  ||| S:20624 E:20628 ||| DT
formation  ||| S:20628 E:20638 ||| NN
of  ||| S:20638 E:20641 ||| IN
inclusion  ||| S:20641 E:20661 ||| NN
bodies  ||| S:20661 E:20668 ||| NNS
when  ||| S:20668 E:20673 ||| WRB
fused  ||| S:20673 E:20679 ||| JJ
to  ||| S:20679 E:20682 ||| TO
a  ||| S:20682 E:20684 ||| DT
heterologous  ||| S:20684 E:20697 ||| JJ
protein ||| S:20697 E:20704 ||| NN
,  ||| S:20704 E:20706 ||| ,
we  ||| S:20706 E:20709 ||| PRP
prepared  ||| S:20709 E:20728 ||| VBD
fusion  ||| S:20728 E:20735 ||| NN
constructs  ||| S:20735 E:20746 ||| NN
with  ||| S:20746 E:20751 ||| IN
enhanced  ||| S:20751 E:20760 ||| JJ
green  ||| S:20760 E:20766 ||| JJ
fluorescent  ||| S:20766 E:20778 ||| JJ
protein  ||| S:20778 E:20796 ||| NN
( ||| S:20796 E:20797 ||| -LRB-
EGFP ||| S:20797 E:20801 ||| NNP
)  ||| S:20801 E:20803 ||| -RRB-
containing  ||| S:20803 E:20814 ||| VBG
either  ||| S:20814 E:20821 ||| DT
full-length  ||| S:20821 E:20833 ||| JJ
Rab24 ||| S:20833 E:20838 ||| NNP
( ||| S:20838 E:20839 ||| -LRB-
D123I ||| S:20839 E:20844 ||| NNP
)  ||| S:20844 E:20846 ||| -RRB-
or  ||| S:20846 E:20849 ||| CC
just  ||| S:20849 E:20864 ||| RB
the  ||| S:20864 E:20868 ||| DT
Rab24  ||| S:20868 E:20874 ||| JJ
C-terminal  ||| S:20874 E:20885 ||| JJ
domain ||| S:20885 E:20891 ||| NN
.  ||| S:20891 E:20893 ||| .
As  ||| S:20893 E:20896 ||| RB
shown  ||| S:20896 E:20902 ||| VBN
in  ||| S:20902 E:20905 ||| IN
Fig.  ||| S:20905 E:20910 ||| CD
9A ||| S:20910 E:20912 ||| CD
,  ||| S:20912 E:20924 ||| ,
EGFP-Rab24 ||| S:20924 E:20934 ||| NNP
( ||| S:20934 E:20935 ||| -LRB-
D123I ||| S:20935 E:20940 ||| NNP
)  ||| S:20940 E:20942 ||| -RRB-
accumulated  ||| S:20942 E:20954 ||| VBN
in  ||| S:20954 E:20957 ||| IN
inclusion  ||| S:20957 E:20967 ||| NN
bodies  ||| S:20967 E:20974 ||| NNS
similar  ||| S:20974 E:20992 ||| JJ
to  ||| S:20992 E:20995 ||| TO
those  ||| S:20995 E:21001 ||| DT
described  ||| S:21001 E:21011 ||| VBN
earlier  ||| S:21011 E:21019 ||| RBR
for  ||| S:21019 E:21023 ||| IN
mycRab24 ||| S:21023 E:21031 ||| NNP
( ||| S:21031 E:21032 ||| -LRB-
D123I ||| S:21032 E:21037 ||| NNP
) ||| S:21037 E:21038 ||| -RRB-
.  ||| S:21038 E:21040 ||| .
In  ||| S:21040 E:21053 ||| IN
contrast ||| S:21053 E:21061 ||| NN
,  ||| S:21061 E:21063 ||| ,
the  ||| S:21063 E:21067 ||| DT
EGFP  ||| S:21067 E:21072 ||| NNP
fusion  ||| S:21072 E:21079 ||| NN
protein  ||| S:21079 E:21087 ||| NN
containing  ||| S:21087 E:21098 ||| VBG
only  ||| S:21098 E:21103 ||| RB
the  ||| S:21103 E:21117 ||| DT
hypervariable  ||| S:21117 E:21131 ||| JJ
domain  ||| S:21131 E:21138 ||| NN
of  ||| S:21138 E:21141 ||| IN
Rab24  ||| S:21141 E:21147 ||| NNP
exhibited  ||| S:21147 E:21157 ||| VBD
a  ||| S:21157 E:21159 ||| DT
diffuse  ||| S:21159 E:21177 ||| JJ
cytoplasmic  ||| S:21177 E:21189 ||| NN
and  ||| S:21189 E:21193 ||| CC
nuclear  ||| S:21193 E:21201 ||| JJ
localization  ||| S:21201 E:21214 ||| NN
that  ||| S:21214 E:21219 ||| WDT
was  ||| S:21219 E:21223 ||| VBD
essentially  ||| S:21223 E:21245 ||| RB
identical  ||| S:21245 E:21255 ||| JJ
to  ||| S:21255 E:21258 ||| TO
the  ||| S:21258 E:21262 ||| DT
pattern  ||| S:21262 E:21270 ||| NN
observed  ||| S:21270 E:21279 ||| VBD
with  ||| S:21279 E:21284 ||| IN
EGFP  ||| S:21284 E:21289 ||| NNP
alone  ||| S:21289 E:21295 ||| RB
( ||| S:21295 E:21296 ||| -LRB-
Fig.  ||| S:21296 E:21311 ||| NNP
9B ||| S:21311 E:21313 ||| NNP
&  ||| S:21313 E:21315 ||| CC
9C ||| S:21315 E:21317 ||| CD
) ||| S:21317 E:21318 ||| -RRB-
.  ||| S:21318 E:21320 ||| .
Therefore ||| S:21320 E:21329 ||| RB
,  ||| S:21329 E:21331 ||| ,
it  ||| S:21331 E:21334 ||| PRP
appears  ||| S:21334 E:21342 ||| VBZ
that  ||| S:21342 E:21347 ||| IN
although  ||| S:21347 E:21356 ||| IN
the  ||| S:21356 E:21370 ||| DT
C-terminal  ||| S:21370 E:21381 ||| JJ
domain  ||| S:21381 E:21388 ||| NN
of  ||| S:21388 E:21391 ||| IN
Rab24  ||| S:21391 E:21397 ||| NNP
is  ||| S:21397 E:21400 ||| VBZ
required  ||| S:21400 E:21409 ||| VBN
to  ||| S:21409 E:21412 ||| TO
promote  ||| S:21412 E:21420 ||| VB
its  ||| S:21420 E:21434 ||| PRP$
incorporation  ||| S:21434 E:21448 ||| NN
into  ||| S:21448 E:21453 ||| IN
inclusion  ||| S:21453 E:21463 ||| NN
bodies ||| S:21463 E:21469 ||| NNS
,  ||| S:21469 E:21471 ||| ,
it  ||| S:21471 E:21474 ||| PRP
does  ||| S:21474 E:21479 ||| VBZ
so  ||| S:21479 E:21482 ||| RB
only  ||| S:21482 E:21487 ||| RB
when  ||| S:21487 E:21502 ||| WRB
expressed  ||| S:21502 E:21512 ||| VBN
in  ||| S:21512 E:21515 ||| IN
the  ||| S:21515 E:21519 ||| DT
context  ||| S:21519 E:21527 ||| NN
of  ||| S:21527 E:21530 ||| IN
a  ||| S:21530 E:21532 ||| DT
Rab  ||| S:21532 E:21536 ||| NNP
GTPase  ||| S:21536 E:21543 ||| NNP
with  ||| S:21543 E:21548 ||| IN
a  ||| S:21548 E:21550 ||| DT
mutation  ||| S:21550 E:21569 ||| NN
in  ||| S:21569 E:21572 ||| IN
the  ||| S:21572 E:21576 ||| DT
N ||| S:21576 E:21577 ||| NNP
( ||| S:21577 E:21578 ||| -LRB-
T ||| S:21578 E:21579 ||| NN
) ||| S:21579 E:21580 ||| -RRB-
KxD  ||| S:21580 E:21584 ||| FW
nucleotide  ||| S:21584 E:21595 ||| FW
binding  ||| S:21595 E:21603 ||| FW
motif ||| S:21603 E:21608 ||| FW
.  ||| S:21608 E:21638 ||| .
Nuclear  ||| S:21638 E:21646 ||| JJ
inclusions  ||| S:21646 E:21657 ||| NNS
generated  ||| S:21657 E:21667 ||| VBN
by  ||| S:21667 E:21670 ||| IN
Rab24 ||| S:21670 E:21675 ||| NNP
( ||| S:21675 E:21676 ||| -LRB-
D123I ||| S:21676 E:21681 ||| NNP
)  ||| S:21681 E:21693 ||| -RRB-
contain  ||| S:21693 E:21701 ||| VBP
ubiquitin  ||| S:21701 E:21711 ||| VBN
and  ||| S:21711 E:21715 ||| CC
Hsp70  ||| S:21715 E:21731 ||| CD
Although  ||| S:21731 E:21740 ||| IN
the  ||| S:21740 E:21744 ||| DT
formation  ||| S:21744 E:21754 ||| NN
of  ||| S:21754 E:21757 ||| IN
intranuclear  ||| S:21757 E:21770 ||| JJ
inclusions  ||| S:21770 E:21781 ||| NN
has  ||| S:21781 E:21795 ||| VBZ
not  ||| S:21795 E:21799 ||| RB
been  ||| S:21799 E:21804 ||| VBN
observed  ||| S:21804 E:21813 ||| VBN
in  ||| S:21813 E:21816 ||| IN
previous  ||| S:21816 E:21825 ||| JJ
studies  ||| S:21825 E:21833 ||| NNS
of  ||| S:21833 E:21836 ||| IN
Ras-related  ||| S:21836 E:21858 ||| JJ
GTPases ||| S:21858 E:21865 ||| NN
,  ||| S:21865 E:21867 ||| ,
it  ||| S:21867 E:21870 ||| PRP
is  ||| S:21870 E:21873 ||| VBZ
a  ||| S:21873 E:21875 ||| DT
common  ||| S:21875 E:21882 ||| JJ
feature  ||| S:21882 E:21890 ||| NN
of  ||| S:21890 E:21893 ||| IN
several  ||| S:21893 E:21911 ||| JJ
neurodegenerative  ||| S:21911 E:21929 ||| JJ
disorders  ||| S:21929 E:21939 ||| NNS
where  ||| S:21939 E:21945 ||| WRB
abnormal  ||| S:21945 E:21954 ||| JJ
proteins  ||| S:21954 E:21973 ||| NNS
containing  ||| S:21973 E:21984 ||| VBG
poly-Gln  ||| S:21984 E:21993 ||| JJ
tracts  ||| S:21993 E:22000 ||| NNS
are  ||| S:22000 E:22004 ||| VBP
synthesized  ||| S:22004 E:22016 ||| VBN
as  ||| S:22016 E:22019 ||| IN
a  ||| S:22019 E:22021 ||| DT
result  ||| S:22021 E:22028 ||| NN
of  ||| S:22028 E:22041 ||| IN
CAG  ||| S:22041 E:22045 ||| NNP
codon  ||| S:22045 E:22051 ||| FW
expansions  ||| S:22051 E:22062 ||| FW
[  ||| S:22062 E:22064 ||| -LRB-
52  ||| S:22064 E:22067 ||| CD
]  ||| S:22067 E:22069 ||| -RRB-
.  ||| S:22069 E:22071 ||| .
Examples  ||| S:22071 E:22080 ||| NNS
include  ||| S:22080 E:22098 ||| VBP
Huntington ||| S:22098 E:22108 ||| NNP
's  ||| S:22108 E:22111 ||| POS
disease  ||| S:22111 E:22119 ||| NN
( ||| S:22119 E:22120 ||| -LRB-
huntingtin ||| S:22120 E:22130 ||| LS
)  ||| S:22130 E:22132 ||| -RRB-
[  ||| S:22132 E:22134 ||| -LRB-
53  ||| S:22134 E:22137 ||| CD
54  ||| S:22137 E:22140 ||| CD
]  ||| S:22140 E:22142 ||| -RRB-
,  ||| S:22142 E:22154 ||| ,
spinocerebellar  ||| S:22154 E:22170 ||| FW
ataxia  ||| S:22170 E:22177 ||| FW
( ||| S:22177 E:22178 ||| -LRB-
SCA ||| S:22178 E:22181 ||| NNP
)  ||| S:22181 E:22183 ||| -RRB-
types  ||| S:22183 E:22189 ||| NNS
1  ||| S:22189 E:22191 ||| CD
and  ||| S:22191 E:22195 ||| CC
3  ||| S:22195 E:22197 ||| CD
( ||| S:22197 E:22198 ||| -LRB-
ataxin-1  ||| S:22198 E:22207 ||| NNP
and  ||| S:22207 E:22221 ||| CC
ataxin-3 ||| S:22221 E:22229 ||| CD
)  ||| S:22229 E:22231 ||| -RRB-
[  ||| S:22231 E:22233 ||| -LRB-
55  ||| S:22233 E:22236 ||| CD
56  ||| S:22236 E:22239 ||| CD
]  ||| S:22239 E:22241 ||| -RRB-
and  ||| S:22241 E:22245 ||| CC
dentatorubral-pallidoluysian  ||| S:22245 E:22284 ||| JJ
atrophy  ||| S:22284 E:22292 ||| NNS
( ||| S:22292 E:22293 ||| -LRB-
atrophin-1 ||| S:22293 E:22303 ||| NNP
)  ||| S:22303 E:22305 ||| -RRB-
[  ||| S:22305 E:22307 ||| -LRB-
57  ||| S:22307 E:22310 ||| CD
]  ||| S:22310 E:22312 ||| -RRB-
.  ||| S:22312 E:22314 ||| .
These  ||| S:22314 E:22320 ||| DT
poly-Gln  ||| S:22320 E:22329 ||| JJ
protein  ||| S:22329 E:22347 ||| NN
aggregates  ||| S:22347 E:22358 ||| NNS
typically  ||| S:22358 E:22368 ||| RB
contain  ||| S:22368 E:22376 ||| VB
ubiquitin  ||| S:22376 E:22386 ||| NNS
[  ||| S:22386 E:22388 ||| -LRB-
58  ||| S:22388 E:22391 ||| CD
]  ||| S:22391 E:22393 ||| -RRB-
and  ||| S:22393 E:22397 ||| CC
members  ||| S:22397 E:22415 ||| NNS
of  ||| S:22415 E:22418 ||| IN
the  ||| S:22418 E:22422 ||| DT
Hsp70  ||| S:22422 E:22428 ||| JJ
chaperone  ||| S:22428 E:22438 ||| JJ
family  ||| S:22438 E:22445 ||| NN
[  ||| S:22445 E:22447 ||| -LRB-
59  ||| S:22447 E:22450 ||| CD
]  ||| S:22450 E:22452 ||| -RRB-
,  ||| S:22452 E:22454 ||| ,
consistent  ||| S:22454 E:22465 ||| JJ
with  ||| S:22465 E:22470 ||| IN
a  ||| S:22470 E:22482 ||| DT
proposed  ||| S:22482 E:22491 ||| JJ
pathway  ||| S:22491 E:22499 ||| NN
for  ||| S:22499 E:22503 ||| IN
cellular  ||| S:22503 E:22512 ||| JJ
clearance  ||| S:22512 E:22522 ||| NN
of  ||| S:22522 E:22525 ||| IN
toxic  ||| S:22525 E:22541 ||| JJ
misfolded  ||| S:22541 E:22551 ||| JJ
proteins ||| S:22551 E:22559 ||| NNS
.  ||| S:22559 E:22561 ||| .
We  ||| S:22561 E:22564 ||| PRP
noted  ||| S:22564 E:22570 ||| VBD
that  ||| S:22570 E:22575 ||| IN
the  ||| S:22575 E:22579 ||| DT
inclusions  ||| S:22579 E:22590 ||| NN
caused  ||| S:22590 E:22607 ||| VBN
by  ||| S:22607 E:22610 ||| IN
expression  ||| S:22610 E:22621 ||| NN
of  ||| S:22621 E:22624 ||| IN
Rab24 ||| S:22624 E:22629 ||| NNP
( ||| S:22629 E:22630 ||| -LRB-
D123I ||| S:22630 E:22635 ||| NNP
)  ||| S:22635 E:22637 ||| -RRB-
were  ||| S:22637 E:22642 ||| VBD
similar  ||| S:22642 E:22660 ||| JJ
morphologically  ||| S:22660 E:22676 ||| NN
to  ||| S:22676 E:22679 ||| TO
those  ||| S:22679 E:22685 ||| DT
described  ||| S:22685 E:22695 ||| VBN
in  ||| S:22695 E:22698 ||| IN
some  ||| S:22698 E:22703 ||| DT
of  ||| S:22703 E:22706 ||| IN
the  ||| S:22706 E:22720 ||| DT
poly-Gln  ||| S:22720 E:22729 ||| JJ
disorders  ||| S:22729 E:22739 ||| NNS
and  ||| S:22739 E:22743 ||| CC
hypothesized  ||| S:22743 E:22756 ||| VBN
that  ||| S:22756 E:22761 ||| IN
they  ||| S:22761 E:22766 ||| PRP
might  ||| S:22766 E:22772 ||| MD
arise  ||| S:22772 E:22788 ||| VB
via  ||| S:22788 E:22792 ||| IN
a  ||| S:22792 E:22794 ||| DT
similar  ||| S:22794 E:22802 ||| JJ
pathway ||| S:22802 E:22809 ||| NN
.  ||| S:22809 E:22811 ||| .
An  ||| S:22811 E:22814 ||| DT
immunofluorescence  ||| S:22814 E:22833 ||| JJ
study  ||| S:22833 E:22839 ||| NN
was  ||| S:22839 E:22853 ||| VBD
performed  ||| S:22853 E:22863 ||| VBN
to  ||| S:22863 E:22866 ||| TO
determine  ||| S:22866 E:22876 ||| VB
whether  ||| S:22876 E:22884 ||| IN
or  ||| S:22884 E:22887 ||| CC
not  ||| S:22887 E:22891 ||| RB
the  ||| S:22891 E:22895 ||| DT
intranuclear  ||| S:22895 E:22918 ||| JJ
Rab24 ||| S:22918 E:22923 ||| NNP
( ||| S:22923 E:22924 ||| -LRB-
D123I ||| S:22924 E:22929 ||| NNP
)  ||| S:22929 E:22931 ||| -RRB-
aggregates  ||| S:22931 E:22942 ||| NNS
might  ||| S:22942 E:22948 ||| MD
sequester  ||| S:22948 E:22958 ||| VB
ubiquitin  ||| S:22958 E:22968 ||| NNS
and  ||| S:22968 E:22982 ||| CC
Hsp70 ||| S:22982 E:22987 ||| NNP
.  ||| S:22987 E:22989 ||| .
Both  ||| S:22989 E:22994 ||| DT
ubiquitin  ||| S:22994 E:23004 ||| NN
( ||| S:23004 E:23005 ||| -LRB-
Fig.  ||| S:23005 E:23010 ||| NNP
10A ||| S:23010 E:23013 ||| NNP
)  ||| S:23013 E:23015 ||| -RRB-
and  ||| S:23015 E:23019 ||| CC
Hsp70  ||| S:23019 E:23025 ||| NNP
( ||| S:23025 E:23026 ||| -LRB-
Fig.  ||| S:23026 E:23031 ||| NNP
10B ||| S:23031 E:23034 ||| NNP
)  ||| S:23034 E:23046 ||| -RRB-
showed  ||| S:23046 E:23053 ||| VBD
substantial  ||| S:23053 E:23065 ||| JJ
overlap  ||| S:23065 E:23073 ||| NN
with  ||| S:23073 E:23078 ||| IN
nuclear  ||| S:23078 E:23086 ||| JJ
and  ||| S:23086 E:23090 ||| CC
cytoplasmic  ||| S:23090 E:23112 ||| JJ
aggregates  ||| S:23112 E:23123 ||| NNS
containing  ||| S:23123 E:23134 ||| VBG
mycRab24 ||| S:23134 E:23142 ||| NNP
( ||| S:23142 E:23143 ||| -LRB-
D123I ||| S:23143 E:23148 ||| NNP
) ||| S:23148 E:23149 ||| -RRB-
.  ||| S:23149 E:23151 ||| .
In  ||| S:23151 E:23154 ||| IN
contrast ||| S:23154 E:23162 ||| NN
,  ||| S:23162 E:23164 ||| ,
the  ||| S:23164 E:23178 ||| DT
aggregates  ||| S:23178 E:23189 ||| NNS
did  ||| S:23189 E:23193 ||| VBD
not  ||| S:23193 E:23197 ||| RB
contain  ||| S:23197 E:23205 ||| VB
Hsp90  ||| S:23205 E:23211 ||| NNP
( ||| S:23211 E:23212 ||| -LRB-
Fig.  ||| S:23212 E:23217 ||| NNP
10C ||| S:23217 E:23220 ||| NNP
) ||| S:23220 E:23221 ||| -RRB-
,  ||| S:23221 E:23223 ||| ,
suggesting  ||| S:23223 E:23244 ||| VBG
that  ||| S:23244 E:23249 ||| IN
the  ||| S:23249 E:23253 ||| DT
sequestration  ||| S:23253 E:23267 ||| NN
of  ||| S:23267 E:23270 ||| IN
Hsp70  ||| S:23270 E:23276 ||| NNP
was  ||| S:23276 E:23280 ||| VBD
specific ||| S:23280 E:23288 ||| JJ
.  ||| S:23288 E:23300 ||| .
To  ||| S:23300 E:23303 ||| TO
determine  ||| S:23303 E:23313 ||| VB
whether  ||| S:23313 E:23321 ||| IN
ubiquitin  ||| S:23321 E:23331 ||| NN
was  ||| S:23331 E:23335 ||| VBD
conjugated  ||| S:23335 E:23346 ||| VBN
directly  ||| S:23346 E:23365 ||| RB
to  ||| S:23365 E:23368 ||| TO
Rab24 ||| S:23368 E:23373 ||| CD
( ||| S:23373 E:23374 ||| -LRB-
D123I ||| S:23374 E:23379 ||| NNP
) ||| S:23379 E:23380 ||| -RRB-
,  ||| S:23380 E:23382 ||| ,
it  ||| S:23382 E:23385 ||| PRP
was  ||| S:23385 E:23389 ||| VBD
necessary  ||| S:23389 E:23399 ||| JJ
to  ||| S:23399 E:23402 ||| TO
solubilize  ||| S:23402 E:23413 ||| VB
the  ||| S:23413 E:23427 ||| DT
protein  ||| S:23427 E:23435 ||| NN
aggregates  ||| S:23435 E:23446 ||| NNS
in  ||| S:23446 E:23449 ||| IN
a  ||| S:23449 E:23451 ||| DT
high-detergent  ||| S:23451 E:23466 ||| JJ
buffer  ||| S:23466 E:23473 ||| NN
that  ||| S:23473 E:23478 ||| WDT
was  ||| S:23478 E:23492 ||| VBD
incompatible  ||| S:23492 E:23505 ||| VBN
with  ||| S:23505 E:23510 ||| IN
standard  ||| S:23510 E:23519 ||| JJ
immunoprecipitation  ||| S:23519 E:23539 ||| JJ
methods ||| S:23539 E:23546 ||| NNS
.  ||| S:23546 E:23558 ||| .
Therefore ||| S:23558 E:23567 ||| RB
,  ||| S:23567 E:23569 ||| ,
we  ||| S:23569 E:23572 ||| PRP
generated  ||| S:23572 E:23582 ||| VBD
a  ||| S:23582 E:23584 ||| DT
mammalian  ||| S:23584 E:23594 ||| JJ
expression  ||| S:23594 E:23605 ||| NN
vector  ||| S:23605 E:23622 ||| NN
encoding  ||| S:23622 E:23631 ||| VBD
a  ||| S:23631 E:23633 ||| DT
His  ||| S:23633 E:23648 ||| PRP$
6  ||| S:23648 E:23650 ||| CD
-tagged  ||| S:23650 E:23658 ||| JJ
version  ||| S:23658 E:23666 ||| NN
of  ||| S:23666 E:23669 ||| IN
Rab24 ||| S:23669 E:23674 ||| NNP
( ||| S:23674 E:23675 ||| -LRB-
D123I ||| S:23675 E:23680 ||| NNP
)  ||| S:23680 E:23682 ||| -RRB-
and  ||| S:23682 E:23696 ||| CC
used  ||| S:23696 E:23701 ||| VBD
Ni  ||| S:23701 E:23704 ||| NNP
2+affinity  ||| S:23704 E:23715 ||| NNP
resin  ||| S:23715 E:23721 ||| NN
to  ||| S:23721 E:23724 ||| TO
isolate  ||| S:23724 E:23732 ||| VB
the  ||| S:23732 E:23736 ||| DT
expressed  ||| S:23736 E:23746 ||| JJ
protein  ||| S:23746 E:23764 ||| NN
from  ||| S:23764 E:23769 ||| IN
detergent  ||| S:23769 E:23779 ||| NN
extracts ||| S:23779 E:23787 ||| NN
.  ||| S:23787 E:23789 ||| .
When  ||| S:23789 E:23794 ||| WRB
expressed  ||| S:23794 E:23804 ||| VBN
in  ||| S:23804 E:23807 ||| IN
293  ||| S:23807 E:23811 ||| CD
cells  ||| S:23811 E:23817 ||| NNS
the  ||| S:23817 E:23831 ||| DT
His  ||| S:23831 E:23846 ||| PRP$
6  ||| S:23846 E:23848 ||| CD
Rab24 ||| S:23848 E:23853 ||| CD
( ||| S:23853 E:23854 ||| -LRB-
D123I ||| S:23854 E:23859 ||| NNP
)  ||| S:23859 E:23861 ||| -RRB-
accumulated  ||| S:23861 E:23873 ||| VBN
in  ||| S:23873 E:23886 ||| IN
inclusion  ||| S:23886 E:23896 ||| NN
bodies  ||| S:23896 E:23903 ||| NNS
that  ||| S:23903 E:23908 ||| WDT
were  ||| S:23908 E:23913 ||| VBD
morphologically  ||| S:23913 E:23929 ||| JJ
identical  ||| S:23929 E:23939 ||| JJ
to  ||| S:23939 E:23952 ||| TO
those  ||| S:23952 E:23958 ||| DT
formed  ||| S:23958 E:23965 ||| VBN
by  ||| S:23965 E:23968 ||| IN
the  ||| S:23968 E:23972 ||| DT
myc-tagged  ||| S:23972 E:23983 ||| JJ
and  ||| S:23983 E:23987 ||| CC
untagged  ||| S:23987 E:23996 ||| JJ
proteins  ||| S:23996 E:24005 ||| NNS
( ||| S:24005 E:24006 ||| -LRB-
not  ||| S:24006 E:24020 ||| RB
shown ||| S:24020 E:24025 ||| VBN
) ||| S:24025 E:24026 ||| -RRB-
.  ||| S:24026 E:24028 ||| .
When  ||| S:24028 E:24033 ||| WRB
the  ||| S:24033 E:24037 ||| DT
His  ||| S:24037 E:24052 ||| PRP$
6  ||| S:24052 E:24054 ||| CD
-tagged  ||| S:24054 E:24062 ||| JJ
protein  ||| S:24062 E:24070 ||| NN
was  ||| S:24070 E:24074 ||| VBD
extracted  ||| S:24074 E:24084 ||| VBN
from  ||| S:24084 E:24099 ||| IN
the  ||| S:24099 E:24103 ||| DT
inclusions  ||| S:24103 E:24114 ||| NN
and  ||| S:24114 E:24118 ||| CC
subjected  ||| S:24118 E:24128 ||| VBN
to  ||| S:24128 E:24131 ||| TO
SDS-PAGE ||| S:24131 E:24139 ||| JJ
,  ||| S:24139 E:24141 ||| ,
we  ||| S:24141 E:24144 ||| PRP
saw  ||| S:24144 E:24148 ||| VBD
no  ||| S:24148 E:24161 ||| DT
evidence  ||| S:24161 E:24170 ||| NN
of  ||| S:24170 E:24173 ||| IN
higher  ||| S:24173 E:24180 ||| JJR
molecular  ||| S:24180 E:24190 ||| JJ
mass  ||| S:24190 E:24195 ||| NN
forms  ||| S:24195 E:24201 ||| NNS
that  ||| S:24201 E:24206 ||| WDT
would  ||| S:24206 E:24222 ||| MD
correspond  ||| S:24222 E:24233 ||| VB
to  ||| S:24233 E:24236 ||| TO
poly-ubiquitinated  ||| S:24236 E:24255 ||| JJ
species ||| S:24255 E:24262 ||| NNS
,  ||| S:24262 E:24264 ||| ,
using  ||| S:24264 E:24270 ||| VBG
either  ||| S:24270 E:24287 ||| DT
anti-His  ||| S:24287 E:24307 ||| JJ
6  ||| S:24307 E:24309 ||| CD
( ||| S:24309 E:24310 ||| -LRB-
Fig.  ||| S:24310 E:24315 ||| NNP
11A ||| S:24315 E:24318 ||| NNP
)  ||| S:24318 E:24320 ||| -RRB-
or  ||| S:24320 E:24323 ||| CC
anti-Rab24  ||| S:24323 E:24334 ||| NNP
( ||| S:24334 E:24335 ||| -LRB-
not  ||| S:24335 E:24339 ||| RB
shown ||| S:24339 E:24344 ||| VBN
)  ||| S:24344 E:24356 ||| -RRB-
antibodies ||| S:24356 E:24366 ||| NNS
.  ||| S:24366 E:24368 ||| .
Moreover ||| S:24368 E:24376 ||| RB
,  ||| S:24376 E:24378 ||| ,
immunoblot  ||| S:24378 E:24389 ||| JJ
analysis  ||| S:24389 E:24398 ||| NN
of  ||| S:24398 E:24401 ||| IN
the  ||| S:24401 E:24405 ||| DT
His  ||| S:24405 E:24420 ||| PRP$
6  ||| S:24420 E:24422 ||| CD
Rab24 ||| S:24422 E:24427 ||| CD
( ||| S:24427 E:24428 ||| -LRB-
D123I ||| S:24428 E:24433 ||| NNP
)  ||| S:24433 E:24435 ||| -RRB-
isolated  ||| S:24435 E:24444 ||| VBN
from  ||| S:24444 E:24449 ||| IN
cells  ||| S:24449 E:24465 ||| NNS
treated  ||| S:24465 E:24473 ||| VBN
with  ||| S:24473 E:24478 ||| IN
lactacystin  ||| S:24478 E:24490 ||| NNS
( ||| S:24490 E:24491 ||| -LRB-
to  ||| S:24491 E:24494 ||| TO
block  ||| S:24494 E:24500 ||| VB
degradation  ||| S:24500 E:24512 ||| VBN
of  ||| S:24512 E:24525 ||| IN
poly-ubiquitinated  ||| S:24525 E:24544 ||| JJ
proteins  ||| S:24544 E:24553 ||| NNS
by  ||| S:24553 E:24556 ||| IN
the  ||| S:24556 E:24560 ||| DT
26S  ||| S:24560 E:24564 ||| CD
proteasome ||| S:24564 E:24574 ||| CD
)  ||| S:24574 E:24576 ||| -RRB-
showed  ||| S:24576 E:24593 ||| VBD
no  ||| S:24593 E:24596 ||| DT
detectable  ||| S:24596 E:24607 ||| JJ
ubiquitin  ||| S:24607 E:24617 ||| NNS
associated  ||| S:24617 E:24628 ||| VBN
with  ||| S:24628 E:24633 ||| IN
the  ||| S:24633 E:24637 ||| DT
protein ||| S:24637 E:24644 ||| NN
,  ||| S:24644 E:24656 ||| ,
although  ||| S:24656 E:24665 ||| IN
the  ||| S:24665 E:24669 ||| DT
same  ||| S:24669 E:24674 ||| JJ
antibody  ||| S:24674 E:24683 ||| NN
detected  ||| S:24683 E:24692 ||| VBD
multiple  ||| S:24692 E:24711 ||| JJ
ubiquitinated  ||| S:24711 E:24725 ||| JJ
polypeptides  ||| S:24725 E:24738 ||| NN
in  ||| S:24738 E:24741 ||| IN
the  ||| S:24741 E:24745 ||| DT
whole-cell  ||| S:24745 E:24756 ||| JJ
lysate  ||| S:24756 E:24763 ||| NNS
( ||| S:24763 E:24764 ||| -LRB-
Fig.  ||| S:24764 E:24779 ||| NNP
11B ||| S:24779 E:24782 ||| NNP
) ||| S:24782 E:24783 ||| -RRB-
.  ||| S:24783 E:24785 ||| .
Again ||| S:24785 E:24790 ||| RB
,  ||| S:24790 E:24792 ||| ,
these  ||| S:24792 E:24798 ||| DT
findings  ||| S:24798 E:24807 ||| NNS
agree  ||| S:24807 E:24813 ||| VBP
with  ||| S:24813 E:24818 ||| IN
recent  ||| S:24818 E:24825 ||| JJ
studies  ||| S:24825 E:24833 ||| NNS
of  ||| S:24833 E:24846 ||| IN
poly-Gln  ||| S:24846 E:24855 ||| JJ
protein  ||| S:24855 E:24863 ||| NN
aggregates ||| S:24863 E:24873 ||| NNS
,  ||| S:24873 E:24875 ||| ,
which  ||| S:24875 E:24881 ||| WDT
indicate  ||| S:24881 E:24890 ||| VBP
that  ||| S:24890 E:24895 ||| IN
although  ||| S:24895 E:24914 ||| IN
ubiquitinated  ||| S:24914 E:24928 ||| JJ
proteins  ||| S:24928 E:24937 ||| NNS
are  ||| S:24937 E:24941 ||| VBP
present  ||| S:24941 E:24949 ||| JJ
in  ||| S:24949 E:24952 ||| IN
the  ||| S:24952 E:24956 ||| DT
inclusions ||| S:24956 E:24966 ||| NN
,  ||| S:24966 E:24978 ||| ,
they  ||| S:24978 E:24983 ||| PRP
are  ||| S:24983 E:24987 ||| VBP
not  ||| S:24987 E:24991 ||| RB
conjugated  ||| S:24991 E:25002 ||| VBN
directly  ||| S:25002 E:25011 ||| RB
to  ||| S:25011 E:25014 ||| TO
the  ||| S:25014 E:25018 ||| DT
initiating  ||| S:25018 E:25039 ||| JJ
poly-Gln  ||| S:25039 E:25048 ||| JJ
polypeptide  ||| S:25048 E:25060 ||| NNS
[  ||| S:25060 E:25062 ||| -LRB-
60  ||| S:25062 E:25065 ||| CD
]  ||| S:25065 E:25067 ||| -RRB-
.  ||| S:25067 E:25100 ||| .
Discussion  ||| S:25100 E:25119 ||| NN
Here  ||| S:25119 E:25124 ||| RB
we  ||| S:25124 E:25127 ||| PRP
have  ||| S:25127 E:25132 ||| VBP
shown  ||| S:25132 E:25138 ||| VBN
that  ||| S:25138 E:25143 ||| IN
single  ||| S:25143 E:25150 ||| JJ
amino  ||| S:25150 E:25156 ||| JJ
acid  ||| S:25156 E:25161 ||| NN
substitutions  ||| S:25161 E:25183 ||| NNS
(  ||| S:25183 E:25194 ||| -LRB-
e.g.  ||| S:25194 E:25199 ||| NNP
,  ||| S:25199 E:25201 ||| ,
D123I  ||| S:25201 E:25207 ||| NNP
and  ||| S:25207 E:25211 ||| CC
T120A ||| S:25211 E:25216 ||| CD
)  ||| S:25216 E:25218 ||| -RRB-
in  ||| S:25218 E:25221 ||| IN
one  ||| S:25221 E:25225 ||| CD
of  ||| S:25225 E:25228 ||| IN
the  ||| S:25228 E:25240 ||| DT
conserved  ||| S:25240 E:25250 ||| FW
guanine  ||| S:25250 E:25258 ||| FW
nucleotide  ||| S:25258 E:25269 ||| FW
binding  ||| S:25269 E:25277 ||| FW
domains  ||| S:25277 E:25285 ||| FW
of  ||| S:25285 E:25288 ||| IN
Rab24  ||| S:25288 E:25294 ||| NNP
can  ||| S:25294 E:25306 ||| MD
cause  ||| S:25306 E:25312 ||| VB
the  ||| S:25312 E:25316 ||| DT
protein  ||| S:25316 E:25324 ||| NN
to  ||| S:25324 E:25327 ||| TO
accumulate  ||| S:25327 E:25338 ||| VB
in  ||| S:25338 E:25341 ||| IN
a  ||| S:25341 E:25343 ||| DT
massive  ||| S:25343 E:25351 ||| JJ
array  ||| S:25351 E:25357 ||| NN
of  ||| S:25357 E:25368 ||| IN
nuclear  ||| S:25368 E:25376 ||| JJ
inclusions  ||| S:25376 E:25387 ||| NN
in  ||| S:25387 E:25390 ||| IN
mammalian  ||| S:25390 E:25400 ||| JJ
cells ||| S:25400 E:25405 ||| NNS
.  ||| S:25405 E:25407 ||| .
Although  ||| S:25407 E:25416 ||| IN
members  ||| S:25416 E:25424 ||| NNS
of  ||| S:25424 E:25435 ||| IN
the  ||| S:25435 E:25439 ||| DT
Ras  ||| S:25439 E:25443 ||| JJ
GTPase  ||| S:25443 E:25450 ||| JJ
superfamily  ||| S:25450 E:25462 ||| NNS
have  ||| S:25462 E:25467 ||| VBP
been  ||| S:25467 E:25472 ||| VBN
studied  ||| S:25472 E:25480 ||| VBN
for  ||| S:25480 E:25484 ||| IN
many  ||| S:25484 E:25489 ||| JJ
years  ||| S:25489 E:25503 ||| NNS
using  ||| S:25503 E:25509 ||| VBG
site-directed  ||| S:25509 E:25523 ||| JJ
mutagenesis  ||| S:25523 E:25535 ||| JJ
approaches ||| S:25535 E:25545 ||| NNS
,  ||| S:25545 E:25547 ||| ,
there  ||| S:25547 E:25553 ||| EX
have  ||| S:25553 E:25558 ||| VBP
been  ||| S:25558 E:25571 ||| VBN
no  ||| S:25571 E:25574 ||| DT
previous  ||| S:25574 E:25583 ||| JJ
reports  ||| S:25583 E:25591 ||| NNS
demonstrating  ||| S:25591 E:25605 ||| VBG
cytopathic  ||| S:25605 E:25616 ||| JJ
effects  ||| S:25616 E:25624 ||| NNS
of  ||| S:25624 E:25635 ||| IN
this  ||| S:25635 E:25640 ||| DT
kind ||| S:25640 E:25644 ||| NN
.  ||| S:25644 E:25646 ||| .
In  ||| S:25646 E:25649 ||| IN
particular ||| S:25649 E:25659 ||| JJ
,  ||| S:25659 E:25661 ||| ,
as  ||| S:25661 E:25664 ||| IN
we  ||| S:25664 E:25667 ||| PRP
have  ||| S:25667 E:25672 ||| VBP
shown  ||| S:25672 E:25678 ||| VBN
in  ||| S:25678 E:25681 ||| IN
Fig.  ||| S:25681 E:25686 ||| CD
2 ||| S:25686 E:25687 ||| CD
,  ||| S:25687 E:25689 ||| ,
a  ||| S:25689 E:25699 ||| DT
variety  ||| S:25699 E:25707 ||| NN
of  ||| S:25707 E:25710 ||| IN
Rab  ||| S:25710 E:25714 ||| NNP
proteins  ||| S:25714 E:25723 ||| VBZ
bearing  ||| S:25723 E:25731 ||| VBG
similar  ||| S:25731 E:25739 ||| JJ
mutations  ||| S:25739 E:25749 ||| NNS
are  ||| S:25749 E:25761 ||| VBP
localized  ||| S:25761 E:25771 ||| VBN
in  ||| S:25771 E:25774 ||| IN
the  ||| S:25774 E:25778 ||| DT
cytoplasmic  ||| S:25778 E:25790 ||| JJ
compartment ||| S:25790 E:25801 ||| NN
.  ||| S:25801 E:25811 ||| .
It  ||| S:25811 E:25814 ||| PRP
remains  ||| S:25814 E:25822 ||| VBZ
unclear  ||| S:25822 E:25830 ||| JJ
whether  ||| S:25830 E:25838 ||| IN
the  ||| S:25838 E:25842 ||| DT
nuclear  ||| S:25842 E:25850 ||| JJ
inclusions  ||| S:25850 E:25869 ||| JJ
induced  ||| S:25869 E:25877 ||| NN
by  ||| S:25877 E:25880 ||| IN
Rab24 ||| S:25880 E:25885 ||| NNP
( ||| S:25885 E:25886 ||| -LRB-
D123I ||| S:25886 E:25891 ||| NNP
)  ||| S:25891 E:25893 ||| -RRB-
are  ||| S:25893 E:25897 ||| VBP
generated  ||| S:25897 E:25916 ||| VBN
de  ||| S:25916 E:25919 ||| IN
novo  ||| S:25919 E:25924 ||| NN
inside  ||| S:25924 E:25931 ||| IN
the  ||| S:25931 E:25935 ||| DT
nucleus  ||| S:25935 E:25943 ||| NN
or  ||| S:25943 E:25946 ||| CC
instead  ||| S:25946 E:25962 ||| RB
penetrate  ||| S:25962 E:25972 ||| VB
the  ||| S:25972 E:25976 ||| DT
nuclear  ||| S:25976 E:25984 ||| JJ
membrane  ||| S:25984 E:25993 ||| NN
after  ||| S:25993 E:25999 ||| IN
being  ||| S:25999 E:26005 ||| VBG
assembled  ||| S:26005 E:26015 ||| VBN
in  ||| S:26015 E:26018 ||| IN
the  ||| S:26018 E:26030 ||| DT
cytoplasmic  ||| S:26030 E:26042 ||| JJ
compartment ||| S:26042 E:26053 ||| NN
.  ||| S:26053 E:26055 ||| .
Rab24  ||| S:26055 E:26061 ||| NNP
does  ||| S:26061 E:26066 ||| VBZ
not  ||| S:26066 E:26070 ||| RB
have  ||| S:26070 E:26075 ||| VB
a  ||| S:26075 E:26077 ||| DT
classic  ||| S:26077 E:26093 ||| JJ
nuclear  ||| S:26093 E:26101 ||| JJ
localization  ||| S:26101 E:26114 ||| JJ
signal  ||| S:26114 E:26121 ||| NN
sequence ||| S:26121 E:26129 ||| NN
,  ||| S:26129 E:26131 ||| ,
but  ||| S:26131 E:26135 ||| CC
monomeric  ||| S:26135 E:26153 ||| CD
mycRab24 ||| S:26153 E:26161 ||| CD
( ||| S:26161 E:26162 ||| -LRB-
D123I ||| S:26162 E:26167 ||| NNP
)  ||| S:26167 E:26169 ||| -RRB-
is  ||| S:26169 E:26172 ||| VBZ
theoretically  ||| S:26172 E:26186 ||| JJ
small  ||| S:26186 E:26192 ||| JJ
enough  ||| S:26192 E:26199 ||| JJ
( ||| S:26199 E:26200 ||| -LRB-
24  ||| S:26200 E:26203 ||| CD
kDa ||| S:26203 E:26206 ||| NN
)  ||| S:26206 E:26208 ||| -RRB-
to  ||| S:26208 E:26219 ||| TO
diffuse  ||| S:26219 E:26227 ||| VB
across  ||| S:26227 E:26234 ||| IN
the  ||| S:26234 E:26238 ||| DT
nuclear  ||| S:26238 E:26246 ||| JJ
pores  ||| S:26246 E:26252 ||| NNS
[  ||| S:26252 E:26254 ||| -LRB-
61  ||| S:26254 E:26257 ||| CD
]  ||| S:26257 E:26259 ||| -RRB-
.  ||| S:26259 E:26261 ||| .
However ||| S:26261 E:26268 ||| RB
,  ||| S:26268 E:26270 ||| ,
it  ||| S:26270 E:26273 ||| PRP
is  ||| S:26273 E:26284 ||| VBZ
less  ||| S:26284 E:26289 ||| RBR
likely  ||| S:26289 E:26296 ||| JJ
that  ||| S:26296 E:26301 ||| IN
this  ||| S:26301 E:26306 ||| DT
could  ||| S:26306 E:26312 ||| MD
occur  ||| S:26312 E:26318 ||| VB
in  ||| S:26318 E:26321 ||| IN
the  ||| S:26321 E:26325 ||| DT
case  ||| S:26325 E:26330 ||| NN
of  ||| S:26330 E:26333 ||| IN
the  ||| S:26333 E:26337 ||| DT
larger  ||| S:26337 E:26352 ||| JJR
EGFP-Rab24 ||| S:26352 E:26362 ||| NNP
( ||| S:26362 E:26363 ||| -LRB-
D123I ||| S:26363 E:26368 ||| NNP
)  ||| S:26368 E:26370 ||| -RRB-
fusion  ||| S:26370 E:26377 ||| NN
construct  ||| S:26377 E:26387 ||| NNS
( ||| S:26387 E:26388 ||| -LRB-
50  ||| S:26388 E:26391 ||| CD
kDa ||| S:26391 E:26394 ||| NN
) ||| S:26394 E:26395 ||| -RRB-
,  ||| S:26395 E:26397 ||| ,
which  ||| S:26397 E:26403 ||| WDT
also  ||| S:26403 E:26416 ||| RB
formed  ||| S:26416 E:26423 ||| VBN
abundant  ||| S:26423 E:26432 ||| JJ
intranuclear  ||| S:26432 E:26445 ||| JJ
inclusions  ||| S:26445 E:26456 ||| NNS
( ||| S:26456 E:26457 ||| -LRB-
Fig.  ||| S:26457 E:26462 ||| CD
9 ||| S:26462 E:26463 ||| CD
) ||| S:26463 E:26464 ||| -RRB-
.  ||| S:26464 E:26466 ||| .
Our  ||| S:26466 E:26478 ||| PRP$
preliminary  ||| S:26478 E:26490 ||| JJ
observations  ||| S:26490 E:26503 ||| NNS
indicate  ||| S:26503 E:26512 ||| VBP
that  ||| S:26512 E:26517 ||| IN
some  ||| S:26517 E:26522 ||| DT
of  ||| S:26522 E:26525 ||| IN
the  ||| S:26525 E:26537 ||| DT
intranuclear  ||| S:26537 E:26550 ||| FW
inclusions  ||| S:26550 E:26561 ||| FW
containing  ||| S:26561 E:26572 ||| FW
Rab24 ||| S:26572 E:26577 ||| FW
( ||| S:26577 E:26578 ||| -LRB-
D123I ||| S:26578 E:26583 ||| NNP
)  ||| S:26583 E:26585 ||| -RRB-
are  ||| S:26585 E:26597 ||| VBP
immunoreactive  ||| S:26597 E:26612 ||| VBN
for  ||| S:26612 E:26616 ||| IN
lamins ||| S:26616 E:26622 ||| NN
,  ||| S:26622 E:26624 ||| ,
while  ||| S:26624 E:26630 ||| IN
those  ||| S:26630 E:26636 ||| DT
outside  ||| S:26636 E:26644 ||| IN
the  ||| S:26644 E:26648 ||| DT
nucleus  ||| S:26648 E:26664 ||| NNS
are  ||| S:26664 E:26668 ||| VBP
not  ||| S:26668 E:26672 ||| RB
( ||| S:26672 E:26673 ||| -LRB-
Fig.  ||| S:26673 E:26678 ||| NNP
4B ||| S:26678 E:26680 ||| NNP
) ||| S:26680 E:26681 ||| -RRB-
.  ||| S:26681 E:26683 ||| .
Moreover ||| S:26683 E:26691 ||| RB
,  ||| S:26691 E:26693 ||| ,
the  ||| S:26693 E:26697 ||| DT
electron  ||| S:26697 E:26706 ||| JJ
micrographs  ||| S:26706 E:26718 ||| JJ
show  ||| S:26718 E:26731 ||| NN
that  ||| S:26731 E:26736 ||| WDT
nuclei  ||| S:26736 E:26743 ||| VBP
containing  ||| S:26743 E:26754 ||| VBG
clusters  ||| S:26754 E:26763 ||| NNS
of  ||| S:26763 E:26766 ||| IN
inclusions  ||| S:26766 E:26777 ||| VBG
often  ||| S:26777 E:26783 ||| RB
have  ||| S:26783 E:26796 ||| VB
regions  ||| S:26796 E:26804 ||| NNS
where  ||| S:26804 E:26810 ||| WRB
the  ||| S:26810 E:26814 ||| DT
nuclear  ||| S:26814 E:26822 ||| JJ
membrane  ||| S:26822 E:26831 ||| NN
appears  ||| S:26831 E:26839 ||| VBZ
to  ||| S:26839 E:26842 ||| TO
be  ||| S:26842 E:26853 ||| VB
discontinuous  ||| S:26853 E:26867 ||| NNS
( ||| S:26867 E:26868 ||| -LRB-
Fig.  ||| S:26868 E:26873 ||| NNP
3C ||| S:26873 E:26875 ||| NNP
) ||| S:26875 E:26876 ||| -RRB-
.  ||| S:26876 E:26878 ||| .
Based  ||| S:26878 E:26884 ||| VBN
on  ||| S:26884 E:26887 ||| IN
these  ||| S:26887 E:26893 ||| DT
findings ||| S:26893 E:26901 ||| NNS
,  ||| S:26901 E:26903 ||| ,
we  ||| S:26903 E:26914 ||| PRP
believe  ||| S:26914 E:26922 ||| VBP
that  ||| S:26922 E:26927 ||| IN
aggregates  ||| S:26927 E:26938 ||| NNS
formed  ||| S:26938 E:26945 ||| VBN
in  ||| S:26945 E:26948 ||| IN
the  ||| S:26948 E:26952 ||| DT
cytoplasm  ||| S:26952 E:26962 ||| NN
may  ||| S:26962 E:26974 ||| MD
transiently  ||| S:26974 E:26986 ||| VB
associate  ||| S:26986 E:26996 ||| NN
with  ||| S:26996 E:27001 ||| IN
and  ||| S:27001 E:27005 ||| CC
disrupt  ||| S:27005 E:27013 ||| VB
the  ||| S:27013 E:27017 ||| DT
nuclear  ||| S:27017 E:27033 ||| JJ
envelope ||| S:27033 E:27041 ||| NN
,  ||| S:27041 E:27043 ||| ,
then  ||| S:27043 E:27048 ||| RB
enter  ||| S:27048 E:27054 ||| VB
the  ||| S:27054 E:27058 ||| DT
nucleus  ||| S:27058 E:27066 ||| NN
through  ||| S:27066 E:27074 ||| IN
the  ||| S:27074 E:27078 ||| DT
resulting  ||| S:27078 E:27096 ||| JJ
gaps ||| S:27096 E:27100 ||| NN
.  ||| S:27100 E:27102 ||| .
Ultimately ||| S:27102 E:27112 ||| RB
,  ||| S:27112 E:27114 ||| ,
the  ||| S:27114 E:27118 ||| DT
accumulation  ||| S:27118 E:27131 ||| NN
of  ||| S:27131 E:27134 ||| IN
nuclear  ||| S:27134 E:27142 ||| JJ
inclusions  ||| S:27142 E:27153 ||| NN
in  ||| S:27153 E:27164 ||| IN
cells  ||| S:27164 E:27170 ||| NNS
expressing  ||| S:27170 E:27181 ||| VBG
Rab24 ||| S:27181 E:27186 ||| NNP
( ||| S:27186 E:27187 ||| -LRB-
D123I ||| S:27187 E:27192 ||| NNP
)  ||| S:27192 E:27194 ||| -RRB-
causes  ||| S:27194 E:27201 ||| VBZ
a  ||| S:27201 E:27203 ||| DT
catastrophic  ||| S:27203 E:27224 ||| JJ
disruption  ||| S:27224 E:27235 ||| NN
of  ||| S:27235 E:27238 ||| IN
the  ||| S:27238 E:27242 ||| DT
nuclear  ||| S:27242 E:27250 ||| JJ
architecture ||| S:27250 E:27262 ||| NN
,  ||| S:27262 E:27264 ||| ,
although  ||| S:27264 E:27273 ||| IN
this  ||| S:27273 E:27278 ||| DT
does  ||| S:27278 E:27291 ||| VBZ
not  ||| S:27291 E:27295 ||| RB
appear  ||| S:27295 E:27302 ||| VB
to  ||| S:27302 E:27305 ||| TO
be  ||| S:27305 E:27308 ||| VB
accompanied  ||| S:27308 E:27320 ||| VBN
by  ||| S:27320 E:27323 ||| IN
classic  ||| S:27323 E:27331 ||| JJ
signs  ||| S:27331 E:27337 ||| NNS
of  ||| S:27337 E:27340 ||| IN
apoptotic  ||| S:27340 E:27358 ||| JJ
cell  ||| S:27358 E:27363 ||| NN
death  ||| S:27363 E:27369 ||| NN
such  ||| S:27369 E:27374 ||| JJ
as  ||| S:27374 E:27377 ||| IN
DNA  ||| S:27377 E:27381 ||| NNP
fragmentation  ||| S:27381 E:27395 ||| NN
or  ||| S:27395 E:27398 ||| CC
caspase  ||| S:27398 E:27414 ||| JJ
activation ||| S:27414 E:27424 ||| NN
.  ||| S:27424 E:27434 ||| .
The  ||| S:27434 E:27438 ||| DT
molecular  ||| S:27438 E:27448 ||| JJ
mechanism  ||| S:27448 E:27458 ||| NN
underlying  ||| S:27458 E:27469 ||| VBG
the  ||| S:27469 E:27473 ||| DT
formation  ||| S:27473 E:27483 ||| NN
of  ||| S:27483 E:27494 ||| IN
nuclear  ||| S:27494 E:27502 ||| JJ
inclusions  ||| S:27502 E:27513 ||| NN
in  ||| S:27513 E:27516 ||| IN
cells  ||| S:27516 E:27522 ||| NNS
expressing  ||| S:27522 E:27533 ||| VBG
the  ||| S:27533 E:27537 ||| DT
mutant  ||| S:27537 E:27544 ||| JJ
forms  ||| S:27544 E:27550 ||| NNS
of  ||| S:27550 E:27561 ||| IN
Rab24  ||| S:27561 E:27567 ||| NNP
remains  ||| S:27567 E:27575 ||| VBZ
to  ||| S:27575 E:27578 ||| TO
be  ||| S:27578 E:27581 ||| VB
defined ||| S:27581 E:27588 ||| VBN
.  ||| S:27588 E:27590 ||| .
An  ||| S:27590 E:27593 ||| DT
extensive  ||| S:27593 E:27603 ||| JJ
body  ||| S:27603 E:27608 ||| NN
of  ||| S:27608 E:27611 ||| IN
published  ||| S:27611 E:27629 ||| JJ
work  ||| S:27629 E:27634 ||| NN
supports  ||| S:27634 E:27643 ||| VBZ
the  ||| S:27643 E:27647 ||| DT
notion  ||| S:27647 E:27654 ||| NN
that  ||| S:27654 E:27659 ||| IN
Rab  ||| S:27659 E:27663 ||| NNP
proteins  ||| S:27663 E:27672 ||| VBZ
bearing  ||| S:27672 E:27688 ||| VBG
mutations  ||| S:27688 E:27698 ||| NNS
in  ||| S:27698 E:27701 ||| IN
the  ||| S:27701 E:27705 ||| DT
N ||| S:27705 E:27706 ||| NNP
( ||| S:27706 E:27707 ||| -LRB-
T ||| S:27707 E:27708 ||| NN
) ||| S:27708 E:27709 ||| -RRB-
KxD  ||| S:27709 E:27713 ||| FW
nucleotide  ||| S:27713 E:27724 ||| FW
binding  ||| S:27724 E:27732 ||| FW
motif  ||| S:27732 E:27738 ||| FW
function  ||| S:27738 E:27755 ||| NN
as  ||| S:27755 E:27758 ||| IN
dominant-suppressors  ||| S:27758 E:27779 ||| JJ
of  ||| S:27779 E:27782 ||| IN
their  ||| S:27782 E:27788 ||| PRP$
endogenous  ||| S:27788 E:27799 ||| JJ
cellular  ||| S:27799 E:27816 ||| JJ
counterparts ||| S:27816 E:27828 ||| NNS
.  ||| S:27828 E:27830 ||| .
Our  ||| S:27830 E:27834 ||| PRP$
domain-exchange  ||| S:27834 E:27850 ||| JJ
experiments  ||| S:27850 E:27862 ||| NNS
with  ||| S:27862 E:27867 ||| IN
Rab24  ||| S:27867 E:27881 ||| NNP
and  ||| S:27881 E:27885 ||| CC
Rab1B  ||| S:27885 E:27891 ||| NNP
( ||| S:27891 E:27892 ||| -LRB-
Fig.  ||| S:27892 E:27897 ||| CD
8 ||| S:27897 E:27898 ||| CD
)  ||| S:27898 E:27900 ||| -RRB-
indicate  ||| S:27900 E:27909 ||| VBP
that  ||| S:27909 E:27914 ||| DT
incorporation  ||| S:27914 E:27928 ||| NN
of  ||| S:27928 E:27931 ||| IN
the  ||| S:27931 E:27943 ||| DT
mutant  ||| S:27943 E:27950 ||| JJ
proteins  ||| S:27950 E:27959 ||| NNS
into  ||| S:27959 E:27964 ||| IN
nuclear  ||| S:27964 E:27972 ||| JJ
inclusions  ||| S:27972 E:27983 ||| NN
requires  ||| S:27983 E:27992 ||| VBZ
the  ||| S:27992 E:28004 ||| DT
specific  ||| S:28004 E:28013 ||| JJ
C-terminal  ||| S:28013 E:28024 ||| JJ
hypervariable  ||| S:28024 E:28038 ||| NNS
targeting  ||| S:28038 E:28048 ||| VBG
domain  ||| S:28048 E:28055 ||| NN
of  ||| S:28055 E:28066 ||| IN
Rab24 ||| S:28066 E:28071 ||| CD
.  ||| S:28071 E:28073 ||| .
Therefore ||| S:28073 E:28082 ||| RB
,  ||| S:28082 E:28084 ||| ,
one  ||| S:28084 E:28088 ||| CD
possibility  ||| S:28088 E:28100 ||| NN
is  ||| S:28100 E:28103 ||| VBZ
that  ||| S:28103 E:28108 ||| IN
the  ||| S:28108 E:28112 ||| DT
inclusions  ||| S:28112 E:28131 ||| JJ
arise  ||| S:28131 E:28137 ||| NN
as  ||| S:28137 E:28140 ||| IN
a  ||| S:28140 E:28142 ||| DT
consequence  ||| S:28142 E:28154 ||| NN
of  ||| S:28154 E:28157 ||| IN
disruption  ||| S:28157 E:28168 ||| NN
of  ||| S:28168 E:28171 ||| IN
the  ||| S:28171 E:28175 ||| DT
normal  ||| S:28175 E:28190 ||| JJ
physiological  ||| S:28190 E:28204 ||| JJ
function  ||| S:28204 E:28213 ||| NN
of  ||| S:28213 E:28216 ||| IN
Rab24 ||| S:28216 E:28221 ||| CD
.  ||| S:28221 E:28223 ||| .
To  ||| S:28223 E:28226 ||| TO
explore  ||| S:28226 E:28234 ||| VB
this  ||| S:28234 E:28239 ||| DT
issue  ||| S:28239 E:28253 ||| NN
further ||| S:28253 E:28260 ||| RBR
,  ||| S:28260 E:28262 ||| ,
we  ||| S:28262 E:28265 ||| PRP
attempted  ||| S:28265 E:28275 ||| VBD
to  ||| S:28275 E:28278 ||| TO
generate  ||| S:28278 E:28287 ||| VB
another  ||| S:28287 E:28295 ||| DT
potential  ||| S:28295 E:28313 ||| JJ
dominant-negative  ||| S:28313 E:28331 ||| JJ
form  ||| S:28331 E:28336 ||| NN
of  ||| S:28336 E:28339 ||| IN
Rab24 ||| S:28339 E:28344 ||| NNP
,  ||| S:28344 E:28346 ||| ,
predicted  ||| S:28346 E:28356 ||| VBD
to  ||| S:28356 E:28359 ||| TO
be  ||| S:28359 E:28362 ||| VB
locked  ||| S:28362 E:28369 ||| VBN
in  ||| S:28369 E:28380 ||| IN
the  ||| S:28380 E:28384 ||| DT
GDP  ||| S:28384 E:28388 ||| NNP
state ||| S:28388 E:28393 ||| NN
.  ||| S:28393 E:28395 ||| .
However ||| S:28395 E:28402 ||| RB
,  ||| S:28402 E:28404 ||| ,
when  ||| S:28404 E:28409 ||| WRB
we  ||| S:28409 E:28412 ||| PRP
made  ||| S:28412 E:28417 ||| VBD
the  ||| S:28417 E:28421 ||| DT
amino  ||| S:28421 E:28427 ||| JJ
acid  ||| S:28427 E:28440 ||| NN
substitution  ||| S:28440 E:28453 ||| VBZ
customarily  ||| S:28453 E:28465 ||| RB
used  ||| S:28465 E:28470 ||| VBN
to  ||| S:28470 E:28473 ||| TO
generate  ||| S:28473 E:28482 ||| VB
such  ||| S:28482 E:28487 ||| JJ
Rab  ||| S:28487 E:28491 ||| JJ
mutants  ||| S:28491 E:28507 ||| NNS
(  ||| S:28507 E:28518 ||| -LRB-
i.e.  ||| S:28518 E:28523 ||| FW
,  ||| S:28523 E:28525 ||| ,
S22N ||| S:28525 E:28529 ||| CD
) ||| S:28529 E:28530 ||| -RRB-
,  ||| S:28530 E:28532 ||| ,
Rab24  ||| S:28532 E:28538 ||| NNP
unexpectedly  ||| S:28538 E:28559 ||| RB
remained  ||| S:28559 E:28568 ||| VBN
in  ||| S:28568 E:28571 ||| IN
the  ||| S:28571 E:28575 ||| DT
GTP  ||| S:28575 E:28579 ||| NNP
state ||| S:28579 E:28584 ||| NN
.  ||| S:28584 E:28586 ||| .
Therefore ||| S:28586 E:28595 ||| RB
,  ||| S:28595 E:28597 ||| ,
pending  ||| S:28597 E:28605 ||| VBG
further  ||| S:28605 E:28621 ||| JJ
investigation ||| S:28621 E:28634 ||| NN
,  ||| S:28634 E:28636 ||| ,
we  ||| S:28636 E:28639 ||| PRP
cannot  ||| S:28639 E:28646 ||| RB
rule  ||| S:28646 E:28651 ||| VB
out  ||| S:28651 E:28655 ||| RP
the  ||| S:28655 E:28659 ||| DT
alternative  ||| S:28659 E:28679 ||| JJ
hypothesis  ||| S:28679 E:28690 ||| NN
that  ||| S:28690 E:28695 ||| IN
mutations  ||| S:28695 E:28705 ||| NNS
in  ||| S:28705 E:28708 ||| IN
the  ||| S:28708 E:28712 ||| DT
N ||| S:28712 E:28713 ||| NNP
( ||| S:28713 E:28714 ||| -LRB-
T ||| S:28714 E:28715 ||| NN
) ||| S:28715 E:28716 ||| -RRB-
KxD  ||| S:28716 E:28720 ||| JJ
motif  ||| S:28720 E:28726 ||| NN
of  ||| S:28726 E:28729 ||| IN
Rab24 ||| S:28729 E:28734 ||| NNP
,  ||| S:28734 E:28744 ||| ,
combined  ||| S:28744 E:28753 ||| VBN
with  ||| S:28753 E:28758 ||| IN
features  ||| S:28758 E:28767 ||| NNS
in  ||| S:28767 E:28770 ||| IN
the  ||| S:28770 E:28774 ||| DT
C-terminal  ||| S:28774 E:28785 ||| JJ
domain ||| S:28785 E:28791 ||| NN
,  ||| S:28791 E:28793 ||| ,
cause  ||| S:28793 E:28807 ||| VB
Rab24  ||| S:28807 E:28813 ||| CD
to  ||| S:28813 E:28816 ||| TO
misfold  ||| S:28816 E:28824 ||| VB
in  ||| S:28824 E:28827 ||| IN
a  ||| S:28827 E:28829 ||| DT
unique  ||| S:28829 E:28836 ||| JJ
manner ||| S:28836 E:28842 ||| NN
,  ||| S:28842 E:28844 ||| ,
attracting  ||| S:28844 E:28863 ||| VBG
non-physiological  ||| S:28863 E:28881 ||| JJ
protein  ||| S:28881 E:28889 ||| NN
partners  ||| S:28889 E:28898 ||| NNS
that  ||| S:28898 E:28903 ||| WDT
can  ||| S:28903 E:28907 ||| MD
promote  ||| S:28907 E:28923 ||| VB
aggregation  ||| S:28923 E:28935 ||| NNS
and  ||| S:28935 E:28939 ||| CC
nuclear  ||| S:28939 E:28947 ||| JJ
localization ||| S:28947 E:28959 ||| NN
.  ||| S:28959 E:28969 ||| .
As  ||| S:28969 E:28972 ||| IN
a  ||| S:28972 E:28974 ||| DT
framework  ||| S:28974 E:28984 ||| NN
for  ||| S:28984 E:28988 ||| IN
future  ||| S:28988 E:28995 ||| JJ
studies  ||| S:28995 E:29003 ||| NNS
we  ||| S:29003 E:29006 ||| PRP
can  ||| S:29006 E:29010 ||| MD
envision  ||| S:29010 E:29019 ||| VB
at  ||| S:29019 E:29030 ||| IN
least  ||| S:29030 E:29036 ||| JJS
three  ||| S:29036 E:29042 ||| CD
models  ||| S:29042 E:29049 ||| NNS
that  ||| S:29049 E:29054 ||| WDT
could  ||| S:29054 E:29060 ||| MD
explain  ||| S:29060 E:29068 ||| VB
the  ||| S:29068 E:29072 ||| DT
accumulation  ||| S:29072 E:29085 ||| NN
of  ||| S:29085 E:29096 ||| IN
inclusion  ||| S:29096 E:29106 ||| NN
bodies  ||| S:29106 E:29113 ||| NNS
in  ||| S:29113 E:29116 ||| IN
cells  ||| S:29116 E:29122 ||| NNS
expressing  ||| S:29122 E:29133 ||| VBG
Rab24 ||| S:29133 E:29138 ||| NNP
( ||| S:29138 E:29139 ||| -LRB-
D123I ||| S:29139 E:29144 ||| NNP
) ||| S:29144 E:29145 ||| -RRB-
.  ||| S:29145 E:29147 ||| .
Our  ||| S:29147 E:29159 ||| PRP$
immunofluorescence  ||| S:29159 E:29178 ||| JJ
studies  ||| S:29178 E:29186 ||| NNS
( ||| S:29186 E:29187 ||| -LRB-
Fig.  ||| S:29187 E:29192 ||| CD
10 ||| S:29192 E:29194 ||| CD
)  ||| S:29194 E:29196 ||| -RRB-
suggest  ||| S:29196 E:29204 ||| VBP
that  ||| S:29204 E:29209 ||| IN
the  ||| S:29209 E:29221 ||| DT
inclusions  ||| S:29221 E:29232 ||| NNS
are  ||| S:29232 E:29236 ||| VBP
complex  ||| S:29236 E:29244 ||| JJ
protein  ||| S:29244 E:29252 ||| NN
assemblies  ||| S:29252 E:29263 ||| NNS
containing  ||| S:29263 E:29274 ||| VBG
Hsp70  ||| S:29274 E:29288 ||| NNP
and  ||| S:29288 E:29292 ||| CC
ubiquitin ||| S:29292 E:29301 ||| NN
.  ||| S:29301 E:29303 ||| .
Therefore ||| S:29303 E:29312 ||| RB
,  ||| S:29312 E:29314 ||| ,
the  ||| S:29314 E:29318 ||| DT
first  ||| S:29318 E:29324 ||| JJ
possibility  ||| S:29324 E:29336 ||| NN
is  ||| S:29336 E:29339 ||| VBZ
that  ||| S:29339 E:29344 ||| IN
the  ||| S:29344 E:29356 ||| DT
presence  ||| S:29356 E:29365 ||| NN
of  ||| S:29365 E:29368 ||| IN
Hsp70  ||| S:29368 E:29374 ||| NNP
and  ||| S:29374 E:29378 ||| CC
ubiquitin  ||| S:29378 E:29388 ||| NN
reflects  ||| S:29388 E:29397 ||| VBZ
a  ||| S:29397 E:29399 ||| DT
failed  ||| S:29399 E:29406 ||| JJ
attempt  ||| S:29406 E:29422 ||| NN
by  ||| S:29422 E:29425 ||| IN
the  ||| S:29425 E:29429 ||| DT
cell  ||| S:29429 E:29434 ||| NN
to  ||| S:29434 E:29437 ||| TO
eliminate  ||| S:29437 E:29447 ||| VB
misfolded  ||| S:29447 E:29457 ||| JJ
protein  ||| S:29457 E:29465 ||| NN
aggregates  ||| S:29465 E:29476 ||| NNS
via  ||| S:29476 E:29488 ||| IN
the  ||| S:29488 E:29492 ||| DT
proteasome  ||| S:29492 E:29503 ||| JJ
pathway ||| S:29503 E:29510 ||| NN
.  ||| S:29510 E:29512 ||| .
Indeed ||| S:29512 E:29518 ||| RB
,  ||| S:29518 E:29520 ||| ,
a  ||| S:29520 E:29522 ||| DT
similar  ||| S:29522 E:29530 ||| JJ
explanation  ||| S:29530 E:29542 ||| NN
has  ||| S:29542 E:29554 ||| VBZ
been  ||| S:29554 E:29559 ||| VBN
invoked  ||| S:29559 E:29567 ||| VBN
to  ||| S:29567 E:29570 ||| TO
explain  ||| S:29570 E:29578 ||| VB
the  ||| S:29578 E:29582 ||| DT
presence  ||| S:29582 E:29591 ||| NN
of  ||| S:29591 E:29594 ||| IN
Hsp70  ||| S:29594 E:29600 ||| NNP
and  ||| S:29600 E:29604 ||| CC
ubiquitin  ||| S:29604 E:29622 ||| NN
in  ||| S:29622 E:29625 ||| IN
nuclear  ||| S:29625 E:29633 ||| JJ
aggregates  ||| S:29633 E:29644 ||| NNS
observed  ||| S:29644 E:29653 ||| VBD
in  ||| S:29653 E:29656 ||| IN
cells  ||| S:29656 E:29662 ||| NNS
expressing  ||| S:29662 E:29673 ||| VBG
abnormal  ||| S:29673 E:29690 ||| JJ
gene  ||| S:29690 E:29695 ||| NN
products  ||| S:29695 E:29704 ||| NNS
with  ||| S:29704 E:29709 ||| IN
poly-Gln  ||| S:29709 E:29718 ||| JJ
tracts ||| S:29718 E:29724 ||| NNS
,  ||| S:29724 E:29726 ||| ,
such  ||| S:29726 E:29731 ||| JJ
as  ||| S:29731 E:29734 ||| IN
huntingtin  ||| S:29734 E:29745 ||| NNS
[  ||| S:29745 E:29747 ||| -LRB-
54  ||| S:29747 E:29758 ||| CD
]  ||| S:29758 E:29760 ||| -RRB-
and  ||| S:29760 E:29764 ||| CC
ataxin-1  ||| S:29764 E:29773 ||| NNP
[  ||| S:29773 E:29775 ||| -LRB-
59  ||| S:29775 E:29778 ||| CD
]  ||| S:29778 E:29780 ||| -RRB-
.  ||| S:29780 E:29782 ||| .
Based  ||| S:29782 E:29788 ||| VBN
on  ||| S:29788 E:29791 ||| IN
reports  ||| S:29791 E:29799 ||| NNS
that  ||| S:29799 E:29812 ||| IN
overexpression  ||| S:29812 E:29827 ||| NN
of  ||| S:29827 E:29830 ||| IN
chaperones  ||| S:29830 E:29841 ||| NNS
[  ||| S:29841 E:29843 ||| -LRB-
59  ||| S:29843 E:29846 ||| CD
62  ||| S:29846 E:29849 ||| CD
]  ||| S:29849 E:29851 ||| -RRB-
or  ||| S:29851 E:29854 ||| CC
a  ||| S:29854 E:29864 ||| DT
dominant-negative  ||| S:29864 E:29882 ||| JJ
form  ||| S:29882 E:29887 ||| NN
of  ||| S:29887 E:29890 ||| IN
the  ||| S:29890 E:29894 ||| DT
ubiquitin-conjugating  ||| S:29894 E:29916 ||| JJ
enzyme  ||| S:29916 E:29931 ||| NNS
[  ||| S:29931 E:29933 ||| -LRB-
63  ||| S:29933 E:29936 ||| CD
]  ||| S:29936 E:29938 ||| -RRB-
can  ||| S:29938 E:29942 ||| MD
suppress  ||| S:29942 E:29951 ||| VB
the  ||| S:29951 E:29955 ||| DT
formation  ||| S:29955 E:29965 ||| NN
of  ||| S:29965 E:29968 ||| IN
poly-Gln  ||| S:29968 E:29977 ||| JJ
protein  ||| S:29977 E:29993 ||| NN
aggregates ||| S:29993 E:30003 ||| NNS
,  ||| S:30003 E:30005 ||| ,
Kaytor  ||| S:30005 E:30012 ||| NNP
and  ||| S:30012 E:30016 ||| CC
Warren  ||| S:30016 E:30023 ||| NNP
[  ||| S:30023 E:30025 ||| -LRB-
58  ||| S:30025 E:30028 ||| CD
]  ||| S:30028 E:30030 ||| -RRB-
proposed  ||| S:30030 E:30039 ||| VBD
a  ||| S:30039 E:30041 ||| DT
three-stage  ||| S:30041 E:30061 ||| JJ
model  ||| S:30061 E:30067 ||| NN
wherein  ||| S:30067 E:30075 ||| NNS
( ||| S:30075 E:30076 ||| -LRB-
i ||| S:30076 E:30077 ||| FW
)  ||| S:30077 E:30079 ||| -RRB-
molecular  ||| S:30079 E:30089 ||| JJ
chaperones  ||| S:30089 E:30100 ||| NNS
initially  ||| S:30100 E:30110 ||| RB
associate  ||| S:30110 E:30128 ||| JJ
with  ||| S:30128 E:30133 ||| IN
the  ||| S:30133 E:30137 ||| DT
misfolded  ||| S:30137 E:30147 ||| JJ
protein ||| S:30147 E:30154 ||| NN
,  ||| S:30154 E:30156 ||| ,
( ||| S:30156 E:30157 ||| -LRB-
ii ||| S:30157 E:30159 ||| LS
)  ||| S:30159 E:30161 ||| -RRB-
failure  ||| S:30161 E:30169 ||| NN
to  ||| S:30169 E:30172 ||| TO
diminish  ||| S:30172 E:30181 ||| VB
the  ||| S:30181 E:30193 ||| DT
pool  ||| S:30193 E:30198 ||| NN
of  ||| S:30198 E:30201 ||| IN
misfolded  ||| S:30201 E:30211 ||| JJ
protein  ||| S:30211 E:30219 ||| NN
leads  ||| S:30219 E:30225 ||| VBZ
to  ||| S:30225 E:30228 ||| TO
aggregation  ||| S:30228 E:30240 ||| VB
and  ||| S:30240 E:30252 ||| CC
ubiquitination  ||| S:30252 E:30267 ||| NNS
and  ||| S:30267 E:30271 ||| CC
( ||| S:30271 E:30272 ||| -LRB-
iii ||| S:30272 E:30275 ||| LS
)  ||| S:30275 E:30277 ||| -RRB-
inefficient  ||| S:30277 E:30289 ||| JJ
degradation  ||| S:30289 E:30301 ||| NN
of  ||| S:30301 E:30304 ||| IN
the  ||| S:30304 E:30316 ||| DT
aggregate  ||| S:30316 E:30326 ||| NN
by  ||| S:30326 E:30329 ||| IN
the  ||| S:30329 E:30333 ||| DT
proteasome  ||| S:30333 E:30344 ||| NN
is  ||| S:30344 E:30347 ||| VBZ
manifested  ||| S:30347 E:30358 ||| VBN
by  ||| S:30358 E:30361 ||| IN
the  ||| S:30361 E:30373 ||| DT
accumulation  ||| S:30373 E:30386 ||| NN
of  ||| S:30386 E:30389 ||| IN
inclusion  ||| S:30389 E:30399 ||| NN
bodies ||| S:30399 E:30405 ||| NNS
.  ||| S:30405 E:30407 ||| .
Although  ||| S:30407 E:30416 ||| IN
this  ||| S:30416 E:30421 ||| DT
model  ||| S:30421 E:30435 ||| NN
implies  ||| S:30435 E:30443 ||| VBZ
that  ||| S:30443 E:30448 ||| IN
the  ||| S:30448 E:30452 ||| DT
misfolded  ||| S:30452 E:30462 ||| JJ
poly-Gln  ||| S:30462 E:30471 ||| JJ
protein  ||| S:30471 E:30479 ||| NN
might  ||| S:30479 E:30485 ||| MD
be  ||| S:30485 E:30488 ||| VB
the  ||| S:30488 E:30500 ||| DT
primary  ||| S:30500 E:30508 ||| JJ
substrate  ||| S:30508 E:30518 ||| NN
for  ||| S:30518 E:30522 ||| IN
ubiquitination ||| S:30522 E:30536 ||| NN
,  ||| S:30536 E:30538 ||| ,
a  ||| S:30538 E:30540 ||| DT
recent  ||| S:30540 E:30547 ||| JJ
study  ||| S:30547 E:30553 ||| NN
by  ||| S:30553 E:30564 ||| IN
Suhr  ||| S:30564 E:30578 ||| NNP
et  ||| S:30578 E:30581 ||| FW
al  ||| S:30581 E:30584 ||| FW
.  ||| S:30584 E:30586 ||| .
[  ||| S:30586 E:30588 ||| -LRB-
60  ||| S:30588 E:30591 ||| CD
]  ||| S:30591 E:30593 ||| -RRB-
suggests  ||| S:30593 E:30602 ||| VBZ
that  ||| S:30602 E:30607 ||| IN
this  ||| S:30607 E:30612 ||| DT
may  ||| S:30612 E:30624 ||| MD
not  ||| S:30624 E:30628 ||| RB
always  ||| S:30628 E:30635 ||| RB
be  ||| S:30635 E:30638 ||| VB
the  ||| S:30638 E:30642 ||| DT
case ||| S:30642 E:30646 ||| NN
.  ||| S:30646 E:30648 ||| .
Specifically ||| S:30648 E:30660 ||| RB
,  ||| S:30660 E:30662 ||| ,
they  ||| S:30662 E:30667 ||| PRP
found  ||| S:30667 E:30673 ||| VBD
that  ||| S:30673 E:30678 ||| IN
when  ||| S:30678 E:30691 ||| WRB
aggregates  ||| S:30691 E:30702 ||| NNS
from  ||| S:30702 E:30707 ||| IN
293  ||| S:30707 E:30711 ||| CD
cells  ||| S:30711 E:30717 ||| NNS
expressing  ||| S:30717 E:30728 ||| VBG
poly-Gln  ||| S:30728 E:30737 ||| JJ
proteins  ||| S:30737 E:30746 ||| NNS
were  ||| S:30746 E:30759 ||| VBD
dissociated ||| S:30759 E:30770 ||| CD
,  ||| S:30770 E:30772 ||| ,
the  ||| S:30772 E:30776 ||| DT
ubiquitin  ||| S:30776 E:30786 ||| JJ
polymers  ||| S:30786 E:30795 ||| NNS
were  ||| S:30795 E:30800 ||| VBD
not  ||| S:30800 E:30804 ||| RB
conjugated  ||| S:30804 E:30823 ||| VBN
directly  ||| S:30823 E:30832 ||| RB
to  ||| S:30832 E:30835 ||| TO
the  ||| S:30835 E:30839 ||| DT
poly-Gln  ||| S:30839 E:30848 ||| JJ
protein  ||| S:30848 E:30856 ||| NN
or  ||| S:30856 E:30859 ||| CC
the  ||| S:30859 E:30863 ||| DT
sequestered  ||| S:30863 E:30883 ||| JJ
Hsp70 ||| S:30883 E:30888 ||| NN
.  ||| S:30888 E:30898 ||| .
An  ||| S:30898 E:30901 ||| DT
alternative  ||| S:30901 E:30913 ||| JJ
mechanism  ||| S:30913 E:30923 ||| NN
for  ||| S:30923 E:30927 ||| IN
the  ||| S:30927 E:30931 ||| DT
formation  ||| S:30931 E:30941 ||| NN
of  ||| S:30941 E:30944 ||| IN
inclusion  ||| S:30944 E:30962 ||| NN
bodies  ||| S:30962 E:30969 ||| NNS
in  ||| S:30969 E:30972 ||| IN
protein  ||| S:30972 E:30980 ||| NN
conformation  ||| S:30980 E:30993 ||| NN
disorders  ||| S:30993 E:31003 ||| NNS
is  ||| S:31003 E:31006 ||| VBZ
suggested  ||| S:31006 E:31016 ||| VBN
by  ||| S:31016 E:31019 ||| IN
a  ||| S:31019 E:31029 ||| DT
recent  ||| S:31029 E:31036 ||| JJ
study  ||| S:31036 E:31042 ||| NN
showing  ||| S:31042 E:31050 ||| VBG
that  ||| S:31050 E:31055 ||| DT
clearance  ||| S:31055 E:31065 ||| NN
of  ||| S:31065 E:31068 ||| IN
poly-Gln  ||| S:31068 E:31077 ||| JJ
and  ||| S:31077 E:31089 ||| CC
poly-Ala  ||| S:31089 E:31098 ||| JJ
inclusions  ||| S:31098 E:31109 ||| NN
is  ||| S:31109 E:31112 ||| VBZ
accelerated  ||| S:31112 E:31124 ||| VBN
by  ||| S:31124 E:31127 ||| IN
compounds  ||| S:31127 E:31137 ||| NN
like  ||| S:31137 E:31150 ||| IN
rapamycin ||| S:31150 E:31159 ||| NN
,  ||| S:31159 E:31161 ||| ,
which  ||| S:31161 E:31167 ||| WDT
stimulate  ||| S:31167 E:31177 ||| VBZ
protein  ||| S:31177 E:31185 ||| JJ
degradation  ||| S:31185 E:31197 ||| NN
by  ||| S:31197 E:31200 ||| IN
autophagy  ||| S:31200 E:31218 ||| NNS
[  ||| S:31218 E:31220 ||| -LRB-
64  ||| S:31220 E:31223 ||| CD
]  ||| S:31223 E:31225 ||| -RRB-
.  ||| S:31225 E:31227 ||| .
Along  ||| S:31227 E:31233 ||| IN
similar  ||| S:31233 E:31241 ||| JJ
lines ||| S:31241 E:31246 ||| NNS
,  ||| S:31246 E:31248 ||| ,
the  ||| S:31248 E:31252 ||| DT
work  ||| S:31252 E:31257 ||| NN
of  ||| S:31257 E:31260 ||| IN
Kegel  ||| S:31260 E:31275 ||| NNP
et  ||| S:31275 E:31278 ||| FW
al  ||| S:31278 E:31281 ||| FW
.  ||| S:31281 E:31283 ||| .
[  ||| S:31283 E:31285 ||| -LRB-
65  ||| S:31285 E:31288 ||| CD
]  ||| S:31288 E:31290 ||| -RRB-
hints  ||| S:31290 E:31296 ||| NNS
that  ||| S:31296 E:31301 ||| IN
poly-Gln  ||| S:31301 E:31318 ||| JJ
huntingtin  ||| S:31318 E:31329 ||| NN
may  ||| S:31329 E:31333 ||| MD
be  ||| S:31333 E:31336 ||| VB
degraded  ||| S:31336 E:31345 ||| VBN
mainly  ||| S:31345 E:31352 ||| RB
in  ||| S:31352 E:31355 ||| IN
autophagic  ||| S:31355 E:31366 ||| FW
vacuoles  ||| S:31366 E:31383 ||| FW
containing  ||| S:31383 E:31394 ||| FW
lysosomal  ||| S:31394 E:31404 ||| FW
proteases ||| S:31404 E:31413 ||| FW
.  ||| S:31413 E:31415 ||| .
Interestingly ||| S:31415 E:31428 ||| RB
,  ||| S:31428 E:31430 ||| ,
Rab24  ||| S:31430 E:31436 ||| NNP
has  ||| S:31436 E:31448 ||| VBZ
been  ||| S:31448 E:31453 ||| VBN
implicated  ||| S:31453 E:31464 ||| VBN
as  ||| S:31464 E:31467 ||| IN
a  ||| S:31467 E:31469 ||| DT
possible  ||| S:31469 E:31478 ||| JJ
mediator  ||| S:31478 E:31487 ||| NN
of  ||| S:31487 E:31490 ||| IN
autophagy  ||| S:31490 E:31500 ||| NN
in  ||| S:31500 E:31503 ||| IN
a  ||| S:31503 E:31513 ||| DT
recent  ||| S:31513 E:31520 ||| JJ
study  ||| S:31520 E:31526 ||| NN
where  ||| S:31526 E:31532 ||| WRB
wild-type  ||| S:31532 E:31542 ||| NNP
GFP-Rab24  ||| S:31542 E:31552 ||| NNP
was  ||| S:31552 E:31556 ||| VBD
observed  ||| S:31556 E:31565 ||| VBN
to  ||| S:31565 E:31576 ||| TO
accumulate  ||| S:31576 E:31587 ||| VB
on  ||| S:31587 E:31590 ||| IN
large  ||| S:31590 E:31596 ||| JJ
autophagic  ||| S:31596 E:31607 ||| JJ
vacuoles  ||| S:31607 E:31616 ||| NN
in  ||| S:31616 E:31619 ||| IN
cells  ||| S:31619 E:31625 ||| NNS
subjected  ||| S:31625 E:31643 ||| VBN
to  ||| S:31643 E:31646 ||| TO
amino  ||| S:31646 E:31652 ||| VB
acid  ||| S:31652 E:31657 ||| JJ
starvation  ||| S:31657 E:31668 ||| NNS
[  ||| S:31668 E:31670 ||| -LRB-
43  ||| S:31670 E:31673 ||| CD
]  ||| S:31673 E:31675 ||| -RRB-
.  ||| S:31675 E:31677 ||| .
Thus ||| S:31677 E:31681 ||| RB
,  ||| S:31681 E:31683 ||| ,
if  ||| S:31683 E:31686 ||| IN
Rab24 ||| S:31686 E:31691 ||| NNP
( ||| S:31691 E:31692 ||| -LRB-
D123I ||| S:31692 E:31697 ||| NNP
)  ||| S:31697 E:31707 ||| -RRB-
functions  ||| S:31707 E:31717 ||| NNS
as  ||| S:31717 E:31720 ||| IN
a  ||| S:31720 E:31722 ||| DT
true  ||| S:31722 E:31727 ||| JJ
dominant  ||| S:31727 E:31736 ||| JJ
suppressor  ||| S:31736 E:31747 ||| NN
of  ||| S:31747 E:31750 ||| IN
endogenous  ||| S:31750 E:31769 ||| CD
Rab24 ||| S:31769 E:31774 ||| CD
,  ||| S:31774 E:31776 ||| ,
the  ||| S:31776 E:31780 ||| DT
inclusions  ||| S:31780 E:31791 ||| NN
observed  ||| S:31791 E:31800 ||| VBD
in  ||| S:31800 E:31803 ||| IN
the  ||| S:31803 E:31807 ||| DT
present  ||| S:31807 E:31815 ||| JJ
study  ||| S:31815 E:31821 ||| NN
may  ||| S:31821 E:31833 ||| MD
consist  ||| S:31833 E:31841 ||| VB
of  ||| S:31841 E:31844 ||| IN
misfolded  ||| S:31844 E:31854 ||| JJ
endogenous  ||| S:31854 E:31865 ||| JJ
proteins  ||| S:31865 E:31874 ||| NNS
that  ||| S:31874 E:31879 ||| WDT
cannot  ||| S:31879 E:31886 ||| RB
be  ||| S:31886 E:31897 ||| VB
degraded  ||| S:31897 E:31906 ||| VBN
because  ||| S:31906 E:31914 ||| IN
basal  ||| S:31914 E:31920 ||| JJ
activity  ||| S:31920 E:31929 ||| NN
of  ||| S:31929 E:31932 ||| IN
the  ||| S:31932 E:31944 ||| DT
autophagosome-lysosome  ||| S:31944 E:31967 ||| JJ
pathway  ||| S:31967 E:31975 ||| NN
is  ||| S:31975 E:31978 ||| VBZ
blocked ||| S:31978 E:31985 ||| VBN
.  ||| S:31985 E:31995 ||| .
Although  ||| S:31995 E:32004 ||| IN
the  ||| S:32004 E:32008 ||| DT
two  ||| S:32008 E:32012 ||| CD
preceding  ||| S:32012 E:32022 ||| JJ
models  ||| S:32022 E:32029 ||| NNS
may  ||| S:32029 E:32033 ||| MD
explain  ||| S:32033 E:32041 ||| VB
the  ||| S:32041 E:32053 ||| DT
presence  ||| S:32053 E:32062 ||| NN
of  ||| S:32062 E:32065 ||| IN
Hsp70  ||| S:32065 E:32071 ||| NNP
and  ||| S:32071 E:32075 ||| CC
ubiquitin  ||| S:32075 E:32085 ||| NN
in  ||| S:32085 E:32088 ||| IN
the  ||| S:32088 E:32092 ||| DT
Rab24 ||| S:32092 E:32097 ||| NNP
( ||| S:32097 E:32098 ||| -LRB-
D123I ||| S:32098 E:32103 ||| NNP
) ||| S:32103 E:32104 ||| -RRB-
-induced  ||| S:32104 E:32121 ||| JJ
aggregates ||| S:32121 E:32131 ||| NNS
,  ||| S:32131 E:32133 ||| ,
the  ||| S:32133 E:32137 ||| DT
incorporation  ||| S:32137 E:32151 ||| NN
of  ||| S:32151 E:32154 ||| IN
glucocorticoid  ||| S:32154 E:32169 ||| JJ
receptor  ||| S:32169 E:32186 ||| NN
( ||| S:32186 E:32187 ||| -LRB-
Fig.  ||| S:32187 E:32192 ||| CD
6 ||| S:32192 E:32193 ||| CD
)  ||| S:32193 E:32195 ||| -RRB-
and  ||| S:32195 E:32199 ||| CC
importin-β  ||| S:32199 E:32210 ||| NNP
( ||| S:32210 E:32211 ||| -LRB-
Fig.  ||| S:32211 E:32216 ||| CD
7 ||| S:32216 E:32217 ||| CD
)  ||| S:32217 E:32219 ||| -RRB-
may  ||| S:32219 E:32223 ||| MD
point  ||| S:32223 E:32229 ||| VB
to  ||| S:32229 E:32232 ||| TO
a  ||| S:32232 E:32234 ||| DT
third  ||| S:32234 E:32248 ||| JJ
distinct  ||| S:32248 E:32257 ||| JJ
scenario ||| S:32257 E:32265 ||| NN
.  ||| S:32265 E:32267 ||| .
Aside  ||| S:32267 E:32273 ||| RB
from  ||| S:32273 E:32278 ||| IN
its  ||| S:32278 E:32282 ||| PRP$
well-characterized  ||| S:32282 E:32301 ||| JJ
role  ||| S:32301 E:32314 ||| NN
in  ||| S:32314 E:32317 ||| IN
protein  ||| S:32317 E:32325 ||| NN
folding  ||| S:32325 E:32333 ||| NNS
[  ||| S:32333 E:32335 ||| -LRB-
66  ||| S:32335 E:32338 ||| CD
]  ||| S:32338 E:32340 ||| -RRB-
,  ||| S:32340 E:32342 ||| ,
Hsp70  ||| S:32342 E:32348 ||| NNP
is  ||| S:32348 E:32351 ||| VBZ
known  ||| S:32351 E:32357 ||| VBN
to  ||| S:32357 E:32360 ||| TO
associate  ||| S:32360 E:32378 ||| NN
with  ||| S:32378 E:32383 ||| IN
the  ||| S:32383 E:32387 ||| DT
GR  ||| S:32387 E:32390 ||| NNP
in  ||| S:32390 E:32393 ||| IN
the  ||| S:32393 E:32397 ||| DT
cytoplasm ||| S:32397 E:32406 ||| NN
,  ||| S:32406 E:32408 ||| ,
where  ||| S:32408 E:32414 ||| WRB
it  ||| S:32414 E:32417 ||| PRP
promotes  ||| S:32417 E:32426 ||| VBZ
formation  ||| S:32426 E:32444 ||| NN
of  ||| S:32444 E:32447 ||| IN
a  ||| S:32447 E:32449 ||| DT
heterocomplex  ||| S:32449 E:32463 ||| NN
between  ||| S:32463 E:32471 ||| IN
the  ||| S:32471 E:32475 ||| DT
inactive  ||| S:32475 E:32484 ||| JJ
GR  ||| S:32484 E:32487 ||| NNP
and  ||| S:32487 E:32491 ||| CC
Hsp90  ||| S:32491 E:32497 ||| NNP
[  ||| S:32497 E:32499 ||| -LRB-
67  ||| S:32499 E:32502 ||| CD
]  ||| S:32502 E:32512 ||| -RRB-
.  ||| S:32512 E:32514 ||| .
In  ||| S:32514 E:32517 ||| IN
addition ||| S:32517 E:32525 ||| NN
,  ||| S:32525 E:32527 ||| ,
Hsp70  ||| S:32527 E:32533 ||| NNP
becomes  ||| S:32533 E:32541 ||| VBZ
concentrated  ||| S:32541 E:32554 ||| VBN
in  ||| S:32554 E:32557 ||| IN
the  ||| S:32557 E:32561 ||| DT
nucleus  ||| S:32561 E:32577 ||| NN
when  ||| S:32577 E:32582 ||| WRB
cells  ||| S:32582 E:32588 ||| NNS
are  ||| S:32588 E:32592 ||| VBP
exposed  ||| S:32592 E:32600 ||| VBN
to  ||| S:32600 E:32603 ||| TO
environmental  ||| S:32603 E:32617 ||| JJ
stress  ||| S:32617 E:32624 ||| NN
[  ||| S:32624 E:32626 ||| -LRB-
68  ||| S:32626 E:32629 ||| CD
]  ||| S:32629 E:32631 ||| -RRB-
.  ||| S:32631 E:32633 ||| .
Of  ||| S:32633 E:32644 ||| IN
particular  ||| S:32644 E:32655 ||| JJ
note ||| S:32655 E:32659 ||| NN
,  ||| S:32659 E:32661 ||| ,
the  ||| S:32661 E:32665 ||| DT
nuclear  ||| S:32665 E:32673 ||| JJ
accumulation  ||| S:32673 E:32686 ||| NN
of  ||| S:32686 E:32689 ||| IN
the  ||| S:32689 E:32693 ||| DT
Hsp70 ||| S:32693 E:32698 ||| NNP
,  ||| S:32698 E:32708 ||| ,
Ssa4p ||| S:32708 E:32713 ||| NNP
,  ||| S:32713 E:32715 ||| ,
in  ||| S:32715 E:32718 ||| IN
response  ||| S:32718 E:32727 ||| NN
to  ||| S:32727 E:32730 ||| TO
nutrient  ||| S:32730 E:32739 ||| VB
deprivation  ||| S:32739 E:32751 ||| VBN
in  ||| S:32751 E:32754 ||| IN
yeast  ||| S:32754 E:32760 ||| NN
appears  ||| S:32760 E:32776 ||| VBZ
to  ||| S:32776 E:32779 ||| TO
occur  ||| S:32779 E:32785 ||| VB
by  ||| S:32785 E:32788 ||| IN
a  ||| S:32788 E:32790 ||| DT
novel  ||| S:32790 E:32796 ||| NN
mechanism  ||| S:32796 E:32806 ||| NN
that  ||| S:32806 E:32811 ||| WDT
involves  ||| S:32811 E:32820 ||| VBZ
its  ||| S:32820 E:32824 ||| PRP$
direct  ||| S:32824 E:32839 ||| JJ
interaction  ||| S:32839 E:32851 ||| NN
with  ||| S:32851 E:32856 ||| IN
Mmd5p ||| S:32856 E:32861 ||| NNP
,  ||| S:32861 E:32863 ||| ,
a  ||| S:32863 E:32865 ||| DT
member  ||| S:32865 E:32872 ||| NN
of  ||| S:32872 E:32875 ||| IN
the  ||| S:32875 E:32879 ||| DT
importin-β  ||| S:32879 E:32890 ||| JJ
family  ||| S:32890 E:32897 ||| NN
[  ||| S:32897 E:32907 ||| -LRB-
69  ||| S:32907 E:32910 ||| CD
]  ||| S:32910 E:32912 ||| -RRB-
.  ||| S:32912 E:32914 ||| .
A  ||| S:32914 E:32916 ||| DT
role  ||| S:32916 E:32921 ||| NN
for  ||| S:32921 E:32925 ||| IN
Rab24  ||| S:32925 E:32931 ||| CD
in  ||| S:32931 E:32934 ||| IN
nuclear  ||| S:32934 E:32942 ||| JJ
trafficking  ||| S:32942 E:32954 ||| NN
would  ||| S:32954 E:32960 ||| MD
be  ||| S:32960 E:32971 ||| VB
unanticipated ||| S:32971 E:32984 ||| JJ
,  ||| S:32984 E:32986 ||| ,
since  ||| S:32986 E:32992 ||| IN
the  ||| S:32992 E:32996 ||| DT
only  ||| S:32996 E:33001 ||| JJ
GTPase  ||| S:33001 E:33008 ||| NN
known  ||| S:33008 E:33014 ||| VBN
to  ||| S:33014 E:33017 ||| TO
function  ||| S:33017 E:33026 ||| VB
in  ||| S:33026 E:33037 ||| IN
nuclear  ||| S:33037 E:33045 ||| JJ
import ||| S:33045 E:33051 ||| NN
/ ||| S:33051 E:33052 ||| CD
export  ||| S:33052 E:33059 ||| NN
( ||| S:33059 E:33060 ||| -LRB-
Ran ||| S:33060 E:33063 ||| NNP
)  ||| S:33063 E:33065 ||| -RRB-
is  ||| S:33065 E:33068 ||| VBZ
structurally  ||| S:33068 E:33081 ||| RB
distinct  ||| S:33081 E:33090 ||| JJ
from  ||| S:33090 E:33103 ||| IN
the  ||| S:33103 E:33107 ||| DT
Rab  ||| S:33107 E:33111 ||| JJ
subgroup  ||| S:33111 E:33120 ||| NN
of  ||| S:33120 E:33123 ||| IN
the  ||| S:33123 E:33127 ||| DT
Ras  ||| S:33127 E:33131 ||| JJ
superfamily  ||| S:33131 E:33143 ||| NNS
[  ||| S:33143 E:33145 ||| -LRB-
70  ||| S:33145 E:33148 ||| CD
71  ||| S:33148 E:33151 ||| CD
]  ||| S:33151 E:33153 ||| -RRB-
.  ||| S:33153 E:33163 ||| .
Nevertheless ||| S:33163 E:33175 ||| RB
,  ||| S:33175 E:33177 ||| ,
we  ||| S:33177 E:33180 ||| PRP
can  ||| S:33180 E:33184 ||| MD
speculate  ||| S:33184 E:33194 ||| VB
that  ||| S:33194 E:33199 ||| IN
if  ||| S:33199 E:33202 ||| IN
Rab24  ||| S:33202 E:33208 ||| CD
participates  ||| S:33208 E:33229 ||| NN
in  ||| S:33229 E:33232 ||| IN
a  ||| S:33232 E:33234 ||| DT
stress-induced  ||| S:33234 E:33249 ||| JJ
pathway  ||| S:33249 E:33257 ||| NN
for  ||| S:33257 E:33261 ||| IN
nuclear  ||| S:33261 E:33269 ||| JJ
import  ||| S:33269 E:33276 ||| NN
of  ||| S:33276 E:33279 ||| IN
Hsp70  ||| S:33279 E:33285 ||| CD
in  ||| S:33285 E:33296 ||| IN
mammalian  ||| S:33296 E:33306 ||| JJ
cells ||| S:33306 E:33311 ||| NNS
,  ||| S:33311 E:33313 ||| ,
the  ||| S:33313 E:33317 ||| DT
constitutive  ||| S:33317 E:33330 ||| JJ
overexpression  ||| S:33330 E:33345 ||| NN
of  ||| S:33345 E:33356 ||| IN
Rab24 ||| S:33356 E:33361 ||| NNP
( ||| S:33361 E:33362 ||| -LRB-
D123I ||| S:33362 E:33367 ||| NNP
)  ||| S:33367 E:33369 ||| -RRB-
might  ||| S:33369 E:33375 ||| MD
stimulate  ||| S:33375 E:33385 ||| VB
aberrant  ||| S:33385 E:33394 ||| JJ
accumulation  ||| S:33394 E:33407 ||| NN
of  ||| S:33407 E:33418 ||| IN
Hsp70 ||| S:33418 E:33423 ||| CD
/ ||| S:33423 E:33424 ||| CD
importin-β  ||| S:33424 E:33435 ||| JJ
aggregates  ||| S:33435 E:33446 ||| NNS
at  ||| S:33446 E:33449 ||| IN
the  ||| S:33449 E:33453 ||| DT
nuclear  ||| S:33453 E:33461 ||| JJ
pore  ||| S:33461 E:33466 ||| JJ
complex ||| S:33466 E:33473 ||| NN
.  ||| S:33473 E:33483 ||| .
This  ||| S:33483 E:33488 ||| DT
might  ||| S:33488 E:33494 ||| MD
ultimately  ||| S:33494 E:33505 ||| RB
result  ||| S:33505 E:33512 ||| VB
in  ||| S:33512 E:33515 ||| IN
disruption  ||| S:33515 E:33526 ||| NN
of  ||| S:33526 E:33529 ||| IN
the  ||| S:33529 E:33533 ||| DT
nuclear  ||| S:33533 E:33549 ||| JJ
envelope  ||| S:33549 E:33558 ||| NN
and  ||| S:33558 E:33562 ||| CC
penetration  ||| S:33562 E:33574 ||| NN
of  ||| S:33574 E:33577 ||| IN
the  ||| S:33577 E:33581 ||| DT
aggregates  ||| S:33581 E:33592 ||| NNS
into  ||| S:33592 E:33597 ||| IN
the  ||| S:33597 E:33609 ||| DT
nucleus ||| S:33609 E:33616 ||| NN
.  ||| S:33616 E:33618 ||| .
If  ||| S:33618 E:33621 ||| IN
the  ||| S:33621 E:33625 ||| DT
Hsp70  ||| S:33625 E:33631 ||| NN
in  ||| S:33631 E:33634 ||| IN
these  ||| S:33634 E:33640 ||| DT
aggregates  ||| S:33640 E:33651 ||| NN
retains  ||| S:33651 E:33659 ||| VBZ
the  ||| S:33659 E:33671 ||| DT
capacity  ||| S:33671 E:33680 ||| NN
to  ||| S:33680 E:33683 ||| TO
bind  ||| S:33683 E:33688 ||| VB
GR ||| S:33688 E:33690 ||| NNP
,  ||| S:33690 E:33692 ||| ,
this  ||| S:33692 E:33697 ||| DT
could  ||| S:33697 E:33703 ||| MD
account  ||| S:33703 E:33711 ||| VB
for  ||| S:33711 E:33715 ||| IN
the  ||| S:33715 E:33727 ||| DT
sequestration  ||| S:33727 E:33741 ||| NN
of  ||| S:33741 E:33744 ||| IN
nascent  ||| S:33744 E:33752 ||| JJ
GR  ||| S:33752 E:33755 ||| NN
in  ||| S:33755 E:33758 ||| IN
these  ||| S:33758 E:33764 ||| DT
structures ||| S:33764 E:33774 ||| NNS
.  ||| S:33774 E:33784 ||| .
It  ||| S:33784 E:33787 ||| PRP
is  ||| S:33787 E:33790 ||| VBZ
well  ||| S:33790 E:33795 ||| RB
established  ||| S:33795 E:33807 ||| VBN
that  ||| S:33807 E:33812 ||| IN
mutations  ||| S:33812 E:33822 ||| NNS
affecting  ||| S:33822 E:33832 ||| VBG
the  ||| S:33832 E:33844 ||| DT
guanine  ||| S:33844 E:33852 ||| JJ
nucleotide  ||| S:33852 E:33863 ||| JJ
state  ||| S:33863 E:33869 ||| NN
of  ||| S:33869 E:33872 ||| IN
Ras  ||| S:33872 E:33876 ||| NNP
are  ||| S:33876 E:33880 ||| VBP
associated  ||| S:33880 E:33891 ||| VBN
with  ||| S:33891 E:33904 ||| IN
neoplastic  ||| S:33904 E:33915 ||| JJ
transformation  ||| S:33915 E:33930 ||| NN
of  ||| S:33930 E:33933 ||| IN
mammalian  ||| S:33933 E:33943 ||| JJ
cells  ||| S:33943 E:33949 ||| NNS
[  ||| S:33949 E:33951 ||| -LRB-
35  ||| S:33951 E:33954 ||| CD
72  ||| S:33954 E:33957 ||| CD
73  ||| S:33957 E:33960 ||| CD
]  ||| S:33960 E:33962 ||| -RRB-
.  ||| S:33962 E:33972 ||| .
However ||| S:33972 E:33979 ||| RB
,  ||| S:33979 E:33981 ||| ,
the  ||| S:33981 E:33985 ||| DT
potential  ||| S:33985 E:33995 ||| JJ
role  ||| S:33995 E:34000 ||| NN
of  ||| S:34000 E:34003 ||| IN
Rab  ||| S:34003 E:34007 ||| NNP
mutations  ||| S:34007 E:34017 ||| NNS
in  ||| S:34017 E:34020 ||| IN
disease  ||| S:34020 E:34028 ||| NN
is  ||| S:34028 E:34039 ||| VBZ
just  ||| S:34039 E:34044 ||| RB
beginning  ||| S:34044 E:34054 ||| VBG
to  ||| S:34054 E:34057 ||| TO
be  ||| S:34057 E:34060 ||| VB
explored ||| S:34060 E:34068 ||| NNS
.  ||| S:34068 E:34070 ||| .
Menasche  ||| S:34070 E:34088 ||| FW
et  ||| S:34088 E:34091 ||| FW
al  ||| S:34091 E:34094 ||| FW
.  ||| S:34094 E:34096 ||| .
[  ||| S:34096 E:34098 ||| -LRB-
74  ||| S:34098 E:34101 ||| CD
]  ||| S:34101 E:34103 ||| -RRB-
found  ||| S:34103 E:34109 ||| VBD
mutations  ||| S:34109 E:34119 ||| VBN
in  ||| S:34119 E:34122 ||| IN
the  ||| S:34122 E:34134 ||| DT
Rab27A  ||| S:34134 E:34141 ||| JJ
gene  ||| S:34141 E:34146 ||| NN
in  ||| S:34146 E:34149 ||| IN
16  ||| S:34149 E:34152 ||| CD
patients  ||| S:34152 E:34161 ||| NNS
with  ||| S:34161 E:34166 ||| IN
Griscelli ||| S:34166 E:34175 ||| NNP
's  ||| S:34175 E:34178 ||| POS
syndrome ||| S:34178 E:34186 ||| NN
,  ||| S:34186 E:34188 ||| ,
an  ||| S:34188 E:34199 ||| DT
autosomal  ||| S:34199 E:34209 ||| JJ
recessive  ||| S:34209 E:34219 ||| NNS
disorder  ||| S:34219 E:34228 ||| VBP
characterized  ||| S:34228 E:34242 ||| VBN
by  ||| S:34242 E:34245 ||| IN
defects  ||| S:34245 E:34253 ||| NNS
in  ||| S:34253 E:34264 ||| IN
skin  ||| S:34264 E:34269 ||| NN
pigmentation  ||| S:34269 E:34282 ||| NNS
and  ||| S:34282 E:34286 ||| CC
T-lymphocyte  ||| S:34286 E:34299 ||| JJ
and  ||| S:34299 E:34303 ||| CC
macrophage  ||| S:34303 E:34322 ||| JJ
activation ||| S:34322 E:34332 ||| NN
.  ||| S:34332 E:34334 ||| .
While  ||| S:34334 E:34340 ||| IN
several  ||| S:34340 E:34348 ||| JJ
of  ||| S:34348 E:34351 ||| IN
the  ||| S:34351 E:34355 ||| DT
mutations  ||| S:34355 E:34365 ||| NN
were  ||| S:34365 E:34370 ||| VBD
deletions ||| S:34370 E:34379 ||| NNS
,  ||| S:34379 E:34389 ||| ,
a  ||| S:34389 E:34391 ||| DT
few  ||| S:34391 E:34395 ||| JJ
were  ||| S:34395 E:34400 ||| VBD
missense  ||| S:34400 E:34409 ||| JJ
mutations  ||| S:34409 E:34419 ||| NNS
that  ||| S:34419 E:34424 ||| WDT
changed  ||| S:34424 E:34432 ||| VBD
single  ||| S:34432 E:34439 ||| JJ
amino  ||| S:34439 E:34453 ||| JJ
acids  ||| S:34453 E:34459 ||| NNS
in  ||| S:34459 E:34462 ||| IN
conserved  ||| S:34462 E:34472 ||| JJ
regions  ||| S:34472 E:34480 ||| NNS
of  ||| S:34480 E:34483 ||| IN
the  ||| S:34483 E:34487 ||| DT
Rab  ||| S:34487 E:34491 ||| JJ
structure ||| S:34491 E:34500 ||| NN
.  ||| S:34500 E:34502 ||| .
Mutations  ||| S:34502 E:34520 ||| NNS
in  ||| S:34520 E:34523 ||| IN
the  ||| S:34523 E:34527 ||| DT
Rab27A  ||| S:34527 E:34534 ||| JJ
gene  ||| S:34534 E:34539 ||| NN
have  ||| S:34539 E:34544 ||| VBP
also  ||| S:34544 E:34549 ||| RB
been  ||| S:34549 E:34554 ||| VBN
detected  ||| S:34554 E:34563 ||| VBN
in  ||| S:34563 E:34566 ||| IN
mice  ||| S:34566 E:34571 ||| NNS
with  ||| S:34571 E:34576 ||| IN
the  ||| S:34576 E:34588 ||| DT
coat  ||| S:34588 E:34593 ||| NN
color  ||| S:34593 E:34599 ||| NN
mutation  ||| S:34599 E:34617 ||| NN
ashen  ||| S:34617 E:34623 ||| NN
,  ||| S:34623 E:34625 ||| ,
which  ||| S:34625 E:34631 ||| WDT
is  ||| S:34631 E:34634 ||| VBZ
regarded  ||| S:34634 E:34643 ||| VBN
as  ||| S:34643 E:34646 ||| IN
a  ||| S:34646 E:34648 ||| DT
model  ||| S:34648 E:34662 ||| NN
for  ||| S:34662 E:34666 ||| IN
Griscelli ||| S:34666 E:34675 ||| NNP
's  ||| S:34675 E:34678 ||| POS
syndrome  ||| S:34678 E:34687 ||| NN
[  ||| S:34687 E:34689 ||| -LRB-
75  ||| S:34689 E:34692 ||| CD
76  ||| S:34692 E:34695 ||| CD
]  ||| S:34695 E:34697 ||| -RRB-
.  ||| S:34697 E:34699 ||| .
Rab24  ||| S:34699 E:34705 ||| NNP
can  ||| S:34705 E:34709 ||| MD
be  ||| S:34709 E:34712 ||| VB
detected  ||| S:34712 E:34729 ||| VBN
in  ||| S:34729 E:34732 ||| IN
many  ||| S:34732 E:34737 ||| JJ
tissues  ||| S:34737 E:34745 ||| NNS
and  ||| S:34745 E:34749 ||| CC
cell  ||| S:34749 E:34754 ||| NN
lines  ||| S:34754 E:34760 ||| NNS
[  ||| S:34760 E:34762 ||| -LRB-
24  ||| S:34762 E:34765 ||| CD
25  ||| S:34765 E:34768 ||| CD
]  ||| S:34768 E:34770 ||| -RRB-
,  ||| S:34770 E:34772 ||| ,
but  ||| S:34772 E:34776 ||| CC
expression  ||| S:34776 E:34795 ||| NN
appears  ||| S:34795 E:34803 ||| VBZ
to  ||| S:34803 E:34806 ||| TO
be  ||| S:34806 E:34809 ||| VB
highest  ||| S:34809 E:34817 ||| JJS
in  ||| S:34817 E:34820 ||| IN
neuronal  ||| S:34820 E:34829 ||| JJ
cells  ||| S:34829 E:34835 ||| NNS
[  ||| S:34835 E:34837 ||| -LRB-
25  ||| S:34837 E:34840 ||| CD
]  ||| S:34840 E:34842 ||| -RRB-
.  ||| S:34842 E:34844 ||| .
At  ||| S:34844 E:34847 ||| IN
present  ||| S:34847 E:34863 ||| JJ
there  ||| S:34863 E:34869 ||| EX
are  ||| S:34869 E:34873 ||| VBP
no  ||| S:34873 E:34876 ||| DT
available  ||| S:34876 E:34886 ||| JJ
data  ||| S:34886 E:34891 ||| NNS
specifically  ||| S:34891 E:34904 ||| RB
linking  ||| S:34904 E:34912 ||| VBG
Rab24  ||| S:34912 E:34926 ||| CD
mutations  ||| S:34926 E:34936 ||| NNS
to  ||| S:34936 E:34939 ||| TO
human  ||| S:34939 E:34945 ||| JJ
disease ||| S:34945 E:34952 ||| NN
.  ||| S:34952 E:34954 ||| .
However ||| S:34954 E:34961 ||| RB
,  ||| S:34961 E:34963 ||| ,
there  ||| S:34963 E:34969 ||| EX
are  ||| S:34969 E:34973 ||| VBP
many  ||| S:34973 E:34978 ||| JJ
case  ||| S:34978 E:34991 ||| NN
reports  ||| S:34991 E:34999 ||| VBZ
describing  ||| S:34999 E:35010 ||| VBG
patients  ||| S:35010 E:35019 ||| NNS
with  ||| S:35019 E:35024 ||| IN
progressive  ||| S:35024 E:35044 ||| JJ
neurodegenerative  ||| S:35044 E:35062 ||| JJ
disorders  ||| S:35062 E:35072 ||| NNS
of  ||| S:35072 E:35075 ||| IN
unknown  ||| S:35075 E:35083 ||| JJ
etiology ||| S:35083 E:35091 ||| NN
,  ||| S:35091 E:35101 ||| ,
collectively  ||| S:35101 E:35114 ||| RB
referred  ||| S:35114 E:35123 ||| VBN
to  ||| S:35123 E:35126 ||| TO
as  ||| S:35126 E:35129 ||| RB
neuronal  ||| S:35129 E:35138 ||| JJ
intranuclear  ||| S:35138 E:35151 ||| JJ
inclusion  ||| S:35151 E:35169 ||| NN
disease  ||| S:35169 E:35177 ||| NN
[  ||| S:35177 E:35179 ||| -LRB-
77  ||| S:35179 E:35182 ||| CD
]  ||| S:35182 E:35184 ||| -RRB-
.  ||| S:35184 E:35186 ||| .
While  ||| S:35186 E:35192 ||| IN
these  ||| S:35192 E:35198 ||| DT
may  ||| S:35198 E:35202 ||| MD
consist  ||| S:35202 E:35210 ||| VB
mainly  ||| S:35210 E:35217 ||| RB
of  ||| S:35217 E:35228 ||| IN
unidentified  ||| S:35228 E:35241 ||| JJ
poly-Gln  ||| S:35241 E:35250 ||| JJ
or  ||| S:35250 E:35253 ||| CC
poly-Ala  ||| S:35253 E:35262 ||| JJ
disorders ||| S:35262 E:35271 ||| NNS
,  ||| S:35271 E:35273 ||| ,
the  ||| S:35273 E:35277 ||| DT
present  ||| S:35277 E:35293 ||| JJ
study  ||| S:35293 E:35299 ||| NN
raises  ||| S:35299 E:35306 ||| VBZ
the  ||| S:35306 E:35310 ||| DT
possibility  ||| S:35310 E:35322 ||| NN
that  ||| S:35322 E:35327 ||| IN
some  ||| S:35327 E:35332 ||| DT
forms  ||| S:35332 E:35338 ||| NNS
of  ||| S:35338 E:35341 ||| IN
this  ||| S:35341 E:35354 ||| DT
disease  ||| S:35354 E:35362 ||| NN
may  ||| S:35362 E:35366 ||| MD
arise  ||| S:35366 E:35372 ||| VB
through  ||| S:35372 E:35380 ||| IN
unexpected  ||| S:35380 E:35391 ||| JJ
mechanisms ||| S:35391 E:35401 ||| NNS
,  ||| S:35401 E:35403 ||| ,
perhaps  ||| S:35403 E:35419 ||| RB
involving  ||| S:35419 E:35429 ||| VBG
mutations  ||| S:35429 E:35439 ||| NNS
in  ||| S:35439 E:35442 ||| IN
Rab24  ||| S:35442 E:35448 ||| NNP
or  ||| S:35448 E:35451 ||| CC
other  ||| S:35451 E:35457 ||| JJ
poorly  ||| S:35457 E:35464 ||| RB
characterized  ||| S:35464 E:35486 ||| VBN
members  ||| S:35486 E:35494 ||| NNS
of  ||| S:35494 E:35497 ||| IN
the  ||| S:35497 E:35501 ||| DT
Rab  ||| S:35501 E:35505 ||| JJ
GTPase  ||| S:35505 E:35512 ||| JJ
family  ||| S:35512 E:35519 ||| NN
that  ||| S:35519 E:35524 ||| IN
mediate  ||| S:35524 E:35532 ||| JJ
trafficking  ||| S:35532 E:35552 ||| NN
of  ||| S:35552 E:35555 ||| IN
misfolded  ||| S:35555 E:35565 ||| JJ
proteins  ||| S:35565 E:35574 ||| NNS
within  ||| S:35574 E:35581 ||| IN
autophagosomes  ||| S:35581 E:35596 ||| NN
and  ||| S:35596 E:35608 ||| CC
lysosomes ||| S:35608 E:35617 ||| NN
.  ||| S:35617 E:35641 ||| .
Conclusions  ||| S:35641 E:35661 ||| NNS
Previous  ||| S:35661 E:35670 ||| JJ
studies  ||| S:35670 E:35678 ||| NNS
have  ||| S:35678 E:35683 ||| VBP
shown  ||| S:35683 E:35689 ||| VBN
that  ||| S:35689 E:35694 ||| IN
Rab24  ||| S:35694 E:35700 ||| NNP
exhibits  ||| S:35700 E:35709 ||| VBZ
several  ||| S:35709 E:35725 ||| JJ
unusual  ||| S:35725 E:35733 ||| JJ
characteristics  ||| S:35733 E:35749 ||| NNS
that  ||| S:35749 E:35754 ||| WDT
distinguish  ||| S:35754 E:35766 ||| VBD
it  ||| S:35766 E:35769 ||| PRP
from  ||| S:35769 E:35774 ||| IN
other  ||| S:35774 E:35788 ||| JJ
members  ||| S:35788 E:35796 ||| NNS
of  ||| S:35796 E:35799 ||| IN
the  ||| S:35799 E:35803 ||| DT
Rab  ||| S:35803 E:35807 ||| JJ
GTPase  ||| S:35807 E:35814 ||| JJ
family  ||| S:35814 E:35821 ||| NN
[  ||| S:35821 E:35823 ||| -LRB-
25  ||| S:35823 E:35826 ||| CD
]  ||| S:35826 E:35828 ||| -RRB-
.  ||| S:35828 E:35830 ||| .
The  ||| S:35830 E:35834 ||| DT
studies  ||| S:35834 E:35850 ||| NNS
described  ||| S:35850 E:35860 ||| VBN
in  ||| S:35860 E:35863 ||| IN
this  ||| S:35863 E:35868 ||| DT
report  ||| S:35868 E:35875 ||| NN
demonstrate  ||| S:35875 E:35887 ||| NN
that  ||| S:35887 E:35892 ||| IN
putative  ||| S:35892 E:35909 ||| JJ
dominant-negative  ||| S:35909 E:35927 ||| JJ
mutant  ||| S:35927 E:35934 ||| JJ
forms  ||| S:35934 E:35940 ||| NNS
of  ||| S:35940 E:35943 ||| IN
Rab24 ||| S:35943 E:35948 ||| NNP
,  ||| S:35948 E:35950 ||| ,
bearing  ||| S:35950 E:35958 ||| VBG
single  ||| S:35958 E:35973 ||| JJ
amino  ||| S:35973 E:35979 ||| JJ
acid  ||| S:35979 E:35984 ||| NN
substitutions  ||| S:35984 E:35998 ||| NN
in  ||| S:35998 E:36001 ||| IN
the  ||| S:36001 E:36005 ||| DT
conserved  ||| S:36005 E:36015 ||| JJ
N ||| S:36015 E:36016 ||| NNP
( ||| S:36016 E:36017 ||| -LRB-
T ||| S:36017 E:36018 ||| NN
) ||| S:36018 E:36019 ||| -RRB-
KxD  ||| S:36019 E:36031 ||| FW
nucleotide  ||| S:36031 E:36042 ||| FW
binding  ||| S:36042 E:36050 ||| FW
motif  ||| S:36050 E:36056 ||| FW
(  ||| S:36056 E:36067 ||| -LRB-
e.g.  ||| S:36067 E:36072 ||| NNP
,  ||| S:36072 E:36074 ||| ,
D123I  ||| S:36074 E:36080 ||| NNP
and  ||| S:36080 E:36084 ||| CC
T120A ||| S:36084 E:36089 ||| CD
) ||| S:36089 E:36090 ||| -RRB-
,  ||| S:36090 E:36092 ||| ,
are  ||| S:36092 E:36096 ||| VBP
targeted  ||| S:36096 E:36113 ||| VBN
to  ||| S:36113 E:36116 ||| TO
numerous  ||| S:36116 E:36125 ||| JJ
inclusion  ||| S:36125 E:36135 ||| NN
bodies  ||| S:36135 E:36142 ||| NNS
that  ||| S:36142 E:36147 ||| WDT
disrupt  ||| S:36147 E:36155 ||| VBZ
the  ||| S:36155 E:36159 ||| DT
nuclear  ||| S:36159 E:36175 ||| JJ
envelope  ||| S:36175 E:36184 ||| NN
and  ||| S:36184 E:36188 ||| CC
enter  ||| S:36188 E:36194 ||| VB
the  ||| S:36194 E:36198 ||| DT
nuclear  ||| S:36198 E:36206 ||| JJ
compartment ||| S:36206 E:36217 ||| NN
.  ||| S:36217 E:36219 ||| .
The  ||| S:36219 E:36223 ||| DT
inclusions  ||| S:36223 E:36242 ||| NNS
bear  ||| S:36242 E:36247 ||| VBP
a  ||| S:36247 E:36249 ||| DT
superficial  ||| S:36249 E:36261 ||| JJ
resemblance  ||| S:36261 E:36273 ||| NN
to  ||| S:36273 E:36276 ||| TO
those  ||| S:36276 E:36282 ||| DT
described  ||| S:36282 E:36292 ||| VBN
in  ||| S:36292 E:36295 ||| IN
some  ||| S:36295 E:36308 ||| DT
of  ||| S:36308 E:36311 ||| IN
the  ||| S:36311 E:36315 ||| DT
polyglutamine  ||| S:36315 E:36329 ||| JJ
disorders ||| S:36329 E:36338 ||| NNS
,  ||| S:36338 E:36340 ||| ,
and  ||| S:36340 E:36344 ||| CC
appear  ||| S:36344 E:36351 ||| VB
to  ||| S:36351 E:36354 ||| TO
sequester  ||| S:36354 E:36372 ||| VB
Hsp70 ||| S:36372 E:36377 ||| CD
,  ||| S:36377 E:36379 ||| ,
ubiquitin ||| S:36379 E:36388 ||| NN
,  ||| S:36388 E:36390 ||| ,
importin-β ||| S:36390 E:36400 ||| NNP
,  ||| S:36400 E:36402 ||| ,
and  ||| S:36402 E:36406 ||| CC
glucocorticoid  ||| S:36406 E:36421 ||| JJ
receptor ||| S:36421 E:36429 ||| NN
.  ||| S:36429 E:36439 ||| .
Studies  ||| S:36439 E:36447 ||| NNS
of  ||| S:36447 E:36450 ||| IN
Rab24 ||| S:36450 E:36455 ||| CD
/ ||| S:36455 E:36456 ||| CD
Rab1B  ||| S:36456 E:36462 ||| CD
chimeras  ||| S:36462 E:36471 ||| NNS
indicate  ||| S:36471 E:36480 ||| VBP
that  ||| S:36480 E:36485 ||| IN
the  ||| S:36485 E:36489 ||| DT
unusual  ||| S:36489 E:36505 ||| JJ
cytopathic  ||| S:36505 E:36516 ||| JJ
effects  ||| S:36516 E:36524 ||| NNS
induced  ||| S:36524 E:36532 ||| VBN
by  ||| S:36532 E:36535 ||| IN
the  ||| S:36535 E:36539 ||| DT
D123I  ||| S:36539 E:36545 ||| CD
mutant  ||| S:36545 E:36552 ||| NNS
require  ||| S:36552 E:36568 ||| VBP
sequence  ||| S:36568 E:36577 ||| JJ
elements  ||| S:36577 E:36586 ||| NNS
within  ||| S:36586 E:36593 ||| IN
the  ||| S:36593 E:36597 ||| DT
Rab24  ||| S:36597 E:36603 ||| NNP
C-terminal  ||| S:36603 E:36614 ||| NNP
hypervariable  ||| S:36614 E:36636 ||| VBZ
targeting  ||| S:36636 E:36646 ||| VBG
domain ||| S:36646 E:36652 ||| NN
.  ||| S:36652 E:36654 ||| .
Similar  ||| S:36654 E:36662 ||| JJ
mutations  ||| S:36662 E:36672 ||| NNS
in  ||| S:36672 E:36675 ||| IN
the  ||| S:36675 E:36679 ||| DT
N ||| S:36679 E:36680 ||| NNP
( ||| S:36680 E:36681 ||| -LRB-
T ||| S:36681 E:36682 ||| NN
) ||| S:36682 E:36683 ||| -RRB-
KxD  ||| S:36683 E:36687 ||| JJ
motif  ||| S:36687 E:36693 ||| NN
of  ||| S:36693 E:36704 ||| IN
other  ||| S:36704 E:36710 ||| JJ
Rab  ||| S:36710 E:36714 ||| JJ
proteins  ||| S:36714 E:36723 ||| NNS
typically  ||| S:36723 E:36733 ||| RB
yield  ||| S:36733 E:36739 ||| VB
soluble  ||| S:36739 E:36747 ||| JJ
cytoplasmic  ||| S:36747 E:36767 ||| JJ
proteins ||| S:36767 E:36775 ||| NNS
.  ||| S:36775 E:36777 ||| .
Confirmatory  ||| S:36777 E:36790 ||| JJ
studies  ||| S:36790 E:36798 ||| NNS
with  ||| S:36798 E:36803 ||| IN
other  ||| S:36803 E:36809 ||| JJ
potential  ||| S:36809 E:36827 ||| JJ
dominant-negative  ||| S:36827 E:36845 ||| JJ
mutants ||| S:36845 E:36852 ||| NN
,  ||| S:36852 E:36854 ||| ,
such  ||| S:36854 E:36859 ||| JJ
as  ||| S:36859 E:36862 ||| IN
those  ||| S:36862 E:36868 ||| DT
bearing  ||| S:36868 E:36884 ||| NN
substitutions  ||| S:36884 E:36898 ||| NN
at  ||| S:36898 E:36901 ||| IN
the  ||| S:36901 E:36905 ||| DT
position  ||| S:36905 E:36914 ||| NN
cognate  ||| S:36914 E:36922 ||| NN
to  ||| S:36922 E:36925 ||| TO
Ras  ||| S:36925 E:36929 ||| NNP
S17 ||| S:36929 E:36932 ||| NNP
,  ||| S:36932 E:36934 ||| ,
were  ||| S:36934 E:36939 ||| VBD
not  ||| S:36939 E:36951 ||| RB
possible  ||| S:36951 E:36960 ||| JJ
with  ||| S:36960 E:36965 ||| IN
Rab24 ||| S:36965 E:36970 ||| NNP
,  ||| S:36970 E:36972 ||| ,
because  ||| S:36972 E:36980 ||| IN
such  ||| S:36980 E:36985 ||| JJ
mutants  ||| S:36985 E:36993 ||| NN
remained  ||| S:36993 E:37002 ||| VBD
in  ||| S:37002 E:37005 ||| IN
the  ||| S:37005 E:37017 ||| DT
GTP  ||| S:37017 E:37021 ||| NNP
state ||| S:37021 E:37026 ||| NN
.  ||| S:37026 E:37028 ||| .
The  ||| S:37028 E:37032 ||| DT
present  ||| S:37032 E:37040 ||| JJ
results  ||| S:37040 E:37048 ||| NNS
further  ||| S:37048 E:37056 ||| RB
highlight  ||| S:37056 E:37066 ||| VB
the  ||| S:37066 E:37070 ||| DT
unique  ||| S:37070 E:37085 ||| JJ
nature  ||| S:37085 E:37092 ||| NN
of  ||| S:37092 E:37095 ||| IN
Rab24  ||| S:37095 E:37101 ||| NNP
and  ||| S:37101 E:37105 ||| CC
raise  ||| S:37105 E:37111 ||| VB
the  ||| S:37111 E:37115 ||| DT
possibility  ||| S:37115 E:37127 ||| NN
that  ||| S:37127 E:37132 ||| IN
it  ||| S:37132 E:37135 ||| PRP
may  ||| S:37135 E:37147 ||| MD
function  ||| S:37147 E:37156 ||| VB
in  ||| S:37156 E:37159 ||| IN
autophagic  ||| S:37159 E:37170 ||| JJ
degradation  ||| S:37170 E:37182 ||| NN
of  ||| S:37182 E:37185 ||| IN
misfolded  ||| S:37185 E:37195 ||| JJ
proteins ||| S:37195 E:37203 ||| NNS
,  ||| S:37203 E:37213 ||| ,
or  ||| S:37213 E:37216 ||| CC
perhaps  ||| S:37216 E:37224 ||| RB
play  ||| S:37224 E:37229 ||| VB
an  ||| S:37229 E:37232 ||| DT
unanticipated  ||| S:37232 E:37246 ||| JJ
role  ||| S:37246 E:37251 ||| NN
in  ||| S:37251 E:37254 ||| IN
nuclear  ||| S:37254 E:37262 ||| JJ
protein  ||| S:37262 E:37278 ||| NN
trafficking  ||| S:37278 E:37290 ||| NN
or  ||| S:37290 E:37293 ||| CC
maintenance ||| S:37293 E:37304 ||| NN
/ ||| S:37304 E:37305 ||| CD
assembly  ||| S:37305 E:37314 ||| NN
of  ||| S:37314 E:37317 ||| IN
the  ||| S:37317 E:37321 ||| DT
nuclear  ||| S:37321 E:37337 ||| JJ
envelope ||| S:37337 E:37345 ||| NN
.  ||| S:37345 E:37369 ||| .
Methods  ||| S:37369 E:37396 ||| NNP
Expression  ||| S:37396 E:37407 ||| NNP
constructs  ||| S:37407 E:37428 ||| VBD
The  ||| S:37428 E:37432 ||| DT
cDNA  ||| S:37432 E:37437 ||| JJ
encoding  ||| S:37437 E:37446 ||| JJ
Rab24  ||| S:37446 E:37452 ||| NN
was  ||| S:37452 E:37456 ||| VBD
obtained  ||| S:37456 E:37465 ||| VBN
by  ||| S:37465 E:37468 ||| IN
PCR  ||| S:37468 E:37482 ||| NNP
amplification  ||| S:37482 E:37496 ||| NN
from  ||| S:37496 E:37501 ||| IN
first  ||| S:37501 E:37507 ||| JJ
strand  ||| S:37507 E:37514 ||| JJ
cDNA  ||| S:37514 E:37519 ||| JJ
template  ||| S:37519 E:37538 ||| JJ
reverse-transcribed  ||| S:37538 E:37558 ||| NN
from  ||| S:37558 E:37563 ||| IN
mouse  ||| S:37563 E:37569 ||| NN
brain  ||| S:37569 E:37575 ||| NN
mRNA ||| S:37575 E:37579 ||| NN
,  ||| S:37579 E:37581 ||| ,
using  ||| S:37581 E:37598 ||| VBG
Taq  ||| S:37598 E:37602 ||| NNP
DNA  ||| S:37602 E:37606 ||| NNP
polymerase  ||| S:37606 E:37617 ||| NNS
( ||| S:37617 E:37618 ||| -LRB-
Perkin  ||| S:37618 E:37625 ||| NNP
Elmer ||| S:37625 E:37630 ||| NNP
) ||| S:37630 E:37631 ||| -RRB-
.  ||| S:37631 E:37643 ||| .
Oligonucleotide  ||| S:37643 E:37659 ||| JJ
primers  ||| S:37659 E:37667 ||| NN
for  ||| S:37667 E:37671 ||| IN
the  ||| S:37671 E:37675 ||| DT
PCR  ||| S:37675 E:37679 ||| NNP
reaction  ||| S:37679 E:37688 ||| NN
were  ||| S:37688 E:37693 ||| VBD
based  ||| S:37693 E:37709 ||| VBN
on  ||| S:37709 E:37712 ||| IN
the  ||| S:37712 E:37716 ||| DT
published  ||| S:37716 E:37726 ||| JJ
sequence  ||| S:37726 E:37735 ||| NN
of  ||| S:37735 E:37738 ||| IN
murine  ||| S:37738 E:37745 ||| CD
Rab24  ||| S:37745 E:37751 ||| CD
[  ||| S:37751 E:37753 ||| -LRB-
24  ||| S:37753 E:37756 ||| CD
]  ||| S:37756 E:37758 ||| -RRB-
.  ||| S:37758 E:37760 ||| .
Kpn1  ||| S:37760 E:37775 ||| NNP
and  ||| S:37775 E:37779 ||| CC
BamH1  ||| S:37779 E:37785 ||| CD
restriction  ||| S:37785 E:37797 ||| NN
sites  ||| S:37797 E:37803 ||| NNS
were  ||| S:37803 E:37808 ||| VBD
added  ||| S:37808 E:37814 ||| VBN
to  ||| S:37814 E:37817 ||| TO
the  ||| S:37817 E:37821 ||| DT
5 ||| S:37821 E:37822 ||| CD
'  ||| S:37822 E:37824 ||| ''
and  ||| S:37824 E:37828 ||| CC
3 ||| S:37828 E:37829 ||| CD
'  ||| S:37829 E:37841 ||| POS
primers  ||| S:37841 E:37849 ||| NN
respectively ||| S:37849 E:37861 ||| RB
,  ||| S:37861 E:37863 ||| ,
to  ||| S:37863 E:37866 ||| TO
facilitate  ||| S:37866 E:37877 ||| VB
cloning  ||| S:37877 E:37885 ||| VBN
of  ||| S:37885 E:37888 ||| IN
the  ||| S:37888 E:37892 ||| DT
PCR  ||| S:37892 E:37906 ||| NNP
product  ||| S:37906 E:37914 ||| NN
in  ||| S:37914 E:37917 ||| IN
frame  ||| S:37917 E:37923 ||| NN
with  ||| S:37923 E:37928 ||| IN
a  ||| S:37928 E:37930 ||| DT
5 ||| S:37930 E:37931 ||| CD
'  ||| S:37931 E:37933 ||| POS
sequence  ||| S:37933 E:37942 ||| FW
cassette  ||| S:37942 E:37951 ||| FW
encoding  ||| S:37951 E:37960 ||| FW
a  ||| S:37960 E:37972 ||| FW
myc  ||| S:37972 E:37976 ||| FW
epitope  ||| S:37976 E:37984 ||| FW
( ||| S:37984 E:37985 ||| -LRB-
EQKLISEEDL ||| S:37985 E:37995 ||| NNP
) ||| S:37995 E:37996 ||| -RRB-
,  ||| S:37996 E:37998 ||| ,
previously  ||| S:37998 E:38009 ||| RB
introduced  ||| S:38009 E:38020 ||| VBN
into  ||| S:38020 E:38025 ||| IN
the  ||| S:38025 E:38039 ||| DT
pCMV5  ||| S:38039 E:38045 ||| JJ
expression  ||| S:38045 E:38056 ||| NN
vector  ||| S:38056 E:38063 ||| NN
[  ||| S:38063 E:38065 ||| -LRB-
78  ||| S:38065 E:38068 ||| CD
]  ||| S:38068 E:38070 ||| -RRB-
.  ||| S:38070 E:38072 ||| .
The  ||| S:38072 E:38076 ||| DT
Rab24  ||| S:38076 E:38082 ||| NNP
cDNA  ||| S:38082 E:38087 ||| NNP
was  ||| S:38087 E:38101 ||| VBD
altered  ||| S:38101 E:38109 ||| VBN
by  ||| S:38109 E:38112 ||| IN
overlap-extension  ||| S:38112 E:38130 ||| NNP
PCR  ||| S:38130 E:38134 ||| NNP
[  ||| S:38134 E:38136 ||| -LRB-
79  ||| S:38136 E:38139 ||| CD
]  ||| S:38139 E:38141 ||| -RRB-
,  ||| S:38141 E:38143 ||| ,
using  ||| S:38143 E:38159 ||| VBG
appropriate  ||| S:38159 E:38171 ||| JJ
mutator  ||| S:38171 E:38179 ||| JJ
oligonucleotides  ||| S:38179 E:38196 ||| NN
and  ||| S:38196 E:38211 ||| CC
Pfu  ||| S:38211 E:38215 ||| NNP
DNA  ||| S:38215 E:38219 ||| NNP
polymerase  ||| S:38219 E:38230 ||| NNS
( ||| S:38230 E:38231 ||| -LRB-
Stratagene  ||| S:38231 E:38252 ||| NNP
Inc. ||| S:38252 E:38256 ||| NNP
,  ||| S:38256 E:38258 ||| ,
La  ||| S:38258 E:38261 ||| NNP
Jolla ||| S:38261 E:38266 ||| NNP
,  ||| S:38266 E:38268 ||| ,
CA ||| S:38268 E:38270 ||| NNP
) ||| S:38270 E:38271 ||| -RRB-
,  ||| S:38271 E:38273 ||| ,
so  ||| S:38273 E:38276 ||| RB
as  ||| S:38276 E:38279 ||| RB
to  ||| S:38279 E:38282 ||| TO
introduce  ||| S:38282 E:38292 ||| VB
amino  ||| S:38292 E:38298 ||| JJ
acid  ||| S:38298 E:38313 ||| NN
substitutions  ||| S:38313 E:38327 ||| NN
at  ||| S:38327 E:38330 ||| IN
D123  ||| S:38330 E:38335 ||| NNP
( ||| S:38335 E:38336 ||| -LRB-
D123I ||| S:38336 E:38341 ||| NNP
) ||| S:38341 E:38342 ||| -RRB-
,  ||| S:38342 E:38344 ||| ,
T120  ||| S:38344 E:38349 ||| NNP
( ||| S:38349 E:38350 ||| -LRB-
T120A ||| S:38350 E:38355 ||| NNP
) ||| S:38355 E:38356 ||| -RRB-
,  ||| S:38356 E:38358 ||| ,
S22  ||| S:38358 E:38362 ||| NNP
( ||| S:38362 E:38363 ||| -LRB-
S22N ||| S:38363 E:38367 ||| NNP
) ||| S:38367 E:38368 ||| -RRB-
,  ||| S:38368 E:38380 ||| ,
S67  ||| S:38380 E:38384 ||| NNP
( ||| S:38384 E:38385 ||| -LRB-
S67Q ||| S:38385 E:38389 ||| NNP
) ||| S:38389 E:38390 ||| -RRB-
,  ||| S:38390 E:38392 ||| ,
and  ||| S:38392 E:38396 ||| CC
a  ||| S:38396 E:38398 ||| DT
deletion  ||| S:38398 E:38407 ||| NN
of  ||| S:38407 E:38410 ||| IN
residues  ||| S:38410 E:38419 ||| CD
127  ||| S:38419 E:38423 ||| CD
through  ||| S:38423 E:38431 ||| IN
130  ||| S:38431 E:38445 ||| CD
( ||| S:38445 E:38446 ||| -LRB-
ΔEDRR ||| S:38446 E:38451 ||| NNP
) ||| S:38451 E:38452 ||| -RRB-
.  ||| S:38452 E:38454 ||| .
The  ||| S:38454 E:38458 ||| DT
cDNA  ||| S:38458 E:38463 ||| JJ
encoding  ||| S:38463 E:38472 ||| JJ
human  ||| S:38472 E:38478 ||| JJ
Rab11  ||| S:38478 E:38484 ||| NN
was  ||| S:38484 E:38488 ||| VBD
obtained  ||| S:38488 E:38497 ||| VBN
by  ||| S:38497 E:38510 ||| IN
PCR  ||| S:38510 E:38514 ||| NNP
amplification  ||| S:38514 E:38528 ||| NN
from  ||| S:38528 E:38533 ||| IN
first  ||| S:38533 E:38539 ||| JJ
strand  ||| S:38539 E:38546 ||| JJ
cDNA  ||| S:38546 E:38551 ||| JJ
template ||| S:38551 E:38559 ||| NN
,  ||| S:38559 E:38571 ||| ,
reverse-transcribed  ||| S:38571 E:38591 ||| JJ
from  ||| S:38591 E:38596 ||| IN
Hela  ||| S:38596 E:38601 ||| NNP
cell  ||| S:38601 E:38606 ||| NN
mRNA ||| S:38606 E:38610 ||| NN
.  ||| S:38610 E:38612 ||| .
This  ||| S:38612 E:38617 ||| DT
sequence  ||| S:38617 E:38636 ||| NN
was  ||| S:38636 E:38640 ||| VBD
cloned  ||| S:38640 E:38647 ||| VBN
into  ||| S:38647 E:38652 ||| IN
pCMV5 ||| S:38652 E:38657 ||| NNP
,  ||| S:38657 E:38659 ||| ,
in-frame  ||| S:38659 E:38668 ||| JJ
with  ||| S:38668 E:38673 ||| IN
a  ||| S:38673 E:38675 ||| DT
5 ||| S:38675 E:38676 ||| CD
'  ||| S:38676 E:38678 ||| POS
myc  ||| S:38678 E:38682 ||| JJ
epitope  ||| S:38682 E:38690 ||| JJ
tag  ||| S:38690 E:38704 ||| NN
sequence ||| S:38704 E:38712 ||| NN
,  ||| S:38712 E:38714 ||| ,
and  ||| S:38714 E:38718 ||| CC
altered  ||| S:38718 E:38726 ||| VBN
to  ||| S:38726 E:38729 ||| TO
encode  ||| S:38729 E:38736 ||| VB
the  ||| S:38736 E:38740 ||| DT
N124I  ||| S:38740 E:38746 ||| NNP
substitution  ||| S:38746 E:38759 ||| VBD
as  ||| S:38759 E:38772 ||| RB
stated  ||| S:38772 E:38779 ||| VBN
above  ||| S:38779 E:38785 ||| IN
for  ||| S:38785 E:38789 ||| IN
Rab24 ||| S:38789 E:38794 ||| CD
.  ||| S:38794 E:38796 ||| .
Other  ||| S:38796 E:38802 ||| JJ
pCMV5  ||| S:38802 E:38808 ||| FW
expression  ||| S:38808 E:38819 ||| FW
vectors  ||| S:38819 E:38837 ||| FW
encoding  ||| S:38837 E:38846 ||| FW
Rab1B ||| S:38846 E:38851 ||| FW
( ||| S:38851 E:38852 ||| -LRB-
N121I ||| S:38852 E:38857 ||| NNP
)  ||| S:38857 E:38859 ||| -RRB-
[  ||| S:38859 E:38861 ||| -LRB-
28  ||| S:38861 E:38864 ||| CD
]  ||| S:38864 E:38866 ||| -RRB-
,  ||| S:38866 E:38868 ||| ,
Rab6 ||| S:38868 E:38872 ||| NNP
( ||| S:38872 E:38873 ||| -LRB-
N126I ||| S:38873 E:38878 ||| NNP
)  ||| S:38878 E:38880 ||| -RRB-
and  ||| S:38880 E:38894 ||| CC
Rab8 ||| S:38894 E:38898 ||| NNP
( ||| S:38898 E:38899 ||| -LRB-
N121I ||| S:38899 E:38904 ||| NNP
)  ||| S:38904 E:38906 ||| -RRB-
[  ||| S:38906 E:38908 ||| -LRB-
32  ||| S:38908 E:38911 ||| CD
]  ||| S:38911 E:38913 ||| -RRB-
have  ||| S:38913 E:38918 ||| VBP
been  ||| S:38918 E:38923 ||| VBN
described  ||| S:38923 E:38933 ||| VBN
in  ||| S:38933 E:38936 ||| IN
the  ||| S:38936 E:38940 ||| DT
indicated  ||| S:38940 E:38960 ||| JJ
references.  ||| S:38960 E:38972 ||| FW
pCMV5  ||| S:38972 E:38978 ||| FW
expression  ||| S:38978 E:38989 ||| FW
vectors  ||| S:38989 E:38997 ||| FW
containing  ||| S:38997 E:39019 ||| FW
Rab24  ||| S:39019 E:39025 ||| FW
and  ||| S:39025 E:39040 ||| CC
Rab1B  ||| S:39040 E:39046 ||| NNP
were  ||| S:39046 E:39051 ||| VBD
engineered  ||| S:39051 E:39062 ||| VBN
by  ||| S:39062 E:39075 ||| IN
overlap-extension  ||| S:39075 E:39093 ||| NNP
PCR  ||| S:39093 E:39097 ||| NNP
to  ||| S:39097 E:39100 ||| TO
encode  ||| S:39100 E:39107 ||| VB
the  ||| S:39107 E:39111 ||| DT
following  ||| S:39111 E:39121 ||| JJ
chimeric  ||| S:39121 E:39140 ||| JJ
proteins ||| S:39140 E:39148 ||| NNS
:  ||| S:39148 E:39150 ||| :
Rab24 ||| S:39150 E:39155 ||| CD
/ ||| S:39155 E:39156 ||| CD
Rab1B ||| S:39156 E:39161 ||| CD
,  ||| S:39161 E:39163 ||| ,
consisting  ||| S:39163 E:39174 ||| VBG
of  ||| S:39174 E:39177 ||| IN
residues  ||| S:39177 E:39186 ||| JJ
1-165  ||| S:39186 E:39192 ||| NN
of  ||| S:39192 E:39205 ||| IN
Rab24  ||| S:39205 E:39211 ||| NNP
[  ||| S:39211 E:39213 ||| -LRB-
24  ||| S:39213 E:39216 ||| CD
]  ||| S:39216 E:39218 ||| -RRB-
fused  ||| S:39218 E:39224 ||| NN
to  ||| S:39224 E:39227 ||| TO
residues  ||| S:39227 E:39236 ||| CD
163-201  ||| S:39236 E:39244 ||| CD
from  ||| S:39244 E:39249 ||| IN
Rab1B  ||| S:39249 E:39255 ||| NNP
[  ||| S:39255 E:39257 ||| -LRB-
80  ||| S:39257 E:39260 ||| CD
]  ||| S:39260 E:39272 ||| -RRB-
;  ||| S:39272 E:39274 ||| :
Rab24 ||| S:39274 E:39279 ||| CD
( ||| S:39279 E:39280 ||| -LRB-
D123I ||| S:39280 E:39285 ||| NNP
) ||| S:39285 E:39286 ||| -RRB-
/ ||| S:39286 E:39287 ||| NNP
Rab1B ||| S:39287 E:39292 ||| NNP
,  ||| S:39292 E:39294 ||| ,
consisting  ||| S:39294 E:39305 ||| VBG
of  ||| S:39305 E:39308 ||| IN
residues  ||| S:39308 E:39317 ||| JJ
1-165  ||| S:39317 E:39323 ||| NN
of  ||| S:39323 E:39336 ||| IN
Rab24  ||| S:39336 E:39342 ||| CD
with  ||| S:39342 E:39347 ||| IN
the  ||| S:39347 E:39351 ||| DT
D123I  ||| S:39351 E:39357 ||| JJ
substitution ||| S:39357 E:39369 ||| NN
,  ||| S:39369 E:39371 ||| ,
fused  ||| S:39371 E:39377 ||| VBG
to  ||| S:39377 E:39380 ||| TO
residues  ||| S:39380 E:39399 ||| CD
163-201  ||| S:39399 E:39407 ||| CD
of  ||| S:39407 E:39410 ||| IN
Rab1B ||| S:39410 E:39415 ||| CD
;  ||| S:39415 E:39417 ||| :
Rab1B ||| S:39417 E:39422 ||| CD
/ ||| S:39422 E:39423 ||| CD
Rab24 ||| S:39423 E:39428 ||| CD
,  ||| S:39428 E:39430 ||| ,
consisting  ||| S:39430 E:39441 ||| VBG
of  ||| S:39441 E:39444 ||| IN
residues  ||| S:39444 E:39463 ||| JJ
1-162  ||| S:39463 E:39469 ||| NN
of  ||| S:39469 E:39472 ||| IN
Rab1B  ||| S:39472 E:39478 ||| CD
fused  ||| S:39478 E:39484 ||| NN
to  ||| S:39484 E:39487 ||| TO
residues  ||| S:39487 E:39496 ||| CD
166-203  ||| S:39496 E:39504 ||| CD
of  ||| S:39504 E:39507 ||| IN
Rab24 ||| S:39507 E:39512 ||| CD
;  ||| S:39512 E:39514 ||| :
and  ||| S:39514 E:39528 ||| CC
Rab1B ||| S:39528 E:39533 ||| NNP
( ||| S:39533 E:39534 ||| -LRB-
N121I ||| S:39534 E:39539 ||| NNP
) ||| S:39539 E:39540 ||| -RRB-
/ ||| S:39540 E:39541 ||| NNP
Rab24 ||| S:39541 E:39546 ||| NNP
,  ||| S:39546 E:39548 ||| ,
consisting  ||| S:39548 E:39559 ||| VBG
of  ||| S:39559 E:39562 ||| IN
residues  ||| S:39562 E:39571 ||| JJ
1-162  ||| S:39571 E:39577 ||| NN
of  ||| S:39577 E:39580 ||| IN
Rab1B  ||| S:39580 E:39596 ||| CD
with  ||| S:39596 E:39601 ||| IN
the  ||| S:39601 E:39605 ||| DT
N121I  ||| S:39605 E:39611 ||| JJ
substitution ||| S:39611 E:39623 ||| NN
,  ||| S:39623 E:39625 ||| ,
fused  ||| S:39625 E:39631 ||| VBG
to  ||| S:39631 E:39634 ||| TO
residues  ||| S:39634 E:39643 ||| CD
166-203  ||| S:39643 E:39651 ||| CD
of  ||| S:39651 E:39664 ||| IN
Rab24 ||| S:39664 E:39669 ||| CD
.  ||| S:39669 E:39671 ||| .
To  ||| S:39671 E:39674 ||| TO
generate  ||| S:39674 E:39683 ||| VB
Rab24  ||| S:39683 E:39689 ||| CD
fusions  ||| S:39689 E:39697 ||| NN
with  ||| S:39697 E:39702 ||| IN
Enhanced  ||| S:39702 E:39711 ||| NNP
Green  ||| S:39711 E:39727 ||| NNP
Fluorescent  ||| S:39727 E:39739 ||| NNP
Protein  ||| S:39739 E:39747 ||| NNP
( ||| S:39747 E:39748 ||| -LRB-
EGFP ||| S:39748 E:39752 ||| NNP
) ||| S:39752 E:39753 ||| -RRB-
,  ||| S:39753 E:39755 ||| ,
cDNAs  ||| S:39755 E:39761 ||| JJ
encoding  ||| S:39761 E:39770 ||| JJ
full-length  ||| S:39770 E:39792 ||| JJ
Rab24 ||| S:39792 E:39797 ||| NNP
( ||| S:39797 E:39798 ||| -LRB-
wt ||| S:39798 E:39800 ||| LS
)  ||| S:39800 E:39802 ||| -RRB-
or  ||| S:39802 E:39805 ||| CC
Rab24 ||| S:39805 E:39810 ||| NNP
( ||| S:39810 E:39811 ||| -LRB-
D123I ||| S:39811 E:39816 ||| NNP
) ||| S:39816 E:39817 ||| -RRB-
,  ||| S:39817 E:39819 ||| ,
or  ||| S:39819 E:39822 ||| CC
the  ||| S:39822 E:39826 ||| DT
Rab24  ||| S:39826 E:39832 ||| FW
C-terminal  ||| S:39832 E:39853 ||| FW
hypervariable  ||| S:39853 E:39867 ||| FW
domain  ||| S:39867 E:39874 ||| FW
( ||| S:39874 E:39875 ||| -LRB-
residues  ||| S:39875 E:39884 ||| FW
166-203 ||| S:39884 E:39891 ||| FW
)  ||| S:39891 E:39893 ||| -RRB-
were  ||| S:39893 E:39898 ||| VBD
generated  ||| S:39898 E:39918 ||| VBN
with  ||| S:39918 E:39923 ||| IN
flanking  ||| S:39923 E:39943 ||| JJ
KpnI  ||| S:39943 E:39948 ||| JJ
and  ||| S:39948 E:39963 ||| CC
BamHI  ||| S:39963 E:39969 ||| JJ
sites  ||| S:39969 E:39975 ||| NNS
and  ||| S:39975 E:39979 ||| CC
subcloned  ||| S:39979 E:39989 ||| NN
into  ||| S:39989 E:40004 ||| IN
pEGFP-C1  ||| S:40004 E:40013 ||| NNP
( ||| S:40013 E:40014 ||| -LRB-
Clontech  ||| S:40014 E:40023 ||| NNP
Inc. ||| S:40023 E:40027 ||| NNP
,  ||| S:40027 E:40029 ||| ,
Palo  ||| S:40029 E:40034 ||| NNP
Alto ||| S:40034 E:40038 ||| NNP
,  ||| S:40038 E:40040 ||| ,
CA ||| S:40040 E:40042 ||| NNP
)  ||| S:40042 E:40044 ||| -RRB-
so  ||| S:40044 E:40047 ||| RB
that  ||| S:40047 E:40052 ||| IN
the  ||| S:40052 E:40056 ||| DT
Rab  ||| S:40056 E:40070 ||| JJ
inserts  ||| S:40070 E:40078 ||| NNS
were  ||| S:40078 E:40083 ||| VBD
in-frame  ||| S:40083 E:40092 ||| JJ
with  ||| S:40092 E:40097 ||| IN
a  ||| S:40097 E:40099 ||| DT
5 ||| S:40099 E:40100 ||| CD
'  ||| S:40100 E:40102 ||| POS
EGFP  ||| S:40102 E:40107 ||| NNP
coding  ||| S:40107 E:40114 ||| JJ
sequence ||| S:40114 E:40122 ||| NN
.  ||| S:40122 E:40124 ||| .
The  ||| S:40124 E:40138 ||| DT
sequences  ||| S:40138 E:40148 ||| NN
of  ||| S:40148 E:40151 ||| IN
all  ||| S:40151 E:40155 ||| DT
constructs  ||| S:40155 E:40166 ||| NN
were  ||| S:40166 E:40171 ||| VBD
verified  ||| S:40171 E:40180 ||| VBN
by  ||| S:40180 E:40183 ||| IN
automated  ||| S:40183 E:40203 ||| JJ
DNA  ||| S:40203 E:40207 ||| NN
sequencing  ||| S:40207 E:40218 ||| VBZ
using  ||| S:40218 E:40224 ||| VBG
a  ||| S:40224 E:40226 ||| DT
Beckman  ||| S:40226 E:40234 ||| NNP
CEQ2000  ||| S:40234 E:40242 ||| NNP
system ||| S:40242 E:40248 ||| NN
.  ||| S:40248 E:40278 ||| .
Cell  ||| S:40278 E:40283 ||| NN
culture  ||| S:40283 E:40291 ||| NN
and  ||| S:40291 E:40295 ||| CC
transfection  ||| S:40295 E:40318 ||| JJ
Human  ||| S:40318 E:40324 ||| JJ
embryonal  ||| S:40324 E:40334 ||| JJ
kidney  ||| S:40334 E:40341 ||| NN
( ||| S:40341 E:40342 ||| -LRB-
HEK ||| S:40342 E:40345 ||| NNP
)  ||| S:40345 E:40347 ||| -RRB-
cells  ||| S:40347 E:40353 ||| NNS
( ||| S:40353 E:40354 ||| -LRB-
line  ||| S:40354 E:40359 ||| NN
293 ||| S:40359 E:40362 ||| CD
)  ||| S:40362 E:40364 ||| -RRB-
and  ||| S:40364 E:40368 ||| CC
NIH  ||| S:40368 E:40382 ||| NNP
3T3  ||| S:40382 E:40386 ||| NNP
mouse  ||| S:40386 E:40392 ||| NN
fibroblasts  ||| S:40392 E:40404 ||| NNS
were  ||| S:40404 E:40409 ||| VBD
obtained  ||| S:40409 E:40418 ||| VBN
from  ||| S:40418 E:40423 ||| IN
American  ||| S:40423 E:40432 ||| NNP
Type  ||| S:40432 E:40447 ||| NNP
Culture  ||| S:40447 E:40455 ||| NNP
Collection  ||| S:40455 E:40466 ||| NNP
( ||| S:40466 E:40467 ||| -LRB-
Rockville ||| S:40467 E:40476 ||| NNP
,  ||| S:40476 E:40478 ||| ,
MD ||| S:40478 E:40480 ||| NNP
)  ||| S:40480 E:40482 ||| -RRB-
and  ||| S:40482 E:40486 ||| CC
were  ||| S:40486 E:40491 ||| VBD
maintained  ||| S:40491 E:40502 ||| VBN
at  ||| S:40502 E:40515 ||| IN
37°C  ||| S:40515 E:40520 ||| CD
in  ||| S:40520 E:40523 ||| IN
a  ||| S:40523 E:40525 ||| DT
5 ||| S:40525 E:40526 ||| CD
%  ||| S:40526 E:40528 ||| NN
CO  ||| S:40528 E:40542 ||| NNP
2  ||| S:40542 E:40544 ||| CD
atmosphere  ||| S:40544 E:40555 ||| NN
in  ||| S:40555 E:40558 ||| IN
Dulbecco ||| S:40558 E:40566 ||| NNP
's  ||| S:40566 E:40569 ||| POS
modified  ||| S:40569 E:40588 ||| JJ
Eagle ||| S:40588 E:40593 ||| NNP
's  ||| S:40593 E:40596 ||| POS
medium  ||| S:40596 E:40603 ||| NN
containing  ||| S:40603 E:40614 ||| VBG
10 ||| S:40614 E:40616 ||| CD
%  ||| S:40616 E:40618 ||| NN
( ||| S:40618 E:40619 ||| -LRB-
v ||| S:40619 E:40620 ||| FW
/ ||| S:40620 E:40621 ||| FW
v ||| S:40621 E:40622 ||| FW
)  ||| S:40622 E:40624 ||| -RRB-
fetal  ||| S:40624 E:40630 ||| JJ
bovine  ||| S:40630 E:40637 ||| JJ
serum ||| S:40637 E:40642 ||| NN
.  ||| S:40642 E:40654 ||| .
On  ||| S:40654 E:40657 ||| IN
the  ||| S:40657 E:40661 ||| DT
day  ||| S:40661 E:40665 ||| NN
before  ||| S:40665 E:40672 ||| IN
transfection ||| S:40672 E:40684 ||| NN
,  ||| S:40684 E:40686 ||| ,
cells  ||| S:40686 E:40692 ||| NNS
were  ||| S:40692 E:40697 ||| VBD
plated  ||| S:40697 E:40704 ||| VBN
in  ||| S:40704 E:40707 ||| IN
6  ||| S:40707 E:40709 ||| CD
cm  ||| S:40709 E:40722 ||| CD
diameter  ||| S:40722 E:40731 ||| CD
dishes  ||| S:40731 E:40738 ||| NNS
at  ||| S:40738 E:40741 ||| IN
5  ||| S:40741 E:40743 ||| CD
×  ||| S:40743 E:40745 ||| CD
10  ||| S:40745 E:40748 ||| CD
5cells ||| S:40748 E:40754 ||| CD
/ ||| S:40754 E:40755 ||| CD
dish  ||| S:40755 E:40760 ||| NN
or  ||| S:40760 E:40763 ||| CC
in  ||| S:40763 E:40766 ||| IN
10  ||| S:40766 E:40769 ||| CD
cm  ||| S:40769 E:40782 ||| CD
diameter  ||| S:40782 E:40791 ||| CD
dishes  ||| S:40791 E:40798 ||| NNS
at  ||| S:40798 E:40801 ||| IN
2  ||| S:40801 E:40803 ||| CD
×  ||| S:40803 E:40805 ||| CD
10  ||| S:40805 E:40808 ||| CD
6cells ||| S:40808 E:40814 ||| CD
/ ||| S:40814 E:40815 ||| CD
dish ||| S:40815 E:40819 ||| NN
.  ||| S:40819 E:40821 ||| .
Cells  ||| S:40821 E:40827 ||| NNS
were  ||| S:40827 E:40842 ||| VBD
transfected  ||| S:40842 E:40854 ||| VBN
with  ||| S:40854 E:40859 ||| IN
the  ||| S:40859 E:40863 ||| DT
indicated  ||| S:40863 E:40873 ||| JJ
expression  ||| S:40873 E:40884 ||| NN
vectors ||| S:40884 E:40891 ||| NN
,  ||| S:40891 E:40893 ||| ,
using  ||| S:40893 E:40909 ||| VBG
Lipofectamine  ||| S:40909 E:40923 ||| NNP
Plus  ||| S:40923 E:40928 ||| NNP
reagent  ||| S:40928 E:40936 ||| NNS
( ||| S:40936 E:40937 ||| -LRB-
Life  ||| S:40937 E:40942 ||| NNP
Technologies ||| S:40942 E:40954 ||| NNPS
,  ||| S:40954 E:40956 ||| ,
Inc. ||| S:40956 E:40960 ||| NNP
,  ||| S:40960 E:40972 ||| ,
Rockville ||| S:40972 E:40981 ||| NNP
,  ||| S:40981 E:40983 ||| ,
MD ||| S:40983 E:40985 ||| NNP
)  ||| S:40985 E:40987 ||| -RRB-
for  ||| S:40987 E:40991 ||| IN
293  ||| S:40991 E:40995 ||| CD
cells  ||| S:40995 E:41001 ||| NNS
or  ||| S:41001 E:41004 ||| CC
Superfect  ||| S:41004 E:41014 ||| NNP
reagent  ||| S:41014 E:41032 ||| NNS
( ||| S:41032 E:41033 ||| -LRB-
Qiagen ||| S:41033 E:41039 ||| NNP
,  ||| S:41039 E:41041 ||| ,
Valencia ||| S:41041 E:41049 ||| NNP
,  ||| S:41049 E:41051 ||| ,
CA ||| S:41051 E:41053 ||| NNP
)  ||| S:41053 E:41055 ||| -RRB-
for  ||| S:41055 E:41059 ||| IN
3T3  ||| S:41059 E:41063 ||| CD
cells ||| S:41063 E:41068 ||| NNS
,  ||| S:41068 E:41070 ||| ,
according  ||| S:41070 E:41080 ||| VBG
to  ||| S:41080 E:41083 ||| TO
the  ||| S:41083 E:41097 ||| DT
protocols  ||| S:41097 E:41107 ||| NNS
recommended  ||| S:41107 E:41119 ||| VBD
by  ||| S:41119 E:41122 ||| IN
the  ||| S:41122 E:41126 ||| DT
manufacturers ||| S:41126 E:41139 ||| NNS
.  ||| S:41139 E:41169 ||| .
Subcellular  ||| S:41169 E:41181 ||| JJ
distribution  ||| S:41181 E:41194 ||| NN
of  ||| S:41194 E:41197 ||| IN
Rab24  ||| S:41197 E:41213 ||| CD
To  ||| S:41213 E:41216 ||| TO
determine  ||| S:41216 E:41226 ||| VB
the  ||| S:41226 E:41230 ||| DT
subcellular  ||| S:41230 E:41242 ||| JJ
distribution  ||| S:41242 E:41255 ||| NN
of  ||| S:41255 E:41268 ||| IN
mycRab24 ||| S:41268 E:41276 ||| NNP
( ||| S:41276 E:41277 ||| -LRB-
wt ||| S:41277 E:41279 ||| LS
)  ||| S:41279 E:41281 ||| -RRB-
and  ||| S:41281 E:41285 ||| CC
mycRab24 ||| S:41285 E:41293 ||| NNP
( ||| S:41293 E:41294 ||| -LRB-
D123I ||| S:41294 E:41299 ||| NNP
) ||| S:41299 E:41300 ||| -RRB-
,  ||| S:41300 E:41302 ||| ,
293  ||| S:41302 E:41306 ||| CD
cells  ||| S:41306 E:41312 ||| NNS
were  ||| S:41312 E:41317 ||| VBD
plated  ||| S:41317 E:41334 ||| VBN
in  ||| S:41334 E:41337 ||| IN
10  ||| S:41337 E:41340 ||| CD
cm  ||| S:41340 E:41343 ||| CD
dishes  ||| S:41343 E:41350 ||| NNS
and  ||| S:41350 E:41354 ||| CC
transfected  ||| S:41354 E:41366 ||| NN
with  ||| S:41366 E:41371 ||| IN
the  ||| S:41371 E:41375 ||| DT
indicated  ||| S:41375 E:41395 ||| JJ
expression  ||| S:41395 E:41406 ||| NN
vectors ||| S:41406 E:41413 ||| NN
.  ||| S:41413 E:41415 ||| .
After  ||| S:41415 E:41421 ||| IN
24  ||| S:41421 E:41424 ||| CD
h ||| S:41424 E:41425 ||| NN
,  ||| S:41425 E:41427 ||| ,
the  ||| S:41427 E:41431 ||| DT
cells  ||| S:41431 E:41437 ||| NNS
were  ||| S:41437 E:41442 ||| VBD
harvested  ||| S:41442 E:41462 ||| VBN
in  ||| S:41462 E:41465 ||| IN
PBS ||| S:41465 E:41468 ||| NNP
,  ||| S:41468 E:41470 ||| ,
collected  ||| S:41470 E:41480 ||| VBN
by  ||| S:41480 E:41483 ||| IN
centrifugation ||| S:41483 E:41497 ||| NN
,  ||| S:41497 E:41499 ||| ,
and  ||| S:41499 E:41503 ||| CC
lysed  ||| S:41503 E:41509 ||| NN
in  ||| S:41509 E:41512 ||| IN
5  ||| S:41512 E:41524 ||| CD
volumes  ||| S:41524 E:41532 ||| NNS
of  ||| S:41532 E:41535 ||| IN
40  ||| S:41535 E:41538 ||| CD
mM  ||| S:41538 E:41541 ||| JJ
Tris-HCl ||| S:41541 E:41549 ||| NN
,  ||| S:41549 E:41551 ||| ,
pH  ||| S:41551 E:41554 ||| JJ
7.4 ||| S:41554 E:41557 ||| CD
,  ||| S:41557 E:41559 ||| ,
containing  ||| S:41559 E:41570 ||| VBG
complete  ||| S:41570 E:41589 ||| JJ
mini-EDTA-free  ||| S:41589 E:41604 ||| FW
protease  ||| S:41604 E:41613 ||| FW
inhibitor  ||| S:41613 E:41623 ||| FW
cocktail  ||| S:41623 E:41632 ||| FW
( ||| S:41632 E:41633 ||| -LRB-
Sigma ||| S:41633 E:41638 ||| NNP
,  ||| S:41638 E:41640 ||| ,
St.  ||| S:41640 E:41654 ||| NNP
Louis ||| S:41654 E:41659 ||| NNP
,  ||| S:41659 E:41661 ||| ,
MO ||| S:41661 E:41663 ||| NNP
) ||| S:41663 E:41664 ||| -RRB-
.  ||| S:41664 E:41666 ||| .
Soluble  ||| S:41666 E:41674 ||| NNP
and  ||| S:41674 E:41678 ||| CC
particulate  ||| S:41678 E:41690 ||| JJ
fractions  ||| S:41690 E:41700 ||| NNS
were  ||| S:41700 E:41715 ||| VBD
obtained  ||| S:41715 E:41724 ||| VBN
by  ||| S:41724 E:41727 ||| IN
centrifuging  ||| S:41727 E:41740 ||| VBG
the  ||| S:41740 E:41744 ||| DT
cell  ||| S:41744 E:41749 ||| NN
lysate  ||| S:41749 E:41756 ||| NN
at  ||| S:41756 E:41759 ||| IN
100,000  ||| S:41759 E:41767 ||| CD
×  ||| S:41767 E:41769 ||| CD
g  ||| S:41769 E:41781 ||| NN
for  ||| S:41781 E:41785 ||| IN
60  ||| S:41785 E:41788 ||| CD
min  ||| S:41788 E:41792 ||| NN
at  ||| S:41792 E:41795 ||| IN
4°C ||| S:41795 E:41798 ||| CD
.  ||| S:41798 E:41800 ||| .
One  ||| S:41800 E:41804 ||| CD
quarter  ||| S:41804 E:41812 ||| NN
of  ||| S:41812 E:41815 ||| IN
each  ||| S:41815 E:41820 ||| DT
fraction  ||| S:41820 E:41829 ||| NN
was  ||| S:41829 E:41843 ||| VBD
subjected  ||| S:41843 E:41853 ||| VBN
to  ||| S:41853 E:41856 ||| TO
SDS-PAGE  ||| S:41856 E:41865 ||| JJ
and  ||| S:41865 E:41869 ||| CC
immunoblot  ||| S:41869 E:41880 ||| JJ
analysis  ||| S:41880 E:41889 ||| NN
using  ||| S:41889 E:41895 ||| VBG
the  ||| S:41895 E:41909 ||| DT
9E10  ||| S:41909 E:41914 ||| JJ
monoclonal  ||| S:41914 E:41925 ||| JJ
antibody  ||| S:41925 E:41934 ||| NN
against  ||| S:41934 E:41942 ||| IN
the  ||| S:41942 E:41946 ||| DT
myc  ||| S:41946 E:41950 ||| JJ
epitope  ||| S:41950 E:41968 ||| NNS
( ||| S:41968 E:41969 ||| -LRB-
Oncogene  ||| S:41969 E:41978 ||| NNP
Research  ||| S:41978 E:41987 ||| NNP
Products ||| S:41987 E:41995 ||| NNPS
,  ||| S:41995 E:41997 ||| ,
Cambridge ||| S:41997 E:42006 ||| NNP
,  ||| S:42006 E:42008 ||| ,
MA ||| S:42008 E:42010 ||| NNP
) ||| S:42010 E:42011 ||| -RRB-
,  ||| S:42011 E:42013 ||| ,
followed  ||| S:42013 E:42022 ||| VBN
by  ||| S:42022 E:42035 ||| IN
HRP-conjugated  ||| S:42035 E:42050 ||| JJ
goat  ||| S:42050 E:42055 ||| JJ
anti-mouse  ||| S:42055 E:42066 ||| JJ
IgG  ||| S:42066 E:42070 ||| JJ
and  ||| S:42070 E:42074 ||| CC
ECL  ||| S:42074 E:42078 ||| NNP
detection  ||| S:42078 E:42098 ||| FW
reagent  ||| S:42098 E:42106 ||| FW
( ||| S:42106 E:42107 ||| -LRB-
Amersham  ||| S:42107 E:42116 ||| NNP
Corp ||| S:42116 E:42120 ||| NNP
,  ||| S:42120 E:42122 ||| ,
Arlington  ||| S:42122 E:42132 ||| NNP
Hts. ||| S:42132 E:42136 ||| NNP
,  ||| S:42136 E:42138 ||| ,
IL ||| S:42138 E:42140 ||| NNP
)  ||| S:42140 E:42142 ||| -RRB-
as  ||| S:42142 E:42145 ||| RB
described  ||| S:42145 E:42165 ||| VBN
previously  ||| S:42165 E:42176 ||| RB
[  ||| S:42176 E:42178 ||| -LRB-
50  ||| S:42178 E:42181 ||| CD
81  ||| S:42181 E:42184 ||| CD
]  ||| S:42184 E:42186 ||| -RRB-
.  ||| S:42186 E:42188 ||| .
To  ||| S:42188 E:42191 ||| TO
determine  ||| S:42191 E:42201 ||| VB
the  ||| S:42201 E:42205 ||| DT
detergent  ||| S:42205 E:42225 ||| NN
solubility  ||| S:42225 E:42236 ||| NN
of  ||| S:42236 E:42239 ||| IN
the  ||| S:42239 E:42243 ||| DT
Rab24 ||| S:42243 E:42248 ||| NNP
( ||| S:42248 E:42249 ||| -LRB-
D123I ||| S:42249 E:42254 ||| NNP
)  ||| S:42254 E:42256 ||| -RRB-
mutant ||| S:42256 E:42262 ||| NN
,  ||| S:42262 E:42264 ||| ,
transfected  ||| S:42264 E:42276 ||| JJ
cells  ||| S:42276 E:42292 ||| NNS
from  ||| S:42292 E:42297 ||| IN
a  ||| S:42297 E:42299 ||| DT
10  ||| S:42299 E:42302 ||| CD
cm  ||| S:42302 E:42305 ||| JJ
culture  ||| S:42305 E:42313 ||| NN
dish  ||| S:42313 E:42318 ||| NN
were  ||| S:42318 E:42323 ||| VBD
homogenized  ||| S:42323 E:42335 ||| VBN
in  ||| S:42335 E:42338 ||| IN
0.2  ||| S:42338 E:42342 ||| CD
ml  ||| S:42342 E:42345 ||| NN
of  ||| S:42345 E:42358 ||| IN
100  ||| S:42358 E:42362 ||| CD
mM  ||| S:42362 E:42365 ||| JJ
Tris-HCl ||| S:42365 E:42373 ||| NN
,  ||| S:42373 E:42375 ||| ,
pH  ||| S:42375 E:42378 ||| JJ
7.4 ||| S:42378 E:42381 ||| CD
,  ||| S:42381 E:42383 ||| ,
containing  ||| S:42383 E:42394 ||| VBG
0.5 ||| S:42394 E:42397 ||| CD
%  ||| S:42397 E:42399 ||| NN
Nonidet  ||| S:42399 E:42407 ||| NNP
P-40 ||| S:42407 E:42411 ||| NNP
,  ||| S:42411 E:42423 ||| ,
0.5 ||| S:42423 E:42426 ||| CD
%  ||| S:42426 E:42428 ||| NN
sodium  ||| S:42428 E:42435 ||| NN
deoxycholate ||| S:42435 E:42447 ||| NN
,  ||| S:42447 E:42449 ||| ,
0.1 ||| S:42449 E:42452 ||| CD
%  ||| S:42452 E:42454 ||| NN
SDS ||| S:42454 E:42457 ||| NNP
,  ||| S:42457 E:42459 ||| ,
and  ||| S:42459 E:42463 ||| CC
2  ||| S:42463 E:42465 ||| CD
mM  ||| S:42465 E:42468 ||| JJ
EDTA ||| S:42468 E:42472 ||| NNP
.  ||| S:42472 E:42484 ||| .
Samples  ||| S:42484 E:42492 ||| NNS
were  ||| S:42492 E:42497 ||| VBD
partitioned  ||| S:42497 E:42509 ||| VBN
into  ||| S:42509 E:42514 ||| IN
soluble  ||| S:42514 E:42522 ||| JJ
and  ||| S:42522 E:42526 ||| CC
particulate  ||| S:42526 E:42548 ||| JJ
components  ||| S:42548 E:42559 ||| NNS
and  ||| S:42559 E:42563 ||| CC
the  ||| S:42563 E:42567 ||| DT
latter  ||| S:42567 E:42574 ||| NN
were  ||| S:42574 E:42579 ||| VBD
subjected  ||| S:42579 E:42589 ||| VBN
to  ||| S:42589 E:42592 ||| TO
SDS-PAGE  ||| S:42592 E:42601 ||| JJ
and  ||| S:42601 E:42615 ||| CC
immunoblot  ||| S:42615 E:42626 ||| JJ
analysis ||| S:42626 E:42634 ||| NN
.  ||| S:42634 E:42664 ||| .
Rab24  ||| S:42664 E:42670 ||| NNP
guanine  ||| S:42670 E:42678 ||| VBD
nucleotide  ||| S:42678 E:42689 ||| JJ
state  ||| S:42689 E:42705 ||| NN
To  ||| S:42705 E:42708 ||| TO
assess  ||| S:42708 E:42715 ||| VB
the  ||| S:42715 E:42719 ||| DT
guanine  ||| S:42719 E:42727 ||| JJ
nucleotide  ||| S:42727 E:42738 ||| JJ
state  ||| S:42738 E:42744 ||| NN
of  ||| S:42744 E:42747 ||| IN
selected  ||| S:42747 E:42766 ||| JJ
mycRab24  ||| S:42766 E:42775 ||| CD
proteins ||| S:42775 E:42783 ||| NNS
,  ||| S:42783 E:42785 ||| ,
cells  ||| S:42785 E:42791 ||| NNS
were  ||| S:42791 E:42796 ||| VBD
transfected  ||| S:42796 E:42808 ||| VBN
with  ||| S:42808 E:42813 ||| IN
the  ||| S:42813 E:42827 ||| DT
indicated  ||| S:42827 E:42837 ||| JJ
constructs  ||| S:42837 E:42848 ||| NN
and  ||| S:42848 E:42852 ||| CC
incubated  ||| S:42852 E:42862 ||| NN
with  ||| S:42862 E:42877 ||| IN
32P-orthophosphate  ||| S:42877 E:42896 ||| CD
for  ||| S:42896 E:42900 ||| IN
5  ||| S:42900 E:42902 ||| CD
h ||| S:42902 E:42903 ||| NN
,  ||| S:42903 E:42905 ||| ,
starting  ||| S:42905 E:42914 ||| VBG
24  ||| S:42914 E:42917 ||| CD
h  ||| S:42917 E:42919 ||| NN
after  ||| S:42919 E:42935 ||| IN
transfection ||| S:42935 E:42947 ||| NN
.  ||| S:42947 E:42949 ||| .
Radiolabeled  ||| S:42949 E:42962 ||| NNP
mycRab24  ||| S:42962 E:42971 ||| NNP
was  ||| S:42971 E:42985 ||| VBD
immunoprecipitated  ||| S:42985 E:43004 ||| JJ
and  ||| S:43004 E:43008 ||| CC
the  ||| S:43008 E:43012 ||| DT
32P-labeled  ||| S:43012 E:43024 ||| FW
guanine  ||| S:43024 E:43042 ||| FW
nucleotides  ||| S:43042 E:43054 ||| FW
eluted  ||| S:43054 E:43061 ||| FW
from  ||| S:43061 E:43066 ||| IN
the  ||| S:43066 E:43070 ||| DT
protein  ||| S:43070 E:43078 ||| NN
were  ||| S:43078 E:43083 ||| VBD
subjected  ||| S:43083 E:43093 ||| VBN
to  ||| S:43093 E:43106 ||| TO
thin-layer  ||| S:43106 E:43117 ||| JJ
chromatography  ||| S:43117 E:43132 ||| NN
to  ||| S:43132 E:43135 ||| TO
resolve  ||| S:43135 E:43143 ||| VB
GDP  ||| S:43143 E:43147 ||| NNP
and  ||| S:43147 E:43151 ||| CC
GTP ||| S:43151 E:43154 ||| NNP
.  ||| S:43154 E:43166 ||| .
Aliquots  ||| S:43166 E:43175 ||| NNP
of  ||| S:43175 E:43178 ||| IN
the  ||| S:43178 E:43182 ||| DT
immunoprecipitated  ||| S:43182 E:43201 ||| JJ
protein  ||| S:43201 E:43209 ||| NN
were  ||| S:43209 E:43214 ||| VBD
also  ||| S:43214 E:43229 ||| RB
subjected  ||| S:43229 E:43239 ||| VBN
to  ||| S:43239 E:43242 ||| TO
immunoblot  ||| S:43242 E:43253 ||| VB
analysis  ||| S:43253 E:43262 ||| NN
with  ||| S:43262 E:43267 ||| IN
antibody  ||| S:43267 E:43276 ||| NN
against  ||| S:43276 E:43294 ||| IN
the  ||| S:43294 E:43298 ||| DT
myc  ||| S:43298 E:43302 ||| JJ
epitope ||| S:43302 E:43309 ||| NN
,  ||| S:43309 E:43311 ||| ,
so  ||| S:43311 E:43314 ||| RB
that  ||| S:43314 E:43319 ||| IN
the  ||| S:43319 E:43323 ||| DT
amount  ||| S:43323 E:43330 ||| NN
of  ||| S:43330 E:43333 ||| IN
bound  ||| S:43333 E:43339 ||| JJ
nucleotide  ||| S:43339 E:43360 ||| NN
could  ||| S:43360 E:43366 ||| MD
be  ||| S:43366 E:43369 ||| VB
related  ||| S:43369 E:43377 ||| VBN
to  ||| S:43377 E:43380 ||| TO
the  ||| S:43380 E:43384 ||| DT
amount  ||| S:43384 E:43391 ||| NN
of  ||| S:43391 E:43394 ||| IN
protein ||| S:43394 E:43401 ||| NN
.  ||| S:43401 E:43403 ||| .
A  ||| S:43403 E:43405 ||| DT
detailed  ||| S:43405 E:43424 ||| JJ
description  ||| S:43424 E:43436 ||| NN
of  ||| S:43436 E:43439 ||| IN
these  ||| S:43439 E:43445 ||| DT
procedures  ||| S:43445 E:43456 ||| NNS
has  ||| S:43456 E:43460 ||| VBZ
been  ||| S:43460 E:43465 ||| VBN
published  ||| S:43465 E:43485 ||| VBN
previously  ||| S:43485 E:43496 ||| RB
[  ||| S:43496 E:43498 ||| -LRB-
25  ||| S:43498 E:43501 ||| CD
]  ||| S:43501 E:43503 ||| -RRB-
.  ||| S:43503 E:43533 ||| .
Immunofluorescence  ||| S:43533 E:43552 ||| NNP
microscopy  ||| S:43552 E:43573 ||| VBD
HEK293  ||| S:43573 E:43580 ||| CD
cells  ||| S:43580 E:43586 ||| NNS
or  ||| S:43586 E:43589 ||| CC
NIH3T3  ||| S:43589 E:43596 ||| CD
cells  ||| S:43596 E:43602 ||| NNS
were  ||| S:43602 E:43607 ||| VBD
seeded  ||| S:43607 E:43614 ||| VBN
on  ||| S:43614 E:43627 ||| IN
laminin-coated  ||| S:43627 E:43642 ||| JJ
coverslips  ||| S:43642 E:43653 ||| NN
in  ||| S:43653 E:43656 ||| IN
60  ||| S:43656 E:43659 ||| CD
mm  ||| S:43659 E:43662 ||| CD
dishes  ||| S:43662 E:43669 ||| NNS
and  ||| S:43669 E:43673 ||| CC
transfected  ||| S:43673 E:43695 ||| VBP
as  ||| S:43695 E:43698 ||| RB
described  ||| S:43698 E:43708 ||| VBN
above ||| S:43708 E:43713 ||| IN
.  ||| S:43713 E:43715 ||| .
Cells  ||| S:43715 E:43721 ||| NNS
were  ||| S:43721 E:43726 ||| VBD
fixed  ||| S:43726 E:43732 ||| VBN
for  ||| S:43732 E:43736 ||| IN
15  ||| S:43736 E:43739 ||| CD
min  ||| S:43739 E:43743 ||| NN
in  ||| S:43743 E:43746 ||| IN
3 ||| S:43746 E:43747 ||| CD
%  ||| S:43747 E:43759 ||| NN
( ||| S:43759 E:43760 ||| -LRB-
w ||| S:43760 E:43761 ||| FW
/ ||| S:43761 E:43762 ||| FW
v ||| S:43762 E:43763 ||| FW
)  ||| S:43763 E:43765 ||| -RRB-
paraformaldehyde ||| S:43765 E:43781 ||| NN
,  ||| S:43781 E:43783 ||| ,
rinsed  ||| S:43783 E:43790 ||| VBG
for  ||| S:43790 E:43794 ||| IN
5  ||| S:43794 E:43796 ||| CD
min  ||| S:43796 E:43800 ||| NN
with  ||| S:43800 E:43805 ||| IN
0.05  ||| S:43805 E:43810 ||| CD
M  ||| S:43810 E:43812 ||| NNP
NH  ||| S:43812 E:43826 ||| NNP
4  ||| S:43826 E:43828 ||| CD
Cl  ||| S:43828 E:43842 ||| CD
2  ||| S:43842 E:43844 ||| CD
,  ||| S:43844 E:43846 ||| ,
permeabilized  ||| S:43846 E:43860 ||| VBG
for  ||| S:43860 E:43864 ||| IN
2  ||| S:43864 E:43866 ||| CD
min  ||| S:43866 E:43870 ||| NN
with  ||| S:43870 E:43875 ||| IN
0.1 ||| S:43875 E:43878 ||| CD
%  ||| S:43878 E:43890 ||| NN
( ||| S:43890 E:43891 ||| -LRB-
v ||| S:43891 E:43892 ||| FW
/ ||| S:43892 E:43893 ||| FW
v ||| S:43893 E:43894 ||| FW
)  ||| S:43894 E:43896 ||| -RRB-
TritonX-100 ||| S:43896 E:43907 ||| NNP
,  ||| S:43907 E:43909 ||| ,
and  ||| S:43909 E:43913 ||| CC
blocked  ||| S:43913 E:43921 ||| VBN
for  ||| S:43921 E:43925 ||| IN
30  ||| S:43925 E:43928 ||| CD
min  ||| S:43928 E:43932 ||| NN
with  ||| S:43932 E:43937 ||| IN
0.1 ||| S:43937 E:43940 ||| CD
%  ||| S:43940 E:43942 ||| NN
( ||| S:43942 E:43943 ||| -LRB-
w ||| S:43943 E:43944 ||| FW
/ ||| S:43944 E:43945 ||| FW
v ||| S:43945 E:43946 ||| FW
)  ||| S:43946 E:43958 ||| -RRB-
BSA ||| S:43958 E:43961 ||| NNP
.  ||| S:43961 E:43963 ||| .
All  ||| S:43963 E:43967 ||| DT
solutions  ||| S:43967 E:43977 ||| NNS
were  ||| S:43977 E:43982 ||| VBD
prepared  ||| S:43982 E:43991 ||| VBN
in  ||| S:43991 E:43994 ||| IN
PBS ||| S:43994 E:43997 ||| NNP
.  ||| S:43997 E:43999 ||| .
To  ||| S:43999 E:44002 ||| TO
detect  ||| S:44002 E:44009 ||| VB
the  ||| S:44009 E:44023 ||| DT
expressed  ||| S:44023 E:44033 ||| VBN
myc-tagged  ||| S:44033 E:44044 ||| JJ
Rab  ||| S:44044 E:44048 ||| JJ
proteins ||| S:44048 E:44056 ||| NNS
,  ||| S:44056 E:44058 ||| ,
cells  ||| S:44058 E:44064 ||| NNS
were  ||| S:44064 E:44069 ||| VBD
incubated  ||| S:44069 E:44089 ||| VBN
for  ||| S:44089 E:44093 ||| IN
60  ||| S:44093 E:44096 ||| CD
min  ||| S:44096 E:44100 ||| NN
with  ||| S:44100 E:44105 ||| IN
either  ||| S:44105 E:44112 ||| RB
the  ||| S:44112 E:44116 ||| DT
9E10  ||| S:44116 E:44121 ||| JJ
mouse  ||| S:44121 E:44127 ||| NN
monoclonal  ||| S:44127 E:44138 ||| NN
antibody  ||| S:44138 E:44157 ||| NN
against  ||| S:44157 E:44165 ||| IN
the  ||| S:44165 E:44169 ||| DT
myc  ||| S:44169 E:44173 ||| JJ
epitope  ||| S:44173 E:44181 ||| NN
or  ||| S:44181 E:44184 ||| CC
a  ||| S:44184 E:44186 ||| DT
rabbit  ||| S:44186 E:44193 ||| JJ
polyclonal  ||| S:44193 E:44204 ||| JJ
antibody  ||| S:44204 E:44223 ||| NN
against  ||| S:44223 E:44231 ||| IN
the  ||| S:44231 E:44235 ||| DT
same  ||| S:44235 E:44240 ||| JJ
epitope  ||| S:44240 E:44248 ||| NNS
( ||| S:44248 E:44249 ||| -LRB-
Upstate  ||| S:44249 E:44257 ||| NNP
Biotechnology ||| S:44257 E:44270 ||| NNP
,  ||| S:44270 E:44272 ||| ,
Lake  ||| S:44272 E:44287 ||| NNP
Placid ||| S:44287 E:44293 ||| NNP
,  ||| S:44293 E:44295 ||| ,
NY ||| S:44295 E:44297 ||| NNP
) ||| S:44297 E:44298 ||| -RRB-
.  ||| S:44298 E:44300 ||| .
In  ||| S:44300 E:44303 ||| IN
some  ||| S:44303 E:44308 ||| DT
experiments  ||| S:44308 E:44320 ||| JJ
nuclei  ||| S:44320 E:44327 ||| NN
were  ||| S:44327 E:44332 ||| VBD
visualized  ||| S:44332 E:44353 ||| VBN
by  ||| S:44353 E:44356 ||| IN
counter-staining  ||| S:44356 E:44373 ||| JJ
with  ||| S:44373 E:44378 ||| IN
4 ||| S:44378 E:44379 ||| CD
' ||| S:44379 E:44380 ||| POS
, ||| S:44380 E:44381 ||| ,
6 ||| S:44381 E:44382 ||| CD
' ||| S:44382 E:44383 ||| POS
-diamidino-2-phenylindole  ||| S:44383 E:44419 ||| NNP
( ||| S:44419 E:44420 ||| -LRB-
DAPI ||| S:44420 E:44424 ||| NNP
)  ||| S:44424 E:44426 ||| -RRB-
( ||| S:44426 E:44427 ||| -LRB-
2  ||| S:44427 E:44429 ||| CD
μg ||| S:44429 E:44431 ||| CD
/ ||| S:44431 E:44432 ||| CD
ml ||| S:44432 E:44434 ||| CD
)  ||| S:44434 E:44436 ||| -RRB-
( ||| S:44436 E:44437 ||| -LRB-
Molecular  ||| S:44437 E:44447 ||| NNP
Probes ||| S:44447 E:44453 ||| NNP
,  ||| S:44453 E:44455 ||| ,
Eugene ||| S:44455 E:44461 ||| NNP
,  ||| S:44461 E:44463 ||| ,
OR ||| S:44463 E:44465 ||| NNP
) ||| S:44465 E:44466 ||| -RRB-
.  ||| S:44466 E:44468 ||| .
Other  ||| S:44468 E:44484 ||| JJ
monoclonal  ||| S:44484 E:44495 ||| JJ
antibodies  ||| S:44495 E:44506 ||| NNS
used  ||| S:44506 E:44511 ||| VBN
in  ||| S:44511 E:44514 ||| IN
combination  ||| S:44514 E:44526 ||| NN
with  ||| S:44526 E:44531 ||| IN
the  ||| S:44531 E:44535 ||| DT
rabbit  ||| S:44535 E:44552 ||| JJ
anti-myc  ||| S:44552 E:44561 ||| JJ
antibody  ||| S:44561 E:44570 ||| NN
were ||| S:44570 E:44574 ||| VBD
:  ||| S:44574 E:44576 ||| :
anti-lamin  ||| S:44576 E:44587 ||| NNP
A  ||| S:44587 E:44589 ||| NNP
+  ||| S:44589 E:44591 ||| NNP
B  ||| S:44591 E:44593 ||| NNP
and  ||| S:44593 E:44607 ||| CC
anti-ubiquitin  ||| S:44607 E:44622 ||| NNP
( ||| S:44622 E:44623 ||| -LRB-
Zymed  ||| S:44623 E:44629 ||| NNP
Laboratories ||| S:44629 E:44641 ||| NNPS
,  ||| S:44641 E:44643 ||| ,
South  ||| S:44643 E:44649 ||| NNP
San  ||| S:44649 E:44653 ||| NNP
Francisco ||| S:44653 E:44662 ||| NNP
,  ||| S:44662 E:44674 ||| ,
CA ||| S:44674 E:44676 ||| NNP
) ||| S:44676 E:44677 ||| -RRB-
,  ||| S:44677 E:44679 ||| ,
anti-Hsp70  ||| S:44679 E:44690 ||| NNP
and  ||| S:44690 E:44694 ||| CC
anti-Hsp90  ||| S:44694 E:44705 ||| NNP
( ||| S:44705 E:44706 ||| -LRB-
Stressgen ||| S:44706 E:44715 ||| NNP
,  ||| S:44715 E:44717 ||| ,
Inc. ||| S:44717 E:44721 ||| NNP
,  ||| S:44721 E:44733 ||| ,
Victoria ||| S:44733 E:44741 ||| NNP
,  ||| S:44741 E:44743 ||| ,
BC ||| S:44743 E:44745 ||| NNP
,  ||| S:44745 E:44747 ||| ,
Canada ||| S:44747 E:44753 ||| NNP
) ||| S:44753 E:44754 ||| -RRB-
,  ||| S:44754 E:44756 ||| ,
anti-GFP  ||| S:44756 E:44765 ||| NNP
( ||| S:44765 E:44766 ||| -LRB-
Clontech ||| S:44766 E:44774 ||| NNP
,  ||| S:44774 E:44776 ||| ,
Inc ||| S:44776 E:44779 ||| NNP
.  ||| S:44779 E:44781 ||| .
Palo  ||| S:44781 E:44796 ||| NNP
Alto ||| S:44796 E:44800 ||| NNP
,  ||| S:44800 E:44802 ||| ,
CA ||| S:44802 E:44804 ||| NNP
) ||| S:44804 E:44805 ||| -RRB-
,  ||| S:44805 E:44807 ||| ,
anti-karyopherin  ||| S:44807 E:44824 ||| JJ
β  ||| S:44824 E:44826 ||| NN
and  ||| S:44826 E:44830 ||| CC
anti-Ran  ||| S:44830 E:44839 ||| JJ
binding  ||| S:44839 E:44857 ||| JJ
protein  ||| S:44857 E:44865 ||| NN
( ||| S:44865 E:44866 ||| -LRB-
Transduction  ||| S:44866 E:44879 ||| NNP
Laboratories ||| S:44879 E:44891 ||| NNPS
,  ||| S:44891 E:44893 ||| ,
Lexington ||| S:44893 E:44902 ||| NNP
,  ||| S:44902 E:44904 ||| ,
KY ||| S:44904 E:44906 ||| NNP
) ||| S:44906 E:44907 ||| -RRB-
.  ||| S:44907 E:44919 ||| .
Depending  ||| S:44919 E:44929 ||| VBG
on  ||| S:44929 E:44932 ||| IN
the  ||| S:44932 E:44936 ||| DT
combination  ||| S:44936 E:44948 ||| NN
of  ||| S:44948 E:44951 ||| IN
primary  ||| S:44951 E:44959 ||| JJ
antibodies ||| S:44959 E:44969 ||| NNS
,  ||| S:44969 E:44971 ||| ,
cells  ||| S:44971 E:44987 ||| NNS
were  ||| S:44987 E:44992 ||| VBD
incubated  ||| S:44992 E:45002 ||| VBN
for  ||| S:45002 E:45006 ||| IN
60  ||| S:45006 E:45009 ||| CD
min  ||| S:45009 E:45013 ||| NN
with  ||| S:45013 E:45018 ||| IN
goat  ||| S:45018 E:45023 ||| JJ
anti-mouse  ||| S:45023 E:45034 ||| NN
( ||| S:45034 E:45035 ||| -LRB-
GAM ||| S:45035 E:45038 ||| NNP
)  ||| S:45038 E:45040 ||| -RRB-
or  ||| S:45040 E:45053 ||| CC
goat  ||| S:45053 E:45058 ||| JJ
anti-rabbit  ||| S:45058 E:45070 ||| NN
( ||| S:45070 E:45071 ||| -LRB-
GAR ||| S:45071 E:45074 ||| NNP
)  ||| S:45074 E:45076 ||| -RRB-
IgG ||| S:45076 E:45079 ||| NNP
's  ||| S:45079 E:45082 ||| POS
conjugated  ||| S:45082 E:45093 ||| NN
with  ||| S:45093 E:45098 ||| IN
either  ||| S:45098 E:45105 ||| DT
FITC  ||| S:45105 E:45120 ||| NNP
or  ||| S:45120 E:45123 ||| CC
rhodamine  ||| S:45123 E:45133 ||| NNS
( ||| S:45133 E:45134 ||| -LRB-
Sigma  ||| S:45134 E:45140 ||| NNP
Chemical  ||| S:45140 E:45149 ||| NNP
Co. ||| S:45149 E:45152 ||| NNP
,  ||| S:45152 E:45154 ||| ,
Louis ||| S:45154 E:45159 ||| NNP
,  ||| S:45159 E:45161 ||| ,
MO ||| S:45161 E:45163 ||| NNP
) ||| S:45163 E:45164 ||| -RRB-
.  ||| S:45164 E:45176 ||| .
Photomicrographs  ||| S:45176 E:45193 ||| NNP
were  ||| S:45193 E:45198 ||| VBD
taken  ||| S:45198 E:45204 ||| VBN
with  ||| S:45204 E:45209 ||| IN
a  ||| S:45209 E:45211 ||| DT
Nikon  ||| S:45211 E:45217 ||| NNP
Eclipse  ||| S:45217 E:45225 ||| NNP
800  ||| S:45225 E:45239 ||| CD
fluorescence  ||| S:45239 E:45252 ||| NNS
microscope  ||| S:45252 E:45263 ||| VBP
equipped  ||| S:45263 E:45272 ||| VBN
with  ||| S:45272 E:45277 ||| IN
a  ||| S:45277 E:45279 ||| DT
digital  ||| S:45279 E:45287 ||| JJ
camera  ||| S:45287 E:45304 ||| NN
and  ||| S:45304 E:45308 ||| CC
ImagePro  ||| S:45308 E:45317 ||| JJ
software  ||| S:45317 E:45326 ||| NN
( ||| S:45326 E:45327 ||| -LRB-
Media  ||| S:45327 E:45333 ||| NNP
Cybernetics ||| S:45333 E:45344 ||| NNP
,  ||| S:45344 E:45346 ||| ,
Silver  ||| S:45346 E:45353 ||| NNP
Spring ||| S:45353 E:45359 ||| NNP
,  ||| S:45359 E:45371 ||| ,
MD ||| S:45371 E:45373 ||| NNP
) ||| S:45373 E:45374 ||| -RRB-
.  ||| S:45374 E:45376 ||| .
In  ||| S:45376 E:45379 ||| IN
some  ||| S:45379 E:45384 ||| DT
cases ||| S:45384 E:45389 ||| NNS
,  ||| S:45389 E:45391 ||| ,
gray  ||| S:45391 E:45396 ||| JJ
scale  ||| S:45396 E:45402 ||| NN
images  ||| S:45402 E:45409 ||| NNS
were  ||| S:45409 E:45414 ||| VBD
pseudo-colored  ||| S:45414 E:45439 ||| JJ
to  ||| S:45439 E:45442 ||| TO
correspond  ||| S:45442 E:45453 ||| VB
to  ||| S:45453 E:45456 ||| TO
the  ||| S:45456 E:45460 ||| DT
red  ||| S:45460 E:45464 ||| JJ
( ||| S:45464 E:45465 ||| -LRB-
Rhodamine ||| S:45465 E:45474 ||| NNP
) ||| S:45474 E:45475 ||| -RRB-
,  ||| S:45475 E:45477 ||| ,
green  ||| S:45477 E:45483 ||| JJ
( ||| S:45483 E:45484 ||| -LRB-
FITC ||| S:45484 E:45488 ||| NNP
)  ||| S:45488 E:45490 ||| -RRB-
or  ||| S:45490 E:45503 ||| CC
blue  ||| S:45503 E:45508 ||| JJ
( ||| S:45508 E:45509 ||| -LRB-
DAPI ||| S:45509 E:45513 ||| NNP
)  ||| S:45513 E:45515 ||| -RRB-
fluorescence ||| S:45515 E:45527 ||| NN
,  ||| S:45527 E:45529 ||| ,
and  ||| S:45529 E:45533 ||| CC
the  ||| S:45533 E:45537 ||| DT
digital  ||| S:45537 E:45545 ||| JJ
images  ||| S:45545 E:45552 ||| NNS
were  ||| S:45552 E:45567 ||| VBD
merged ||| S:45567 E:45573 ||| VBN
.  ||| S:45573 E:45603 ||| .
Nuclear  ||| S:45603 E:45611 ||| JJ
translocation  ||| S:45611 E:45625 ||| NN
of  ||| S:45625 E:45628 ||| IN
glucocorticoid  ||| S:45628 E:45653 ||| JJ
receptor  ||| S:45653 E:45672 ||| NN
The  ||| S:45672 E:45676 ||| DT
expression  ||| S:45676 E:45687 ||| FW
vector  ||| S:45687 E:45694 ||| FW
pK7-GR-GFP  ||| S:45694 E:45705 ||| FW
[  ||| S:45705 E:45707 ||| -LRB-
48  ||| S:45707 E:45710 ||| CD
]  ||| S:45710 E:45712 ||| -RRB-
,  ||| S:45712 E:45714 ||| ,
which  ||| S:45714 E:45730 ||| WDT
encodes  ||| S:45730 E:45738 ||| VBZ
a  ||| S:45738 E:45740 ||| DT
fusion  ||| S:45740 E:45747 ||| NN
of  ||| S:45747 E:45750 ||| IN
the  ||| S:45750 E:45754 ||| DT
glucocorticoid  ||| S:45754 E:45769 ||| JJ
receptor  ||| S:45769 E:45778 ||| NN
( ||| S:45778 E:45779 ||| -LRB-
GR ||| S:45779 E:45781 ||| NNP
)  ||| S:45781 E:45783 ||| -RRB-
with  ||| S:45783 E:45798 ||| IN
green  ||| S:45798 E:45804 ||| JJ
fluorescent  ||| S:45804 E:45816 ||| JJ
protein  ||| S:45816 E:45824 ||| NN
( ||| S:45824 E:45825 ||| -LRB-
GFP ||| S:45825 E:45828 ||| NNP
) ||| S:45828 E:45829 ||| -RRB-
,  ||| S:45829 E:45831 ||| ,
was  ||| S:45831 E:45835 ||| VBD
provided  ||| S:45835 E:45844 ||| VBN
by  ||| S:45844 E:45847 ||| IN
Dr.  ||| S:45847 E:45851 ||| NNP
Ian  ||| S:45851 E:45865 ||| NNP
Macara ||| S:45865 E:45871 ||| NNP
,  ||| S:45871 E:45873 ||| ,
University  ||| S:45873 E:45884 ||| NNP
of  ||| S:45884 E:45887 ||| IN
Virginia ||| S:45887 E:45895 ||| NNP
,  ||| S:45895 E:45897 ||| ,
Charlottesville ||| S:45897 E:45912 ||| NNP
,  ||| S:45912 E:45914 ||| ,
USA ||| S:45914 E:45917 ||| NNP
.  ||| S:45917 E:45919 ||| .
NIH  ||| S:45919 E:45933 ||| NNP
3T3  ||| S:45933 E:45937 ||| NNP
cells  ||| S:45937 E:45943 ||| NNS
were  ||| S:45943 E:45948 ||| VBD
seeded  ||| S:45948 E:45955 ||| VBN
on  ||| S:45955 E:45958 ||| IN
glass  ||| S:45958 E:45964 ||| NN
coverslips  ||| S:45964 E:45975 ||| NN
in  ||| S:45975 E:45978 ||| IN
DMEM  ||| S:45978 E:45993 ||| NNP
containing  ||| S:45993 E:46004 ||| VBG
10 ||| S:46004 E:46006 ||| CD
%  ||| S:46006 E:46008 ||| NN
charcoal-stripped  ||| S:46008 E:46026 ||| NNP
FCS ||| S:46026 E:46029 ||| NNP
,  ||| S:46029 E:46031 ||| ,
without  ||| S:46031 E:46039 ||| IN
phenol  ||| S:46039 E:46046 ||| JJ
red ||| S:46046 E:46049 ||| NN
.  ||| S:46049 E:46061 ||| .
Twenty  ||| S:46061 E:46068 ||| CD
four  ||| S:46068 E:46073 ||| CD
hours  ||| S:46073 E:46079 ||| NNS
after  ||| S:46079 E:46085 ||| IN
transfection ||| S:46085 E:46097 ||| NN
,  ||| S:46097 E:46099 ||| ,
the  ||| S:46099 E:46103 ||| DT
cells  ||| S:46103 E:46109 ||| NNS
were  ||| S:46109 E:46124 ||| VBD
changed  ||| S:46124 E:46132 ||| VBN
to  ||| S:46132 E:46135 ||| TO
fresh  ||| S:46135 E:46141 ||| JJ
medium  ||| S:46141 E:46148 ||| NN
with  ||| S:46148 E:46153 ||| IN
or  ||| S:46153 E:46156 ||| CC
without  ||| S:46156 E:46164 ||| IN
1  ||| S:46164 E:46166 ||| CD
μM  ||| S:46166 E:46179 ||| JJ
dexamethasone  ||| S:46179 E:46193 ||| NNS
( ||| S:46193 E:46194 ||| -LRB-
Dex ||| S:46194 E:46197 ||| NNP
) ||| S:46197 E:46198 ||| -RRB-
.  ||| S:46198 E:46200 ||| .
All  ||| S:46200 E:46204 ||| DT
cells  ||| S:46204 E:46210 ||| NNS
were  ||| S:46210 E:46215 ||| VBD
fixed  ||| S:46215 E:46221 ||| VBN
for  ||| S:46221 E:46235 ||| IN
immunofluorescence  ||| S:46235 E:46254 ||| CD
microscopy  ||| S:46254 E:46265 ||| CD
10  ||| S:46265 E:46268 ||| CD
min  ||| S:46268 E:46272 ||| NN
after  ||| S:46272 E:46278 ||| IN
addition  ||| S:46278 E:46287 ||| NN
of  ||| S:46287 E:46300 ||| IN
Dex ||| S:46300 E:46303 ||| NNP
.  ||| S:46303 E:46305 ||| .
The  ||| S:46305 E:46309 ||| DT
localization  ||| S:46309 E:46322 ||| NN
of  ||| S:46322 E:46325 ||| IN
GR-GFP  ||| S:46325 E:46332 ||| NNP
was  ||| S:46332 E:46336 ||| VBD
determined  ||| S:46336 E:46347 ||| VBN
in  ||| S:46347 E:46360 ||| IN
comparison  ||| S:46360 E:46371 ||| NN
to  ||| S:46371 E:46374 ||| TO
mycRab24 ||| S:46374 E:46382 ||| CD
,  ||| S:46382 E:46384 ||| ,
detected  ||| S:46384 E:46393 ||| VBN
with  ||| S:46393 E:46398 ||| IN
anti-myc  ||| S:46398 E:46407 ||| JJ
monoclonal  ||| S:46407 E:46428 ||| JJ
antibody  ||| S:46428 E:46437 ||| NN
and  ||| S:46437 E:46441 ||| CC
rhodamine-conjugated  ||| S:46441 E:46462 ||| JJ
GAM-IgG ||| S:46462 E:46469 ||| NN
,  ||| S:46469 E:46471 ||| ,
as  ||| S:46471 E:46474 ||| RB
described  ||| S:46474 E:46494 ||| VBN
above ||| S:46494 E:46499 ||| IN
.  ||| S:46499 E:46529 ||| .
Electron  ||| S:46529 E:46538 ||| NNP
microscopy  ||| S:46538 E:46559 ||| VBD
Transfected  ||| S:46559 E:46571 ||| JJ
cells  ||| S:46571 E:46577 ||| NNS
were  ||| S:46577 E:46582 ||| VBD
washed  ||| S:46582 E:46589 ||| VBN
twice  ||| S:46589 E:46595 ||| RB
with  ||| S:46595 E:46600 ||| IN
PBS  ||| S:46600 E:46604 ||| NNP
and  ||| S:46604 E:46618 ||| CC
scraped  ||| S:46618 E:46626 ||| NN
from  ||| S:46626 E:46631 ||| IN
the  ||| S:46631 E:46635 ||| DT
dish  ||| S:46635 E:46640 ||| NN
using  ||| S:46640 E:46646 ||| VBG
a  ||| S:46646 E:46648 ||| DT
rubber  ||| S:46648 E:46655 ||| NN
policeman ||| S:46655 E:46664 ||| NN
.  ||| S:46664 E:46666 ||| .
The  ||| S:46666 E:46680 ||| DT
resulting  ||| S:46680 E:46690 ||| JJ
cell  ||| S:46690 E:46695 ||| NN
suspensions  ||| S:46695 E:46707 ||| NNS
were  ||| S:46707 E:46712 ||| VBD
centrifuged  ||| S:46712 E:46724 ||| VBN
in  ||| S:46724 E:46727 ||| IN
Eppendorf  ||| S:46727 E:46747 ||| NNP
®tubes  ||| S:46747 E:46754 ||| NNP
and  ||| S:46754 E:46758 ||| CC
cell  ||| S:46758 E:46763 ||| NN
pellets  ||| S:46763 E:46771 ||| NNS
were  ||| S:46771 E:46776 ||| VBD
fixed  ||| S:46776 E:46782 ||| VBN
for  ||| S:46782 E:46786 ||| IN
5  ||| S:46786 E:46788 ||| CD
min  ||| S:46788 E:46792 ||| NN
at  ||| S:46792 E:46795 ||| IN
room  ||| S:46795 E:46810 ||| NN
temperature  ||| S:46810 E:46822 ||| NN
using  ||| S:46822 E:46828 ||| VBG
a  ||| S:46828 E:46830 ||| DT
1 ||| S:46830 E:46831 ||| CD
%  ||| S:46831 E:46833 ||| NN
glutaraldehyde  ||| S:46833 E:46848 ||| NN
in  ||| S:46848 E:46851 ||| IN
0.2M  ||| S:46851 E:46856 ||| CD
sodium  ||| S:46856 E:46873 ||| JJ
cacodylate ||| S:46873 E:46883 ||| NN
,  ||| S:46883 E:46885 ||| ,
pH  ||| S:46885 E:46888 ||| JJ
7.2 ||| S:46888 E:46891 ||| CD
.  ||| S:46891 E:46893 ||| .
Fixed  ||| S:46893 E:46899 ||| JJ
cell  ||| S:46899 E:46904 ||| NN
pellets  ||| S:46904 E:46912 ||| NNS
were  ||| S:46912 E:46917 ||| VBD
washed  ||| S:46917 E:46924 ||| VBN
twice  ||| S:46924 E:46940 ||| RB
with  ||| S:46940 E:46945 ||| IN
cacodylate  ||| S:46945 E:46956 ||| JJ
buffer  ||| S:46956 E:46963 ||| NN
and  ||| S:46963 E:46967 ||| CC
twice  ||| S:46967 E:46973 ||| RB
with  ||| S:46973 E:46978 ||| IN
0.5  ||| S:46978 E:46982 ||| CD
M  ||| S:46982 E:46984 ||| NNP
ammonium  ||| S:46984 E:47003 ||| NN
chloride ||| S:47003 E:47011 ||| NN
.  ||| S:47011 E:47013 ||| .
Each  ||| S:47013 E:47018 ||| DT
sample  ||| S:47018 E:47025 ||| NN
was  ||| S:47025 E:47029 ||| VBD
dehydrated  ||| S:47029 E:47040 ||| VBN
via  ||| S:47040 E:47044 ||| IN
a  ||| S:47044 E:47046 ||| DT
graded  ||| S:47046 E:47053 ||| JJ
series  ||| S:47053 E:47070 ||| NN
of  ||| S:47070 E:47073 ||| IN
chilled  ||| S:47073 E:47081 ||| JJ
ethanol  ||| S:47081 E:47089 ||| NN
solutions  ||| S:47089 E:47099 ||| NNS
and  ||| S:47099 E:47103 ||| CC
infiltrated  ||| S:47103 E:47115 ||| NNS
and  ||| S:47115 E:47119 ||| CC
embedded  ||| S:47119 E:47138 ||| VBN
in  ||| S:47138 E:47141 ||| IN
LR  ||| S:47141 E:47144 ||| NNP
White  ||| S:47144 E:47150 ||| NNP
®Embedding  ||| S:47150 E:47161 ||| NNP
media  ||| S:47161 E:47167 ||| NNS
( ||| S:47167 E:47168 ||| -LRB-
London  ||| S:47168 E:47175 ||| NNP
Resin  ||| S:47175 E:47181 ||| NNP
Co. ||| S:47181 E:47184 ||| NNP
,  ||| S:47184 E:47186 ||| ,
Ltd. ||| S:47186 E:47190 ||| NNP
,  ||| S:47190 E:47202 ||| ,
Berkshire ||| S:47202 E:47211 ||| NNP
,  ||| S:47211 E:47213 ||| ,
England ||| S:47213 E:47220 ||| NNP
) ||| S:47220 E:47221 ||| -RRB-
,  ||| S:47221 E:47223 ||| ,
also  ||| S:47223 E:47228 ||| RB
at  ||| S:47228 E:47231 ||| IN
2°C ||| S:47231 E:47234 ||| CD
.  ||| S:47234 E:47236 ||| .
Polymerized  ||| S:47236 E:47248 ||| JJ
cell  ||| S:47248 E:47253 ||| NN
blocks  ||| S:47253 E:47270 ||| NNS
were  ||| S:47270 E:47275 ||| VBD
ultra-thin  ||| S:47275 E:47286 ||| JJ
sectioned  ||| S:47286 E:47296 ||| NN
with  ||| S:47296 E:47301 ||| IN
a  ||| S:47301 E:47303 ||| DT
Reichert  ||| S:47303 E:47312 ||| NNP
Ultracut  ||| S:47312 E:47321 ||| NNP
S  ||| S:47321 E:47333 ||| NNP
ultramicrotome  ||| S:47333 E:47348 ||| NNS
( ||| S:47348 E:47349 ||| -LRB-
Leica  ||| S:47349 E:47355 ||| NNP
Microsystems ||| S:47355 E:47367 ||| NNPS
,  ||| S:47367 E:47369 ||| ,
Wien ||| S:47369 E:47373 ||| NNP
,  ||| S:47373 E:47375 ||| ,
Austria ||| S:47375 E:47382 ||| NNP
)  ||| S:47382 E:47384 ||| -RRB-
and  ||| S:47384 E:47398 ||| CC
sections  ||| S:47398 E:47407 ||| NNS
collected  ||| S:47407 E:47417 ||| VBN
on  ||| S:47417 E:47420 ||| IN
gold  ||| S:47420 E:47425 ||| JJ
200-mesh  ||| S:47425 E:47434 ||| FW
electron  ||| S:47434 E:47443 ||| FW
microscopy  ||| S:47443 E:47464 ||| FW
support  ||| S:47464 E:47472 ||| FW
grids ||| S:47472 E:47477 ||| FW
.  ||| S:47477 E:47479 ||| .
Sections  ||| S:47479 E:47488 ||| NNS
were  ||| S:47488 E:47493 ||| VBD
incubated  ||| S:47493 E:47503 ||| VBN
with  ||| S:47503 E:47508 ||| IN
PBS  ||| S:47508 E:47512 ||| NNP
for  ||| S:47512 E:47516 ||| IN
5  ||| S:47516 E:47528 ||| CD
min ||| S:47528 E:47531 ||| NN
,  ||| S:47531 E:47533 ||| ,
then  ||| S:47533 E:47538 ||| RB
blocked  ||| S:47538 E:47546 ||| VBN
in  ||| S:47546 E:47549 ||| IN
a  ||| S:47549 E:47551 ||| DT
solution  ||| S:47551 E:47560 ||| NN
of  ||| S:47560 E:47563 ||| IN
10 ||| S:47563 E:47565 ||| CD
%  ||| S:47565 E:47567 ||| NN
fish  ||| S:47567 E:47572 ||| NN
gelatin  ||| S:47572 E:47580 ||| NN
in  ||| S:47580 E:47593 ||| IN
PBS  ||| S:47593 E:47597 ||| NNP
for  ||| S:47597 E:47601 ||| IN
15  ||| S:47601 E:47604 ||| CD
minutes ||| S:47604 E:47611 ||| NNS
.  ||| S:47611 E:47613 ||| .
Reaction  ||| S:47613 E:47622 ||| NN
with  ||| S:47622 E:47627 ||| IN
the  ||| S:47627 E:47631 ||| DT
9E10  ||| S:47631 E:47636 ||| JJ
mouse  ||| S:47636 E:47642 ||| NN
anti-myc  ||| S:47642 E:47661 ||| JJ
antibody  ||| S:47661 E:47670 ||| NN
( ||| S:47670 E:47671 ||| -LRB-
1 ||| S:47671 E:47672 ||| LS
: ||| S:47672 E:47673 ||| :
100  ||| S:47673 E:47677 ||| CD
dilution  ||| S:47677 E:47686 ||| NN
in  ||| S:47686 E:47689 ||| IN
PBS ||| S:47689 E:47692 ||| NNP
)  ||| S:47692 E:47694 ||| -RRB-
was  ||| S:47694 E:47698 ||| VBD
carried  ||| S:47698 E:47706 ||| VBN
out  ||| S:47706 E:47710 ||| RP
for  ||| S:47710 E:47714 ||| IN
2  ||| S:47714 E:47716 ||| CD
h ||| S:47716 E:47717 ||| NN
,  ||| S:47717 E:47729 ||| ,
followed  ||| S:47729 E:47738 ||| VBN
by  ||| S:47738 E:47741 ||| IN
6  ||| S:47741 E:47743 ||| CD
washes  ||| S:47743 E:47750 ||| NN
with  ||| S:47750 E:47755 ||| IN
PBS ||| S:47755 E:47758 ||| NNP
.  ||| S:47758 E:47760 ||| .
Sections  ||| S:47760 E:47769 ||| NNS
were  ||| S:47769 E:47774 ||| VBD
then  ||| S:47774 E:47789 ||| RB
incubated  ||| S:47789 E:47799 ||| VBN
for  ||| S:47799 E:47803 ||| IN
1  ||| S:47803 E:47805 ||| CD
h  ||| S:47805 E:47807 ||| NN
with  ||| S:47807 E:47812 ||| IN
GAM  ||| S:47812 E:47816 ||| NNP
IgG  ||| S:47816 E:47820 ||| JJ
conjugated  ||| S:47820 E:47831 ||| NN
with  ||| S:47831 E:47836 ||| IN
10  ||| S:47836 E:47839 ||| CD
nm  ||| S:47839 E:47852 ||| CD
colloidal  ||| S:47852 E:47862 ||| JJ
gold  ||| S:47862 E:47867 ||| NN
( ||| S:47867 E:47868 ||| -LRB-
Ted  ||| S:47868 E:47872 ||| NNP
Pella ||| S:47872 E:47877 ||| NNP
,  ||| S:47877 E:47879 ||| ,
Inc. ||| S:47879 E:47883 ||| NNP
,  ||| S:47883 E:47885 ||| ,
Redding ||| S:47885 E:47892 ||| NNP
,  ||| S:47892 E:47894 ||| ,
CA ||| S:47894 E:47896 ||| NNP
) ||| S:47896 E:47897 ||| -RRB-
,  ||| S:47897 E:47899 ||| ,
followed  ||| S:47899 E:47918 ||| VBN
by  ||| S:47918 E:47921 ||| IN
3  ||| S:47921 E:47923 ||| CD
changes  ||| S:47923 E:47931 ||| NNS
of  ||| S:47931 E:47934 ||| IN
PBS ||| S:47934 E:47937 ||| NNP
.  ||| S:47937 E:47939 ||| .
The  ||| S:47939 E:47943 ||| DT
samples  ||| S:47943 E:47951 ||| NNS
were  ||| S:47951 E:47956 ||| VBD
post-fixed  ||| S:47956 E:47967 ||| JJ
with  ||| S:47967 E:47972 ||| IN
1 ||| S:47972 E:47973 ||| CD
%  ||| S:47973 E:47985 ||| NN
glutaraldehyde  ||| S:47985 E:48000 ||| NNS
and  ||| S:48000 E:48004 ||| CC
stained  ||| S:48004 E:48012 ||| NN
with  ||| S:48012 E:48017 ||| IN
uranyl  ||| S:48017 E:48024 ||| JJ
acetate  ||| S:48024 E:48032 ||| NN
and  ||| S:48032 E:48036 ||| CC
lead  ||| S:48036 E:48051 ||| JJ
citrate ||| S:48051 E:48058 ||| NN
.  ||| S:48058 E:48060 ||| .
They  ||| S:48060 E:48065 ||| PRP
were  ||| S:48065 E:48070 ||| VBD
then  ||| S:48070 E:48075 ||| RB
blot-dried  ||| S:48075 E:48086 ||| JJ
and  ||| S:48086 E:48090 ||| CC
examined  ||| S:48090 E:48099 ||| VBN
with  ||| S:48099 E:48104 ||| IN
a  ||| S:48104 E:48116 ||| DT
Philips  ||| S:48116 E:48124 ||| NNP
CM  ||| S:48124 E:48127 ||| NNP
10  ||| S:48127 E:48130 ||| CD
transmission  ||| S:48130 E:48143 ||| NN
electron  ||| S:48143 E:48152 ||| NN
microscope  ||| S:48152 E:48163 ||| NN
for  ||| S:48163 E:48177 ||| IN
localization  ||| S:48177 E:48190 ||| NN
of  ||| S:48190 E:48193 ||| IN
the  ||| S:48193 E:48197 ||| DT
colloidal  ||| S:48197 E:48207 ||| JJ
gold  ||| S:48207 E:48212 ||| NN
probe ||| S:48212 E:48217 ||| NN
.  ||| S:48217 E:48247 ||| .
Solubilization  ||| S:48247 E:48262 ||| NNP
of  ||| S:48262 E:48265 ||| IN
Rab24 ||| S:48265 E:48270 ||| NNP
( ||| S:48270 E:48271 ||| -LRB-
D123I ||| S:48271 E:48276 ||| NNP
)  ||| S:48276 E:48278 ||| -RRB-
from  ||| S:48278 E:48283 ||| IN
inclusions  ||| S:48283 E:48294 ||| NN
and  ||| S:48294 E:48308 ||| CC
assay  ||| S:48308 E:48314 ||| NN
for  ||| S:48314 E:48318 ||| IN
ubiquitination  ||| S:48318 E:48343 ||| VBG
The  ||| S:48343 E:48347 ||| DT
cDNAs  ||| S:48347 E:48353 ||| JJ
encoding  ||| S:48353 E:48362 ||| JJ
Rab24 ||| S:48362 E:48367 ||| NNP
( ||| S:48367 E:48368 ||| -LRB-
wt ||| S:48368 E:48370 ||| LS
)  ||| S:48370 E:48372 ||| -RRB-
and  ||| S:48372 E:48376 ||| CC
Rab24 ||| S:48376 E:48381 ||| NNP
( ||| S:48381 E:48382 ||| -LRB-
D123I ||| S:48382 E:48387 ||| NNP
)  ||| S:48387 E:48389 ||| -RRB-
were  ||| S:48389 E:48404 ||| VBD
subcloned  ||| S:48404 E:48414 ||| VBN
into  ||| S:48414 E:48419 ||| IN
a  ||| S:48419 E:48421 ||| DT
pCMV5  ||| S:48421 E:48427 ||| JJ
vector  ||| S:48427 E:48434 ||| NN
that  ||| S:48434 E:48439 ||| WDT
had  ||| S:48439 E:48443 ||| VBD
been  ||| S:48443 E:48448 ||| VBN
modified  ||| S:48448 E:48457 ||| VBN
by  ||| S:48457 E:48470 ||| IN
PCR  ||| S:48470 E:48474 ||| NNP
to  ||| S:48474 E:48477 ||| TO
encode  ||| S:48477 E:48484 ||| VB
an  ||| S:48484 E:48487 ||| DT
in-frame  ||| S:48487 E:48496 ||| JJ
polyhistidine  ||| S:48496 E:48510 ||| JJ
tag  ||| S:48510 E:48514 ||| NN
( ||| S:48514 E:48515 ||| -LRB-
His  ||| S:48515 E:48530 ||| PRP$
6  ||| S:48530 E:48532 ||| CD
)  ||| S:48532 E:48534 ||| -RRB-
at  ||| S:48534 E:48537 ||| IN
the  ||| S:48537 E:48541 ||| DT
amino-terminus  ||| S:48541 E:48556 ||| JJ
of  ||| S:48556 E:48559 ||| IN
the  ||| S:48559 E:48563 ||| DT
Rab  ||| S:48563 E:48577 ||| JJ
protein ||| S:48577 E:48584 ||| NN
.  ||| S:48584 E:48586 ||| .
HEK  ||| S:48586 E:48590 ||| NNP
293  ||| S:48590 E:48594 ||| CD
cells  ||| S:48594 E:48600 ||| NNS
grown  ||| S:48600 E:48606 ||| VBN
in  ||| S:48606 E:48609 ||| IN
10  ||| S:48609 E:48612 ||| CD
cm  ||| S:48612 E:48615 ||| CD
diameter  ||| S:48615 E:48624 ||| CD
dishes  ||| S:48624 E:48641 ||| NNS
were  ||| S:48641 E:48646 ||| VBD
transfected  ||| S:48646 E:48658 ||| VBN
with  ||| S:48658 E:48663 ||| IN
either  ||| S:48663 E:48670 ||| DT
pCMV5-  ||| S:48670 E:48688 ||| NNP
His  ||| S:48688 E:48703 ||| NNP
6  ||| S:48703 E:48716 ||| CD
Rab24  ||| S:48716 E:48722 ||| CD
or  ||| S:48722 E:48725 ||| CC
pCMV5-  ||| S:48725 E:48743 ||| VBZ
His  ||| S:48743 E:48758 ||| PRP$
6  ||| S:48758 E:48771 ||| CD
Rab24 ||| S:48771 E:48776 ||| CD
( ||| S:48776 E:48777 ||| -LRB-
D123I ||| S:48777 E:48782 ||| NNP
)  ||| S:48782 E:48784 ||| -RRB-
as  ||| S:48784 E:48787 ||| RB
described  ||| S:48787 E:48797 ||| VBD
earlier.  ||| S:48797 E:48816 ||| CD
20  ||| S:48816 E:48819 ||| CD
μM  ||| S:48819 E:48822 ||| JJ
lactacystin  ||| S:48822 E:48834 ||| NNS
( ||| S:48834 E:48835 ||| -LRB-
Sigma ||| S:48835 E:48840 ||| NNP
,  ||| S:48840 E:48842 ||| ,
St.  ||| S:48842 E:48846 ||| NNP
Louis ||| S:48846 E:48851 ||| NNP
,  ||| S:48851 E:48853 ||| ,
MO ||| S:48853 E:48855 ||| NNP
)  ||| S:48855 E:48857 ||| -RRB-
was  ||| S:48857 E:48861 ||| VBD
added  ||| S:48861 E:48867 ||| VBN
to  ||| S:48867 E:48870 ||| TO
the  ||| S:48870 E:48884 ||| DT
medium  ||| S:48884 E:48891 ||| NN
18  ||| S:48891 E:48894 ||| CD
h  ||| S:48894 E:48896 ||| NN
after  ||| S:48896 E:48902 ||| IN
transfection  ||| S:48902 E:48915 ||| NN
and  ||| S:48915 E:48919 ||| CC
cells  ||| S:48919 E:48925 ||| NNS
were  ||| S:48925 E:48930 ||| VBD
incubated  ||| S:48930 E:48950 ||| VBN
with  ||| S:48950 E:48955 ||| IN
the  ||| S:48955 E:48959 ||| DT
proteasome  ||| S:48959 E:48970 ||| JJ
inhibitor  ||| S:48970 E:48980 ||| NN
for  ||| S:48980 E:48984 ||| IN
4  ||| S:48984 E:48986 ||| CD
h  ||| S:48986 E:48988 ||| NNS
prior  ||| S:48988 E:48994 ||| RB
to  ||| S:48994 E:48997 ||| TO
harvest ||| S:48997 E:49004 ||| NN
.  ||| S:49004 E:49016 ||| .
Cells  ||| S:49016 E:49022 ||| NNS
were  ||| S:49022 E:49027 ||| VBD
scraped  ||| S:49027 E:49035 ||| VBN
from  ||| S:49035 E:49040 ||| IN
the  ||| S:49040 E:49044 ||| DT
dish ||| S:49044 E:49048 ||| NN
,  ||| S:49048 E:49050 ||| ,
collected  ||| S:49050 E:49060 ||| VBN
by  ||| S:49060 E:49073 ||| IN
centrifugation ||| S:49073 E:49087 ||| NN
,  ||| S:49087 E:49089 ||| ,
and  ||| S:49089 E:49093 ||| CC
homogenized  ||| S:49093 E:49105 ||| NN
in  ||| S:49105 E:49108 ||| IN
0.25  ||| S:49108 E:49113 ||| CD
ml  ||| S:49113 E:49116 ||| JJ
Buffer  ||| S:49116 E:49123 ||| NNP
A ||| S:49123 E:49124 ||| NNP
:  ||| S:49124 E:49126 ||| :
0.15  ||| S:49126 E:49141 ||| CD
M  ||| S:49141 E:49143 ||| NNP
NaCl ||| S:49143 E:49147 ||| NNP
,  ||| S:49147 E:49149 ||| ,
20  ||| S:49149 E:49152 ||| CD
mM  ||| S:49152 E:49155 ||| JJ
MgCl  ||| S:49155 E:49171 ||| JJ
2  ||| S:49171 E:49173 ||| CD
,  ||| S:49173 E:49175 ||| ,
0.05 ||| S:49175 E:49179 ||| CD
%  ||| S:49179 E:49181 ||| NN
( ||| S:49181 E:49182 ||| -LRB-
w ||| S:49182 E:49183 ||| FW
/ ||| S:49183 E:49184 ||| FW
v ||| S:49184 E:49185 ||| FW
)  ||| S:49185 E:49187 ||| -RRB-
SDS ||| S:49187 E:49190 ||| NNP
,  ||| S:49190 E:49192 ||| ,
20  ||| S:49192 E:49195 ||| CD
mM  ||| S:49195 E:49198 ||| JJ
HEPES ||| S:49198 E:49203 ||| NNP
,  ||| S:49203 E:49205 ||| ,
pH  ||| S:49205 E:49218 ||| JJ
7.4 ||| S:49218 E:49221 ||| CD
,  ||| S:49221 E:49223 ||| ,
supplemented  ||| S:49223 E:49236 ||| VBG
with  ||| S:49236 E:49241 ||| IN
protease  ||| S:49241 E:49250 ||| JJ
inhibitor  ||| S:49250 E:49260 ||| JJ
cocktail ||| S:49260 E:49268 ||| NN
.  ||| S:49268 E:49270 ||| .
The  ||| S:49270 E:49284 ||| DT
cell  ||| S:49284 E:49289 ||| NN
lysate  ||| S:49289 E:49296 ||| NNS
was  ||| S:49296 E:49300 ||| VBD
mixed  ||| S:49300 E:49306 ||| VBN
with  ||| S:49306 E:49311 ||| IN
0.25  ||| S:49311 E:49316 ||| CD
ml  ||| S:49316 E:49319 ||| NN
of  ||| S:49319 E:49322 ||| IN
Buffer  ||| S:49322 E:49329 ||| NNP
B  ||| S:49329 E:49331 ||| NNP
( ||| S:49331 E:49332 ||| -LRB-
Buffer  ||| S:49332 E:49339 ||| NNP
A  ||| S:49339 E:49351 ||| NNP
containing  ||| S:49351 E:49362 ||| VBG
1 ||| S:49362 E:49363 ||| CD
%  ||| S:49363 E:49365 ||| NN
NP-40  ||| S:49365 E:49371 ||| NN
and  ||| S:49371 E:49375 ||| CC
1 ||| S:49375 E:49376 ||| CD
%  ||| S:49376 E:49378 ||| NN
deoxycholate ||| S:49378 E:49390 ||| NN
)  ||| S:49390 E:49392 ||| -RRB-
and  ||| S:49392 E:49396 ||| CC
the  ||| S:49396 E:49410 ||| DT
insoluble  ||| S:49410 E:49420 ||| JJ
material  ||| S:49420 E:49429 ||| NN
was  ||| S:49429 E:49433 ||| VBD
removed  ||| S:49433 E:49441 ||| VBN
by  ||| S:49441 E:49444 ||| IN
centrifugation  ||| S:49444 E:49459 ||| NN
at  ||| S:49459 E:49472 ||| IN
100,000  ||| S:49472 E:49480 ||| CD
×  ||| S:49480 E:49482 ||| CD
g  ||| S:49482 E:49484 ||| NN
for  ||| S:49484 E:49488 ||| IN
30  ||| S:49488 E:49491 ||| CD
min ||| S:49491 E:49494 ||| NNS
.  ||| S:49494 E:49496 ||| .
The  ||| S:49496 E:49500 ||| DT
supernatant  ||| S:49500 E:49512 ||| JJ
fraction  ||| S:49512 E:49521 ||| NN
was  ||| S:49521 E:49535 ||| VBD
diluted  ||| S:49535 E:49543 ||| VBN
1 ||| S:49543 E:49544 ||| CD
: ||| S:49544 E:49545 ||| :
1  ||| S:49545 E:49547 ||| CD
with  ||| S:49547 E:49552 ||| IN
Buffer  ||| S:49552 E:49559 ||| NNP
C  ||| S:49559 E:49561 ||| NNP
( ||| S:49561 E:49562 ||| -LRB-
Buffer  ||| S:49562 E:49569 ||| NNP
A  ||| S:49569 E:49571 ||| NNP
containing  ||| S:49571 E:49582 ||| VBG
0.5 ||| S:49582 E:49585 ||| CD
%  ||| S:49585 E:49587 ||| NN
NP-40  ||| S:49587 E:49603 ||| NN
and  ||| S:49603 E:49607 ||| CC
0.5 ||| S:49607 E:49610 ||| CD
%  ||| S:49610 E:49612 ||| NN
deoxycholate ||| S:49612 E:49624 ||| NN
,  ||| S:49624 E:49626 ||| ,
with  ||| S:49626 E:49631 ||| IN
no  ||| S:49631 E:49634 ||| DT
SDS ||| S:49634 E:49637 ||| NNP
)  ||| S:49637 E:49639 ||| -RRB-
and  ||| S:49639 E:49643 ||| CC
loaded  ||| S:49643 E:49650 ||| VBN
on  ||| S:49650 E:49653 ||| RP
to  ||| S:49653 E:49656 ||| TO
a  ||| S:49656 E:49668 ||| DT
Ni-NTA  ||| S:49668 E:49675 ||| JJ
spin  ||| S:49675 E:49680 ||| NN
column  ||| S:49680 E:49687 ||| NN
( ||| S:49687 E:49688 ||| -LRB-
Qiagen ||| S:49688 E:49694 ||| NNP
) ||| S:49694 E:49695 ||| -RRB-
.  ||| S:49695 E:49697 ||| .
The  ||| S:49697 E:49701 ||| DT
column  ||| S:49701 E:49708 ||| NN
was  ||| S:49708 E:49712 ||| VBD
washed  ||| S:49712 E:49719 ||| VBN
with  ||| S:49719 E:49734 ||| IN
Buffer  ||| S:49734 E:49741 ||| NNP
D  ||| S:49741 E:49743 ||| NNP
( ||| S:49743 E:49744 ||| -LRB-
0.15  ||| S:49744 E:49749 ||| NNP
M  ||| S:49749 E:49751 ||| NNP
NaCl ||| S:49751 E:49755 ||| NNP
,  ||| S:49755 E:49757 ||| ,
20  ||| S:49757 E:49760 ||| CD
mM  ||| S:49760 E:49763 ||| JJ
MgCl  ||| S:49763 E:49779 ||| JJ
2  ||| S:49779 E:49781 ||| CD
,  ||| S:49781 E:49783 ||| ,
0.025 ||| S:49783 E:49788 ||| CD
%  ||| S:49788 E:49790 ||| NN
SDS ||| S:49790 E:49793 ||| NNP
,  ||| S:49793 E:49795 ||| ,
0.5 ||| S:49795 E:49798 ||| CD
%  ||| S:49798 E:49800 ||| NN
deoxycholate ||| S:49800 E:49812 ||| NN
,  ||| S:49812 E:49824 ||| ,
0.5 ||| S:49824 E:49827 ||| CD
%  ||| S:49827 E:49829 ||| NN
NP-40 ||| S:49829 E:49834 ||| NN
,  ||| S:49834 E:49836 ||| ,
20  ||| S:49836 E:49839 ||| CD
mM  ||| S:49839 E:49842 ||| JJ
HEPES ||| S:49842 E:49847 ||| NNP
,  ||| S:49847 E:49849 ||| ,
pH  ||| S:49849 E:49852 ||| JJ
7.4 ||| S:49852 E:49855 ||| CD
)  ||| S:49855 E:49857 ||| -RRB-
and  ||| S:49857 E:49861 ||| CC
the  ||| S:49861 E:49865 ||| DT
His  ||| S:49865 E:49880 ||| PRP$
6  ||| S:49880 E:49882 ||| CD
-tagged  ||| S:49882 E:49890 ||| JJ
protein  ||| S:49890 E:49898 ||| NN
was  ||| S:49898 E:49902 ||| VBD
eluted  ||| S:49902 E:49909 ||| VBN
with  ||| S:49909 E:49924 ||| IN
Buffer  ||| S:49924 E:49931 ||| NNP
D  ||| S:49931 E:49933 ||| NNP
containing  ||| S:49933 E:49944 ||| VBG
0.25  ||| S:49944 E:49949 ||| CD
M  ||| S:49949 E:49951 ||| NNP
imidazole ||| S:49951 E:49960 ||| NN
.  ||| S:49960 E:49962 ||| .
Samples  ||| S:49962 E:49970 ||| NNS
of  ||| S:49970 E:49973 ||| IN
the  ||| S:49973 E:49987 ||| DT
eluted  ||| S:49987 E:49994 ||| JJ
protein  ||| S:49994 E:50002 ||| NN
were  ||| S:50002 E:50007 ||| VBD
subjected  ||| S:50007 E:50017 ||| VBN
to  ||| S:50017 E:50020 ||| TO
SDS-PAGE  ||| S:50020 E:50029 ||| JJ
and  ||| S:50029 E:50033 ||| CC
immunoblot  ||| S:50033 E:50054 ||| JJ
analysis  ||| S:50054 E:50063 ||| NN
as  ||| S:50063 E:50066 ||| IN
described  ||| S:50066 E:50076 ||| VBN
previously ||| S:50076 E:50086 ||| RB
,  ||| S:50086 E:50088 ||| ,
using  ||| S:50088 E:50094 ||| VBG
a  ||| S:50094 E:50096 ||| DT
polyclonal  ||| S:50096 E:50117 ||| JJ
antibody  ||| S:50117 E:50126 ||| NN
against  ||| S:50126 E:50134 ||| IN
Rab24  ||| S:50134 E:50140 ||| NNP
[  ||| S:50140 E:50142 ||| -LRB-
25  ||| S:50142 E:50145 ||| CD
]  ||| S:50145 E:50147 ||| -RRB-
,  ||| S:50147 E:50149 ||| ,
or  ||| S:50149 E:50152 ||| CC
monoclonal  ||| S:50152 E:50163 ||| JJ
antibodies  ||| S:50163 E:50184 ||| NNS
against  ||| S:50184 E:50192 ||| IN
the  ||| S:50192 E:50196 ||| DT
His  ||| S:50196 E:50211 ||| PRP$
6  ||| S:50211 E:50213 ||| CD
-tag  ||| S:50213 E:50218 ||| NNS
( ||| S:50218 E:50219 ||| -LRB-
Sigma ||| S:50219 E:50224 ||| NNP
)  ||| S:50224 E:50226 ||| -RRB-
or  ||| S:50226 E:50229 ||| CC
ubiquitin  ||| S:50229 E:50239 ||| NNS
( ||| S:50239 E:50240 ||| -LRB-
Zymed  ||| S:50240 E:50256 ||| NNP
Laboratories ||| S:50256 E:50268 ||| NNPS
) ||| S:50268 E:50269 ||| -RRB-
.  ||| S:50269 E:50299 ||| .
Cell  ||| S:50299 E:50304 ||| NN
death  ||| S:50304 E:50310 ||| NN
assay  ||| S:50310 E:50326 ||| VBD
Cells  ||| S:50326 E:50332 ||| NNP
were  ||| S:50332 E:50337 ||| VBD
transfected  ||| S:50337 E:50349 ||| VBN
with  ||| S:50349 E:50354 ||| IN
pCMV5  ||| S:50354 E:50360 ||| FW
expression  ||| S:50360 E:50371 ||| FW
vectors  ||| S:50371 E:50389 ||| FW
encoding  ||| S:50389 E:50398 ||| FW
mycRab24 ||| S:50398 E:50406 ||| FW
( ||| S:50406 E:50407 ||| -LRB-
D123I ||| S:50407 E:50412 ||| NNP
)  ||| S:50412 E:50414 ||| -RRB-
as  ||| S:50414 E:50417 ||| RB
described  ||| S:50417 E:50427 ||| VBN
earlier ||| S:50427 E:50434 ||| RBR
.  ||| S:50434 E:50436 ||| .
DNA  ||| S:50436 E:50450 ||| NNP
fragmentation  ||| S:50450 E:50464 ||| NN
was  ||| S:50464 E:50468 ||| VBD
detected  ||| S:50468 E:50477 ||| VBN
by  ||| S:50477 E:50480 ||| IN
terminal  ||| S:50480 E:50489 ||| FW
deoxynucleotidyl  ||| S:50489 E:50516 ||| FW
transferase-mediated  ||| S:50516 E:50537 ||| FW
dUTP  ||| S:50537 E:50542 ||| FW
nick  ||| S:50542 E:50547 ||| FW
end  ||| S:50547 E:50551 ||| FW
labeling  ||| S:50551 E:50560 ||| FW
( ||| S:50560 E:50561 ||| -LRB-
TUNEL ||| S:50561 E:50566 ||| NNP
)  ||| S:50566 E:50578 ||| -RRB-
assay ||| S:50578 E:50583 ||| NN
,  ||| S:50583 E:50585 ||| ,
using  ||| S:50585 E:50591 ||| VBG
fluorescein-12-dUTP ||| S:50591 E:50610 ||| NNP
,  ||| S:50610 E:50612 ||| ,
according  ||| S:50612 E:50622 ||| VBG
to  ||| S:50622 E:50625 ||| TO
the  ||| S:50625 E:50639 ||| DT
instructions  ||| S:50639 E:50652 ||| NNS
supplied  ||| S:50652 E:50661 ||| VBN
by  ||| S:50661 E:50664 ||| IN
the  ||| S:50664 E:50668 ||| DT
manufacturer  ||| S:50668 E:50681 ||| NN
( ||| S:50681 E:50682 ||| -LRB-
Promega  ||| S:50682 E:50690 ||| NNP
Corp. ||| S:50690 E:50695 ||| NNP
,  ||| S:50695 E:50707 ||| ,
Madison ||| S:50707 E:50714 ||| NNP
,  ||| S:50714 E:50716 ||| ,
WI ||| S:50716 E:50718 ||| NNP
) ||| S:50718 E:50719 ||| -RRB-
.  ||| S:50719 E:50721 ||| .
Following  ||| S:50721 E:50731 ||| VBG
the  ||| S:50731 E:50735 ||| DT
TUNEL  ||| S:50735 E:50741 ||| NNP
reaction ||| S:50741 E:50749 ||| NN
,  ||| S:50749 E:50751 ||| ,
the  ||| S:50751 E:50755 ||| DT
cells  ||| S:50755 E:50771 ||| NNS
were  ||| S:50771 E:50776 ||| VBD
incubated  ||| S:50776 E:50786 ||| VBN
with  ||| S:50786 E:50791 ||| IN
monoclonal  ||| S:50791 E:50802 ||| JJ
anti-myc  ||| S:50802 E:50811 ||| JJ
antibody  ||| S:50811 E:50820 ||| NN
and  ||| S:50820 E:50834 ||| CC
Rhodamine-conjugated  ||| S:50834 E:50855 ||| NNP
GAM  ||| S:50855 E:50859 ||| NNP
IgG  ||| S:50859 E:50863 ||| NNP
to  ||| S:50863 E:50866 ||| TO
detect  ||| S:50866 E:50873 ||| VB
the  ||| S:50873 E:50877 ||| DT
expressed  ||| S:50877 E:50887 ||| VBN
Rab  ||| S:50887 E:50901 ||| JJ
protein ||| S:50901 E:50908 ||| NN
.  ||| S:50908 E:50910 ||| .
Fluorescence  ||| S:50910 E:50923 ||| JJ
microscopy  ||| S:50923 E:50934 ||| NN
was  ||| S:50934 E:50938 ||| VBD
used  ||| S:50938 E:50943 ||| VBN
to  ||| S:50943 E:50946 ||| TO
determine  ||| S:50946 E:50966 ||| VB
the  ||| S:50966 E:50970 ||| DT
number  ||| S:50970 E:50977 ||| NN
of  ||| S:50977 E:50980 ||| IN
transfected  ||| S:50980 E:50992 ||| JJ
cells  ||| S:50992 E:50998 ||| NNS
that  ||| S:50998 E:51003 ||| WDT
were  ||| S:51003 E:51008 ||| VBD
TUNEL-positive ||| S:51008 E:51022 ||| JJ
,  ||| S:51022 E:51034 ||| ,
compared  ||| S:51034 E:51043 ||| VBN
to  ||| S:51043 E:51046 ||| TO
non-transfected  ||| S:51046 E:51062 ||| JJ
cells  ||| S:51062 E:51068 ||| NNS
in  ||| S:51068 E:51071 ||| IN
the  ||| S:51071 E:51075 ||| DT
same  ||| S:51075 E:51080 ||| JJ
culture ||| S:51080 E:51087 ||| NN
.  ||| S:51087 E:51089 ||| .
As  ||| S:51089 E:51102 ||| IN
a  ||| S:51102 E:51104 ||| DT
positive  ||| S:51104 E:51113 ||| JJ
control  ||| S:51113 E:51121 ||| NN
for  ||| S:51121 E:51125 ||| IN
apoptosis ||| S:51125 E:51134 ||| NN
,  ||| S:51134 E:51136 ||| ,
parallel  ||| S:51136 E:51145 ||| JJ
cultures  ||| S:51145 E:51154 ||| NNS
were  ||| S:51154 E:51169 ||| VBD
treated  ||| S:51169 E:51177 ||| VBN
for  ||| S:51177 E:51181 ||| IN
24  ||| S:51181 E:51184 ||| CD
h  ||| S:51184 E:51186 ||| NN
with  ||| S:51186 E:51191 ||| IN
1  ||| S:51191 E:51193 ||| CD
μM  ||| S:51193 E:51196 ||| JJ
staurosporine ||| S:51196 E:51209 ||| NN
.  ||| S:51209 E:51242 ||| .
Authors ||| S:51242 E:51249 ||| NNP
'  ||| S:51249 E:51251 ||| POS
contributions  ||| S:51251 E:51273 ||| NNS
W.A.M.  ||| S:51273 E:51280 ||| VBP
drafted  ||| S:51280 E:51288 ||| VBN
the  ||| S:51288 E:51292 ||| DT
manuscript  ||| S:51292 E:51303 ||| NN
and  ||| S:51303 E:51307 ||| CC
supervised  ||| S:51307 E:51318 ||| VBD
the  ||| S:51318 E:51330 ||| DT
studies ||| S:51330 E:51337 ||| NNS
.  ||| S:51337 E:51339 ||| .
G.S.  ||| S:51339 E:51344 ||| NNP
generated  ||| S:51344 E:51354 ||| VBD
the  ||| S:51354 E:51358 ||| DT
Rab24  ||| S:51358 E:51364 ||| CD
constructs  ||| S:51364 E:51375 ||| NNS
and  ||| S:51375 E:51379 ||| CC
carried  ||| S:51379 E:51395 ||| VBD
out  ||| S:51395 E:51399 ||| RP
the  ||| S:51399 E:51403 ||| DT
immunofluorescent  ||| S:51403 E:51421 ||| NN
and  ||| S:51421 E:51425 ||| CC
western  ||| S:51425 E:51433 ||| JJ
blot  ||| S:51433 E:51438 ||| JJ
studies ||| S:51438 E:51445 ||| NNS
.  ||| S:51445 E:51447 ||| .
W.G.  ||| S:51447 E:51460 ||| NNP
and  ||| S:51460 E:51464 ||| CC
E.C.  ||| S:51464 E:51469 ||| NNP
performed  ||| S:51469 E:51479 ||| VBD
the  ||| S:51479 E:51483 ||| DT
immunogold  ||| S:51483 E:51494 ||| JJ
electron  ||| S:51494 E:51503 ||| JJ
microscopy ||| S:51503 E:51513 ||| NN
.  ||| S:51513 E:51515 ||| .
B.A.  ||| S:51515 E:51528 ||| NNP
performed  ||| S:51528 E:51538 ||| VBD
the  ||| S:51538 E:51542 ||| DT
TUNEL  ||| S:51542 E:51548 ||| NNP
assays ||| S:51548 E:51554 ||| NN
.  ||| S:51554 E:51571 ||| .
